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ABSTRACT 
 
The principle aims of this work were two fold; firstly to identify the current dietary 
intakes (specifically dietary glycaemic carbohydrate (CHO)) and physical activity 
(PA) and cardiorespiratory fitness (CRF) levels of a UK, postpubertal, adolescent 
population (n = 105) and assess the relationship between these factors, adiposity 
and cardiometabolic health. Diet and health relationships were assessed whilst 
accounting for energy misreporting and controlling for levels of PA and CRF. The 
effect of excluding dietary misreporters on the associations between glycaemic 
CHO and health was assessed whilst comparing an established technique (the 
Goldberg equation) to a novel approach (the ratio of energy intake (EI) to energy 
expenditure (EE)), which utilised RT3 accelerometry data (EI:EE(RT3)). 
Associations of PA and metabolic risk factors were also assessed whilst comparing 
two child specific PA thresholds for the assessment of PA subcomponents.  
Secondly, the impact of a flexible, ad libitum, low GI dietary intervention on 
cardiometabolic health was examined in an „at risk‟, overweight, postpubertal, 
adolescent population.  
 
Glycaemic index (GI) but not glycaemic load (GL) was shown to be associated 
significantly with anthropometric measures (body mass index (BMI), waist 
circumference (WC)) and adiposity (body fat percentage (BF%)) in this general 
group of post-pubertal adolescents from Bedfordshire. When adjusting for dietary 
intake, CRF was also associated with adiposity but PA was not. The prevalence of 
misreporting varied depending on the method used to assess the validity of dietary 
intakes; between 23% and 31% increasing to 62.1% (in overweight) of adolescents 
under reported energy intakes and up to 11.1% over reported. The novel application 
of a triaxial accelerometer to measure EE resulted in more under and over reporters 
being identified than when compared to the widely used Goldberg equation. 
Increased dietary GI was associated with increased odds of having a high WC; 
however, associations between GL and other risk factors were less clear; no 
associations with risk were observed. Excluding dietary misreporters from analysis 
had important implications for these associations. Only after removal of misreporters 
by EI:EE(RT3) was a borderline significant positive association between GL and 
blood glucose (BG) revealed using multiple analysis of covariance (MANCOVA), 
that was not present in prior analyses. Increased GI (moderate vs low GI intake) 
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was significantly associated with reduced high density lipoprotein cholesterol (HDL) 
and increased triglyceride (TG) levels (borderline significant) after removal of 
misreporters. In addition, using different PA thresholds to assess PA intensity 
resulted in different relationships between PA subcomponents and metabolic risk 
factors. Regardless of the threshold used, evidence suggested that limiting 
sedentary (SED) behaviour and engaging in moderate to vigorous PA (MVPA) is 
beneficial for blood pressure (BP) in this adolescent population. Additionally, 
irrespective of the threshold utilised, higher levels of vigorous PA (VPA) were 
associated with reduced odds of having a high clustered risk score and the 
associations observed between CRF and risk factors were stronger than those 
observed with PA. 
 
Despite a lack of significant improvement in individual metabolic risk factors as a 
result of the low GI (LGI) dietary intervention, there was a significant reduction in 
clustered risk score for the LGI group at week 12. A borderline significant 
improvement in glycated haemoglobin (HbA1c) was also observed as a result of the 
LGI intervention compared to those in the control group. Conversely, there 
appeared to be an unfavourable effect of the LGI diet on fasting insulin levels and 
thus the diet‟s impact on health overall is unclear. The small sample size of this 
randomised controlled trial (RCT) means that caution is required when interpreting 
the results. 
 
These data suggest that future research in this age group should target 
improvements in CRF and a lower dietary GI to reduce adiposity. Controlling for 
dietary misreporting appears to have a significant impact on associations of 
glycaemic CHO and cardiometabolic health and should be an important 
consideration of future research. The low GI intervention may be an effective 
approach for reducing glycaemic CHO, whilst maintaining a healthy macronutrient 
intake, in comparison to more restricted dietary regimens published in the literature. 
However, the impact of this regime needs to be confirmed utilising a larger sample 
of adolescents.  This may provide a useful approach for future research aiming to 
assess the impact of reduced GI and GL. 
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Chapter One: General introduction 
 
1.0 Introduction  
The metabolic syndrome represents a clustering of health risk factors (adverse lipid 
profile, hypertension, hyperglycaemia and insulin resistance) (Despres and 
Lemieux, 2006, Schindler, 2007). It is recognised as an important marker of ill 
health; adults with the metabolic syndrome, particularly those with increased 
adiposity, are at greatly increased risk of developing CVD and type II diabetes 
(Jolliffe and Janssen, 2007). Obesity (excessive adiposity) is regarded as an 
important determinant of metabolic risk factors (Mathieu et al., 2009). Overweight 
and obese individuals, particularly those with centrally stored, abdominal obesity, 
are at a markedly increased risk of developing the metabolic syndrome and 
subsequent CVD and type II diabetes (Despres and Lemieux, 2006). This evidence 
is concerning given that childhood and adolescent obesity rates in England 
increased from 3.1% to 6.9% and 5.2% to 7.4% in boys and girls, respectively 
between 1995 and 2007. (Stamatakis et al., 2010). The prevalence of overweight 
and obesity in the UK is 17.9% and 21.8% for boys and girls, respectively 
(Stamatakis et al., 2010). The prevalence of the metabolic syndrome is also rising in 
youngsters (Eckel et al., 2005) and has been observed in 4.5% of US (Ford et al., 
2008)  and 4.1 % of European (Vissers et al., 2007) adolescents. Young people with 
the metabolic syndrome are more likely to express these risk factors in adulthood 
(Camhi and Katzmarzyk, 2010); highlighting the importance of developing 
appropriate strategies for improving metabolic health in youths. 
 
Obesity has been associated with „unhealthy‟ eating behaviours (Phillips et al., 
2010, Galgani et al., 2008), physical inactivity (Ekelund et al., 2012) and leading a 
sedentary lifestyle (Hussey et al., 2007), and there is also evidence that genetics 
can play an important role in its development (Stunkard et al., 1990, Allison et al., 
1996). 
 
Recently, the suitability of the traditional „healthy‟ diet (restricted in energy and fat 
but high in carbohydrate (CHO)) has been questioned (Summerbell et al., 2008). 
Where energy restricted, low fat diets have proven successful in the short term, 
evidence suggests that longer term adherence is poor (Astrup, 2008). In the USA, 
obesity rates have risen at the same time as dietary fat consumption has decreased 
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(Weinberg, 2004), providing some support for the notion that low fat, high CHO diets 
may not be the most appropriate way to target metabolic health. Subsequent to this 
notion, more recent evidence suggests that a reduced CHO diet elicits greater 
improvements in adiposity and lipid profile (Esposito et al., 2007).  
 
Within the last 20 years, the speed at which CHO foods release their energy has 
been identified as a potential factor linking CHO consumption to ill health (Ludwig, 
2000). This led to the development of a CHO classification system know as the 
glycaemic index (GI), which ranks CHO containing foods by the speed at which they 
release glucose into the bloodstream (Jenkins et al., 1981). Because the quantity of 
carbohydrate consumed also affects the postprandial glucose response, in the 
1990s, this concept was furthered to include the glycaemic load (GL) which 
combines the quality (GI) and quantity of CHO in a food or meal (Salmerón et al., 
1997). Dietary GI and GL will collectively be referred to as „glycaemic CHO‟ for the 
purpose of this thesis.   
 
Observational studies, supported by controlled intervention studies have provided 
evidence that modifying the quality (GI) of dietary CHO (Rizkalla et al., 2004, Jebb 
et al., 2010) can beneficially alter a number of risk factors linked to the development 
of type II diabetes and CVD, in healthy and „metabolically at risk‟ adults and youths. 
Although a number of dietary approaches have proved successful in improving 
health outcomes (Jebb et al., 2010, Pereira, 2004, Fajcsak et al., 2008), including 
low GI and GL interventions, they tend to be heavily controlled or „restrictive‟ which 
may account for the lack of evidence for their efficacy in the longer term (Astrup, 
2008). The feasibility of dietary interventions and long term adherence are issues 
which warrant further investigation, particularly in youths. The lack of evidence in 
younger populations, particularly those from the UK, has made it difficult to 
ascertain whether reducing dietary glycaemic CHO is an effective approach to 
improving metabolic health. Furthermore, there is a lack of intervention evidence in 
adolescents with existing metabolic risk factors and therefore the effect of a low GI 
dietary intervention in „at risk‟ youths is unknown.  
 
A further limitation of much of the previous literature in adolescents is that it does 
not account for the impact that puberty can have on adiposity, insulin resistance and 
subsequent metabolic complications (Hannon et al., 2006). Thus, the previous 
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research in adolescents assessing associations between diet and health may be 
methodologically flawed. 
 
A common issue when assessing dietary intake is that of misreporting, which is 
described as a discrepancy between reported energy intake (EI) and measured 
energy expenditure (EE) (Posluna et al., 2009). Misreporting may distort intakes of 
energy as well as nutrients and  if unaccounted for, it is likely to result in spurious 
associations between diet and health markers (Rosell et al., 2003). It has been 
evidenced that associations between dietary GI and GL with type II diabetes risk 
were strengthened following removal of dietary misreporters from analyses, and 
thus should be an important consideration when assessing these relationships. 
Moreover, little is known of the impact of dietary misreporting on these associations 
in an adolescent population. 
 
An established method of assessing misreporting is the application of the Goldberg 
equation which involves calculating the cut-off of EI:basal metabolic rate (BMR) to 
distinguish if EI represents habitual or random low intake (Black et al., 1997). This 
equation requires knowledge of physical activity (PA) engagement and this is often 
estimated from PA questionnaires, an approach which can be flawed in terms of its 
validity (Sirard and Pate, 2001, Trost, 2007). Very few studies have utilised 
accelerometry to objectively measure PA in the assessment of misreporting in 
youngsters and none have used triaxial accelerometry to directly estimate EE in 
comparison to EI, which may provide a more accurate representation of energy 
misreporting. Thus, the potential for this technique in the assessment of dietary 
misreporting, with a more valid measure of PA and its ease of application may be an 
attractive prospect for future studies assessing diet and health relationships.  
 
Additionally, another limitation of previous research in the area of diet and health 
has been the failure to adjust statistical analysis for PA and CRF (CRF). Both 
variables  have been evidenced to attenuate associations between diet and health 
in adults (Héroux et al., 2010), thus, making the previous research methodologically 
flawed. 
 
Furthermore, the evidence is unclear with regards to the most effective approach 
recommended for improving metabolic health through manipulation of PA and 
sedentary behaviours (Healey e al., 2008, Ekelund et al., 2012). There are 
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inconsistencies in the way in which PA behaviours are measured and quantified in 
youths which may be a contributing factor to the equivocal findings in the literature 
(Ekelund., 2011). For example, there are now various different thresholds utilised to 
derive PA subcomponents (such as sedentary, light, moderate and vigorous PA) 
from accelerometry data in children and adolescents  (Chu et al., 2007a, Rowlands 
et al., 2004a, Vanhelst et al., 2010b) yet there is no consensus as to which is most 
effective for assessing PA in youths. Bailey et al (2013) identified that the use of 
different thresholds for assessing PA levels resulted in markedly different 
classification of the same accelerometry data in children. No studies have compared 
the use of different accelerometry thresholds when assessing the associations 
between physical activity and metabolic health in postpubertal adolescents.  
 
 Moreover, there is a general lack of research assessing associations between diet, 
PA and metabolic health in adolescents, yet this is a group who are making more 
independent lifestyle choices about diet and PA in comparison to children; therefore 
understanding their PA and dietary behaviours and how these relate to metabolic 
health is important (Ebbeling et al., 2003). Furthermore, there appears to be no 
research in youths which accounts for relative macronutrient intake when assessing 
the associations between PA and metabolic health. Furthermore, because 
metabolic aberrations in this group track into adulthood (Camhi and Katzmarzyk, 
2010) identifying an effective intervention programme which can be adhered to by 
an adolescent population needs to be identified. 
 
To this end, this thesis will explore the current dietary glycaemic CHO intakes and 
PA levels of a postpubertal population of UK adolescents and how they relate to 
markers of the metabolic syndrome. Associations between glycaemic CHO and 
metabolic health will be assessed whilst accounting for PA and CRF. Additionally 
the impact of dietary misreporting on these associations will be considered, whilst 
comparing the novel application of EI:EE(accelerometry), to an established 
technique (Goldberg equation). Furthermore, the associations between metabolic 
health, PA and sedentary behaviour will be assessed using two different youth-
specific thresholds for quantifying PA engagement whilst accounting for 
macronutrient intake. Finally, the impact of a flexible, ad libitum, low GI dietary 
intervention, compared to a control group on markers of metabolic health will also 
be assessed in a sample of specifically „at risk‟ (expressing risk factors for the 
metabolic syndrome) overweight or obese postpubertal adolescents.  
5 
 
1.1 Aims and objectives 
The principle aim of this work is to identify the current dietary intakes and PA and 
CRF levels of a UK, postpubertal, adolescent population and to assess the 
relationship between these factors, adiposity and cardiometabolic health. Diet and 
health relationships will be assessed whilst accounting for misreporting and 
controlling for levels of PA and CRF. The impact of a flexible, ad libitum, low GI 
dietary intervention on metabolic health will be assessed in an „at risk‟ postpubertal 
overweight adolescent population. 
 
Primary objectives: 
 
Study 1: Physical activity levels and nutritional intake of postpubertal Bedfordshire 
adolescents: associations with adiposity. 
 
a) To investigate the current dietary intakes, PA and CRF levels of postpubertal   
adolescents from the UK. 
 
b) To assess the relationship between dietary CHO, PA and CRF and metabolic 
risk factors  
 
Study 2: The use of objective physical activity monitoring to assess the accuracy of 
recorded energy intake in adolescents. 
 
a) To compare the novel application of EI:EE (triaxial accelerometry) versus the 
Goldberg equation in the assessment of dietary misreporting in postpubertal 
adolescents from the UK 
 
Study 3: Associations between glycaemic index, glycaemic load and other dietary 
factors with the metabolic syndrome in postpubertal UK adolescents. 
 
a) To explore the associations between dietary glycaemic CHO with metabolic 
risk factors whilst accounting for PA and CRF in postpubertal adolescents. 
 
b) To compare the associations between glycaemic CHO and health markers 
whilst accounting for dietary misreporting and to compare how a novel 
technique for identifying misreporters impacts on these associations. 
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Study 4: Associations between physical activity and fitness with the metabolic 
syndrome in postpubertal UK adolescents: the impact of different PA thresholds. 
 
a) To explore the associations between PA, CRF and metabolic risk factors 
whilst accounting for energy and relative macronutrient intake in postpubertal 
adolescents. 
 
b) To compare the associations between PA and health markers whilst utilising 
two different child specific PA thresholds. 
 
Study 5: The impact of a low glycaemic index diet on the metabolic health of 
postpubertal adolescents with features of the metabolic syndrome. 
 
a) To assess the impact of a flexible, ad libitum, low glycaemic index dietary 
intervention on metabolic syndrome risk factors in a group of „at risk‟ 
postpubertal adolescents from the UK. 
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Chapter Two: Literature Review 
      
2.0 Obesity and the Metabolic Syndrome 
 
2.0.1 Obesity 
 
Obesity is an excessive amount of total body fat (adipose tissue) relative to 
body weight that may impair health, classified by the body mass index (BMI) as 
a ratio of body weight (kilograms) to height (meters) of greater than 30 kg/m2 
and above 25 kg/m2 for overweight (World Health Organisation [WHO], 2011). 
Overweight and obesity is the 5th leading mortality risk globally and according to 
the WHO (2012), it is responsible for at least 2.8 million adult deaths each year. 
Forty four percent of burdens associated with diabetes, ischemic heart disease 
(23%) and certain cancers (7% and 4%) are attributable to overweight and 
obesity (WHO, 2012). In 2008, the WHO reported that more than 1 in 10 of the 
worlds adult population was obese, however, according to recent estimations, 
by 2015, this figure is projected to rise to 1 in 3 (WHO, 2012 overweight & 
obesity fact sheet, accessed July 2012). Previously overweight and obesity 
were considered to be a problem for developed countries, however, obesity 
rates have increased in middle and low-income countries, particularly in urban 
environments (WHO, 2012). Importantly, obesity is not isolated to adult 
populations, according to the WHO (2012), in 2010 over 40 million children 
under 5 years old were overweight. 
 
 
2.0.2 Aetiology of Obesity 
 
The proximate cause of increased adiposity is energy imbalance, when food EI 
exceeds that of total energy expenditure (TEE) (Popkin, 2005). This imbalance 
is thought to be a consequence of the environmental changes that have shaped 
the modern western lifestyle (Swinburn et al., 2011). Altered eating habits and 
expanded food options have led to increased production of readily available, 
high fat, energy dense (Hill et al., 2000), and more recently sugar rich foods 
(Prentice and Jebb, 2003). Furthermore, people are less physically active as a 
result of advances in technology, such as mechanisation and automation (Hill et 
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al., 2000). These factors combined have increased the likelihood of consuming 
more whilst expending less energy; leading to weight gain and obesity. 
 
Obesity, however, isn‟t just a result of overeating or lack of exercise; it is 
affected by the interaction of physiological, behavioural, environmental and 
genetic factors. Studies of twins reared apart suggest that approximately two-
thirds of the variability in BMI is due to genetics (Stunkard et al., 1990, Allison et 
al., 1996). The study of genomics has advanced current knowledge of the role 
that genes play in the development of obesity. These advances have identified 
gene mutations, such as those affecting the central pathways of food intake 
regulation, for example, the „ob‟ gene may result in improper coding of leptin (a 
satiety hormone) leading to overeating and obesity (Andersson, 1996). The 
interaction between genes and the environment is important, as it seems that 
some individuals are genetically predisposed to develop obesity, but only under 
certain adverse environmental conditions (sedentary lifestyle and high fat diet), 
may that genotype be expressed (Stunkard, 1988). 
 
2.0.3 Implications of obesity for disease: the metabolic syndrome  
 
Adipose tissue is now regarded as a complex organ understood to play an 
important role in the regulation of energy transfer, interacting with the 
inflammatory system and vascular wall (Mathieu et al, 2009). Of particular 
concern is centrally stored adipose tissue, located amongst internal organs of 
the abdomen, known as visceral fat. Abdominal obesity is associated with 
insulin resistance and the development of type II diabetes, atherogenic 
dyslipidemia and subsequent cardiovascular disease (CVD) (Despres and 
Lemieux, 2006). The metabolic syndrome represents a cluster of these obesity 
related cardiovascular risk determinants, such as central obesity, hypertension, 
insulin resistance and an abnormal lipid profile. For example, low high-density 
lipoprotein cholesterol (HDL), raised low-density lipoprotein cholesterol (LDL) 
and hypertriglyceridemia (high levels of circulating triglycerides [TG] in the 
blood) (Schindler, 2007). An individual is identified as having the metabolic 
syndrome when three or more of these determinants coexist (Chen et al., 
2006). Those demonstrating factors associated with the metabolic syndrome 
are at greatly increased risk of CVD and Type 2 diabetes (Joliffe & Janssen, 
2007). Furthermore, clustering of these risk factors may present cumulative risk 
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exceeding that from individual risk combined (Golden et al., 2002). According to 
the International Diabetes Federation (IDF, 2007) one quarter of the world‟s 
adult population suffer from the metabolic syndrome and the prevalence is 
increasing in children and adolescents due to the growing obesity epidemic 
within this population (Weiss and Kaufman, 2008). As Clustered risk in children 
and adolescents has been observed to track into adulthood (Camhi and 
Katzmarzyk, 2010), identifying and treating clustered metabolic risk in 
adolescents is of great importance. 
 
2.1 Pathogenesis of the metabolic syndrome 
 
2.1.1 Insulin resistance 
Insulin resistance occurs when insulin sensitive tissues (muscle, liver and 
adipose tissue) are less responsive to the action of insulin (Eckel et al., 2005). 
An insulin resistant state is associated with cardiometabolic aberrations, the 
development of CVD and type II diabetes (DeFronzo and Ferrannini, 1991). 
Obesity is understood to contribute to insulin resistance via an increased supply 
of non-esterified fatty acids or free fatty acids (FFA), derived from the lipolysis 
of triglyceride (TG) stored in expanded adipose tissue deposits (particularly 
visceral adipose tissue) (Grundy, 2004). In an insulin resistant state the 
antilipolytic action of insulin on adipose tissue is suppressed, leading to 
continued breakdown and release of TG stored in adipose tissue, resulting in 
excessive levels of FFA. FFA are the main source of nutrient energy in the 
fasted state. When FFA levels exceed that of tissue needs, they are taken up 
by muscle tissue and the liver (Grundy et al., 2004). Randle et al (1963) 
postulated that an influx of FFA into muscle tissue inhibits glucose oxidation 
(glucose-fatty acid cycle). More recently, Shulman (2000) suggested that FFA 
within muscle tissue leads to an increase of intracellular fatty acid metabolites 
(diacylglycerol, fatty acyl-CoA and ceremides). These metabolites activate a 
serine/threonine kinase cascade which results in serine/threonine 
phosphorylation of insulin receptors and thus inhibiting insulin signalling. The 
subsequent insulin resistance results in hyperglycaemia, as glucose uptake into 
the muscle is impaired (Shulman, 2000).  
 
At the liver, insulin‟s primary role is to regulate glucose production (Pereira and 
Maahs, 2009).  An increased supply of FFA to the liver increases hepatic 
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glucose output through the inhibition of insulin-mediated suppression of 
glycogenolysis (Boden et al, 2002). It is suggested that this effect occurs via 
similar mechanisms as those described in muscle tissue (Schinner et al, 2005; 
Schulman, 2000). Additionally, FFAs stimulate the production of glucose by the 
liver (gluconeogenesis) through the formation of acyl-CoA and consequent 
synthesis of intermediate substrates during FFA oxidation. Under normal 
circumstances, hepatic autoregulation prevents FFA-induced increases in 
gluconeogenesis from increasing glucose production (Clore et al, 1991). In 
those who exhibit insulin resistance, however, hepatic autoregulation is 
impaired and hepatic glucose production is increased as a result of of FAA 
elevations (Boden et al., 2002). 
 
2.1.2 Glucose intolerance 
The defective action of insulin, subsequent to insulin resistance, results in a 
decreased ability of insulin to mediate the uptake and metabolism of glucose in 
skeletal muscle and adipose tissue, and to suppress gluconeogenesis (Eckel et 
al, 2005). In order to maintain euglycaemia, in the presence of insulin 
resistance, insulin secretions (from pancreatic β cells) must be increased 
resulting in hyperinsulinemia, however, this compensatory mechanism will 
maintain normal blood glucose (BG) levels (Rao et al., 2004). In those who will 
develop type II diabetes, on the other hand, the compensatory hyperinsulinemia 
will result in a defect in insulin secretion and an inability to maintain normal 
postprandial glucose levels (impaired glucose tolerance), and eventually to 
impaired fasting glucose. Ultimately, persistently high levels of circulating 
insulin leads to β cell dysfunction (Kahn, 2001). A number of different 
mechanisms have been postulated as explanations for the development of β 
cell dysfunction. These include β cell exhaustion, as a result of the increased 
secretary demand for insulin (DeFronzo et al, 1991) and desensitisation of the β 
cell due to the progressive elevation of BG as impaired glucose tolerance 
develops (Robertson et al., 1994, Yki-Järvinen, 2003). Furthermore, excessive 
supply of FFA to the pancreas may create a state of lipotoxicity within β cells, 
having a deleterious effect on insulin secretions (Unger, 1995, Joseph et al., 
2004). 
2.1.3 Dyslipidemia 
FFA accumulation at the liver is understood to impact on lipid metabolism 
resulting in an abnormal lipid profile (low HDL, raised LDL and 
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hypertriglyceridemia (Schindler, 2007). Low-density lipoproteins transport FFA 
(packaged as TG) to cells, including those lining arterial walls, when oxidised 
they form atherosclerotic plaques via the stimulation of monocyte-macrophage 
infiltration and lipoprotein deposition (McArdle et al, 2007). Alternatively, HDL 
facilitates the reverse transport of surplus cholesterol from peripheral tissues 
(including arterial walls) where they are eventually taken up by the liver, 
catabolised and excreted (McArdle et al, 2007). 
 
At the liver, raised FFA flux is associated with increased synthesis of 
triglyceride (TG)-rich very low-density lipoproteins (VLDL) (Eckel et al, 2005). 
After cholesteryl ester transfer protein promotes exchange of TG‟s from VLDLs 
to less dense LDLs and the reverse transport of cholesteryl ester transfer 
protein to VLDLs, TG enriched LDL particles are produced in large amounts 
(Mauriege et al., 1993) contributing to hypertriglyceridemia (Eckel et al, 2005). 
By the action of hepatic lipase, TG enriched LDL become smaller and denser; 
studies have shown that small dense LDL particles are potentially highly 
atherogenic (Despres and Lemieux, 2006).  
 
In addition to LDL, the composition of HDL is altered in a similar way, resulting 
in a reduction in HDL levels. In the presence of hypertriglyceridemia, a 
decrease in the cholesterol content of HDL is a consequence of reduced 
cholesteryl ester content of the lipoprotein core, in combination with cholesteryl 
ester protein-mediated alteration in TG (Eckel et al, 2005). This makes HDL 
particles small and dense and results in their increased clearance from the 
circulation (Eckel et al, 2005). 
 
An atherogenic state brought on by dyslipidemia, increases the likelihood of 
CVD, by means of hardening arterial walls and the formation of atherosclerotic 
plaques. An increase in circulating small, dense-LDL is associated with 
formation of fatty streaks within the lining of arterial walls (Grundy, 2004). 
These are characterised by an accumulation of lipid-filled macrophages within 
the intima of the artery, which continue to accumulate and eventually form 
lesions known as fibrous plaques (Stary et al., 1995). Fibrous plaques can be 
responsible for obstructing blood vessels and potentially leading to myocardial 
infarction, furthermore, these plaques can rupture, releasing thrombotic 
substances that can lead to ischemic stroke (Daniels et al., 2008). 
12 
 
 
2.1.4 Hypertension 
An elevated blood pressure is more prevalent in obese compared to lean 
individuals (Grundy, 2004), and is a strong risk factor for CVD (Chobanian et 
al., 2003). The notion that insulin resistance is associated with hypertension is 
well established (Ferrannini et al., 1987). Under normal conditions, insulin is a 
vasodilator with secondary effects on sodium reabsorption by the kidney 
(Steinberg et al., 1994, DeFronzo et al., 1975). In the presence of insulin 
resistance the vasodilatory effects of insulin can be lost as the mediating role of 
the endothelium-derived nitric oxide can become impaired, whilst at the same 
time, sodium reabsorption is maintained (Tooke and Hannemann, 2000, Kuroda 
et al., 1999). It has been observed that vasoconstriction may be further 
promoted by angiotensin, generated by angiotensinogen, released from an 
expanded adipose tissue mass (Egan and Julius, 2004). Moreover, relative 
vasoconstriction may be mediated by FFA (Tripathy et al., 2003).Together, this 
can lead to an increased extracellular volume in the blood, whilst blood vessels 
remain constricted, thus resulting in hypertension (Kuroda et al, 1999).  
 
2.1.5 Further metabolic complications 
Insulin resistance is often accompanied by a number of complications that do 
not comprise the diagnostic criteria for the metabolic syndrome. These include 
an increase in proinflammatory cytokines and the presence of non-alcoholic 
fatty liver disease (NAFLD) and or non-alcoholic steatohepatitis (NASH) (Eckel 
et al, 2005). The metabolic syndrome has been associated with inflammation 
(Sutherland et al, 2004) as a result of proinflammatory cytokines including 
interlukin 6 (IL-6), resistin, tumour necrosis factor α (TNF α) and C-reactive 
protein (CRP) (Fernandez-Real & Ricart, 2003). These cytokines mirror over 
production by the expanded adipose tissue mass (Trayhurn, 2004), possibly 
generated, in part, by monocyte-derived macrophages found within adipose 
tissue (Weisberg et al., 2003). Inflammatory cytokines are understood to 
produce more insulin resistance and the lipolysis of adipose tissue, resulting in 
further increased supply of FFA (Eckel, 2005). Circulating cytokines, including 
IL-6, may enhance hepatic glucose production, synthesis of VLDL by the liver, 
insulin resistance in muscle and a prothrombotic state (Eckel et al., 2005). 
Furthermore, an expanding adipose tissue mass reflects a reduced production 
of the anti-inflammatory and insulin sensitising cytokine adiponectin, enhancing 
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the proinflammatory state associated with insulin resistance and the metabolic 
syndrome. 
 
  2.2 Physical Activity, Fitness and the Metabolic Syndrome 
 
PA is any bodily movement generated by skeletal muscles that requires energy 
to be expended (WHO, 2012). Lack of PA has been identified as responsible for 
27% of diabetes; 25% of breast and colon cancers and approximately 30% of 
ischaemic heart disease burden (WHO, 2012). CRF can be defined as the 
ability of the cardiorespiratory system to adequately and safely meet the 
demand of bodily tissues and organs for blood, oxygen and other nutritional 
requirements, primarily for working muscles during PA (Keong, 1981). A review 
of literature evidenced that those with a higher CRF had at least a 50% lower 
mortality rate compared with less fit individuals (Blair et al., 2001b). Moreover, it 
has been reported that mortality rates are three to four-fold higher in 
participants with the lowest CRF compared to those with the highest CRF (Blair 
et al., 1989, Blair et al., 1991). There is some debate surrounding PA and CRF 
with regard to which is most important for health. Lee et al (2010) compared 
metabolic risk factors and the prevalence of the metabolic syndrome across 
levels of CRF, assessed by a treadmill VO2 max test, and observed that 
physical fitness was an independent predictor of the metabolic syndrome in 909 
young Korean adults (24 yrs) (Lee et al., 2010). This is supported by 
(Carnethon et al., 2003) who found that those who demonstrate lower levels of 
CRF had an increased CVD risk than those who were classified as moderately 
to highly fit. (Karelis et al., 2008) assessed the associations of PA as well as 
CRF with the metabolic syndrome in overweight and obese postmenopausal 
women. Those classified as having the metabolic syndrome demonstrated 
significantly lower levers of PA energy expenditure (measured by doubly 
labelled water (DLW)) and CRF (measured by peak oxygen consumption).  
2.2.1 Assessment of CRF  
Direct measurement of oxygen consumption during maximal exertion (VO2 
max), is regarded as the best single marker for the functional capacity of the 
cardiorespiratory system; often referred to as CRF (Dencker et al., 2008). It was 
previously outlined that CRF has been associated with markers of poor health 
in adults and youths. However, a vast range of techniques have been used to 
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assess CRF in children and adolescents. These methods include direct and 
indirect assessment of VO2 max via sub-maximal and maximal cycle ergometer 
test, as well as treadmill tests and shuttle run tests (Rizzo et al., 2007, Boreham 
et al., 1997, Tomkinson and Olds, 2007). Indirect methods generally include 
prediction equations utilising workload data (Brage et al., 2004) and heart rate 
(Krekoukia et al., 2007).  Although these methods may be regarded as less 
technical and require less specialist equipment (Dencker et al., 2008), indirect 
methods of estimating VO2 max present prediction errors that may dilute any 
existing associations of CRF with the health marker or parameter under 
analysis (Rowland, 1996) limiting a study‟s ability to draw accurate conclusions 
from its data and make comparisons with other research. Research 
investigating associations of directly assessed CRF with health markers is 
limited in children (Parrett et al., 2010) and there appears to be a lack in 
adolescent populations.  
 
2.2.2 Assessment of Physical Aactivity 
A number of methods are available for quantifying PA, the DLW technique is 
regarded as a reference measure of energy expenditure (EE).  DLW, however, 
is a time consuming and relatively expensive method. Other techniques for 
assessing EE include self reported physical activity questionnaires that are 
prone to reporting error (Sirard and Pate, 2001, Trost, 2007). Technology has 
allowed for the introduction of more practical objective measures of PA, such as 
pedometry and accelerometry. Accelerometry has been recommended over self 
report questionnaires and pedometers due to their greater accuracy when 
assessing PA as compared to the measurement of oxygen consumption 
(Adamo et al., 2009, Eston et al., 1998). 
Accelerometry detects the acceleration of body movements which can be 
transformed into a measure referred to as activity „counts‟ (Romanzini et al., 
2012). Due to the arbitrary nature of accelerometer counts, EE calibration 
studies have been utilised in order to derive biological meaning to this 
information through the use of cut-points or thresholds corresponding to PA 
intensities (Rowlands et al., 2004b, Vanhelst et al., 2010a, Chu et al., 2007b). 
Following these developments, the accelerometer has become a popular tool 
for investigating the associations of health markers with total PA or 
accumulated minutes of PA at various intensities: time spent sedentary (SED); 
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in light PA (LPA); in moderate PA (MPA); in vigorous PA (VPA) and in 
moderate to vigorous PA (MVPA) (Ekelund et al., 2007a, Bailey et al., 2012a). 
Furthermore, this data can be used to estimate the proportions of a population 
meeting PA guidelines (Ekelund et al., 2011b). For instance, current UK 
guidelines recommend that youths should engage in a minimum of 60 minutes 
of MVPA per day and that SED time should be minimised (DOH, 2012).  Recent 
accelerometry data suggests that only 24% of girls and 32% of boys are 
meeting these recommendations (DOH, 2008).  
2.2.3 Physical Activity and CRF in Youths 
In a study of adolescents aged 12-19 years; boys classed as „not fit‟ had 
significantly increased levels of total cholesterol (TC), TG, insulin and CRP 
compared to those classified as „fit‟ (Kwon et al., 2010). In the girls assessed, 
only TC was significantly increased in the „not fit‟ group. This suggests that in 
adolescents, independent of fatness (as data were adjusted for WC and BMI), 
being fitter may be beneficial for lipid profile in girls and insulin metabolism, lipid 
profile and inflammation in males. However, fitness was assessed via a sub-
maximal treadmill test, thus allowing for error in the estimation of maximal 
oxygen consumption. In 586 Danish children, PA independently shared a 
significant inverse association with metabolic risk, this association was 
weakened after adjustment for fitness which was significantly, positively 
associated with PA (Brage et al., 2004). This interaction between fitness and 
PA suggests that any benefits of PA will be seen most strongly in those with 
lower CRF. Ekelund et al (2007) investigated the independent associations of 
PA (measured via 3-4 day accelerometry) and CRF (via a maximal cycle 
ergometer test) with metabolic risk factors in 9-16 year olds. Both PA and CRF 
were separately and independently associated with individual risk factors (WC, 
BP, BG, insulin, TG and HDL) and clustered metabolic risk. However, after 
adjusting the analysis for WC, associations between clustered risk and CRF 
were attenuated and thus appeared to be mediated by adiposity, whilst 
associations with PA were unaltered. Although there are discrepancies between 
which is the most beneficial for health, both CRF and PA appear to be 
important predictors of the metabolic syndrome. 
Despite widespread use of accelerometers there is no standardised procedure 
for the reduction of raw data, furthermore, there are variations in the derivation 
of PA data that can impact on outcome variables and the conclusions drawn 
from this information  (Masse et al., 2005). Additionally the various thresholds 
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for deriving PA intensities when utilising accelerometers means that there are 
inconsistencies surrounding the analysis of accelerometry data (Ekelund et al, 
2011). A recent review identified that the prevalence of youths (from studies of 
9-19 year old males and females) meeting the recommended 60 minutes per 
day of MVPA ranged between 1% and 100%. This highlights the confounding 
amongst these types of studies, which has been predominantly attributed to 
differences in intensity thresholds (Ekelund et al, 2011). 
Triaxial accelerometry, which combines the acceleration of body movements 
across three planes, has been utilised to assess free-living PA and its 
relationship with health in children and adolescents using the RT3 (Stayhealthy, 
Inc., CA, USA) accelerometer. For instance,  (Krekoukia et al., 2007) assessed 
associations of PA (measured via RT3 over 4 consecutive days) and CRF 
(estimated from heart rate) with insulin resistance, lipid profile and inflammation 
in 110 lean and obese 9-11 year old children. Total daily PA (negatively 
associated) and WC (positively associated) explained 49% (P < 0.1) of the 
variance in insulin resistance (measured by the homeostatic model of insulin 
resistance (HOMA-IR)). CRF was negatively associated with insulin resistance 
but this disappeared following adjustment for age, sex and fat mass (FM). 
Additionally, the RT3 was used to assess the relationships between time spent 
in moderate and vigorous PA (measured over 4 days), CRF and body 
composition in 152 7-10 year olds (Hussey et al., 2007). CRF was assessed via 
a multistage shuttle run test to estimate oxygen consumption and PA intensities 
were determined using the cut points of Rowlands et al (2004) see Table 1. In 
boys, WC was significantly correlated (negatively) with minutes of VPA and 
positively correlated with SED time; in girls, however, these associations were 
not expressed. CRF, on the other hand was significantly negatively associated 
with BMI and WC in both sexes. Bailey et al (2012) identified, in 100 10-14 year 
old children that clustered metabolic risk was significantly lower in those 
identified as fit following a maximal cycle ergometer test that predicts oxygen 
uptake from a formula based on work rate. PA subcomponents were derived 
using the thresholds of Rowlands et al (2004); clustered risk was not associated 
with any PA subcomponents. Unlike previous studies utilising RT3 data in 
youths (Hussey et al., 2007, Krekoukia et al., 2007), Bailey et al., (2012) 
collected accelerometry data over 7 consecutive days and participants were 
only included if they had worn the accelerometer for 3 or more days. The 
authors explain that a minimum daily wear time of 9 hours for weekdays and 8 
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hours for weekend days was required; information which many authors neglect 
to note. The lack of uniformity of studies utilising accelerometry and CRF data 
may be attributable to the confounding associations of PA and CRF with 
metabolic health in youth. If associations of PA and CRF with health markers 
are to be accurately understood, the most valid tools available for gathering 
these data should be utilised across studies. There appears to be a lack of 
investigations in adults and particularly adolescents that make use of triaxial 
accelerometry and directly measured CRF when assessing associations with 
health, furthermore there is a lack of data on „at risk‟ youths already exhibiting 
risk factors for the metabolic syndrome. 
The Rowlands cut points have been utilised to derive PA subcomponents in a 
number of studies of youths; Rowlands et al (2004) derived thresholds for 
activity intensities (SED, LPA, MPA, VPA) whilst validating the RT3 in 19 boys 
(mean age 9 ±1 years).  More recently, however, different cut points have been 
validated using the RT3 accelerometer which have also been validated against 
oxygen consumption (Chu et al., 2007, Vanhelst et al., 2010). Chu et al (2007) 
identified intensity thresholds using the RT3 in 35 8-12 year old Chinese 
children; thresholds were derived from receiver operator curves (ROC). ROC 
analyses showed sensitivity and specificity values ranging from 72-98%, 
indicating that the intensity thresholds gave an accurate distinction between 
intensity categories. Later, Vanhelst et al (2010) identified a lack of intensity 
thresholds for adolescent populations and thus validate the RT3 against oxygen 
consumption in 40 10-16 year old children and adolescents. The thresholds 
values obtained at various PA levels were not significantly different when 
compared to an independent sample of 20 10-16 year olds. ROC analyses 
revealed sensitivity and specificity values for intensity thresholds ranged from 
0.86-0.99 indicating accurate distinction of intensity categories. See table 1 for 
PA intensity thresholds. 
       Table 1. Activity-intensity thresholds for the RT3 accelerometer 
Variable (CPM) Rowlands Vanhelst  Chu  
SED <288 <41 <420 
LPA  288-969 41-950 420-1859 
MPA  970-2,332 951-3,410 1860-4109 
VPA  ≥2,333 >3,410 ≥4110 
           cpm, counts per min; PA, physical activity 
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The thresholds of Vanhelst et al (2010) and Rowlands et al (2004) are 
comparable and the similarities between the threshold for MPA (915 and 970 
cpm, respectively) would likely place a similar proportion of participants within 
the MVPA category of which 60 minutes per day is recommended as sufficiently 
active (DOH, 2011). However, the threshold for MPA according to Chu et al 
(2007) begins at 1860 cpm; this is a markedly higher activity level and thus 
fewer participants would fall into the MVPA category in comparison to the 
thresholds of Rowlands et al (2004) and Vanhelst et al (2007). Furthermore, 
Bailey et al (2013) has compared the thresholds of Rowlands et al (2004) and 
Chu et al (2007) in a general population of 104, 10-14 year old children from the 
UK. The authors identified that 97.6% of boys and 93.7% of girls achieved the 
recommended 60 minutes of MVPA, when using the Rowlands thresholds. This 
very high proportion of sufficiently active youths may not be an accurate 
representation due to the low threshold for MPA (personal communication). 
When using the Chu thresholds, however, Bailey et al (2013) observed that 
only 31.7% and 20.6% of boys and girls, respectively, were sufficiently active. 
To date, no published studies have assessed the impact of different PA 
intensity thresholds on associations of PA and health markers in adolescents; 
this is of great importance as the guidelines for sufficient PA are based on 
these associations with health (DOH, 2011). Furthermore, these thresholds 
have not been compared when investigating the associations of CRF with time 
accumulated in various PA intensities in adolescents. 
 
 2.3 Diet and the Metabolic Syndrome 
 
2.3.1 Traditional dietary treatments  
Poor dietary choices have been acknowledged to predispose to the metabolic 
syndrome. Energy dense foods are one of the primary determinants of obesity, 
CVD (Phillips et al., 2010) and metabolic complications (Druet and Ong, 2008). 
Energy restriction has played a fundamental role in the reduction of obesity 
(Abete et al., 2010) but macronutrient distribution is also viewed as a potential 
mediator of weight reduction and certain metabolic alterations(Muzio et al., 
2007).  
Traditionally, energy restricted diets focused on reducing the intake of energy 
dense fat (Hill, 2002) for the treatment and prevention of obesity and its 
19 
 
associated morbidities (Abete et al, 2010). In addition to reducing energy 
intake, the benefits of lowering fat intake on cardiovascular health, meant that a 
low fat  and subsequent high carbohydrate (CHO) diet was the primary 
nutritional treatment of obesity related disorders since the second half of the 
last century (Giugliano et al., 2008) 
According to various health organisations such as the British Diabetic 
Association (BDA), (1992), the American Diabetes Association (ADA), (2002) 
and the U.K. Scientific advisory committee on Nutrition (SACN), (2008), for the 
prevention and treatment of metabolic aberrations, dietary fat intake should not 
exceed 35% of total energy. Saturated fatty acids (SFA) should not exceed 
11%, mono-unsaturated fatty acids (MUFA) 13% and poly-unsaturated fatty 
acids (PUFA) 6.5% (SACN, 2008), whilst trans fatty acids should not exceed 
1% of total energy (American Heart Association scientific statement; Grundy et 
al, 2005). Increased dietary fat intake has been positively associated with body 
weight in large cross-sectional studies of males and females (Satia-About, 
2002; Park et al, 2005) as well as children and adolescents (Ortega et al, 
1995). Although the majority of these data were gathered via means of self 
report, the consistency of the findings supports the notion that increased dietary 
fat is associated with increased weight. However, in terms of health risk, the 
composition of dietary fat appears to be more important than the total amount 
consumed (Abete et al, 2011). Studies have shown that the consumption of 
SFAs is associated with insulin resistance independent of body fat (Marshall et 
al., 1997, Maron et al., 1991), whereas PUFA may have an inverse relationship 
with insulin resistance (Feskens et al., 1994). Epidemiological evidence 
suggests that SFAs are also positively associated with elevated blood pressure 
whilst MUFA consumption is associated with lower blood pressure (Trevisan et 
al., 1990, Stamler et al., 1997). Associations of dietary fats with weight gain 
were assessed in an 8 year prospective cohort study of 41,518 female nurses 
aged 41-68 years (Field et al., 2007). Per 1% increase, the percentage of 
energy from total fat intake was only modestly associated with weight gain (beta 
estimate (β) = 0.11)), whilst increases in SFA and trans fats were more strongly 
associated (β = 0.40 and 0.54, respectively). Furthermore, increases in MUFA 
and PUFA were not associated with weight gain. The consumption of Omega 3 
long chain PUFA (Ώ3FA) have been evidenced as beneficial for good metabolic 
health (Abete et al, 2011). Weight loss regimes promoting fatty fish intakes rich 
in Ώ3FA have shown independent increased benefits on fasting insulin, lipid 
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profile and blood pressure from Ώ3FA consumption (Sirtori et al., 2009, Cicero 
et al., 2010). Moreover, dietary Ώ3FA via oily fish consumption were highly 
positively associated with plasma Ώ3FA and HDL levels and negatively 
correlated with plasma insulin, insulin resistance (HOMA-IR), TG and DBP in 
447 Alaskan Eskimos (Ebbesson et al., 2005). 
 
Recommendations for dietary protein (PRO) intake are set at 15-20% of total 
energy (BDA, 1992; ADA, 2002; SACN, 2008). Recommended protein intakes 
have not vastly changed over time, however, it is important that adequate 
quality PRO is consumed to meet amino acid requirements (St. Jeor et al., 
2001). Increased dietary protein is associated with reduced energy 
consumption and weight loss due to the greater satiety from PRO compared to 
fat and CHO (Eisenstein et al., 2002). Furthermore, overweight women on high 
protein, hypo-energetic diets, have been shown to maintain greater fat free 
mass during weight loss compared to a low protein hypo-energetic diet 
matched for total energy (Campbell and Kelly, 2012). This may result in a 
sustained basal metabolic rate which will aid weight loss via increased energy 
expenditure (Baba et al, 1999). Consumption of PRO above the requirements 
may not be sufficiently utilised resulting in additional burdens associated with 
the metabolism and excretion of waste products such as ammonia and urea by 
the liver and kidneys (St. Joer et al, 2001). 
The traditionally „low fat focused‟ recommendations for a healthy diet, leaves 
CHO typically ranging from 50-60% of total energy. This macronutrient 
composition proved successful at reducing energy density and inducing weight 
loss over short periods, but the lack of satiety it achieved, meant that 
adherence to such diets could be poor (Astrup, 2008). Observations of these 
types of diets for weight loss revealed that they were often not suitable over 
long durations, with weight gain occurring after 18 months (Summerbell et al., 
2008). In fact, in the USA, since 1976 as dietary fat consumption has 
decreased, rates of obesity and associated morbidities have continued to rise 
(Weinberg, 2004), suggesting that a low fat high CHO diet may not necessarily 
be an appropriate way to target obesity and metabolic complications. Further to 
this, the impact of the Mediterranean style diet (consumption of fruits, 
vegetables, nuts whole grain and olive oil) on body weight, over a 2 year follow 
up was assessed in 190 overweight Italian women (Esposito et al., 2007). Of 
the sample, 115 participants had a CHO intake greater than 50% of energy 
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(mean macronutrient composition: 58% CHO; 28% fat; 14% PRO), compared to 
75 participants with a CHO intake below 50% of energy (45% CHO; 36% fat; 
19% PRO). Those consuming a lower CHO diet benefited from significantly 
greater weight loss (p=0.01); reductions in TG (p=0.003) and increases in 
adiponectin (p=0.02) than those consuming a high CHO diet. These data 
suggest that a lower CHO (<50% of energy) diet with greater fat intake may be 
better for targeting the metabolic syndrome. It is important to note that the 
increased intake of PUFA  and vegetable fats (Salmerón et al., 2001, Halton et 
al., 2006), associated with the Mediterranean style diet (Esposito et al., 2007), 
are likely to have a protective effect against metabolic complications and are 
thus important factors to consider when increasing fat intake. This notion is 
highlighted by (de Koning et al., 2011) who conducted a prospective cohort 
study of males aged 40-75 years, over a 20 year follow up and found that 
consumption of a low CHO diet high in animal protein and fat was significantly 
associated with type II diabetes. However, consuming a low CHO diet high in 
vegetable protein and fat was not significantly associated with Type 2 diabetes 
and in those <65 years old, the latter dietary profile was inversely associated 
with type II diabetes.  
Further investigation into dietary CHO has identified sugar consumption as a 
potential burden to metabolic health. As recommendations on reducing total fat 
and SFA were increasingly adopted, food industries substituted sugar, fructose 
and high fructose corn syrup in their place (Johnson et al., 2009). Evidence 
suggests that this shift towards increased sugar intake may be responsible for 
reduced HDL and increased TG levels (Hellerstein, 2002, Ma et al., 2006). 
Sugar-sweetened beverages have been identified as the primary source of 
added sugars in the diets of Americans including children and adolescents 
(Guthrie and Morton, 2000, Wang et al., 2008). High sugar beverages 
contribute 10-15% of total daily energy among US children (Wang et al., 2008). 
Further to this a meta-analysis by (Forshee et al., 2008) positively associated 
their consumption with weight gain in paediatric populations.  
To this end, the potential hindrance to metabolic health associated with higher 
CHO diets has been, in part, attributed to the speed at which CHO release their 
energy into the bloodstream (Ludwig, 2002); this notion has lead to the 
development of the glycaemic index.  
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2.4 Glycaemic Index and Glycaemic Load 
 
2.4.1 Glycaemic index and glycaemic load conceptualised 
The glycaemic index (GI) was first conceptualised by Jenkins et al (1981), it 
classifies carbohydrate containing foods according to their impact on the body‟s 
postprandial glycaemic response (Du et al., 2006). GI is defined as “the 
incremental area under the BG response curve (AUC) of a test food containing 
50g of available carbohydrate, expressed as a percentage of the response to 
the same amount of available carbohydrate from a reference food (traditionally 
white bread or glucose)” (Jenkins et al, 1981). A foods GI is measured by 
measuring the average BG response of 10 or more healthy individuals for 2 
hours following the consumption of a test food and repeating this process for 
the reference food (glucose or white bread) at a different time (Brand-Miller et 
al, 2005). 
Based upon the degree to which carbohydrate containing foods impact on BG 
levels, they are assigned a GI value, categorised as low (< 55), medium (56-69) 
or high (> 70), (against glucose, GI = 100) (Du et al, 2006). As the quantity of 
carbohydrate in a food and not just its GI impacts upon the postprandial 
glucose response, the concept of glycaemic load (GL) was introduced by 
Harvard researchers in the 1990s, it combines the quality (GI) and quantity of 
CHO (GL = GI x available carbohydrate (g)/100) in a food or meal (Salmeron, 
1997).  GL values are also categorised as low (<10); Medium (11-19) and High 
(>20) for individual foods. Some researchers suggest that the quantity of 
carbohydrate (Bouche et al., 2002), whilst others believe carbohydrate quality 
(GI) (Wolever and Bolognesi, 1996), is more important when determining the 
glycaemic impact a food has on the body.  Table 2, demonstrates how the 
quantity and quality (GI) of carbohydrate relationship can cause variation in the 
GI and GL of a single food. Although brown rice has a low GI value and 
Charlotte potato a high GI value, the GL of both foods (150g serving) is 
moderate; this is due to the lower amount of available carbohydrate in the 
potato offsetting its considerably higher GI value. 
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Table 2. Effects of the GI/CHO relationship on GL. 
 GI 
Available carbohydrate 
per 150g serving 
GL per 150g 
serving 
Brown rice 
(USA) 
50 
(low) 
33 16 (moderate) 
Charlotte 
potato, boiled 
(UK) 
81 
(High) 
23 19 (moderate) 
(Adapted from Brand-Miller et al., 2005) 
 
Low GI foods have a slow digestion and absorption rate, thereby causing a 
slow and gradual rise in postprandial plasma glucose. High GI foods have a fast 
digestion and absorption rate resulting in a large and rapid increase in 
postprandial plasma glucose levels, subsequently increasing insulin and 
reducing glucagon secretions to counter act the rise in plasma glucose (Ludwig, 
2002); see figure 1. 
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Figure 1. Glucose and insulin responses, following consumption of a low vs high 
GI food (Brand-Miller et al., 2005) 
 
2.4.2 Effects of additional dietary variables on the GI of mixed meals 
 
A number of factors can impact on the body‟s glycaemic response to a food or 
meal, including the method and or duration of cooking, the ripeness of a food, 
the method of food processing and the combination of foods eaten (Jenkins et 
al., 2002). Additionally a foods composition will alter glycaemic response, such 
as the amount of starch and sugar; the amount of protein, fat or fibre in a food 
or meal will reduce its GI through the slowing of digestion and rate of gastric 
emptying, as will acidity (Wolever and Bolognesi, 1996, Radulian et al., 2009). 
Low GL CHO foods are usually high in dietary fibre which contributes to 
delayed carbohydrate digestion and thus slows the release of glucose into the 
circulation (Riccardi and Rivellese, 2000).  Furthermore, a foods structure, such 
as the presence of insoluble fibre found in whole intact grains will determine 
how quickly it is broken down and absorbed by the gut (Radulian et al, 2009). 
For example, raw and partially gelatinised starches, associated with low GI 
foods (such as legumes, pastas and whole grains) are more slowly digested 
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than the fully gelatinised starches associated with high GI foods (most breads 
and breakfast cereals) (Jenkins et al., 1987). 
 
 
2.4.3 Application of the Glycaemic index 
There is disagreement as to whether the GI should be promoted in the general 
public, as some regard it as too complex for public understanding (Pi-Sunyer, 
2002, Franz, 2003). Despite an equivocal stand point on the concept of GI and 
its value to health at the time, in a Joint Expert Consultation, the Food and 
Agriculture Organisation (FAO) and the World Health Organisation (WHO) 
endorsed the use of GI for categorising dietary carbohydrates and to guide food 
choices (FAO/WHO, 1997). Dietary GI can be lowered through the use of 
simple food swaps utilising GI food lists without the need for complex decision 
making or major dietary changes (Brand-Miller and Marsh, 2008). Studies of 
adults and children conducted in Australia have shown that a low GI diet was 
easier to follow than a conventional diet (Gilbertson et al., 2001, Moses et al., 
2006). However, there is limited evidence supporting the application of low GI 
diets in the United Kingdom (UK). The majority of published GI data are based 
upon analysis conducted in Australia and the United States of America (USA) 
and many of the food brands published in GI tables are not accessible in the 
UK (Aston et al., 2008). 
 
2.5 Associations of GI and GL with metabolic health  
 
2.5.1 GI, GL and obesity 
 
Evidence suggests that raised dietary GI and GL can play a role in the onset of 
obesity (Brand-Miller et al., 2002), as well as CVD and type II diabetes through 
the development of risk factors for the metabolic syndrome (Salmeron et al, 
1997). However, as outlined below, in some of the literature there are equivocal 
data, regarding whether GI or GL is more important for metabolic health. 
 
In healthy adults, dietary GI and GL have been positively associated with 
obesity (Brand-Miller et al., 2002); prospective cohort studies have identified 
that increases in GI  appear to be associated with gains in body fat and WC (Du 
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et al, 2009; Hare-Bruun et al, 2006). Over a 6 year follow up of 89,432 males 
and females, a 10-unit increase in GI was significantly associated with a 
0.19cm increase in WC per year, GL was not significantly associated with gains 
in WC (Du et al, 2009). Hare-Bruun et al (2006) identified that a 10-unit gain in 
GI, over 6 years, was significantly associated with gains in body weight (6%), 
body fat (3%) and WC (7cm) in sedentary women. In active women and all men 
associations with GI were not significant; GL shared no significant associations 
with adiposity variables. These data in adults suggest that reducing the GI of 
the diet rather than GL is more impactful on lowering adiposity and that this 
may be more important in females. Furthermore, these findings suggest that 
fitness may play a protective role in the development of diet-induced adiposity. 
Moreover, in 1354 healthy adult females from Japan, cross-sectional evidence 
suggests that GI but not GL is significantly associated with BMI, however body 
weight was self reported which may have implications for the validity of BMI 
calculations (Murakami et al, 2006). In children and adolescents, however, 
there is limited observational evidence of significant positive associations of GI 
or GL with adiposity, furthermore, evidence in UK populations is lacking. In 
studies of healthy, normal weight children (Scaglioni et al, 2005; Buyken et al, 
2008) and pubertal adolescents (Cheng et al 2009) from Europe, neither GI nor 
GL were found to be associated with adiposity measures. Further to this, Hui 
and Nelson (2006) found that GL was not a significant independent factor 
associated with overweight in a sample of normal and overweight children from 
Hong Kong, however, intake from snacks was not considered when calculating 
GL. More recently, Joslowski et al (2011) suggested that postprandial increases 
in insulinemia, as estimated by the food insulin index, were associated with 
adiposity, whilst GI and GL where not associated with body fat % in 262 
pubertal German participants aged 9-15 years. Conversely, in 10 and 16 year 
olds from Denmark, dietary GI and GL were significantly positively associated 
with body fatness as measured by the sum of four skinfolds but only in males 
aged 16 (Nielsen et al, 2005). Neither GI nor GL were associated with fatness 
in girls or in boys aged 10; associations of GI and GL with BMI were not 
significant. It was proposed that the greater degree of reporting bias by females 
may have been responsible for the differences in association observed for GI 
and GL with fatness. It appears that Neilsen et al (2005) are the only group to 
have reported association of GI and GL with adiposity in a group who are 
potentially entirely postpubertal (16 year old males; n = 181), however, pubertal 
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status was not assessed, highlighting a lack of evidence in postpubertal groups. 
Similarly to Nielsen et al, in 15,974 Japanese children (6-11 years old) and 
adolescents (12-15 years old) increasing dietary GL was significantly 
associated with greater risk of overweight (BMI) in male but not female 
adolescents, however, GL was also associated with overweight in male and 
female children (Murakami et al, 2011). A noteworthy limitation of this study is 
the use of self-reported weight and height and thus the calculations of BMI for 
categorisation of overweight may not be valid. To this end there appears to be 
limited evidence that glycaemic CHO are linked to increasing adiposity, but a 
common limitation of the above research is the potential confounding impact of 
puberty on adiposity which is rarely accounted for. 
 
2.5.2 Impact of puberty on adiposity and metabolic health 
During puberty, there is a transient increase in insulin resistance and 
associated metabolic health parameters (Hannon et al. 2006). During puberty 
hormonal changes are responsible for altered substrate metabolism and a 
transient increase in insulin resistance which return to pre-pubertal levels in the 
last stage of maturational growth (Staiano and Katzmarzyk, 2012, Moran et al., 
1999) Furthermore, during puberty, fat mass, including visceral fat has been 
shown to increase in males and females, although, females are more 
susceptible to increased adiposity (Staiano and Katzmarzyk, 2012). Puberty 
begins at an average biological age of 13 years in boys and 11 years in girls 
(Tanner et al. 1975). The end of puberty is reached, on average, at the age of 
14.9 and 14.4 years in boys and girls, respectively (Marshall and Tanner, 1969, 
Marshall and Tanner, 1970b). As such, the outcomes of observational research 
or interventional studies that aim to improve metabolic health might be flawed 
when including participants who fall within this age range. Indeed, many diet 
based intervention studies in children and adolescents fail to account for these 
pubertal changes and are thus methodologically flawed. Moreover, there 
appears to be a distinct lack of research investigating the effects of lowering 
dietary GI in postpubertal adolescents. 
 
2.5.3 GI and GL with metabolic health 
Observational evidence suggests that increasing dietary GI and GL are 
associated with risk factors for the metabolic syndrome in healthy adults, as 
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outlined below. In 1,354 healthy Japanese female farmers, aged 21-64 years, 
GI was significantly positively correlated with fasting TG and BG (as was GL), 
BMI and glycated haemoglobin (HbA1c); a marker of long term glucose control. 
GL however was inversely associated with fasting HDL levels (Murakami et al, 
2006). Further to this, in healthy American (Culberson et al., 2009) and Mexican 
(Denova-Gutiérrez et al., 2010) adults, increasing dietary GI and GL have been 
associated with an adverse lipid profile and greater relative risk of CHD. In 1420 
British adults (mean age 39 years old), (Frost et al., 1999) identified that GI was 
inversely associated with HDL levels; interestingly GI was the only dietary 
variable to be associated with any lipoprotein subfractions. It therefore appears 
that GI and GL may be associated with an adverse lipid profile. Furthermore In 
37,846, healthy Dutch adults (21-70 years old), a 10 year prospective cohort 
study found that greater GI, GL and CHO intakes were associated with the 
incidence of type II diabetes; associations with GL were stronger than GI (Sluijs 
et al., 2010). This study also identified a reduced risk of type II diabetes with 
increasing fibre intakes. Moreover, in a prospective cohort (11.9 year follow up) 
of 19, 608, healthy (at baseline) Dutch adults, increased GL was associated 
with greater risk of CHD in men whilst GI was not associated with CHD in either 
sex (Burger et al, 2011). Additionally, greater GI was associated with an 
increased risk of stroke but also only in males. Conversely, in a general 
population of American males and females, although increased dietary GL was 
associated with lower HDL levels in all participants and males, no association 
was observed between GL and the prevalence of metabolic syndrome in either 
sex (Culberson et al, 2009). Additionally, TG and glucose levels, BP and WC 
were not associated with dietary GL. Dietary GI has also been associated with 
liver steatosis (measured by liver echography) in 247 apparently healthy adults; 
associations were strengthened in those exhibiting insulin resistance (Valtuena 
et al, 2006) suggesting that high GI foods are a greater burden to those who 
have difficulty controlling BG levels. 
 
There is also evidence in “metabolically at risk” adult populations that GI and 
GL are associated with factors linked with the metabolic syndrome as well as 
mortality rates. In 780 adult males from America with type II diabetes, diets 
lower in GI and GL and higher in cereal fibre were associated with increased 
adiponectin levels (Qi et al, 2005). Moreover, Burger et al (2012) conducted a 
4.4 year prospective cohort study, of 6,192 subjects with diabetes; the 
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investigation involved 10 European countries (not including the UK). 
Associations of dietary fibre, GI, GL, and CHO intakes with mortality risk were 
assessed; fibre intakes were significantly negatively associated with mortality, 
yet exposures of GL, GI and CHO intakes were not significantly associated with 
mortality risk. Interestingly, when analysed according to weight status, GL, CHO 
and total sugar were significantly associated with greater mortality risk in 
normal weight (according to BMI) adults. Moreover, following further analysis, 
associations were strengthened after exclusion of dietary under-reporters. 
 
There is limited and equivocal observational research into associations of GI 
and GL with factors of the metabolic syndrome in children and adolescents. 
Davis et al (2007) investigated the relationships of dietary sugar and GI with 
insulin dynamics (insulin sensitivity, insulin response and disposition index) and 
adiposity in 120 overweight Latino youths (10-17 years old) with a family history 
of type II diabetes. Dietary fibre, GI and GL were not associated with adiposity 
or insulin sensitivity, however, total sugar intake was positively associated with 
BMI, fat mass and negatively associated with insulin sensitivity and disposition 
index (Davis et al, 2007). In a prospective cohort of 769 healthy 13-15 year old 
Australian adolescents, O‟Sullivan et al (2010) investigated the associations of 
CHO, GI and GL with the presence of the metabolic syndrome as defined by 
two internationally recognised adolescent definitions; the international diabetes 
federation (IDF) and the Adult Treatment Panel III (ATPIII). Additionally, 
associations of insulin resistance (HOMA-IR) and a sample defined metabolic 
cluster (based on BMI, fasting insulin, glucose, TG and blood pressure values 
(„high risk‟ or „low risk‟)) were assessed. The prevalence of the metabolic 
syndrome was 3.6% (IDF), and 4% (ATPIII); 25.9% of participants were in the 
high risk cluster. A 20 unit increase in GL and a 30g increase in CHO were 
associated with significantly increased odds of having metabolic syndrome 
(IDF). No significant associations were observed when utilising the ATPIII, 
cluster-defined or HOMA-IR definitions. The IDF criteria is the only definition 
that requires the presence of a high WC, thus, WC may be a mediating factor 
for associations of GL with the prevalence of the metabolic syndrome in 
adolescents (O‟Sullivan et al, 2010). 
 
The above observational evidence highlights the potential risk posed by a high 
GI and or GL diet. Both GI and GL have been associated with obesity 
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measures including WC, an adverse lipid profile and risk of CVD, as well as 
markers of inflammation, raised fasting glucose and HbA1c. Furthermore, GI 
and GL have been associated with prevalence of the metabolic syndrome and 
mortality rates. In some cases, however, total CHO, sugar and fibre intakes 
have been associated with factors of the metabolic syndrome when GI and GL 
have not. There is a lack of evidence in child and adolescent populations, 
particularly for adolescent from the UK. There is also evidence that associations 
may be mediated by fitness or physical activity, weight status and sex. 
 
2.6 Nutritional Assessment 
 
2.6.1 Nutritional assessment techniques 
Due to the association between diet and metabolic health (Giugliano et al., 
2008), dietary intake measurement has become an important tool to assess the 
impact of nutritional interventions and associations in observational research. 
There are methodological challenges relating to the accuracy of dietary 
assessment, with additional difficulty in the assessment of children, due to their 
lesser ability to remember and record their diets as well as a limited knowledge 
of food and food preparation (Rockett and Colditz, 1997). Several different 
techniques are available for dietary assessment and those commonly used in 
the literature include: 24 hour dietary recall interviewing, food frequency 
questionnaires, and food diaries/records which can require participants to 
estimate or weigh portion sizes (Hu, 2008). Seven day weighed dietary records 
are considered a reference tool for nutritional assessment (Kipnis et al 2001). 
This is because participants are not required to remember and recall intakes as 
the diary can be completed immediately after consuming a meal. Furthermore, 
the fact that food can be weighed reduces the need to make estimations and 
increases accuracy of recorded food quantities (MRC DAPA toolkit).  Weighed 
food diaries have been deemed valid and utilised for dietary assessment in U.K. 
national surveys (Gregory et al., 2000, Henderson et al., 2002) and studies of 
children and adolescents (Robinson et al., 1999, Tuomilehto et al., 2001, 
Reinehr et al., 2003, Balagopal et al., 2005). Robinson et al (1999) used 
weighed dietary records, completed on 7 consecutive days as a reference tool 
for dietary assessment in adolescents. Reinehr et al (2003) used weighed 
dietary records to assess dietary changes from a lifestyle intervention in 
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children and adolescents aged 7-15 years, however, the researchers used 3 
day food diaries, as they are less onerous than 7 day records and are thus 
likely to be more accurately completed. Three day weighed records are often 
utilised in observational studies and to assess dietary changes of lifestyle 
interventions on adults and children expressing metabolic complications 
(Tuomilehto et al, 2001; Balagopal et al, 2005). 
Errors in self reporting of nutritional intakes (misreporting) can lead to 
inaccurate assessment of dietary intakes, either through failure to recall all 
foods consumed or by underestimating the amount eaten; underreporting is 
more common, but overreporting of intakes is also a source of error.  It is 
therefore important to identify and control for reporting error. It is important to 
identify and attempt to control for reporting error when assessing associations 
of diet and health as measurement error can attenuate correlations between 
nutrients and outcome variables (Poslusna et al, 2009). Furthermore this may 
result in error when calculating GI based on carbohydrate intakes (Collins et al, 
2010). 
 
2.7 Dietary  Misreporting  
 
Dietary misreporting is a discrepancy between reported energy intake (EI) and 
measured energy expenditure (EE) where body weight is assumed constant 
during the reference period (Poslusna et al, 2009). Misreporting increases error 
in the estimation of EI but also that of other nutrients. It is evidenced that 
population characteristics can affect the degree of misreporting, such as age, 
sex and adiposity (Collins et al., 2010). Ascertaining accurate intakes in 
overweight and obese can be more challenging than in normal weight 
individuals, as under reporting generally increases with BMI (Poslusna et al, 
2009). According to (Subar et al., 2003) and (Mahabir et al., 2006) BMI was a 
significant predictor of underreporting in adults. Additionally, studies have 
identified that a higher proportion of females and older participants underreport 
nutritional intakes (de Vries et al., 1994, Hirvonen et al., 1997).  
 
 
During the 1980‟s, the validity of self reported nutritional intakes was assessed 
utilising biomarkers, namely, 24 hour urinary nitrogen excretions to assess 
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validity of protein intakes (Isaksson, 1980) and measurement of EE by doubly 
labelled water (DLW) (Schoeller and van Santen, 1982). Comparison of 
reported EI with EE (DLW) allows for bias in reported intakes to be assessed, 
based on the principle that in weight stable individuals EI and EE are equal 
(Rosenbaum et al., 1996). These principles were furthered by Goldberg et al 
(1991) who introduced the assessment of reported EI by comparison with 
estimated energy requirement (ER). Through the use of measured or estimated 
BMR and thus accounting for individual variations in minimal ER, mean EI can 
be compared with the presumed mean ER of the population, both expressed as 
a multiple of BMR (EI:BMR and EE:BMR). The ratio of EE:BMR represents the 
component of total EE from physical activity (PA) known as the physical activity 
level (PAL) (Black et al, 1997). Goldberg devised an equation (Goldberg et al, 
1991) for calculating the confidence limit or cut-off of EI:BMR below which it is 
unlikely that mean EI is representative of habitual intake or a random low 
intake. This technique assumes a PAL value, relative to BMR, for the 
population. The Goldberg equation has become a useful tool for the 
assessment of underreporting (Black et al, 1976), and is widely used in the 
literature. The calculation accounts for the errors associated with sample size, 
length of dietary assessment as well as variation in food intakes, physical 
activity and BMR. Studies employing this technique have demonstrated that 
underreporting of reported EI is common. Black et al (1991) identified that two 
thirds of 37 studies had a mean reported EI (at group level) below the Goldberg 
cut-off, these studies compared EI:BMR with a group PAL value of 1.55 x BMR, 
based on the value for „light activity‟ defined by the WHO (1985). This value 
was commonly used based on calorimetry and early DLW studies confirming 
that 1.55 x BMR as a likely minimum ER for healthy sedentary individuals 
(Goldberg et al, 1991). If EE is unknown and PAL is therefore assumed, only 
the lower confidence limit can be calculated and reported EI is classified as low 
or non-low. However, if a population‟s PA is known such that an appropriate 
mean PAL is assigned, the upper confidence limit can also be calculated 
(Black, 2000). The Goldberg cut-off has also been used to identify 
underreporters at the individual level (n=1), allowing for the characteristics of 
underreporters to be assessed (Pryer et al, 1997; Rotishauser et al, 1994), 
utilising the 1.55 x BMR PAL value. However, a presumed PAL value 
representative of „light‟ activity can only identify bias in reported intakes of those 
leading a sedentary lifestyle (Black et al, 1997; Black, 2000). Furthermore, the 
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extent and degree of reporting bias has likely been under estimated in those 
with a higher PAL value than the traditional 1.55 x BMR. As many dietary 
surveys include participants with a broad range of EE, a PAL value should be 
estimated for stratified sub-groups of the population based on physical activity 
habits, or to be more specific, an individual PAL value can be applied when 
calculating a cut-off for EI:BMI. The utility of the Goldberg cut-off in identifying 
underreporters compared to direct measurement of EE (DLW) was assessed in 
45 adults who completed a 16 day weighed food diary (Black et al., 1997). 
Underreporting was present at all levels of EE highlighting that misreporting is 
likely regardless of a groups PA engagement. Furthermore, the Goldberg 
equation was shown to be a good predictor of misreporting compared to DLW (r 
=0.65, P= <0.0001), but only when information regarding PA was known, 
moreover, when a specific PAL was calculated from DLW data the validity of 
the Goldberg equation improved further (Black et al., 1997). Thus if an 
individual PAL can be ascertained, misreporting can be quantified with greater 
validity. A PA questionnaire can be used to assign a sub-group (e.g. sedentary, 
low active, moderately active or highly active) or individual PAL. Self reported 
PA, however, can be prone to reporting error (Sirard and Pate, 2001:Trost, 
2007) and may lack the accuracy required to gain valid insight into an 
individual‟s PA habits. For instance, most PA questionnaires are designed to 
gather information on high-intensity activities, yet much of the variation between 
participants comes from sitting and standing activities of which can be hard to 
quantify in self report (Poslusna et al, 2009). Therefore, more recently the use 
of accelerometry has allowed for an objective assessment of PA that can be 
applied to the assessment of misreporting, however, it seems only a few 
studies have utilised accelerometry in this manner (Samuel-Hodge et al, 2004; 
Noel et al, 2010).  
 
If individual EE is known it can be directly compared with EI and the bias of 
these values represents the degree of misreporting (assuming body weight is 
constant) (Rosenbaum et al, 1996). DLW provides an objective and 
independent measure of EE, however, its expensive and time consuming 
nature as well as the requirement of a sophisticated laboratory set up means 
that it cannot be routinely used to validate EI. Although accelerometry has been 
used to assign a PAL when estimating the Goldberg cut-off, very few studies 
have directly compared accelerometry obtained EE with EI for the assessment 
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of misreporting. Samuel-Hodge et al, (2004) assessed the validity of dietary 
data by comparing EI (3 x 24 hour recalls) with EE estimated by 7 day uniaxial 
accelerometry in 185 African females (mean age 59 years) with type II 
diabetes. Underreporting was assessed by direct comparison of EI and EE and 
by calculating a participant specific PAL for use in the Goldberg cut-off; derived 
from measured EE. Participants were classified as underreporting if the ratio of 
EI:EE was <0.79 (where EI:EE should equal 1 in weight stable individuals). This 
cut-off is representative of the lower 95% confidence limit of EI:EE, based on 
studies utilising DLW data (Black and Cole, 2001). According to EI:BMR, 58% 
of the population underreported compared to 81% as assessed by EI:EE. This 
suggests that using EE data from accelerometry compared directly to EI yields 
a greater proportion of underreporters than the Goldberg cut-off utilising an 
individual PAL derived from the same EE data. However, this study employed 
the use of uniaxial accelerometry which is likely to underestimate the 
measurement of activities with limited vertical accelerations. Moreover, 
accelerometer data was included if 4 days consisting of >4 hours wear time per 
day was achieved. A low wear time criteria such as the four hour minimum 
could result in an underestimation of PA, which in turn would result in 
underestimation of energy underreporting (Samuel-Hodge et al, 2004). 
 
 It appears that the objective nature and accuracy of triaxial accelerometry has 
not yet been exploited when measuring TEE to identify misreported EI, 
furthermore, there appears to be a distinct lack of research assessing EI:EE 
using accelerometry in a U.K. adolescent population. 
        
2.7.1 Impact of dietary misreporting: Associations of diet and health 
 
Misreporting can have important implications for the outcome of studies 
investigating diet and health relationships (Poslusna et al, 2009). Amelioration 
of these distorted associations between diet and health as a consequence of 
underreporting is hindered by the evidence that misreporting is not random and 
is selective for different macronutrients. In 301 healthy males, 7 day food 
diaries were used to investigate the effects of underreporting on associations 
with the metabolic syndrome (Rosell et al, 2003). The prevalence of overweight, 
a raised WC, raised systolic BP and the metabolic syndrome were significantly 
higher among underreporters. Furthermore, associations of fasting insulin with 
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PUFA and fats from milk were significantly stronger in underreporters compared 
to non-underreporters, highlighting that underreporting could introduce spurious 
associations between diet and health. However, Rosell et al (2003) did not 
identify and account for overreporting in the non-underreporting group, and 
therefore intakes from this group may not represent valid reporting. In terms of 
macronutrients, evidence suggests that underreporters tend to report higher 
intakes of PRO than non-underreporters, however, data for FAT and CHO are 
inconsistent (Poslusna et al, 2009).  
 
It is noteworthy that some studies assessing associations of GI and GL with 
health found that dietary misreporting had minimal impact on associations. 
Excluding misreporters had a minimal impact on associations between 
glycaemic CHO (assessed by food frequency questionnaire (FFQ)) and BMI in 
6334, 30 to 60 year old adults (Lau et al., 2006). Furthermore, Sluijs et al 
(2010) identified that removal of misreporters strengthened associations of GI 
and GL with type II diabetes risk, but the change was only slight and of minimal 
clinical importance. This was also observed in a study of British children (n= 
818, 4-10 yrs old) and adolescents (n= 818, 11-18 yrs old) where there was no 
effect of removing or adjusting statistical analysis for misreporters on 
associations between adiposity and glycaemic CHO (Murakami et al., 2013). 
These data suggest that associations of glycaemic CHO with health markers 
may not be hindered by inaccurate food intakes. However, this will only be the 
case in circumstances where food intakes are merely underestimated, but if 
some foods are entirely omitted, this is likely to produce false values for GI and 
subsequently GL. It should be noted that Sluijs et al (2010), did not account for 
the PAL of the population when estimating misreporting through use of the 
Goldberg equation. Furthermore, Marukami et al (2013) calculated misreporting 
based on comparison of EI with estimated EE captured via PA diary and 
therefore may have underestimated EE and subsequently underreporting. 
 
Removing individuals who misreport energy intakes from statistical analysis has 
not been recommended by some individuals, on the basis that it introduces 
unknown bias into the sample, being that only those participants reporting 
„normal‟ intakes are examined (Gibson, 2005). A different approach, however, 
is to analyse all participants, but control for reported EI through the use of 
statistics. If dietary intakes can be observed relative to energy intake this may 
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attenuate the effect of over and underreporting (Poslusna et al., 2009), this will 
of course only be of value in those who misreport their entire diet as a whole 
rather than selectively for different macronutrients. 
 
The nutrient density and residual method are the two most common techniques 
of energy adjustment (Mirmiran et al., 2006, Pryer et al., 1997). The nutrient 
density model is the sum of a total nutrient intake (e.g. total CHO intake) 
divided by total energy intake (Poslusna et al., 2009). This method is of course 
dependant on changes in reported EI and after adjustment nutrients will remain 
correlated with EI and thus, this technique may not be appropriate when 
assessing diet and health relationships. When utilising the residual method, 
however, adjusted nutrients are independent of EI (Mirmiran et al., 2006). The 
residual method utilises linear regression, with EI as the dependent variable 
and the intake of the nutrient being adjusted as the independent variable 
(Gibson, 2005). Each participant‟s energy adjusted nutrient intake is determined 
by calculating the residual difference between the observed nutrient value of 
each participant and their nutrient value predicted from the regression equation.  
 
 2.8 Glycaemic index and Glycaemic load Intervention 
studies 
 
       2.8.1 Intervention Studies: GI, GL and Obesity 
Intervention studies have demonstrated that reducing dietary GI and GL can 
enhance weight loss over that of conventional energy restricted, high GI and 
low fat diets (Pereira et al, 2004; Speith et al, 2000), however, evidence 
suggests that low GI and GL may be more beneficial for individuals with 
features of the metabolic syndrome (Ebbeling et al, 2007; Pittas et al, 2005; 
Klemsdal et al, 2010). Overweight and obese adults have been shown to lose 
more weight when assigned to a low GI compared to a high GI (Pittas et al, 
2005), and low fat diet (Ebbeling et al, 2007). However this was only observed 
in participants who at baseline had raised insulin responses to an oral glucose 
challenge, suggesting that low GI may not benefit those without reduced insulin 
sensitivity (Pittas et al, 2005; Ebbeling et al, 2007). This is in line with evidence 
demonstrating a more favourable effect on WC from a low GL diet in obese 
adults with the metabolic syndrome compared to those without (Klemsdal et al., 
2010). However, in 11 moderately overweight (BMI 28 kg/m2 ± 1), non-diabetic 
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men, who did not exhibit insulin resistance or other features of the metabolic 
syndrome, a 5 week low GI compared to high GI diet induced significantly 
greater fat loss (Bouche et al., 2002). In contrast to the findings of low GI and 
GL interventions in adults, greater fat loss has been observed in 16 obese 
adolescents (aged 13-21 years) consuming an ad libitum low GL versus a 
reduced fat diet (Ebbeling et al, 2003) over a 6 month period. Although no 
significant difference in calorie consumption was reported, the actual mean 
difference between baseline and intervention energy intake was 692 and 148 
kcals in the low GI and reduced fat diet groups, respectively. Therefore it is 
unclear if the greater fat loss was a result of lower calorie consumption or 
reducing dietary GI. In a study of healthy obese children (mean age 10 ± 4 yrs), 
Spieth et al (2000), demonstrated that significantly more participants in a low GI 
diet group reduced their BMI by 3 kg/m2 compared to an energy restricted, low 
fat diet group. 
 
Gains in adiposity associated with increased dietary GI and GL have been 
explained in the literature by two potential mechanisms: increased satiety and 
increased fat oxidation (Mcmillan-Price and Bran-Miller, 2006). Low GI 
compared to high GI foods, matched for appearance and nutrient content, have 
been shown to induce greater satiety and are proceeded by less energy intake 
at subsequent meals (Ludwig, 2000). Furthermore, the consumption of a low GI 
breakfast has been shown to significantly reduce food intake at lunch in 37 
normal and overweight children age 9-12 (Warren et al., 2003). Additionally, 
Holt et al (1992), showed that low GI mixed meals induced a greater secretion 
of the gut peptide cholecystokinin, which is associated with satiety and fullness, 
over a 180 minute period in healthy adult males. Satiety may be increased due 
to the slower rates of digestion and absorption in the small intestine associated 
with low GI foods (Lavin et al., 1998). This could result in extended feedback, 
via gut peptides such as cholecystokinin, ghrelin, glucagons and glucagons-like 
peptide-1, to the satiety centre in the brain as nutrient receptors are stimulated 
for a greater period of time (Lavin et al., 1998; Radulian et al., 2009). 
Furthermore, at the late postprandial stage following a high GI meal, both BG 
and fatty acid levels decline, often below fasting levels, a state that could be 
interpreted by the central nervous system as “low fuel status” (Ludwig 2002). 
Moreover, transient declines in BG during the post-absorptive state have been 
shown to correspond with spontaneous meal requests (Melanson et al., 1999).  
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Stevenson et al (2009) observed significantly greater fat oxidation over a 3 hour 
rest period following a low compared to high GI breakfast and lunch in 
recreationally active males, subsequent plasma glucose and insulin levels were 
significantly lower following the low GI meals. This group also reported 
significantly greater fat oxidation during exercise following a low compared to 
high GI breakfast (Wu et al., 2003). Alterations in fuel oxidation related to 
differing GI have been explained by postprandial increases in glycaemia and 
insulinaemia, which result in the rapid activation of key rate-limiting enzymes 
that increase CHO oxidation (Wolfe, 1998). An intermediate of CHO oxidation, 
malonyl-CoA, strongly inhibits fatty acid transport into the mitochondria, and 
thus, consumption of high GI foods can decrease fat oxidation (Wolf, 1998). 
Furthermore, the improved fasting insulin observed after low GL diets, and  
subsequent reduction in lipoprotein lipase enzyme (LPL) expression in adipose 
tissue may induce a decreased fat depot (Bouche et al, 2002). LPL stimulates 
the breakdown of triglyceride in the circulation into fatty acids to be stored in 
adipose tissue (Fielding and Frayn, 1998) and is correlated with insulinaemia 
(Boivin et al, 1994).  
 
Further to this, habitual intake of high GI foods has been suggested to have a 
proteolytic effect, reducing muscle mass over time (McMillan-Price and Brand-
Miller, 2006), as a result of the counter regulatory hormone response during the 
late postprandial hypoglycaemia (Zurlo et al., 1990, Weyer et al., 2000). This 
may result in a reduced BMR increasing the potential for a positive energy 
balance and weight gain. Low vs high GI (Agus et al., 2000) and low GI vs low 
fat diets that induce weight loss have reported significantly reduced declines in 
resting energy expenditure despite comparable body composition changes. 
 
Together these data highlight the potential for low GI diets in body weight 
regulation through improved satiety and better maintenance of lean tissue, and 
thus greater potential for negative energy balance as well as an increased 
propensity to utilise fat stores in favour of CHO. 
2.8.2 Intervention Studies: GI, GL and the Metabolic Syndrome  
In adults with insulin resistance, the implementation of low GI and GL diets has 
improved a number of factors associated with the metabolic syndrome (Rizkalla 
et al, 2004; Jenkins et al, 2008). A low GI diet regime was found to significantly 
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reduce insulin resistance, improve lipid profile and long term glucose control 
(HbA1C), when compared to a high GI diet, in a 4 week cross over intervention 
of 12 overweight men (Rizkalla et al., 2004) and in 210 men and women with 
type II diabetes (Jenkins et al, 2008). It is important to note that there were no 
significant changes in body weight and body composition, and that total daily 
calorie and macronutrient intakes were equal. Improved glucose utilisation and 
oxidation, as a result of the low GL intervention, may relate to the significant (P 
<0.01) reduction in plasma FFAs observed (Rizkalla et al, 2004). In one of the 
few published low GI dietary intervention conducted in the UK, Jebb et al (2010) 
compared 4, 24 week dietary interventions following a 4 week high SFA 
(HSFA)/high GI (HGI) run in diet: HMUFA/HGI; HMUFA/LGI; low fat/HGI and 
low fat /low GI, in 548 adults featuring metabolic syndrome components. 
Reducing SFA improved lipid profile via reduced TC, LDL and apoB 
concentrations, however, lowering total fat content reduced HDL levels. 
Reducing dietary GI further enhanced TC and LDL improvements. All groups 
failed to significantly improve insulin sensitivity, however the low fat/LGI group 
improved insulin sensitivity to the greatest extent. Due to the HGI 4 week run in 
and a lack of data on its health impact, the effect of raising dietary GI was not 
elucidated. In healthy overweight and obese adults (n=39), a low GI diet has 
been shown to significantly reduce blood TG levels and insulin resistance 
compared to a conventional low fat, high carbohydrate diet (the intervention 
duration was the time taken to achieve 10% of weight loss) (Pereira et al, 
2004). Both diets were calorie restricted to 60% of the energy requirements of 
each participant. Health improvements were observed despite no significant 
difference between weight and fat mass reductions in both groups, suggesting 
that there may be benefits of a low GI diet over and above that (or independent) 
of fat loss by conventional means (Pereira et al, 2004). Similarly, despite 
comparable reductions in BF%, between a low GL and low fat diet in 
overweight adults, BP was significantly reduced in the low GI group, (Klemsdal 
et al., 2010). Also in overweight but otherwise healthy men and women 
(Melanson et al., 2012) investigated the effects of 3 variations of a weight loss 
programme (weight watchers) over a 12 week period: 1) focused on portion 
control (restricted by energy and total fat with a minimum fibre intake), 2) low 
energy density (ad libitum consumption of wholesome low energy foods) 3) low 
GI (ad libitum consumption of foods based on the low GI Pyramid (Ludwig, 
2000). All diets, however, induced significant reductions in FM and BF% as well 
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as factors associated with the metabolic syndrome (WC, systolic and diastolic 
BP, TG, insulin, HOMA-IR, glucose tolerance and CRP) with no significant 
difference between groups. All diets resulted in significantly increased PRO 
intakes and reduced total energy, % energy from fat and SFA with no between 
groups difference. Therefore, metabolic changes could be result of similar 
macronutrient and energy alterations. Although all 3 groups improved their 
metabolic risk components this could have been a result of a reduced GI and 
GL of which there was no significant difference between the low energy density, 
low GI and portion controlled diets after 12 weeks (GI: 30.04, 30.71 and 31.59; 
GL 54.39, 44.75 and 41.58, respectively). This highlights the importance of 
controlling for changes in dietary variable when comparing different dietary 
interventions. 
 
A limited number of studies have investigated the impact of low GI diets on 
factors associated with the metabolic syndrome in healthy children and 
adolescents (Fajcsak et al, 2008; Ebbeleing et al, 2003), however, the evidence 
is ambiguous. Fajcsak et al (2008) found a significant reduction in body fat and 
metabolic risk factors following a 6 week ad libitum (which defines a diet with no 
restriction on consumption amount) low GL diet intervention in healthy, obese 
and overweight, prepubertal 11 year olds. The intervention focused on 
exchanging 50% of the high GI foods consumed with low GI foods. There was 
no significant difference between the calories consumed between baseline and 
intervention diets; dietary glycaemic changes were not reported however. This 
study also failed to include a control group for comparison, and furthermore, by 
attempting to control the glycaemic load of the diet, portion sizes were indirectly 
restricted, therefore failing to make the diet truly ad libitum. Ad libitum diets may 
be especially beneficial for adolescents, due to their flexibility. The desire to 
make choices and the lack of adherence to energy restricted diets that has 
been observed in adolescent populations may be better suited of the flexibility 
of ad libitum diets (Ebbeling et al, 2005). In contrast to Fajcsak et al (2008), a 
study of 16 obese adolescents assessing the impact of a 6 month low GI 
compared to low fat diet, Ebbeling et al (2003) found insulin resistance 
increased in both the low GI (non significant increase) and reduced fat diet 
groups. The authors suggested that this increase was associated with hormonal 
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changes during puberty, highlighting the importance of controlling for hormonal 
changes in studies of childhood and early adolescence.  
Additionally, the impact of an unrestricted low GI diet compared to a standard 
reduced fat diet on obesity was examined in 190 children (10 yrs old) from the 
USA (Spieth et al., 2000). With the low GI diet children were advised to 
consume low GI CHO, PRO and fat at every meal and snack. The low fat diet 
emphasised consumption of low energy (approximate energy restriction of 250-
500 kcals per day), low fat and low sugar and foods. The low fat group showed 
no change in BMI, contrastingly, a significant decrease in BMI of 1.15 kg/m2 
was observed in the low GI group. The low GI intervention was not restricted, 
whereas the low fat diet was heavily energy restricted. The difference in 
macronutrient intake of these diets makes it difficult to attribute the effect solely 
to GI. This evidence provides support for a flexible low GI diet in the reduction 
of obesity in children. Unfortunately, however, the authors did not monitor diet 
during the intervention and thus little is known of its impact on dietary intakes. 
Furthermore, there are no studies exploring the effect of a flexible, ad libitum, 
low GI diet on metabolic risk factors.  
 
The following mechanisms have been suggested to promote the development 
of an adverse lipid profile, CVD, insulin resistance and type II diabetes as a 
result of a high GI diet. During the middle postprandial stage, following a high 
GI meal, the rise in circulating insulin leads to a rapid down regulation of BG; 
often to below fasting level. At the late postprandial stage, hypoglycaemia 
stimulates the release of hormones, such as adrenaline and glucagon to restore 
euglycaemia and activate fat oxidation to meet the energy demands of the 
body. The promotion of raised levels of circulating FFAs at rest, however, is 
associated with an adverse lipid profile and CVD as well as peripheral insulin 
resistance (in insulin sensitive non-adipose tissue such as the liver and skeletal 
muscle) (Weiss & Kaufman, 2008). Whereas, following a low GI meal, 
postprandial rises in gut hormones and insulin are reduced and the prolonged 
absorption of CHO suppresses the counteregulatory response and FFA release 
(Jenkins et al, 2002). Moreover, lipid profile improvements could be associated 
with a lower insulin response following a low GI resulting in reduced activity of 
insulin–stimulated 5-hydroxi-3-methylglutoryl-CoA reductase (the rate-limiting 
enzyme in cholesterol synthesis) (Rodwell, 1976). A low GI diet has been 
shown to benefit thrombolytic function, by reducing levels of plasminogen 
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activator inhibitor 1 (PAI-1), a protein involved with plaque and blood clot 
formation and thus reducing CVD risk in type II diabetic adults, (Järvi et al., 
1999). 
 
Furthermore, prolonged exposure to raised glucose and insulin levels can 
mimic a state of insulin resistance, which can lead to impairment or even failure 
of the β-cells of the pancreas in the longer term, and eventually to type II 
diabetes (Weiss and Kaufman, 2008). In insulin resistant individuals consuming 
a high GI diet, postprandial hyperglycaemia and insulinaemia are further 
magnified, possibly enhancing the likelihood of β-cell exhaustion and the 
development of type II diabetes (Salmeron et al, 1997 a; Salmeron et al, 2000). 
High GI foods may contribute to a state of glucotoxicity that can result in 
overproduction of reactive oxygen species by the mitochondrial electron 
transport chain leading to increased inflammation (Augustin et al., 2002). 
Furthermore, increased exposure to insulin has been associated with excessive 
amyloid deposits upon pancreatic β-cells leading to reduced β-cell function 
(Wolever, 2000). 
In summary, there is a lack of low GI or GL intervention studies that include 
participants with poor metabolic health. Often, studies include overweight and 
or obese individuals that do not necessarily have poor metabolic health 
(Ebbeling et al, 2003; Fajcsak et al, 2008). This makes generalising the findings 
of such studies to metabolically „at risk‟ populations difficult. There also appears 
to be an absence of dietary investigations and interventions, especially low GI 
interventions, in adolescents. Further to this, there is a lack of interventions that 
employ a control group. The most effective treatment for overweight young 
people with poor metabolic health is thus yet to be concluded. Therefore, in this 
population; an age group at risk of developing metabolic abnormalities that 
track into adulthood (Camhi and Katzmarzyk, 2010); a healthy diet that is well 
adhered to could be of great value, in order to promote a healthier lifestyle. To 
this end, nutritional intake, in relation to metabolic risk factors and the impact of 
a truly ad libitum dietary regime on metabolic health, compared to a control 
group, needs to be assessed. The proposed study therefore aims to provide 
knowledge on the current nutritional intakes and effectiveness of a low GI diet 
regime on improving metabolic health in overweight or obese, post-pubertal 
adolescents, exhibiting one risk factor of the metabolic syndrome,  and thus 
help to inform future health-improving strategies. 
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Chapter Three: General Methodology 
3.0 Introduction 
This chapter describes the equipment and procedures used to conduct the 
investigations within this thesis. 
The research is contextualised within 2 separate investigations:  
1) A cross-sectional study examining the association of nutritional intake, fitness 
and physical activity with metabolic risk in postpubertal adolescents; entitled the 
CROSS- Sectional Study: Risk of Adolescent Disease (CROSSROADS);  
2) An intervention study investigating the impact of a nutritional intervention upon 
the metabolic health of postpubertal adolescents who are overweight and obese; 
entitled The Study of Insulin Resistance Factors: Exercise and Nutritional Strategies 
(SIRENS).  
 
3.1 CROSSROADS 
Ethical approval was granted by the University of Bedfordshire research ethics 
committee. Participants were recruited from the University of Bedfordshire as well 
as schools and colleges within the Bedfordshire area. Schools and colleges were 
mixed sex, and the study was offered to those who expressed a willingness to take 
part. Data collection took place within the institution form which the respective 
participants were from. Participants were provided an information and consent form 
(see appendix 1) to be completed and signed by their parent or guardian if the 
participant was less than 16 years of age. The consent form included a physical 
activity readiness questionnaire (PARQ); participants were excluded if they 
indicated they could not safely take part in physical activity or if they had a known 
blood born disease that could be a hazard to the health of the researcher whilst 
acquiring a fingerpick blood sample. Participants could not take part if they were 
smokers. 
To be classed as a postpubertal adolescent participant, the recruitment age was 15-
19 in order to avoid the increased insulin resistance observed during puberty, which 
returns to prepubertal levels after completion of puberty (13.8 ± 0.9 years of age) 
(Moran et al, 1999). Ethical approval was granted by the University of Bedfordshire 
ethics review board. 
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3.2 SIRENS 
Ethical approval was granted by the eastern region ethics committee (EREC). The 
SIRENS study is a collaborative project with the Centre for Obesity Research (COR) 
conducted entirely within the Luton and Dunstable Hospital (L&DH) NHS Trust. 
Collaborators from the L&DH included paediatricians, diabetologists, dieticians and 
pathologists, who had input in the experimental design of the investigation. 
 Participants consisted of postpubertal adolescents aged 14-19 years old. 
Participants were recruited through posters, local newspaper advertisements, local 
radio, school and college newsletters as well as via referral through local general 
practitioners (GP) and collaborating dieticians and paediatricians. Interested 
participants contacted the research team who subsequently sent a sex-specific 
consent and information form (see appendix 2) to be completed and signed by the 
participant. The consent form included a physical activity readiness questionnaire 
(PARQ); participants were excluded if they indicated they could not safely 
participate in exercise. Participants were informed (on the consent form) that they 
could not take part if they had any of the following conditions: Type 1 or Type 2 
diabetes mellitus, heart dysfunction, thyroid problems, or if they: were receiving long 
term treatment for a health condition, were pregnant, had an eating disorder, had 
experienced recent dramatic weight changes, use medications containing steroids, 
were an alcohol or drug abuser, or  had a known family history of: cardiac disease, 
renal disease, hypercholesterolemia or haemoglobinopathy. Participants could also 
not take part if they were smokers. 
The application for ethical approval, recruitment process, data collection and 
intervention sessions were all conducted by the PhD candidate. 
 
3.3 Data collection 
For screening of metabolic health (blood samples, blood pressure and body 
composition); measures were taken in the morning and the participants were 
required to be fasted. Participants were advised to bring breakfast or a snack with 
them, to consume immediately after testing. Participants were also required to be 
well hydrated and thus were advised to sip water. Venepuncture was only 
conducted as part of the SIRENS study and thus was only carried out at the COR, 
L&DH. All other measures outlined below were taken from all participants at all 
research sites. 
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3.4 Haematology 
3.4.1 Venepuncture Blood Sampling  
Venous blood was collected at the L&DH only, by one of three trained technicians. 
Collection of venous blood samples adhered to the current L&DH clinical guidelines 
for Venepuncture. 
Each participant was required to sit or assume a supine position on a medical bed 
before a tourniquet was applied above the distal region of the participant‟s bicep. 
The participants forearm was sterilised using a 70% isopropyl alcohol swab 
(Cutisoft® wipe, BSN medical, Hamburg, Germany) after the site had dried, blood 
samples were drawn using the S-Monovette system (Sarstedt AG and Co., 
Numbrecht, Germany). In order of draw, the following four blood collection tubes 
were filled to accommodate the various assays required (total blood sample of 17.6 
ml): 2 x serum tube (brown tube - 4.7 ml) containing clot activator gel; 1 x glucose 
tube (yellow tube- 5.5 ml) containing 1.2 mg EDTA and 1.0 mg fluoride/ml; 1 x 
EDTA tube (pink tube- 2.7 ml) containing 1.6 mg EDTA/ml. 
Once blood samples were collected, they were immediately delivered to the L&DH 
biochemistry laboratories where the samples were analysed by L&DH biochemistry 
staff and stored in multiple aliquots for further assessment at a later stage. 
3.4.2 Fingerprick Blood Sampling 
The fingerprick blood sampling procedures adhered to the University of 
Bedfordshire‟s guidelines for blood sampling. The participant‟s finger tip (usually 
index finger) was sterilised using a 70% isopropyl alcohol swab (Cutisoft® wipe, 
BSN medical, Hamburg, Germany) and then punctured using an autolancet. The 
first blood droplet was discarded, then, intermittent pressure was applied to the 
participant‟s finger (proximal to puncture site) using the thumb and index finger to 
promote the formation of a blood droplet. The tip of a heparinised capillary tube was 
placed into the droplet to draw a 40 µl blood sample. The sample was immediately 
transferred into a LDX® cassette sample well for the measurement of full lipid profile 
(total cholesterol, HDL, LDL, triglycerides) and glucose levels from arterialised 
capillary blood using the Alere Cholestech LDX® system, CA, USA.  
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3.5 Anthropometry 
 
Waist circumference (mid axillary)  
A tape measure was placed midway between the lower rib margin and the iliac crest 
of the participant whilst standing. When the iliac crest could not be identified the 
tape was placed at the level of the umbilicus. Following a gentle expiration by the 
participant waist circumference was measured to the nearest 0.1mm, whilst they 
were stood straight with feet together, arms by their side and looking directly ahead. 
Standing height (stature) 
Standing height was measured without shoes to the nearest 0.5 cm with a 
transportable stadiometer. During standing height measurements, participants were 
instructed to keep their shoulders in a relaxed position with their arms hanging freely 
and their head in the Frankfurt plane. They were then asked to take a deep inhaled 
breath prior to measurement whilst looking straight ahead. Participants were also 
required to maintain contact between their heels and the floor. 
 
3.6 Weight and Body composition 
Body mass and fat free mass (FFM) were measured to the nearest 0.1 kg and body 
fat % to the nearest 0.1 %, using the Tanita BC-418® Segmental Body Composition 
Analyser (Tanita Corp., Tokyo, Japan). The devise utilises bioelectrical impedance 
analyses (BIA) to estimate each participant‟s fat mass and FFM. Participant 
information (sex, age and height) was manually entered in to the device. 
Participants, in light clothing and bare feet, were then required to step onto the 
platform at the base of the device placing both feet on the electrode plates and 
stand steadily whilst their weight is measured. Then participants were required to 
grasp the handles (one in each hand), ensuring a firm grip around the electrode of 
each handle. Whilst stood still with arms held to the side, slightly abducted from the 
body, a current is passed through the hands and feet around the body for 
approximately 5 seconds whilst body composition is measured. After a tone is 
sounded the participant can replace the handles and step off the platform. 
BIA assesses the impedance of the electrical current through body tissues, utilising 
the principle that the electrical conductivity of FFM is greater than that of fat tissue 
(Lukaski et al, 1985). The resistance to the current can be used to estimate body fat 
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and fat free tissues, (heyward et al, 2004). The BIA estimates resistive impedance 
and bioconductor volume (corrected for height) which are used with the 
manufacturer prediction equations to estimate total body water, fat and FFM.  
 
3.7 Resting heart rate and blood pressure 
Resting heart rate and BP was measured using an Omron M5-I automated 
oscillatory device (Omron Matsusaka Co. Ltd., Matsusaka, Japan). Following 
a 5 minute seated rest period, the cuff of the monitor is placed on the left arm, 
proximal to the anticubital fossa, at the brachial artery. With the participant sat still 
and their left arm supported on an adjacent table, at the level of their heart, three 
blood pressure readings were taken at 2 minute intervals. The mean of the lowest 2 
readings was recorded (Chobanian et al, 2003)  
 
3.8 CRF  
CRF (CRF) was determined by a maximum cycle ergometer test as described by 
Hansen et al (1989) and employed in the European Youth Heart Study (Ekelund et 
al. 2007). Participants were required to cycle at a cadence between 50-70 
revolutions per minute (rpm) on a Monark ergomedic 818e cycle ergometer 
(Monark, Varberg, Sweden). The test protocol was sex and age-specific in terms of 
the work load at each stage. 
Following the initial work rate for 3-minutes (40 watts [W] for females, 50W for 
males), the incremental workload increased every 3 minutes (by 40W for females, 
50W for males). Heart rate was recorded continuously throughout the test via a 
Polar heart rate monitor, worn on the chest of each participant. The test continued 
until the participant could no longer continue. An exhaustive effort was considered 
to have been achieved if the participant had a heart rate > 185 beats/minute when 
the researcher had observed that the participant could no longer continue 
exercising. If the participant‟s pedalling rate dropped below 30 rpm, the participant 
was considered to have stopped the test. 
During the test, in order to assess CRF, each participant was required to breathe 
through a portable indirect calorimetry gas exchange system that is suitable for 
wearing during exercise (Cortex MetaMax 3B). Data was analysed using MetaSoft 
3.9 software to determine peak oxygen uptake. A suitably sized facemask and base 
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jacket (in which the MetaMax is held) was selected for the participant prior to 
testing. Prior to each fitness test, the appropriate equipment was cleaned and 
calibrated following manufacturer guidelines.  
 
3.9 Physical activity 
Physical activity was assessed utilising the RT3 ® triaxial acclerometer 
(Stayhealthy, Inc., Monrovia, CA). Triaxial accelerometry measures accelerations 
and decelerations of movement on 3 planes (vertical (x), anterioposterior (y), and 
mediolateral (z)). Activity categories (SED, LPA, MPA, VPA, MVPA) were identified 
from the vector magnitude, calculated from the output of all three axes. From this 
data the average time spent in each activity category throughout the monitoring 
period was calculated.  
 Each participant was required to wear an accelerometer (clipped to their waist 
band) for the duration of their waking hours for 7 consecutive days (5 weekdays and 
2 weekend days). Exceptional circumstances included: bathing, showering or 
swimming (as the monitor is not waterproof), during sleeping or whilst participating 
in contact sports that may result in injury to the participant or damage to the device. 
In these circumstances, participants were required to log the actives during which 
they removed their accelerometer.  To be included participants were required to 
wear the activity monitor for a minimum of 3 days (2 week days and one weekend 
day); minimum wear time for a week day was 9 hours (Mattocks et al., 2008)  and 
for a weekend day was 8 hours (Rowlands et al., 2004). Each activity monitor was 
programmed to capture activity counts in one minute time frames (epochs), a 
shorter epoch was not possible over a monitoring period of 7 days due to the 
memory capacity of the device. Prior to analysis, data was recoded and sustained 
10 second periods of zero activity counts were removed as it was deemed that the 
monitor was not worn in these circumstances (Riddoch et al., 2004). Time 
accumulated in different PA intensities was averaged for week days and weekend 
days separately, the average of these values was then summed. The RT3 has been 
validated against oxygen uptake in free-living children and adolescents (r = 0.87, P 
<0.001) (Vanhelst et al., 2010) and relative to body mass in children within a 
controlled laboratory setting (r= 0.87, P <0.01) (Rowlands et al., 2004). 
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3.10 Nutritional assessment 
Habitual nutritional intake was assessed via a 3 day weighed food diary based on a 
published example and accompanying material which was used in the National Diet 
and Nutrition Survey (NDNS) (Henderson et al., 2002). Participants were instructed 
in groups on how to complete, all participants were given an instruction sheet and 
example diary which clearly outlined how the diary should be completed (See 
appendix 3 for further details). Participants were required to detail, in an open diary, 
all of the food and drink they consumed over a 3 day period comprised of 2 week 
days and 1 weekend day consecutively. So that food items could be weighed, 
participants were provided with a set of dietary weighing scales and instructed on 
how to effectively use the scales to weigh mixed meals and individual food items. 
Where possible, participants were asked to provide food packaging and labels that 
provided specific nutritional information to aid analysis. Participants were 
encouraged to weigh all food items but in the circumstance where food could not be 
weighed, portion sizes had to be estimated and detailed within the diary. In order to 
accurately obtain the weight of food eaten, participants were required to record the 
weight of the container (e.g. cup or plate) that any food or drink items were eaten 
from and re-weigh the container after eating to provide a weight of food leftover. 
This method has been used by the NDNS and is suggested to minimise the burden 
of weighing leftover food items and increase adherence to this practice. All 
participants had a 10 minute one-to-one dietary follow up session, where the 
researcher and participant checked through the food diary to ensure all entries were 
legible and completed correctly. Where information appeared to be missing or 
erroneous, the researcher prompted the participant to recall this information in an 
attempt to minimise any unrecorded or inaccurately weighed items. 
Food diaries were manually entered into a dietary analysis computer programme 
(CompEat Pro, Nutrition Systems, UK) which utilises McCane and Widdowson‟s 
composition of foods, 6th edition (Krebs, 2002). Estimates of daily intake of selected 
nutrients and energy were averaged over the 3 day recording period.  
 
 
Assignment of GI values 
Assignment of individual food GI values from the weighed food records were based 
on the latest international tables of GI (Atkinson et al., 2008). Foods that contained 
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less than 0.5 grams (g) of CHO per 100g were assigned a GI value of zero. Where 
no specific GI value is available the most closely related food (based on 
macronutrient and fibre content) from the international tables of GI was assigned.  
 
Calculation of dietary glycaemic index and glycaemic Load 
Daily GI was calculated based on the procedures outlined by (Jenkins et al., 1981). 
The percentage contribution to total carbohydrate of each carbohydrate containing 
food (above 0.5g CHO per 100g) was quantified. The respective GI value of each 
food was then multiplied by its percentage contribution to total carbohydrate; these 
values were summed to give a dietary GI value for each participant‟s diet. To 
calculate daily GL, the amount of carbohydrate in each food was multiplied by its GI 
value/100, this was summed to give an overall daily GL.  
 
3.11 Sample size calculations 
CROSSROADS 
The required sample size was calculated based on a cross-sectional study 
investigating the relationship between dietary GI/GL and metabolic health 
(O‟Sullivan et al, 2010). The calculation was based on logistic regression analyses 
that revealed a significantly (p =0.03) increased likelihood of having the metabolic 
syndrome per unit increase in dietary GI (odds ratio: 1.89 95% CI; 1.06-3.36) and 
GL (odds ratio: 1.62 95% CI; 1.05-2.49). The calculation estimated that a minimum 
of 137 (based on the smaller effect size observed for GL) participants are required 
in order to reach sufficient statistical power in logistic regression analysis when 
assessing the relationship between dietary GI/GL and metabolic health (alpha set at 
0.05, power of 0.85). 
 
SIRENS 
Sample size was calculated, based on a previous paper (Kadoglou et al. 2007) in 
which a significant decrease (P =0.023) in HOMA-IR (primary outcome measure) 
was found following treatment (aerobic exercise training) compared to a control 
group. To produce a significant effect size on HOMA-IR between treatment and 
non-treatment groups, a minimum sample size of 3 in each group is necessary 
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(alpha set at 0.05, power of 0.95). Moreover, a further power calculation was 
performed to determine the sample size required to detect a significant difference 
between two treatment types (e.g. aerobic exercise vs. diet), a sample size of 15 in 
each group was calculated (alpha set at 0.05, power of 0.80). Thus the required 
target sample size for the SIRENS study was 25 participants per group in order to 
achieve a minimum of 15 participants in each group (allowing for a 40% drop out 
rate). 
Sample size was estimated using the computer software package (G*power 3.1.2) 
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Chapter Four: Study One 
 Physical activity levels and Nutritional intake of postpubertal 
Bedfordshire adolescents: associations with adiposity 
 
4.0 Introduction 
 
A healthy lifestyle can be characterised by one which consists of adequate PA and 
a „healthy‟ diet, both of which have been positively associated with a lower 
incidence of overweight and obesity (Wareham et al., 2005). Obesity and 
particularly centrally located adiposity has been associated with a cluster of 
metabolic disorders associated with type II diabetes, atherogenic dyslipidemia and 
subsequent CVD (Despres and Lemieux, 2006).  
Diet and Adiposity 
Energy dense foods are considered a primary determinant of obesity and related 
diseases such as CVD (Phillips et al., 2010) and metabolic complications (Druet et 
al., 2007). Energy restriction has fundamentally been used to reduce obesity (Abete 
et al., 2011) but manipulation of macronutrient distribution has also been associated 
with weight reduction (Muzio et al, 2007). Traditionally, high fat diets were 
associated with increased adiposity and thus treatment of overweight and obesity 
was facilitated through lowering fat intake (Abete et al., 2010) which was 
subsequently compensated for by increasing CHO in place of fat. Increased dietary 
fat has been positively associated with body weight in large cross-sectional studies 
of males and females (Satia-About, 2002; Park et al., 2005) as well as in youth 
populations (Tucker et al., 1997; Ortega et al., 1995). This „low fat focused‟ 
approach proved successful at reducing energy density and weight loss for a short 
period; however, these diets appeared to have poor adherence over a longer period 
due to a lack of satiety which is now associated with low fat diets (Atrup, 2008) and 
some studies have shown weight re-gains after 18 months of dieting (Summerbell et 
al., 2008). Since 1976, as dietary fat consumption has declined, rates of obesity and 
its co-morbidities have continued to rise (Weinburg, 2004). It thus appears that low 
fat, high CHO diets may not be the most appropriate technique for targeting 
adiposity. Over more recent years evidence has emerged that the composition of 
CHOs can alter the speed at which they are metabolised and this can have 
implications for satiety and fat metabolism leading to weight gain (Ludwig, 2000, Du 
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et al., 2006). To this end, research has assessed the associations of CHO 
consumption with adiposity, in terms of the speed at which CHOs are absorbed into 
the blood stream; ranked by the GI and GL. The GI classifies CHO containing foods 
according to their impact on the body‟s postprandial glycaemic response (Du et al., 
2006), furthermore, as the quantity and not just the quality (GI) of CHO will impact 
on postprandial glucose levels the GL of the diet has also been considered. It has 
been evidenced that GI is positively associated with adiposity (Brand-Miller et al., 
2002), in adults; prospective cohort studies of adults have shown BF% and WC 
significantly increase in relation to dietary GI (Du et al., 2009; Hare-Bruun et al., 
2006). Furthermore, GI has been positively associated with BMI in  1354 Japanese 
females (20-78 yrs) (Murakami et al., 2006).  
There is limited evidence supporting positive associations of GI and GL in 
youngsters; in normal weight children (Scaglioni et al., 2005; Buyken et a.l, 2008) 
and overweight youths (Hui and Nelson 2006) higher glycaemic CHO was not 
associated with fatness. Furthermore, Joslowski et al (2011) observed that 
postprandial insulinemia was associated with adiposity but that GI and GL shared 
no association in 262 9-15 year olds. However, in 486 children and adolescents 
from Denmark, both GI and GL were associated with body fatness, in 16 year old 
males but not children or females; the lack of association in girls was purported to 
be related to the increased reporting bias observed in the young females of this 
study Nielsen et al (2005). These findings (Neilsen et al., 2005) appear to be the 
only to report association of GI and GL with adiposity in a potentially entirely 
postpubertal group (16 year old males; n = 181), however, pubertal status was not 
assessed. One study has assessed associations of glycaemic CHO and adiposity in 
(818) British children (4-10 yr olds) and adolescents (11-18 yr olds) based on data 
from The National Diet and Nutrition Survey (NDNS) (Murakami et al., 2013). The 
authors observed that increasing GL was independently associated with increased 
risk of overweight (BMI) in children (P= 0.04) and central obesity (assessed by waist 
to height ratio) in adolescents (P= 0.02) but GI was not associated with adiposity 
(Murakami et al., 2013). Although this recent publication is a relatively large 
representative sample of UK youths, the NDNS data analysed is not current; data 
were collected in 1997 and therefore are unlikely to represent current glycaemic 
CHO consumption. A further limitation is that this investigation utilised an age range 
of adolescents (11-18 yrs) that is likely to encompass individuals of varying pubertal 
status and thus findings may be confounded by puberty (Moran et al., 1999).  
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During puberty hormonal changes are responsible for altered substrate metabolism 
and a transient increase in insulin resistance which return to pre-pubertal levels in 
the last stage of maturational growth (Staiano and Katzmarzyk, 2012, Moran et al., 
1999); it is understood that these factors can influence metabolic health parameters 
(Hannon et al., 2006).  Furthermore, during puberty, fat mass, including visceral fat 
has been shown to increase in males and females, although, females are more 
susceptible to increased adiposity (Staiano and Katzmarzyk, 2012). Therefore, 
puberty may confound associations of GI and GL with adiposity.  
 
In summary, there is limited evidence of an association between glycaemic CHO 
and adiposity in youths. However, studies of children and adolescents tend to 
assess participants across a broad age range which encompasses pre-pubertal, 
pubertal and post-pubertal individuals. Therefore, it will be of benefit to assess these 
associations in a solely postpubertal adolescent population in an attempt to negate 
these confounding factors. The few studies investigating associations of adiposity 
with GI and GL in adolescents have only assessed adiposity according to BF% and 
BMI and not assessed associations with WC.  Adolescents are at a stage in their 
lives where they are making more autonomous lifestyle choices regarding their 
eating behaviours (Ebbeling et al., 2003) and thus an understanding of their dietary 
GI and GL and the associations they share with adiposity important. However, little 
is known of the dietary GI and GL of adolescents from the UK. One reason for this 
could be that the lack of published GI data on foods commonly consumed in the UK 
and many of the food brands published in GI tables are not accessible in the UK 
(Aston et al., 2008). Currently the most comprehensive data are based upon 
analysis conducted in Australia and the USA and thus the application of dietary GI 
and GL in a health context is little understood in UK adolescents (Aston et al., 
2008). 
Physical Activity, CRF and Adiposity 
It is well established that time spent being physically active shares an important 
association with obesity and associated co-morbidities (Wareham et al., 2005). 
Physical inactivity, or being sedentary may also play an equally important role in the 
development of adiposity (Healy et al., 2011). A cross-sectional study of European 
adults showed that being physically inactive (time spent sitting) shared a dose 
response relationship with obesity as assessed by BMI (Martínez-González et al., 
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1999). Two studies, one of healthy American and one of diabetic Australian adults, 
provide evidence in adults that objectively assessed SED time may be a more 
important determinant of obesity than MVPA. All physical activity categories 
(negatively) including sedentary (positively) were associated with an increased WC 
(Healy et al., 2008b, Healy et al., 2011). SED time was shown to be independently 
associated with WC regardless of time in MVPA, however after adjustment for SED 
time MVPA was no longer associated with WC. Additionally, (Healy et al., 2008a) 
evidenced that breaks in SED time were associated with a lower WC suggesting 
that a transition from SED to LPA may be a useful strategy for weight reduction. 
In children and adolescents PA engagement is negatively associated with adiposity 
(Deforche et al., 2003, Ekelund et al., 2012); however, compared to adults there is 
contrasting evidence in respect to which activity category is most important for 
adiposity. A study of school children identified that obese pupils, compared to non-
obese, engaged in a similar amount of PA in leisure time (LTPA) but took part in 
significantly less higher intensity sporting activities (Deforche et al., 2003), although 
PA was assessed by questionnaire. In a study of 9-10 year old British males, SED 
time was associated with an increased WC and fat mass (as in adults), however, 
associations were attenuated after adjustment for time in MVPA (Steele et al., 
2009). Furthermore, total PA and MVPA, were inversely associated with adiposity 
following adjustment for SED time (Steele et al., 2009). Similarly, MVPA was 
associated with WC independent of time spent SED in a large study of pooled data 
(n = 20871) in 4-18 year olds (Ekelund et al., 2012). As part of living a more 
independent lifestyle, adolescents are also making important decisions about their 
PA and exercise engagement. As children enter their adolescent years PA 
engagement begins to decline (Kimm et al., 2002) and a concomitant increase in 
weight status has been observed (Kimm et al., 2005). This may have important 
health implications as physical inactivity (measured by self assessed questionnaire) 
during adolescence (16-18 years old) has been shown to independently predict total 
and abdominal obesity levels in adulthood (25 years old) (Pietiläinen et al., 2008). In 
light of the evidence that MVPA is an important determinant of fatness and related 
health outcomes, the UK government recommend that children and adolescents 
should engage in >60 minutes of MVPA per day (DOH, 2011). 
In addition to PA, CRF is an important factor associated with obesity and metabolic 
aberrations (Ekelund et al., 2007b). In a study of 366 SED males, those with 
moderate CRF had a lower average total fat mass, WC and visceral fat than those 
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categorised in to the low CRF group (Janssen et al., 2004). Similarly, in a sample of 
3719 male and 3854 female adults (20-60 yrs), those with high CRF levels, 
demonstrated a lower WC and total fat mass compared to those with low CRF 
(Ross and Katzmarzyk, 2003) 
In 1045 children aged 6-13 total and abdominal body fat (assessed by the skinfold 
method) were lower in those with a high, compared to low CRF (estimated via 20 
metre shuttle run) (Nassis et al., 2005). In a large study of Spanish adolescents (13-
19 year olds), BMI and WC were inversely associated with CRF (20 metre shuttle 
run) and positively with SED activities (assessed by self report questionnaire); 
however, no relationship was seen between LTPA and adiposity variables (Ortega 
et al., 2007). CRF (20 metre shuttle run) and PA were objectively assessed (RT3 
accelerometer) in 7-10 year olds from Ireland; in girls fitness was also the only 
factor associated with body composition (inversely). In boys however body 
composition was negatively associated with both fitness and VPA (Hussey et al., 
2007). Very few studies have assessed the association of adiposity with PA and 
CRF in children and adolescents and there is a distinct lack of evidence for 
objectively assessed PA and directly measured CRF (VO2 uptake). Furthermore 
very few studies have assessed these relationships whilst controlling for dietary 
variables. 
Therefore the following study investigated the current: 1) dietary GI and GL intakes; 
2) objectively assessed physical activity levels; 3) directly measured CRF levels, of 
postpubertal adolescents from Bedfordshire. Due to the implications of overweight 
and obesity on cardio-metabolic health, the associations of dietary GI and GL, CRF 
and PA with adiposity were assessed in this group. 
 
4.1 Methodology 
Participants 
The 105 males and female adolescents recruited for this cross-sectional research 
were part of the CROSS-Sectional Study: Risk of Adolescent Disease 
(CROSSROADS) or Study of Insulin Resistance Factors: Exercise and Nutritional 
Strategies (SIRENS) studies. Participants were recruited on a voluntary basis from 
Bedford and Luton schools, colleges, GP surgeries and through paediatric 
consultants from the Luton and Dunstable Hospital (SIRENS only). Participants 
were excluded from the study if they were smokers, could not safely participate in 
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PA or if they had any known blood born diseases that could be hazardous to the 
health of the researchers. Ethical approval was granted by the University of 
Bedfordshire ethics board (CROSSROADS) and the NHS EREC (SIRENS). 
Informed consent was gained from all participants over the age of 16 and parental 
consent was gained for all participants under 16. 
 
Experimental Design 
Data collection was conducted at multiple locations to facilitate the research: the 
University of Bedfordshire Sports Science Laboratory, schools and colleges 
(CROSSROADS) and the Luton and Dunstable Hospital Centre for Obesity 
Research (SIRENS). Measures were taken between 7 and 10 am in an allocated 
data collection room within the school or consultation room at the COR. Participants 
were required to arrive ready for testing after having fasted since 9pm the previous 
night; they were instructed to consume water during this period (up to 4 hours prior 
to testing) to ensure they were hydrated. 
 
Measurements 
Age, Ethnicity and Social Economic Status 
The participants‟ date of birth was used to calculate age to two decimal places on 
the date of data collection. Ethnicity was recorded as non-white or white. 
Socioeconomic status (SES) was calculated for each participant based on home 
postcode converted into indices of multiple deprivation (IMD) using the 2007 IMD 
Geoconvert application (MIMAS 2008). A lower score represents greater 
deprivation. 
 
Anthropometry and Body Composition 
Suture and WC were recorded to the nearest 0.5 cm and 0.1 mm, respectively as 
outlined in section 3.5.  Body mass, and fat mass were recorded to the nearest 0.1 
kg using the Tanita BC-418 ® Segmental Body Composition Analyser (See section 
3.6). BMI was calculated using the following equation: BMI =body mass (kg)/height2 
(m2). 
 
Dietary Intake 
A three day (2 week days and 1 weekend day) weighed food diary was completed 
by each participant within 1 week of data collection as outlined in section 3.10. 
Intakes of nutrients and energy were averaged over the 3 day recording period. 
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Daily dietary GI and GL were calculated as outlined in section 3.10 of the 105 
participants recruited 98 (93.3%) adequately completed the 3 day weighed food 
diary.  
 
Physical Activity 
PA engagement was monitored using the RT3 triaxial accelerometer (Stayhealthy, 
Inc., Monrovia, CA) for 7 consecutive days. To be included in the analysis 
participants had to wear the accelerometer for a minimum of 3 days (2 week days 1 
weekend day), the minimum wear time was 9 hours per week day (Mattocks et al., 
2008) and 8 hours for a weekend day (Rowlands et al., 2004). See section 3.9 for 
further details. Of the 105 participants assessed a total of 75 participants (71.42%) 
met the required wear time for accelerometry.  
 
Time spent in different PA subcategories was assessed using the thresholds of 
Rowlands (Rowlands et al., 2004). The activity counts recorded each minute (CPM) 
were utilised to determine PA intensity based on the following thresholds: SED <288 
CPM; LPA 288-969 CPM; 970-2,332 CPM and VPA ≥ 2,333 CPM. Time 
accumulated in each PA category was subsequently calculated. Rowlands et al 
(2004) validated the RT3 against oxygen uptake relative to body mass in children 
within a controlled laboratory setting (r= 0.87, P <0.01) (Rowlands et al., 2004). 
 
CRF 
CRF was assessed by an incremental maximal cycle erometer test as outlined in 
section 3.8. Peak oxygen uptake at maximal exercise was measured using the 
Cortex MetaMax 3B breath by breath online gas analyser. Of the 105 participants 
98 (93.3%) participants completed CRF testing. 
 
Statistical Analysis 
Analyses were completed using the Statistical Package for Social Sciences (SPSS 
Inc., IL.), descriptive statistics are presented as mean and standard deviation (SD). 
The following variables were non-normally distributed and were subsequently log 
transformed to improve their distribution (BMI, BF%, WC, energy intake, GL, PRO, 
fat, CHO, PUFA, MUFA, SFA, sugar, salt, %fat, % PUFA and % SFA). After log 
transformation the relevant dietary variables were adjusted relative to energy 
(GL/1000kcal and fibre/1000kcal). Adiposity variables, BMI and BF% were 
converted to Z-scores based on population means for the age group. A raw WC 
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value has been used as the population mean data does not address the upper age 
range (17-19 yrs) of the population under investigation. Differences between sexes 
were assessed by One-way ANOVA. The relationship between dietary variables 
and adiposity variables were assessed by partial Pearson correlation analysis 
following adjustment for age, sex, SES and time spent SED. Partial correlations 
were also used to assess the relationship of PA, CRF and adiposity variables 
following adjustment for age, Sex, SES, %CHO, %PRO, %FAT and Fibre/1000kcal. 
MANCOVA was used to assess differences in adiposity (z-BMI, z-BF% and WC) 
between upper and lower quantiles of GI and GL these analysis were adjusted for 
the following covariates: age, sex, SES, %PRO, %FAT, %CHO, FIBRE/1000kcal, % 
time spent SED. MANCOVA was also employed to explore adiposity across upper 
and lower quantiles CRF (adjusted for  age, sex, ses, %PRO, %FAT, %CHO, 
FIBRE/1000kcal, % SED) of time spent in PA  subcomponents and in those who did 
and did not achieve >60 mins MVPA (adjusted for age, sex, ses, %PRO, %FAT, 
%CHO, FIBRE/1000kcal and total PA). As a result of adjusting the MANCOVA 
analyses for PA and diet a total of 72 participants were assessed due to the 
combination of participants providing both adequate diet and PA data. No colinearity 
was observed between covariates of MANCOVA models and the assumption of 
homogeneity of regression slopes was not violated as no significant interaction 
effects on adiposity variables were observed between any covariate or independent 
variables. Significance level was set at P <0.05 for all analysis. 
 
4.2 Results 
Table 3. Participant characteristics 
 
 
COMBINED 
(n=98) 
Males 
(n=61) 
Females 
(n=37) 
P 
Age (y) 
 
17.36 (1.40) 17.46 (1.22) 17.21 (1.64) .389 
Height (cm) 
 
172.40 (9.85) 177.80 (7.32) 163.64 (6.59) .000 
Weight (kg) 
 
71.25 (16.30) 71.66 (15.45) 70.59 (17.78) .746 
BMI (kg/m
2
) 
 
23.89 (5.59) 22.64 (4.65) 25.92 (6.39) .003 
BF (%) 
 
23.30 (10.89) 17.98 (7.49) 31.94 (10.02) .000 
WC (cm) 
 
80.33 (12.20) 79.44 (11.64) 81.76 (13.08) .346 
Table 3 shows anthropometric and adiposity characteristics of the population; P 
significant at <0.05 for comparison of males and females 
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Males and females had a similar mean age, males were significantly taller, yet 
females were of a similar weight to males. Females have a significantly greater BMI 
and BF% compared to males but share a slightly raised WC. 
 
Table 4 displays the mean intakes of dietary variable and the respective 
recommended intake according to SACN (2008). Mean GI values represented a 
low-moderate intake in all groups and a similar GI was consumed by males and 
females. Unadjusted mean GL values represented a high intake with males 
consuming a significantly greater GL than females (P =0.002), however, when 
adjusted for energy intake per 1000kcal females consumed a greater GL compared 
to males but this was not significant. Mean intake values were similar to 
recommended intakes for the total group as a whole and males and females 
separately. Minimum fibre intake recommendations were slightly exceeded and total 
fat intake appears to be within the recommendations. Females consumed 
significantly greater %CHO (P =0.031) whilst males consumed significantly greater 
salt (<0.001) and fat intake including: %FAT (P= 0.041), %SFA (P= 0.005), %MUFA 
(P=0.043) as well as fibre/1000kcal (P= 0.042) than females. 
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Table 4. Comparison of dietary intake versus current recommendations 
 
 
RECOMMENDED 
INTAKE
a 
TOTAL 
(n=98) 
Males 
(n=61) 
Females 
(n=37) 
P 
Value 
GI 
<55 Low 
55-69 Mod 
>70 High 
58.40 58.22 (4.94) 58.71 (4.23) .619 
GL (g) 
<80 Low 
81-119 Mod 
>120 High 
166.20 (59.43) 180.44 (56.69) 142.71 (57.00) .002 
Adj GL (g) 
(GL/1000kcal)  
77.37 75.36 (56.69) 80.69 (14.10) .059 
Energy (Kcal) 
 
Males: 2964      
b 
Females: 2110 
2169.61 
2423.60 
(811.70) 
1750.86 
(584.90) 
<.001 
PROTEIN (g) Males: 111      
b 
Females: 79 
87.21 (41.44) 100.13 (45.50) 65.91 (20.72) <.001 
CARBOHYDRATE (g) Males: 370      
b 
Females: 264 
283.58 
(103.97) 
310.80 (101.2) 238.99 (93.74) <.001 
FAT (g) Males: < 115     
b 
Females: <  82 
83.47 (36.70) 95.54 (37.15) 63.58 (26.00) <.001 
SATURATED FAT (g) Males: <  36    
b 
Females: < 26 
29.99 (14.20) 34.95 (14.12) 21.83 (10.05) <.001 
MONOUNSATURATED FAT 
(g) 
Males: 43    
b 
Females: 30 
27.08 (12.69) 31.14 (12.84) 20.40 (9.23) <.001 
POLYUNSATURATED FAT 
(g) 
Males: 21      
b 
Females: 15 
12.48 (6.77) 13.75 (7.11) 10.39 (5.66) .007 
PROTEIN 
(% of total energy) 
15 
 
16.12 
16.41 (3.78) 15.62 (3.96) .242 
CARBOHYDRATE 
(% of total energy) 
50 49.76 48.62 (6.71) 51.63 (6.46) .031 
Sugar % 
  
20.33 (7.77) 19.66 (7.81) 21.45 (7.69) .221 
FAT (% of total energy) < 35 34.29 35.38 (7.20) 32.49 (5.76) .041 
SATURATED FAT 
(% of total energy) 
< 11 
 
12.31 
12.99 (3.48) 11.18 (3.16) .005 
MONOUNSATURATED FAT 
(% of total energy) 
13 11.07 11.49 (2.59) 10.37 (2.68) .043 
POLYUNSATURATED FAT 
(% of total energy) 
6.5 5.17 5.10 (1.96) 5.28 (2.15) .687 
Fibre (g) 
 
11 13.82 14.79 (6.77) 12.22 (5.39) .050 
Fibre (g/1000kcal) 
  
6.49 (2.20) 6.14 (2.11) 7.07 (2.43) .042 
Salt (g) 
 
6 7.69 (3.19) 8.80 (3.27) 5.87 (2.02) <.001 
Mean and standard deviation; P significant at <0.05 for comparison of males and 
females; a, SACN (2008); b, SACN (2011) 
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GI was significantly positively associated with BMI (r= .240, P= <0.05), but GL was 
not correlated with any adiposity variables. GI was significantly inversely associated 
with fibre (r = -.281, P=<0.05) whilst GL was significantly negatively associated with 
PRO (r= -.366, P= <0.01) and positively with %CHO (r= .878, P= <0.01). 
Additionally, %CHO had a significant negative correlation with both %fat (r= -.713, 
P= <0.01) and PRO (r= -.426, P= <0.01). GL was significantly negatively correlated 
with % fat (r= -.606, P= <0.01) and with proportions of SFA, MUFA and PUFA 
(P=<0.01) (table 5). 
 
Table 5. Partial correlation coefficients for diet and adiposity variables. 
N=72 GI GL
a % 
CHO
 
% 
FAT
 
% 
SFA 
% 
MUFA 
% 
PUFA      
% 
PRO
 FIBRE
a 
BMI(kg/m
2
) 0.240* 0.038 -0.014 -0.107 -0.137 -.037  0.042 0.181 
BF% 0.218 0.128 0.095 -0.107 -0.132 -.042  -0.119 0.301* 
WC (cm) 0.191 0.125 0.098 -0.149 -0.123 -.055  -0.116 0.288* 
%CHO
 
0.101 0.878** 
  
   
  
%FAT
 
-0.037 -0.606** -0.713** 
 
   
  
%SFA -0.093 -0.431** -0.556** 0.825**    
  
%MUFA -0.053 -0.642** -0.712** 0.761** 0.622**   
  
%PUFA -0.170 -0.370** -0.404* 0.434** 0.032 0.489  
  
%PRO
 
-0.041 -0.366** -0.426** 0.045 -0.102 0.037 0.219 
  
FIBRE
a 
-0.281* 0.015 0.175 -0.219 -0.177 -0.202 -0.094 0.212 
 
Correlations adjusted for: sex, SES, age, MVPA;  a, Dietary variable per 1000kcal; *, 
P=<0.05; **, P=0.01  
 
 
 
Table 6. Crude mean and standard deviation of adiposity variables across 
quantiles of GI and GL  
 
GI GL 
N=72 
1 
(GI 54) 
2 
(GI 62) 
F  
value 
P 
value 
1 
(GL 66) 
2 
(GL 88) 
F  
value 
P  
value 
         
BMI 23.16 (5.76) 24.50 (5.68) 7.26 .009 23.14 (5.15) 24.51 (6.24) 0.69 .410 
         
BF% 22.45 (11.06) 23.96 (11.13) 5.88 .018 21.26 (10.01) 25.15 (11.81) 2.42 .125 
         
WC 78.70 (10.67) 81.72 (14.07) 6.07 .017 79.49 (12.69) 80.93 (12.42) 0.985 .325 
         
1 and 2 represent the lower and upper quantile, respectively; analysis adjusted for: 
sex, age, SES, %PRO, %FAT, %CHO, FIBRE/1000kcal, MVPA 
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As shown in table 6, the higher quintile of GI (62) vs lower (54) was associated with 
a significantly greater BMI, BF% and WC (P=0.009, 0.018 and 0.017, respectively). 
Although adiposity variables were higher in those grouped in the higher quintile of 
GL, none of these associations were significant. 
 
Table 7. Energy expenditure, physical activity and fitness characteristics 
 
Total 
n=98 
Male 
n=61 
Female 
n=37 
P value 
TEE (kcal)
 a
 2474.48 (523.97) 2636.16 (511.79) 2231.96 (448.70) <0.001 
TotalPA
a 
718.37 (110.10) 712.15 (112.93) 728.82 (106.38) 0.529 
SED T (min)
a
 517.82 (107.64) 508.65 (108.48) 533.22 (106.36) 0.342 
 LPA T
a
 135.77 (57.10) 134.49 (63.08) 137.92 (46.35) 0.804 
MPA T
a
 50.90 (23.74) 53.24 (24.41) 46.98 (22.46) 0.273 
VPA T
a
 14.67 (12.99) 16.45 (15.01) 11.68 (7.99) 0.212 
MVPA T
a
 66.29 (35.87) 71.40 (39.48) 57.71 (27.37) 0.110 
SED P
a
 72.16 (10.22) 71.56 (11.33) 73.17 (8.12) 0.513 
LPA P
a
 18.63 (7.10) 18.61 (8.00) 18.68 (5.39) 0.966 
MPA P
a
 7.12 (3.58) 7.46 (3.38) 6.55 (3.90) 0.363 
VPA P
a
 2.11 (2.02) 2.42 (2.36) 1.60 (1.12) 0.149 
MVPA P
a
 
(>60 mins/day 
recommended
b
) 
9.11 (4.96) 9.69 (5.13) 8.15 (4.57) 0.456 
% achieving  
60 min MVPA 
a
 
54.7% 61.7%  42.9% - 
VO2 peak (ml/kg/min) 42.65 (13.0) 49.53 (10.18) 31.18 (8.19) <0.001 
Mean (standard deviations); a, n= 75, combined; 47, males; 28, females; b, (DOH, 
2011); T, time in minutes; P, percentage; P, significant at <0.05 for comparison of 
males and females. 
 
Table 7 displays PA and CRF characteristics; there were no significant differences 
between males and females for time spent in any PA category including SED time. 
Females spent a greater proportion of time SED and engaging in LPA whilst males 
spent more time in MPA and VPA, but these differences were not statistically 
significant. On average participants spent > 60 minutes engaging in MVPA (66.29 
minutes; 54.7%), however, females only spent 57.71 minutes (42.9%) in MVPA 
whilst males engaged in 71.40 minutes (61.7%).  
64 
 
The average VO2 peak for all participants was 42.65 ml/kg/min, in males this value 
was significantly greater when compared to females (49.53 ml/kg/min vs 31.18 
ml/kg/min, respectively; P= <0.001). 
 
Table 8. Partial correlation coefficients for PA and CRF variables with 
adiposity. 
N=72 SED LPA MPA VPA MVPA CRF 
BMI -0.209 -0.076 0.059 -0.203 -0.016 -0.672** 
BF% -0.188 -0.052 0.148 -0.119 0.056 -0.707** 
WC -0.198 -0.078 0.112 -0.188 -0.013 -0.668** 
LPA -0.319* 
     
MPA -0.438** 0.671** 
    
VPA -0.191 0.295* 0.453** 
   
MVPA -0.401** 0.624** 0.851** .683** 
  
CRF 0.057 0.203 -0.011 .103 -.023 
 
*, P =<0.05; **, P= <0.01; Correlation adjusted for: Sex, age, SES, %CHO, %PRO, 
%FAT and Fibre 
 
Table 8, shows that time spent SED is significantly and inversely correlated with 
engagement in LPA (P= <0.05), MPA and MVPA (P=< 0.001). LPA, MPA, VPA and 
MVPA were all significantly and positively correlated with each other. Correlations 
show that no PA variables were significantly correlated with adiposity, however, 
CRF was significantly and negatively associated with all adiposity variables 
(P=<0.001). 
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Table 9. MANCOVA: Mean and standard deviation for adiposity variables 
across 50th percentiles of time spent in PA categories. 
N=72 SED (mins) LPA (mins) MPA (mins) 
 1 
(43.48) 
2 
(598.86) 
F 
value 
P 
value 
1 
(90.74mins) 
2 
(178.28) 
f P 
1 
(31.49) 
2 
(68.37) 
F 
value 
P 
value 
BMIz 
0.84 
(1.49) 
0.87 
(1.67) 
0.63 .432 
0.78 
(1.46) 
0.93 
(1.69) 
0.07 .789 
0.83 
(1.66) 
0.87 
(1.51) 
1.33 .254 
BF%z 
1.51 
(3.27) 
1.95 
(3.11) 
0.56 .457 
1.55 
(3.05) 
1.92 
(3.34) 
0.00 .969 
1.67 
(3.11) 
1.79 
(3.28) 
2.17 .146 
WC 
(cm) 
81.75 
(14.08) 
81.04 
(11.74) 
0.65 .425 
82.36 
(13.08) 
80.44 
(12.78) 
0.53 .470 
81.19 
(12.05) 
81.60 
(13.77) 
0.77 .382 
 
 VPA (mins) MVPA (mins) 60 mins 
 1 
(5.83) 
2 
(23.12) 
F 
value 
P 
1 
(46.23) 
2 
(84.97) 
f P >60 <60 
F 
value 
P 
BMIz 
1.04 
(1.64) 
0.67 
(1.50) 
0.42 .519 
0.83 
(1.68) 
0.87 
1.48) 
1.64 .205 
0.82 
(1.52) 
0.90 
1.65) 
1.21 .276 
BF%z 
1.92 
(3.08) 
1.54 
(3.30) 
0.05 .817 
1.52 
(3.06) 
1.95 
(3.32) 
3.75 .057 
1.82 
(3.30) 
1.64 
(3.07) 
3.19 .079 
WC (cm) 
81.80 
(12.36) 
80.99 
(13.53) 
0.31 .577 
80.83 
(11.74) 
81.97 
14.06) 
1.10 .298 
81.52 
(13.88) 
81.25 
(11.79) 
0.86 .357 
1 and 2 represent the lower and upper quantile, respectively; analysis adjusted for: sex, 
age, ses, PRO, FAT, CHO, FIBRE, total PA and CRF. 
 
MANCOVA revealed that adiposity variables were not significantly different across quintiles 
of PA (table 9).  
 
Table 10. MANCOVA: Means and standard deviation for adiposity variables across 
VO2 peak 
N=72 VO2 PEAK CRF risk 
 
1 
(31.48 
ml/kg/min) 
2 
(53.00 ml/kg/min) 
F 
value 
P 
value 
LOW RISK 
HIGH 
RISK 
F 
value 
P 
value 
         
BMI Zscore 1.95 (0.26) -0.14 (0.25) 20.74 <.001 0.04 (0.21) 2.05 (0.25) 26.45 <.001 
         
BF% Z score 3.86 (0.51) -0.19 (0.49) 21.46 <.001 0.82 (0.39) 4.15 (0.48) 31.73 <.001 
         
WC (cm) 1.95 (0.01) 1.85 (0.01) 17.81 <.001 1.87 (0.01) 1.96 (0.01) 26.93 <.001 
         
1 and 2 represent the lower and upper quantile, respectively; analyses adjusted for: 
Sex, age, SES, PRO, FAT, CHO, FIBRE and MVPA. 
 
Table 10 compares adiposity variables across quantiles of CRF; individuals in the 
higher compared to lower quintile of VO2 peak had a significantly lower BMI, BF% 
66 
 
and WC (P= <0.001). When CRF was categorised in terms of health risk; high risk 
(VO2 peak < 42 and < 37 ml/kg/min) and low risk (VO2 peak > 42 and > 37 
ml/kg/min) for males and females, respectively, those in the high risk category had a 
significantly greater BMI, BF% and WC (P= <0.001). 
 
4.3 Discussion 
The current study investigated the associations of dietary intake, PA level, and CRF 
with adiposity (BMI, BF% and WC) in a postpubertal adolescent population from 
Bedfordshire. The main findings of this investigation were that GI but not GL is 
significantly associated with adiposity (BMI, BF% and WC). Furthermore CRF but 
not PA was associated with adiposity when analyses were adjusted for 
macronutrient intakes. Additionally, this population of postpubertal adolescents from 
Bedfordshire appear to be consuming a similar proportion of macronutrients (CHO, 
49.76; PRO, 16.12; fat, 34.29 % of energy) to the current recommendations (see 
table 4). MUFA and PUFA are also being consumed in line with government 
guidelines, % intake of SFA however are being slightly over consumed (by 1.31%) 
and salt intake appears to be slightly above recommended levels (by 1.69%). Males 
are consuming significantly greater proportions of energy as fat and less 
fibre/1000kcal compared to females. Partial correlations demonstrated that PRO 
and fat were significantly and negatively correlated with CHO. Furthermore males 
consumed significantly lower proportion of energy as CHO (P=0.031) and a higher 
proportion of PRO compared to females.  
 
Although the proportions of macronutrients consumed were congruent with 
government guidelines (table 4), it appears that this sample of adolescents is under 
consuming energy compared to that of current guidelines (2500 kcal for males and 
2000 kcal for females); however, these recommendations are specific to adults and 
may not be relevant to the younger adolescents in the current sample. Males and 
females consumed 2423.60 and 1750.86 kcal/day, respectively, which is 
comparable to findings from a study involving a large sample (n=2869) of UK 
adolescents (mean age 13.79 years) where males and females consumed 2155 ± 
13.4 and 1784.85 ± 10.2, respectively, based on 3 day dietary records (Noel et al., 
2010). In contrast, in a sample of Danish 16 year olds from the European Youth 
Heart Study, mean energy intakes of males and females were 3033.34 and 2149 
kcal/day which is considerably higher than that of the current sample; however, this 
group are younger than those in the current sample and PA engagement was not 
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reported and thus cannot be compared. Furthermore, data were obtained by a 
combination of a 24 hr recall and qualitative food records (Nielsen et al., 2005).  
When considering a more specific UK national average energy intake for 
adolescents, according to SACN (2011), this discrepancy is more exaggerated; 
2964 and 2110 kcal/day, respectively for males and females. It may not, however, 
be that this group as a whole are consuming less energy than they require as it is 
possible that some individuals may be underreporting their nutritional intake 
(Livingstone et al., 2004).  Misreporting of energy intake can impact on associations 
of diet and health markers (Rosell et al., 2003) and therefore should be assessed 
and potentially controlled for in this population. As energy requirement is determined 
by PA and body mass, it makes comparison of energy intakes between different 
studies difficult and thus understanding misreporting, relevant to individual energy 
requirements, is important when comparing nutritional intakes across studies. 
 
The dietary GI of this group represents a low-moderate value (58.40; moderate GI= 
55-69) and this value is similar in both males and females. Unadjusted GL, 
however, represents a high intake and males consume a significantly greater GL 
than females (180.44 vs 142.71 g, respectively). After adjustment for total energy, 
GL/1000kcal becomes borderline-significantly higher in females compared to males 
(80.69 vs 75.36 g/1000kcal; P=0.059), this is likely due to the higher proportion of 
energy as CHO consumed by females (51.63%) compared to males (48.62%). 
These glycaemic CHO data for the group are very similar to that of a sample (n=16) 
of overweight males and female adolescents from the USA who consumed a mean 
GI of 58 and GL (g)/1000kcal of 79, based on 7 day food diary data (Ebbeling et al., 
2003). In Danish 16 year olds, however, compared to the current sample, GI was 
46% and 26% higher and GL was 71.8% and 103% higher, for males and females 
respectively, assessed by 24 hr recall. Different methods of dietary assessment can 
influence the assessment of GL (Nielsen et al., 2005), this may therefore explain the 
differences seen between Danish adolescents and the current sample of UK 
adolescents. Furthermore, this notion may support the similarities noted between 
adolescents from the USA (Ebbeling et al., 2003) and the current sample as both 
studies utilised multiple day food diaries. There appears to be limited investigation 
into the habitual dietary GI and GL levels of adolescents (Nielsen et al., 2005) and 
more so for UK adolescent populations. In comparison to the current study, a similar 
mean dietary GI (59.4 and 58.2, for males and females, respectively) was also 
identified in a large study (n=1275) utilising UK NDNS data of adults (+ 65 years), 
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suggesting dietary GI of UK older adults and adolescents may be similar. However, 
dissimilar GI values compared to the current sample of adolescents have been 
observed in adults when assessed by FFQ;  in males from USA enrolled in the 
Health Professionals Study (Salmerón et al., 1997) and female adults (Michaud et 
al., 2002) from the Nurses‟ Health Study in the UK (GI 72.4 and 73.4), however GL 
values for male and female adults were similar to adolescents in the current 
investigation (GL 160 and 126.6, respectively). There appear to be contrasting 
findings in terms of habitual GI and GL intake amongst adolescents from the UK 
and Europe, however, apparent differences in dietary assessment method may help 
explain some of this discrepancy. 
 
In the present study dietary GI was associated with adiposity; partial correlations 
revealed that GI was significantly and positively correlated with BMI (P=<0.05). The 
only other dietary variable to be associated with adiposity was fibre, which was 
significantly positively associated with BF% and WC (P= <0.05). The narrow range 
of dietary GI consumed by this group makes stratifying the sample into categories of 
low, moderate and high GI implausible, however, when split into quantiles, mean GI 
consumption of the two groups represented a low GI (54) and moderate GI (62). 
MANCOVA demonstrated that individuals in the moderate compared to low GI 
group have a significantly higher BMI (P=0.009), BF% (P=0.018) and WC (P= 
0.017). GL, however, was not associated with adiposity in any analyses. In contrast 
to these findings, in Italian children (8 years old), BMI was not associated with GL or 
GI when assessed by FFQ (Scaglioni et al., 2005) and in German youngsters 
between the ages of 2 and 7 years GI and GL (measured by 3 day records) were 
not associated with BMI or BF% (Buyken et al., 2008). It is possible that the age 
difference of the current population is, in part, responsible for these contrasting 
associations; however, in a longitudinal study of pubertal adolescents from 
Germany, assessed over 4 years between the ages of 10.3 and 14.3 years old, 
changes in GI and GL (3 day diet records) were not associated with concurrent 
alterations in BMI or BF% (Cheng et al., 2009).  In line with the current investigation, 
only a small number of studies have found positive association of GI with adiposity, 
Nielsen et al (2005) found that fatness assessed by skinfold analysis was 
significantly and positively associated with both GI and GL in 16 year old males. 
Association with females, however, were non-significant and it was postulated that 
the greater degree of reporting bias in females may be responsible for the lack of 
association (Nielsen et al., 2005), indeed, under reporting seems to increase as 
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children mature into adolescence (Bandini et al., 2003). This is supported by 
evidence from Japanese adolescents where higher GL was associated with greater 
relative risk of overweight (BMI >25 kg/m2), but only in males (Murakami et al., 
2011).  It is possible that the apparent reporting bias observed in the current 
investigation may be responsible for the lack of association seen between GL and 
adiposity. Under-reporting is likely to result in underestimation of GL, whereas GI 
may not be affected due to the nature of its calculation (Nielsen et al., 2005). This 
highlights the importance of considering dietary misreporting when assessing diet 
and health relationships. It is clear that there is a lack of consistency in terms of 
dietary assessment method when investigating associations of GI and GL and thus 
it is difficult to make clear comparisons between these data.  
 
Increased adiposity associated with higher dietary GI have been explained by 
evidence that low GI foods increase satiety and have been shown to result in less 
energy intake at subsequent meals (Ludwig., 2000); this has been evidenced in 37 
normal and overweight children aged 9-12 yrs who achieved greater satiation and 
consumed less energy at later meals following a low compared to high GI breakfast 
(Warren et al., 2003). Indeed, low GI mixed meals have induced greater secretion of 
satiety hormones (gut peptide cholecystokinin) in male adults (Holt et al., 1992). The 
slower rates of digestion and thus absorption at the small intestine subsequent to 
low GI foods are likely to result in extended feedback via gut peptides, including 
ghrelin, glucagons and glucagons-like peptite-1 to the satiety centre of the brain 
whilst nutrients receptors are stimulated for a longer period of time compared to 
more rapidly digested and absorbed high GI foods (Radulian et al., 2009). 
 
Higher fat oxidation has also been associated with low compared to high GI foods; 
significantly greater fat oxidation over a 3 hour rest period and during a 60 minute 
bout of moderate intensity exercise, was observed following consumption of a low 
vs high GI breakfast and lunch in sedentary adult females (Stevenson et al., 2009). 
Scazzina et al (2011) compared rates of fat oxidation and diet induced energy 
expenditure elicited from 3 isocaloric breakfasts: 1) high GI (HGI)-high GL (HGL); 2) 
HGI-LGL (LGI); 3) LGI-LGL in 16 young adult males (23 ± 2 yrs old) , significantly 
greater fat oxidation was observed following both the HGI-LGL and LGI-LGL 
compared to the HGI-HGL breakfast; interestingly the authors observed that the 
LGI-LGL breakfast consistently increased postprandial energy expenditure and fat 
utilisation compared to the other diets, furthermore this effect was observed even 
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after the following meal . Therefore, it appears that lowering the GI and GL of the 
meals induced greater fat utilisation and energy expenditure as compared to lower 
GL alone. According to Wolfe (1998) postprandial increases in glycaemia and 
insulinaemia, following high GI meals, results in activation of key rate-limiting 
enzymes that increase CHO oxidation. Furthermore, malonyl-CoA; an intermediate 
of CHO oxidation, strongly inhibits fatty acid transport into the mitochondria (Wolfe, 
1998). More recently (Roberts et al., 2008) demonstrated that a high CHO diet, 
comparable to high GI and GL altered fatty acid partitioning towards esterification 
and away from oxidation. Additionally, the late postprandial hypoglycaemia following 
high GI foods and subsequent counter regulatory hormone response is associated 
with an increased propensity for protein metabolism in order to restore euglycaemia 
(Zurlo et al., 1990; Weyer et al., 2000). Thus, low GI eating has been associated 
with preserved lean mass compared to high GI (McMillan-Price and Brand-Miller, 
2006); a greater BMR would increase energy expenditure and lower energy storing 
which is likely to have a favourable impact on adiposity (Scazzina et al., 2011). 
Therefore, it would appear, that in support of current findings, low GI foods increase 
rates of fat metabolism and postprandial energy expenditure and that reducing the 
GI of the diet may be more impactful.  
 
Government guidelines for PA state that children and adolescents should achieve 
≥60 minutes MVPA in order to maintain or improve health (DOH, 2012). The current 
investigation identified that 54.7% of the population achieved ≥60 minutes MVPA 
and, on average, participants achieved 66.29 ± 35.87 minutes of MVPA, 517.82 ± 
107.64 minutes of SED and a total PA of 718.37 ±110.10 minutes. Males spent 
more time in MVPA (71.40 ± 39.48 minutes) than females who as a group did not 
meet the current recommendations (57.71 ± 27.37 minutes), differences, however, 
were non-significant. Differences in time spent in any PA category between males 
and females were non-significant, although females appear to spend more time 
SED and engaging in LPA where males spent more time in MPA and VPA . A 
younger sample of children (10-14 years old) also from Bedfordshire, UK (Bailey et 
al., 2012a), spent less time SED (451.91 ± 79.74) and more time in MVPA (109.24 ± 
37.31) as compared to the current sample. The difference in age between 
Bedfordshire children (Bailey et al., 2012a) and adolescents in the current study is 
likely to, in part, be responsible for the difference in PA engagement and this is 
supported by evidence that PA engagement declines as children enter adolescence 
(Kimm et al., 2002). As Bailey et al (2012a) and the current study used the same 
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methods for assessing PA (7 day triaxial accelerometry), these comparisons can be 
made with a relatively good level of confidence. Further comparisons can be drawn 
from a large sample of pooled data from the International Children‟s Accelerometry 
Database (ICAD), where children and adolescents (4-18 years old) engaged, on 
average, in 835 minutes of total PA, 30 minutes MVPA and 354 minutes SED 
(Ekelund et al., 2012). In this international study males also engaged in greater 
MVPA (37 ± 23 vs 24 ± 17 mins) and spent less time SED (345 ± 96 vs 365 ± 96 
mins) compared to females, respectively, however, unlike in the current study, in 
this large sample (n=20,871) differences were significant (P=0.001). It is important 
to note the difference between the cut-points used to define PA categories between 
the current study and that of (Ekelund et al., 2012), as this will undoubtedly result in 
dissimilarities between time spent in different PA categories. Ekelund et al (2012) 
utilised PA cut points of >3000 counts per minute (CPM) and < 100 CPM to define 
MVPA and time spent SED, respectively, compared to the current study which 
utilised cut points of >970 CPM and < 288 CPM, to define MVPA and SED, 
respectively. Indeed, a study of 104 Bedfordshire children (10-14 yrs old) identified 
markedly different times accumulated in PA categories when comparing 3 different 
published cut-points (Bailey et al., 2013). The authors also observed that the use of 
different cut points resulted in different associations of PA and metabolic health 
markers including BF%. This highlights the issues related to the lack of continuity 
between PA cut-points used to calculate PA in the literature. 
 
In the current investigation PA parameters including MVPA and time spent SED 
were not associated with adiposity. However, in a previous study of 9-10 year old 
children, BMI, WC and fat mass were associated inversely with MVPA and MPA 
and VPA individually as assessed by a uniaxial actigraph accelerometer, and 
adjusted for total energy  intake (Steele et al., 2009).  In a similar study, which 
assessed an age range of  4-18 year olds, Eckelund et al (2012) identified that 
MVPA was inversely associated with WC in a pooled sample of 20,871 4-18 year 
olds. However these studies (Eckelund et al., 2012 and Steele et al., 2009) did not 
adjust for macronutrient intake. The present investigation, however, did control for 
macronutrient intake (fat, PRO, CHO and fibre) and therefore, adjustment for 
nutritional intake may have attenuated the associations of PA with adiposity.  
 
In the present study CRF standardised for body weight was significantly higher in 
males than females (P=<0.001), mean CRF values for all participants and males 
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and females, respectively were very similar to that of 10-14 year old children from 
Bedfordshire (Bailey et al., 2012); all participants‟ CRF: 42.65 ± 13.0 vs 41.58 ± 
9.38, males: 49.53 ± 10.18 vs 45.96 ± 8.21 and females: 31.18 ± 8.19 vs 38.54 ± 
8.98 ml/kg/min, respectively.   
 
In the current sample of postpubertal adolescents, partial correlations revealed that 
CRF was significantly inversely correlated with BMI, BF% and WC (Table 8). 
Furthermore, MANCOVA revealed that BMI, BF% and WC were significantly higher 
(P= <0.001) in individuals in the lower vs higher quintile of VO2 peak (31.48 vs 53.00 
ml/kg/min) and in those grouped into the high risk (< 42 and < 37 ml/kg/min) 
compared to low risk (> 42 and > 37 ml/kg/min, for males and females, respectively) 
CRF group. Similarly, Bailey et al (2012) showed that WC was significantly higher 
when children were stratified as unfit compared to fit (assessed by maximal cycle 
ergometer test) but no association was observed when grouped in terms of PA 
engagement (measured by RT3 triaxial accelerometer) in 10-14 year olds from 
Bedfordshire. In further support of these findings, in a similar age group to the 
present study, Ortega et al (2007), observed inverse associations for CRF with BMI 
and WC independent of SED activities and leisure time physical activity (CRF 
assessed by 20 metre shuttle run) in Spanish adolescents (13-18.5 years old). The 
current findings and supporting research suggest that CRF is more strongly 
associated with adiposity than PA. 
 
It is possible that the lack of relationship between PA and adiposity may be 
explained by  limitations surrounding the use of accelerometry; the sporadic nature 
of PA in youngsters (Baquet et al., 2007) may mean that the 1 minute epochs 
utilised in the current study may not capture some higher intensity activities, 
however shorter sampling rates were not possible within the remit of the equipment 
available. Furthermore, accelerometry is limited in its ability to capture certain 
activities, for instance, it may not accurately measure upper body movements, 
cycling or activities on an incline and cannot be used to assess water based 
activities. Additionally, PA categories were assigned based on the cut-points of 
Rowlands, which have been validated in children and adults (Rowlands et al., 
2004a). However, there are inconsistencies between cut-points used in the literature 
and thus the most representative PA cut-points for youths are not fully understood 
(Ridgers and Fairclough, 2011) making comparisons between studies difficult. 
Another limitation is the study‟s cross-sectional design, and thus, the direction of 
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causality cannot be elucidated, however, future work will assess the impact of 
interventions on health markers in this group. 
Strengths of this study include the direct measurement of oxygen uptake during a 
maximal cycle ergometer test to assess CRF and the use of weighed food diaries to 
measure nutritional intake. Furthermore, the use of a postpubertal adolescent 
population means the impact of hormonal changes during puberty are likely to be 
minimised. 
 
  In conclusion, GI but not GL is associated with adiposity in this group of post-
pubertal adolescents from Bedfordshire. When adjusting for dietary intake, CRF was 
also associated with adiposity but PA was not. These data suggest that 
recommendations for this age group should target improvements in CRF and a 
lower dietary GI to reduce adiposity. This is of particular importance in light of 
evidence that the metabolic abnormalities associated with increased adiposity 
(Despres and Lemieux, 2006) have been shown to track from adolescents  into 
adulthood (Camhi and Katzmarzyk, 2010). It appears that this group are consuming 
below that of recommended energy intakes. However, it is quite possible that a 
proportion of this group are misreporting their nutritional intake (de Vries et al., 
1994, Posluna et al., 2009) which may distort associations of GI, GL and adiposity. 
Thus future research should aim to account for dietary reporting bias when 
assessing the associations of GI and GL with health markers in this population. 
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Chapter Five: Study Two  
The use of objective physical activity monitoring to assess 
the accuracy of recorded energy intake in adolescents. 
 
5.0 Introduction 
 
Measurement of nutritional intake is an important tool that can be used to guide an 
individual through a weight loss programme or to assess the relationship between 
dietary and health parameters during a dietary intervention (Anderssen et al., 
2007a) or observational study (Murakami et al., 2013). However, accurately 
measuring dietary intake is not a straight forward process as currently the only time 
and cost effective method for assessment is self report. Errors in self reporting of 
nutritional intakes can lead to inaccurate assessment of dietary intakes, either 
through failure to recall all foods consumed or by underestimating the amount 
eaten, known as misreporting. Dietary misreporting is defined as a deviation 
between reported EI and measured EE when body weight is assumed constant 
during the assessment period (Poslusna et al., 2009). Population characteristics, 
such as age, sex and adiposity, have been shown to affect the degree of 
misreporting (Collins et al., 2010, Murakami et al., 2012) . Ascertaining accurate 
intakes in overweight and obese can be more challenging than in normal weight 
individuals, as under reporting generally increases with BMI (Poslusna et al., 2009); 
according to Subar et al (2003) and Mahir et al (2006) BMI was a significant 
predictor of underreporting in adults. Additionally, studies have identified that a 
higher proportion of females and older participants underreport nutritional intakes 
(Hirvonen et al., 1997; de Vries et al., 1994). Furthermore, there is evidence that 
under reporting increases with age, from childhood into adolescence (de Vries et al., 
1994). This is of particular importance as evidence suggests that misreporting can 
cause spurious associations between diet and health outcomes; in 301 65 yr old 
men, Rosell et al (2003), observed that associations of PUFA, Ώ 3 fatty acids and 
fats from milk with fasting insulin concentrations were significantly stronger in under-
reporters compared to non under-reporters. Furthermore, although under-reporters 
had higher food and nutrient densities, suggesting they followed a more healthy diet 
compared to non under-reporters, the prevalence of the metabolic syndrome was 
significantly higher in under-reporters (18 vs 9 %; P= 0.029) compared to non 
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under-reporters. Therefore it appears that misreporting has important implications 
for studies investigating diet-health relationships (Poslusna et al., 2009).  
 
Traditionally, biomarkers were utilised to assess the validity of self reported 
nutritional intakes; namely 24 hour urinary nitrogen excretions to assess validity of 
protein intakes (Isaksson, 1980) and measurement of EE by DLW (Scholler and 
Van Santen, 1982). Based on the principle that in weight stable individuals EI and 
EE are equal (Rosenbaum et al., 1996) the comparison of reported EI with EE 
(DLW) allows for bias in reported intakes to be assessed. This work was furthered 
by (Goldberg et al., 1991) who assessed reported EI by comparison with estimated 
ER. The Goldberg et al (1991) equation calculates the confidence limit or cut-off of 
the sum of EI:BMR ratio below which it is unlikely that mean EI is representative of 
habitual intake or a random low intake. This technique assumes a PA level (PAL 
value), relative to BMR, for the population and accounts for the within-subject 
variation in estimated EI, the variation of the precision of BMR estimates, the total 
variation in PAL and the sample size being assessed (see literature review, section 
2.7, Dietary Misreporting, for more detail). The Goldberg equation has become a 
useful tool for the assessment of underreporting (Black et al., 1976), and is widely 
used in more recent research (Vågstrand et al., 2009, Lanctot et al., 2008, 
Lillegaard et al., 2007). Early studies utilised a PAL value of 1.55 x BMR, based on 
the value for „light activity‟ defined by the WHO (1985) and is a likely minimum ER 
for sedentary but healthy individuals (Goldberg et al., 1991). If EE is unknown and 
PAL is therefore assumed, only the lower confidence limit can be calculated and 
reported EI is classified as „low‟ or „non-low‟. If the PA of a population is known an 
appropriate PAL value can be assigned and the upper confidence limits can be 
calculated; in these circumstances over-reporters can be identified (Black, 2000). 
For the purpose of this thesis dietary reporting will be defined as under, valid or over 
reporting. Studies have utilised the Goldberg equation to assess reporting at the 
individual level and thus the characteristics of „under-reporters‟ has been assessed 
(Pryer et al., 1997; Rotishauser et al., 1994). However these studies presumed a 
1.55 PAL value and would only be able to accurately identify bias in reported food 
intakes of those leading a low active lifestyle (Black et al., 1997; Black, 2000). 
Moreover, the degree of misreporting has likely been underestimated in those with a 
higher PAL value than the traditional 1.55 x BMR. As many dietary surveys include 
participants with a broad range of EE, a PAL value should be estimated for stratified 
sub-groups of the population based on physical activity habits, or to be more 
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specific, an individual PAL value can be applied when calculating a cut-off for 
EI:BMI. The Goldberg equation was shown to be a good predictor of misreporting 
compared to directly assessed EE by DLW (r =0.65, P= <0.0001), but only when 
information regarding PA was known, moreover, when a specific PAL was 
calculated from directly assessed energy EE (DLW) data the validity of the Goldberg 
equation improved further (Black et al., 1997). This highlights the importance of PA 
information and that if an individual PAL can be ascertained then misreporting can 
be quantified with greater validity. Physical activity data can be gained via 
questionnaire and can be used to assign a PA sub-group (e.g. sedentary, low 
active, moderately active or highly active) or individual PAL. Self reported PA, 
however, can be prone to reporting error (Sirard and Pate, 2001: Trost, 2007) and 
may lack the accuracy required to gain valid insight into an individual‟s PA habits. 
Therefore, more recently, accelerometry has allowed for a more objective 
assessment of PA that can be applied to the assessment of misreporting by 
estimating an appropriate PAL based on time spent in different PA subcategories, 
namely MVPA, however, it seems very few studies have utilised accelerometry in 
this manner (Samuel-Hodge et al., 2004; Noel et al., 2010). Although, when a more 
specific sub-grouping of PAL (using accelerometry) is applied to the calculation of 
the Goldberg cut-offs, it is likely that PAL will be under estimated in some 
individuals, particularly those who engage in more LPA and less MVPA being that 
MVPA   is used to assign  PAL sub-groups (Noel et al., 2010) 
 
If individual EE is known it can be directly compared with EI; and the ratio of EI:EE 
will therefore represent the degree of reporting bias (Rosenbaum et al., 1996). The 
expensive and time consuming nature of DLW as well as the requirement for a 
sophisticated laboratory set up means that it cannot be routinely used to measure 
EE and validate EI (Poslusna et al., 2009). Although accelerometry has been used 
to assign a PAL (based on time accumulated in MVPA) when estimating the 
Goldberg cut-off, very few studies have directly compared accelerometry obtained 
EE with EI for the assessment of misreporting. Underreporting has been assessed 
by direct comparison of EI and EE (assessed by 3 x 24 hour recalls and uniaxial 
accelerometry, respectively) and compared to EI:BMI by calculating a participant 
specific PAL for use in the Goldberg cut-off (Samuel-Hodge et al., 2004). 
Participants were classified as under-reporters if the ratio of EI:EE was <0.79 
(where EI:EE should equal 1 in weight stable individuals); representing the lower 
95% confidence limit of EI:EE, based on studies utilising DLW data (Black and Cole, 
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2001). According to EI:BMR, 58% of the population underreported compared to 
81% as assessed by EI:EE. This suggests that using EE data from accelerometry 
compared directly to EI yields a greater proportion of underreporters than the 
Goldberg cut-off utilising an individual PAL derived from the same EE data. 
However, Samuel-Hodge et al‟s (2004) study employed uniaxial accelerometry 
which is likely to underestimate the measurement of activities with limited vertical 
accelerations (Butte et al., 2012). Moreover, accelerometer data were included if 4 
days consisting of >4 hours wear time per day was achieved. A low wear time 
criteria such as a 4 hour minimum could result in an underestimation of PA, which in 
turn would result in underestimation of energy underreporting (Samuel-Hodge et al., 
2004). Very few studies have used accelerometry to assess misreporting in 
adolescents, however, Noel et al (2010) used accelerometry to assign individual 
PAL values and compared three variants of PAL estimations in 13 year olds from 
the UK: 1) assigned a low-active PAL (1.13 boys 1.16 girls); 2) assigned PAL values 
from EE(actigraph)/BMR (estimated from Schofield equation); 3) assigned PAL from 
total minutes of MVPA (based on PAL & PA coefficients (Institute-of-Medicine, 
2005)). Both variant 1 and 2 identify similar proportions of misreporters (under 
reporters: 51.5 vs 51.8%; valid reporters: 40.8 vs 37.9%, respectively; over 
reporters: 7.7 vs 10.3%), whereas variant 3 performed quite differently, identifying 
less under reporters and more over reporters (under reporters: 37.1%, valid 
reporters 42.4% and over reporters: 20.4%). It was proposed that calculating PAL 
from MVPA will not account for LPA and therefore may assign those who do not 
engage in MVPA as sedentary and thus under estimate there ER (Noel et al., 2010). 
Furthermore, a biaxial accelerometer (MTI actigraph) was utilised alongside the 
Goldberg equation to assess misreporting in African-American female adolescents 
(Lanctot et al., 2008), where 58.4% were classified as under reporters and 45.3 as 
valid reporters. In these studies under reporting was significantly and positively 
associated with BMI, WC and BF% (Noel et al., 2010) as well as unhealthy eating 
behaviours and older age (P= <0.001) (Lanctote et al., 2008). 
 
To date it appears that only uniaxial and biaxial accelerometry has been used to 
assign a PAL in the assessment of dietary misreporting in adults (Samuel-Hodge et 
al., 2004) and adolescents (Noel et al., 2010; Lanctote et al., 2008). The triaxial RT3 
accelerometer, which has been validated for use in children and adolescents 
against oxygen uptake (Chu et al., 2007; Vanhelst et al., 2010; Rowlands et al., 
2004), has seemingly not yet been utilised to assess misreporting. Furthermore, 
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there appears to be a distinct lack of research assessing EI:EE using triaxial 
accelerometry in any population. The use of accelerometry to derive EE may be 
more appropriate than using accelerometry to assign a subject specific PAL in 
conjunction with the Goldberg equation as it does not require calculation of MVPA. 
Furthermore, accelerometry provides a more cost effective alternative to DLW in the 
assessment of EE. 
 
Therefore, the purpose of the current investigation is to compare established dietary 
misreporting techniques: 1) the Goldberg equation incorporating a low activity PAL 
and 2), the Goldberg equation utilising the application of triaxial accelerometry to 
assign a specific PAL, to 3), a novel approach utilising EI:EE, based on the direct 
assessment of EE by triaxial accelerometry. Additionally this investigation will 
explore the degree of adiposity between misreporters and valid reporters using the 
different assessment techniques. 
5.1 Methodology  
 
Participants 
Participants were adolescents recruited as part of the SIRENS and CROSSROADS 
studies as previously explained in (section 3.0). A total of 72 participants (45 males 
and 27 females) provided adequate diet and PA data.  
 
Experimental Design 
As part of the CROSSROADS and SIRENS studies PA and dietary data were 
assessed; food diaries and PA monitors were distributed to the participants during 
data collection (see sections 3.9 and 3.10) in schools and colleges around Bedford 
and at the COR of the Luton and Dunstable Hospital. The reporting bias of dietary 
intakes was assessed by three different techniques. 
 
Measurements 
Age 
Each participant had their age assessed as previously described. 
 
Anthropometry and Body Composition 
Stature, body mass, BMI, body fat %, fat free mass and waist circumference were 
assessed as previously described in section 3.5 and 3.6. 
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Dietary Intake 
Participants were given 3 day weighed food diaries to complete within 1 week of 
data collectionas outlined in section 3.10. Intakes of energy, nutrients and GI and 
GL were averaged over the 3 day recording period as described in section 3.10. 
 
Physical Activity 
Information on physical activity engagement was required for the calculation of 
dietary misreporting. The rt3 traxial accelerometer was used to monitor PA and 
energy expenditure of 7 consecutive days. See section 3.9 for PA monitoring 
protocol. Time spent in PA subcategories was determined using the thresholds of 
Rowlands et al., (2004), as previously explained in section 3.9. 
 
Basal Metabolic Rate (BMR) 
The schofield equation (Schofield, 1985) for estimating basal energy requirement in 
10-19 year olds was used to estimate BMR for each individual base on sex, weight 
and height and is as follows: 
Males:      BMR = 0.068 x weight (kg) + 0.574 x height (m) + 2.157 
Females:  BMR = 0.035 x weight (kg) + 1.948 x height (m) +0.837 
 
Dietary misreporting 
The following three methods for assessing dietary misreporting (one, a novel 
approach) were compared to identify how they performed when classifying reporting 
bias of adolescents. 
 
The Goldberg et al (1991) equation calculates the confidence limit or cut-off of the 
EI:BMR ratio below which it is unlikely that mean EI is representative of habitual 
intake or a random low intake. The ratio of energy expenditure (EE) to BMR 
(EE:BMR) equals the energy utilised in addition to BMR known as the physical 
activity level (PAL) and because, in weight stable individuals, EI should equal EE, 
the ratio of energy intake (EI) to BMR (EI:BMR) should also be equal to PAL (Black, 
2000). The equation requires information on physical activity to assign a relevant 
PAL value or a PAL value can be assumed. The equation accounts for the within-
subject variation in estimated EI, the variation of the precision of BMR estimates, 
the total variation in PAL and the sample size being assessed and is as follows. 
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To calculate the lower 95% confidence limit (CL) at the individual level below which 
EI:BMR represents under-reporting: 
PAL x exponent [ SDmin x ]  
 
To calculate the upper 95% CL at the individual level above which EI:BMR 
represents over-reporting (the upper limit can only be calculated when PAL is 
estimated rather than assumed for a population or individual): 
 
PAL x exponent [ SDmax x ]     (Black., 2000) 
 
Here, PAL is the mean PAL for the population being examined and SDmin is -2 for 
the 95% lower CL and SDmax equals +2 for the upper 95% CL and n (1) is the 
sample size of the study.  
 
S =     
 
Where, as stated by Black (2002), CVwEI is the within subject coefficient of 
variation (CV) in reported energy intake (23), d is the number of days of dietary 
assessment (3) CVwB is the CV of BMR estimates (8.5) and CVtP is the total 
variation (within and between subject variation) in PAL. 
 
Method 1) The Goldberg equation - ratio of energy intake to basal metabolic rate 
EI:BMR (1.55 PAL) 
This original version of the technique assumes a PAL value, relative to BMR, for the 
population of 1.55 x BMR, based on the value for „light activity‟ defined by the WHO 
(1985). 
 
Method 2) The Goldberg equation - ratio of energy intake to basal metabolic rate 
EI:BMR (MVPA PAL) 
This variant of the Goldberg equation used the information gathered by 
accelerometry to assigns individual participants a PAL which is determined based 
on the subcategory of time spent in MVPA that they fall into. This method of 
assigning PAL values was also used in a large study of UK adolescents (Noel et al., 
2010). These categories were based on the dietary reference intakes (DRIs) from 
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the institute of Medicine description of PAL and PA coefficients which state that 
engaging in an additional 30 minutes of MPA raises an individual from the 
„sedentary‟ to the „low-active PAL‟ where as an additional 60 minutes of MPA would 
raise them into the „active PAL category‟ (Institute-of-Medicine, 2005). Therefore, in 
the present study, time spent in MVPA was calculated and categorised as follows 
(table 11 ):  
 
Table11. PAL categories and respective value based on time spent in MVPA 
 
 
 
Method 3) RT3 accelerometer assessed energy expenditure and the ratio of energy 
intake to energy expenditure (EI:EE). 
 
This method used the direct comparison of EI and EE (EI:EE) to assess the bias in 
reported intakes. Based on this technique the expected ratio of EI:EE should equal 
1. The 95% CLs of the ratio of EI:EE when EE was measured by the reference 
method DLW were reported to be 0.21 above and below 1 (Black and Cole, 2001, 
Black et al., 1997). Therefore under- and over-reporting were defined as a EI:EE of 
<0.79 and > 1.21, respectively. 
 
Energy expenditure was estimated using the RT3 accelerometer using a novel 
approach. The accelerometer was worn based on the requirements of the study 
protocol as outlined earlier in this section. However, the accelerometry data was 
analysed differently as compared to the procedures previously outlined for 
calculating time spent in PA intensities (see section 3.9). Of the days where 
acceptable accelerometer wear time was achieved (as outlined previously), the 
energy expenditure for each minute over a 24 hour period (between 00.00 to 00.00 
GMT) as calculated by the RT3 software, was summed giving a daily EE. The 
average of all days assessed was used as the total daily EE. The minute by minute 
energy expenditure is calculated based on energy expenditure equations utilising 
information on sex, height and weight and the metabolic equivalents in kilocalories 
PAL Category Minutes in MVA PAL Value  
Sedentary < 30 mins 1.25  
Low active 30 to <60 mins 1.5  
Moderately active 60 to120 mins 1.75  
Very active 
≥60 mins of VPA 
and/or >120 mins of MPA 
2.2  
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for CPM registered by the device. Average metabolic rate (AMR) was assigned by 
the software for each minute when no activity was registered by the device, AMR 
represents BMR x a factor of 1.1 to account for the thermic effect of food (Erceg., 
2012, director of stayhealthy inc. CA, personal communication) which is assumed to 
be 10%. 
 
Statistical Analysis 
Analyses were completed using the Statistical Package for Social Sciences (SPSS 
Inc., IL.), descriptive statistics are presented as mean and standard deviation (SD). 
The following variables were non-normally distributed and were therefore log 
transformed to normalise their distribution (BMI, BF%, WC, energy intake, % of 
energy from fat, PUFA and SFA). Differences between sexes of participant 
characteristics were assessed by one-way ANOVA. One way ANOVA was also 
employed to test the difference between anthropometric, adiposity and nutritional 
intake variables for each category of misreporting (under, valid and over-report) as 
assessed by the following misreporting assessment techniques: EI:BMR (1.55 PAL), 
EI:BMR (MVPA PAL) and EI:EE (RT3). The significance level for this analysis was 
set at P <0.05 for all analysis. 
 
5.2 Results 
 
Table 12. Anthropometric and dietary reporting characteristics  
 
Combined 
n=72 
Male 
n=45 
Female 
n=27 
 
P
 
Age (y) 17.35 (1.49) 14.48 (1.27) 17.34 (1.50) .290 
Height (cm) 172.05 (9.77) 177.68 (6.79) 162.99 (6.44) .000 
Weight (kg) 72.77 (16.97) 71.81 (16.189) 74.31 (18.36) .544 
BMI (kg/m
2
) 24.49 (6.03) 22.71 (4.79) 27.34 (6.78) .001 
EI (Kcal) 2181.22 (829.74) 2417.91 (854.54) 1800.83 (634.39) .002 
EE (Kcal) 2515.45 (519.10) 2652.41 (520.84) 2295.33 (441.55) .004 
EI:EE 0.88 (0.31) 0.93 (0.32) 0.80 (0.27) .087 
BMR (Kcal) 1792.57 (285.24) 1925.14 (266.45) 1579.50 (157.80) .000 
EI:BMR 1.22 (0.43) 1.27 (0.45) 1.15 (0.40) .246 
EE:BMR (PAL) 1.39 (0.17) 1.37 (0.16) 1.41 (0.18) .092 
Means and standard deviation; P significant at <0.05 for comparison of males and 
females 
 
83 
 
Table 12 shows that females had a significantly greater BMI than males (P=0.001). 
Furthermore, EI (P=0.002), EE (P=0.004) and predicted BMR (P=<0.001) were 
significantly lower in females than males.  
 
 
 
 
Table 13. Cut-points defining misreporting of  energy intakes. 
Method Cut-off value 
 
Goldberg: 
EI:BMR (1.55 PAL) 
1.47  (group level) 
1.00  (individual level) 
Goldberg: 
EI:BMR (MVPA  PAL) 
(individual level) 
 
<30 mins MVPA = 0.81 
>30 mins MVPA = 0.97 
>60 mins MVPA =1.13 
>120 mins MVPA or >60 mins VPA = 1.42 
EI:EE 0.79 
 
Table 13, Shows the calculated cut-offs for both variants of the Goldberg equation 
and EI:EE. Cut-offs are for the group (PAL1.55) and individual participants (PAL 
1.55, MVPA PAL and EI:EE). MVPA PAL has specific cut-offs for individuals in 
respective categories of MVPA and VPA. 
 
Table 14. Frequency of misreporters across sex and weight status 
n=72 EI:BMR (PAL 1.55) EI:BMR (MVPA PAL) EI:EE 
  UNDER VALID UNDER VALID OVER UNDER VALID OVER 
Total (n) 
 
 (%) 
23  
(31.9) 
49  
(68.1) 
24  
(33.3) 
45 
 (62.5) 
3  
(4.2) 
31  
(42.5) 
35  
(47.0) 
7  
(9.6) 
Males (n) 12 33 14 29 2 16 25 4 
% of males 26.7 % 73.3 % 31.1 % 64.4 % 4.4 % 35.6 % 55.6 % 8.9 % 
Females (n) 11 16 10 16 1 14 10 3 
% of females 40.7 % 59.3 % 37 % 59.3 % 3.7 % 51.9 % 37 % 11.1 % 
Normal weight 8 35 10 31 2 12 27 4 
% of normal weight 18.6 % 81.4 % 23.3 % 72.1 % 4.7 % 27.9 % 62.8 % 9.3 % 
Over weight 15 14 14 14 1 18 8 3 
% of over weight 51.7 % 48.3% 48.3 % 48.3% 3.4% 62.1 27.6 % 10.3 % 
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Prevalence of participants within each reporting category for each dietary reporting  
assessment method  
 
 
 
 
 
                 
 
      
             
 
Figure 2. Bar chart showing % of reporters in each reporting category by 
method of misreport assessment for all (a), male (b), female (c), normal 
weight   (d) and (e), overweight participants.
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Figure 2 shows that both of the EI:BMI techniques (PAL 1.55 and PAL MVPA) 
identified a very similar proportion of under reporters (approximately 30%), whereas 
EI:EE identified the greatest proportion of the sample as under-reporters (42%) 
when assessed as an entire group. In males (figure 2a), under reporting was also 
prevalent in approximately 30 % of the population, however EI:EE identified the 
greatest proportion of under reporters (35.6%). A greater proportion of females 
(figure 2b) under reported compared to males, the Goldberg equation identified 
roughly 40% where EI:EE identified 51.9% of females as under reporters. Normal 
weight individuals (figure 2c) appeared to under report the least, with only 18.7%, 
23.3% and 27.9% underreporting based on PAL 1.55, MVPA PAL and EI:EE 
respectively. Overweight individuals under reported the most, with the Goldberg 
equation identifying approximately 50% and EI:EE 62.1% of the group as under 
reporters (figure 2d). In all cases, EI:EE identified the greatest proportion under and 
over reporters. 
 
As displayed in table 15, under reporters were significantly heavier, and had a 
significantly greater WC then valid reporters when assessed by either technique 
(P=<0.007), when assessed by EI:EE and PAL1.55. Under reporters had a 
significantly greater BMI (P= 0.014 and 0.004, respectively) and BF% (P=0.009 and 
0.007, respectively). Across reporting categories, BMI was not significantly different 
when assessed by MVPA PAL. 
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         Table 15. Characteristics of misreporters and valid reporters according to EI:BMR (1.55 PAL and MVPA PAL) and EI:EE. 
          Means (± SD); *, P=<0.05; †, significantly different from valid reporters 
. 
  PAL 1.55 
 
MVPA PAL  EI:TEE  
 
UNDER 
n=23 
VALID 
n= 49 
P 
UNDER 
n=24 
VALID 
n=45 
OVER 
n=3 
P 
UNDER 
n=31 
VALID 
n=35 
OVER 
n=7 
P 
Age (yrs) 17.01 (1.90) 17.49 (1.28) 0.206 16.91 (1.81) 17.58 (1.28) 17.36 (1.89) 0.206 17.22 (1.80) 17.36 (1.24) 17.69 (1.38) 0.745 
Height (cm) 170.75 (10.90) 172.81 (9.29) 0.409 172.88 (11.49) 171.34 (9.39) 178.40 (10.03) 0.443 172.11 (10.58) 172.36 (9.25) 171.29 (9.96) 0.966 
Weight (cm) 81.80 (18.86) 68.95 (14.37) 0.003 81.43 (18.37)*† 68.25 (14.33) 78.17 (17.64) 0.006 80.52 (17.43)*† 67.21 (14.95) 70.33 (15.55) 0.003 
BMI (kg/m
2
) 27.60 (7.28) 23.14 (4.82) 0.004 26.80 (7.04) 23.34 (5.06) 24.93 (7.64) 0.081 26.89 (6.65)*† 22.67 (4.99) 24.07 (5.57) 0.014 
BF % 29.92 (12.69) 21.26 (9.93) 0.007 28.30 (11.68) 21.85 (10.66) 22.53 (17.58) 0.081 28.80 (11.52)*† 20.35 (10.10) 21.96 (11.99) 0.009 
FFM (kg) 52.56 (10.77) 52.79 (10.27 0.930 53.93 (11.11) 51.68 (10.35) 58.53 (4.99) 0.428 53.60 (10.18) 51.73 (10.94) 53.89 (9.34) 0.736 
WC (cm) 88.01 (15.73) 78.43 (10.63 0.004 86.83 (15.00)*† 78.62 (11.29) 81.85 (12.97) 0.043 86.81 (14.42) *† 77.45 (11.27) 78.49 (11.00) 0.008 
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Table 16 shows that energy intake was significantly greater in over and valid 
reporters compared to under reporters. When looking at macronutrients adjusted for 
total energy intake there were no significant differences between variables across 
reporting categories. However, although this was not the case with PAL1.55, when 
observing nutrients across reporting categories (under through to over-reporting) 
defined by EI:BMR and EI:TEE there appeared to be a reduced CHO% and a 
decreasing GI and GL/1000kcal, but none of these differences were significant.
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Table 16. Dietary characteristics of misreporters and valid reporters according to EI:BMR and EI:EE 
 
PAL 1.55 MVPA PAL  EI:TEE 
 
 
UNDER 
n=23 
VALID 
n= 49 
P 
UNDER 
n=24 
VALID 
n=45 
OVER 
n=3 
P 
UNDER 
n=31 
VALID 
n=35 
OVER 
n=7 
P 
Energy 
(kcal) 
1523.76 
(387.61) 
2512 (786. 
24) 
<0.001 
1594.43 
(452.91)** †‡ 
2350.58 
(536.04)** ‡ 
4709.91 
(1050.62)**† 
<0.001 
1664.79 
(444.25)**†‡ 
2328.78 
(446.94)**‡ 
3817.31 
(1186.72)**† 
<0.001 
CHO  
(% energy) 
49.73 (7.59) 50.23 (6.53) 0.774 50.17 (7.59) 50.16 (6.53) 47.97 (3.06) 0.864 50.46 (6.72) 49.96 (6.79) 48.99 (7.78) 0.870 
FAT  
(% energy) 
35.21 (9.89) 35.58 (5.88) 0.533 34.48 (9.89) 33.83 (5.88) 35.15 (4.43) 0.927 34.23 (8.76) 34.00 (6.55) 34.08 (3.23) 0.974 
PRO  
(% energy) 
16.83 (4.25) 15.90 (3.76) 0.476 16.93 (4.25) 15.79 (3.76) 16.39 (4.02) 0.501 16.57 (4.35) 15.82 (3.11) 16.45 (6.05) 0.853 
SFA 
 (% energy) 
12.82 (4.96) 11.80 (2.68) 0.475 12.47 (4.96) 11.87 (2.68) 13.17 (1.39) 0.747 11.99 (4.55) 12.25 (2.82) 12.09 (1.97) 0.774 
GI 59.04 (4.77) 58.70 (4.27) 0.754 59.08 (4.77) 58.64 (4.27) 55.30 (4.27) 0.342 59.15 (4.79) 59.00 (3.67) 56.41 (3.73) 0.291 
GL 
g/1000kcal 
77.65 
(13.79) 
78.61 
(13.21) 
0.775 78.60 (13.79) 78.66 (13.21) 70.66 (6.45) 0.590 78.27 (13.20) 79.29 (13.15) 73.51 (11.79) 0.570 
Means (± SD). *, P=<0.05; **, P=<0.0001; †, significantly different from valid reporters; ‡, significantly different from over reporters
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                            Scatter plot of EI:BMR (-95% CI) with EI:EE (±95% CI) by sex. 
Figure 3. X, Males; O, Females; R2 =0.887; ------, horizontal dashed line represents 
the lower 95%CI cut off for EI:BMR (1.55 PAL) 
Figure 3, highlights that the ratio of EI:EE identified under reporters that were not 
detected by the Goldberg equation. Furthermore, females had a lower EI:BMR and 
EI:EE and are thus are more likely to under report than males, however, males and 
females both under and over report. 
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5.3 Discussion 
The purpose of the current investigation was to compare a novel approach to 
assessing dietary misreporting to a method which has been widely used in research 
(the Goldberg equation), in a group of adolescents from Bedfordshire. Triaxial 
accelerometry was used to directly estimate EE for the comparison of EI to EE to 
ascertain the degree of reporting bias at the individual level. This was compared 
with two variants of the Goldberg equation which defines cut-off values to determine 
misreporting at the individual level based on the ratio of energy consumed to basal 
energy requirements (EI:BMR); 1) utilising a minimal physical activity level (1.55 
PAL) and 2) applying a sub category of time in MVPA to assign a more specific 
PAL.  
 
Assessment of reporting characteristics revealed that, as a group, average intakes 
were under reported (EI:BMR 1.22 ± 0.43) based on the 1.47 cut-off calculated by 
the 1.55 PAL Goldberg equation. Mean EI:BMR in females was lower compared to 
males (1.15 ± 0.40 vs 1.27 ± 0.45), but this difference was non-significant. EI:BMR 
was higher in 9 year olds from Norway compared the current study: 1.55 (boys) and 
1.48 (girls) (Lillegaard et al., 2007). PAL was also higher in Norwegian children; 
1.86 and 1.78 x BMR, compared to a PAL of 1.37 and 1.41 x BMR (males and 
females, respectively) in the current study (PAL calculated from EE:BMR assessed 
by triaxial accelerometry). This difference in PAL between the two studies could be 
due to a higher habitual PAL in children compared to adolescents as PA has been 
shown to decline from childhood into adolescence (Riddoch et al., 2004, Kimm et 
al., 2005). Furthermore, the novel use of the RT3 to estimate EE has not yet been 
validated and thus EE could have been under estimated. However, previous studies 
in youngsters comparing EI:EE based on the reference DLW method have found an 
overall under reporting of 18-23% in 9-10 year olds (Champagne et al., 1998) and 3-
16% in 8-10 year olds (Bandini et al., 1997); a range of under reporting which  is 
similar to that of EI:EE in the present study (12%). Moreover, comparison of the 
present study with a previous study in children (12.6 ± 2 yrs) utilising DLW, show 
similar EE estimates: 2515.45 vs 2350.24 kcal; 2652.41 vs 2409.96 and 2295.33 vs 
2302.47 for all participants, males and females, respectively (Perks et al., 2000). 
 
Prevalence of misreporting was assessed across method of reporting for the group 
and for males and females separately. Due to the known impact of weight status on 
misreporting (Poslusna et al., 2009) it was also of interest to assess misreporting of 
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the group across normal and overweight. Both variants of the Goldberg equation 
(EI:BMR) identified approximately 30% of participants as under reporters for the 
group as a whole and in males, however, EI:EE identified a greater proportion of 
under reporters, 42% and 35.6% (for the group and males, respectively). A greater 
proportion of females under reported compared to males, 40% according to both 
Goldberg equations and 51.9% by EI:TEE. Compared with the current sample of 
female adolescents, similar proportions of females (54.8%) were shown to under 
report in a study of pre-adolescent Afro-American girls (aged 8-10 yrs), when 
utilising the Goldberg equation and a very conservative PAL (1.35 x BMR) (Lanctot 
et al., 2008). Although, there is a difference in age between females of the two 
studies, yet PAL is similar to the mean PAL of 1.41 x BMR identified in the current 
sample of female adolescents. In the current study, when assessed across weight 
status, normal weight participants under reported to a lesser extent than over 
weight. Underreporting by normal weight was approximately 20% and 27.9% and in 
overweight participants was 50% and 62.1% according to the Goldberg equations 
and EI:EE, respectively; highlighting the markedly greater proportion of under 
reporters in overweight compared to normal weight. It is noteworthy that the females 
in this group of adolescents have a significantly greater BMI than the males and 
therefore females and those classed as overweight may consist of similar 
participants and this should be considered when viewing reporting. The similarities 
between these groups in terms of reporting prevalence appears to support this 
notion. 
 
In a study of 13 year olds from the UK, BMI, weight, WC and fatness were 
significantly higher and FFM significantly lower in under reporters compared to valid 
and over reporters (P= <0.05) (Noel et al., 2010). The present study also found a 
positive association between adiposity and under reporting; associations with 
adiposity were comparable when reporting was assessed by the Goldberg equation 
and EI:EE method; weight and WC were significantly higher in under reporters 
compared to valid reporters assessed by either method. BF% and BMI were also 
significantly higher in under reporters but not when reporting was assessed by 
Goldberg MVPA PAL (See table 15); a reason for this may be that MVPA PAL 
identified less overweight under reporters compared to 1.55 PAL and EI:EE. Unlike 
previous research in youths from the UK (Noel et al., 2010), FFM was not 
significantly different across reporting categories and adiposity was not significantly 
different between valid and over reporters in the present study. In contrast, a study 
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of 9 year olds from Norway (Lillegaard and Andersen, 2005), observed no 
significant difference between under and valid reporters when reporting was 
assessed by EI:EE.  
 
In a sample of Norwegian 9 year old children (Lillegaard et al., 2007), under 
reporting (Goldberg equation) was lower (12.2%) in comparison to the current 
adolescent sample, this difference may in part be explained by past research that 
has linked increasing age with higher prevalence of under reporting (de Vries et al., 
1994, Posluna et al., 2009). A limitation of Lilllegaard et al‟s (2007) study is that a 
„blanket cut-off‟ was applied to EI:BMR based on a generalised motion and position 
sensor-derived PAL (specific to sex) and thus a PAL may have been 
underestimated. In the current study, however, by utilising EI:EE to assess 
misreporting, EE was estimated directly for each individual from accelerometry. It is 
important to note that estimating EE in this manner is also not without limitations 
and these will be drawn upon later in this section. In a group of 15-18 year olds from 
Sweden, (Vågstrand et al., 2009) a lower prevalence of under reporters was 
reported compared to the current study sample; under reporting was 13% in males 
and 16% in females, however, over reporting was higher in this group compared to 
the current sample when assessed by the Goldberg equation and grouped into 4 
PAL groups: 19% vs 4.4% in males and 17% vs 8.9% in females. These 
differences, however, can probably be attributed ot the lower BMI of the Swedish 
adolescents compared to those of the present study, furthermore, diet was 
assessed by a diet history questionnaire and thus differences could be due to 
method of dietary assessment (Vågstrand et al., 2009). The authors also reported a 
significantly increased odds of under reporting females having mothers that under 
report (P= 0.002) and this was not accounted for in the current study. 
 
A comparable study of 2868 UK adolescents (mean age 13 yrs) (Noel et al., 
2010,see section 4.3 for details) reported similar proportions of under reporters to 
the current study, both studies utilised 3 day diet records. Under reporting was 
between 37.1 and 51.8% depending on the method used to assign a PAL based on 
7 day accelerometry. In the current study approximately 30% under-reported when 
using an assigned PAL from accelerometry (EI:BMR) whereas EI:EE identified 
42.5% of the group as under reporters. It thus appears that EI:EE may identify a 
reasonable number of misreporters based on previous evidence from a comparable 
population. 
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To the authors knowledge only one study has used a device to estimate EE (for 
comparison with EI) form body movement in youths. Lillegaard and Andersen 
(2005) used a position and motion sensor (ActiReg ®) worn at the waist to assess 
nutritional intakes from a pre-coded food diary in 51 Norwegian 9 year olds. EI:EE 
was similar to that of the current study (see table 12) for all participants 0.83 ± 0.16 
and females 0.88 ± 0.17, however boys had a greater discrepancy between EI and 
EE (0.79 ± 0.13) compared to males in the current study. EI:EE may have been 
lower in Lillegaard and Anderson‟s study because the equations used with the 
ActReg ® to calculate EE have been shown to systematically overestimate EE in 
children (Müller et al., 2004) thus, potentially resulting in a smaller EI:EE. 
Furthermore, the position sensor only determines when an individual is standing or 
sitting and the movement sensor registers movement on an „all or nothing‟ principle 
and thus cannot distinguish activity intensity. Thirty-nine % of the Norwegian 
children were classed as under reporters and 4% as over reporters, these 
proportions represent values between those obtained by the MVPA PAL Goldberg 
equation and EI:EE in the current investigation (See figure 2). EI:EE from a uniaxial 
accelerometer has been compared to the Goldberg equation utilising a MVPA 
assigned PAL from accelerometry in  185 African-American, obese women with type 
II diabetes (Samuel-Hodge et al., 2004). Like the present study, EI:EE identified a 
greater proportion of under reporters compared to the Goldberg equation 81% vs 
58% (Samuel-Hodge et al., 2004). The greater BMI of the African-American women 
could be responsible for the greater prevalence of under reporting (Forrestal, 2011) 
compared to females in the present study (35.7 vs 27.3 kg/m2). This study utilised a 
uniaxial accelerometer to assess EE of which acceptable daily wear time was 4 
days (minimum 4 hours per day) compared to the current study which employed 
triaxial accelerometry with a minimal wear time of 3 days (minimum 8 hours per 
day). Uniaxial accelerometry only assesses movement on one plane (vertical) and 
thus provide a less comprehensive measurement of body movements and has been 
shown to have weaker correlations than triaxial accelerometry with measured EE 
(Butte et al., 2012). 
 
In the present study EI:EE consistently identifies a greater proportion of participants 
as under reporters compared to the Goldberg equation; both variants of the 
Goldberg equation identified similar proportions of misreporting. Research has 
shown that PAL (for the Goldberg equation) may be underestimated when assigned 
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based on MVPA (Noel et al., 2010). This is because individuals that engage in less 
MVPA are likely to expend more energy in LPA which is not accounted for (Noel et 
al., 2010), resulting in an under estimation of under reporters. When utilising 
accelerometry, no assumption or estimation of PAL is required as it is incorporated 
within each participants total EE and thus EI:EE may identify a more reasonable 
proportion of participants as under reporters (Forrestal, 2011). It appears this may 
also be the case with over reporting, a greater proportion of over reporters (at least 
double) was identified by EI:EE compared to the Goldberg equation (MVPA PAL) in 
each group of participants. Interestingly, although females and overweight 
participants under reported to the greatest extent, they also over reported in higher 
proportion to males and normal weight participants when assessed by EI:EE (figure 
2). This was not the case when assessed by EI:BMR, where similar proportions of 
over reporting were identified by 1.55 PAL and MVPA PAL cut-offs (approximately 
4%). 
 
In the present study, total EI and subsequently macronutrient intakes were 
significantly lower in under reporters compared to valid and over reporters (P= 
0.001). Energy adjusted macronutrient intakes, however, were not significantly 
different between under-, valid- and over-reporters when assessed by either method 
of misreporting. In Afro-American and European children there was also no 
significant difference in energy adjusted macronutrient intakes between under and 
valid reporters (Lillegaard et al., 2007, Lanctot et al., 2008). In adults with Type 2 
diabetes, however, although no significant difference was observed in adjusted 
CHO intakes, energy adjusted protein was significantly higher and fat intakes were 
significantly lower in under reporters compared to valid reporters (Samuel-Hodge et 
al., 2004). 
 
A strength of the current study was the identification of over reporting by EI:EE, if 
over reporting is not accounted for, those identified as „valid‟ reporters may not all 
be reporting a plausible dietary intake. A further strength is that obtaining EE data 
from the RT3 accelerometer is less time consuming than recoding the data to 
quantify time spent in MVPA and thus may be a more practical approach to 
assessing misreporting in larger samples with this device. The reference technique 
for assessing EE in individuals is DLW, however this is expensive and requires the 
collection of urine samples (Lillegaard and Andersen, 2005). Accelerometers can be 
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re-issued, making them more cost-effective and potentially more appropriate for 
younger populations as the technique is less invasive.  
 
Potential limitations of using the RT3 to quantify EE include the fact that sleeping 
metabolic rate is not accounted for by the system, instead, for each minute of data 
that a participant is not active, an average metabolic rate (AMR/min) value is 
quantified which is likely to result in an over estimation of metabolic rate during 
sleep and ultimately total EE. If EE is over estimated EI:EE will be lower increasing 
the chances of misclassifying individuals as under reporters. The fact that 
accelerometry cannot be used to measure certain activities such as swimming or 
cycling, however, means that aspects of daily EE may also be under estimated, 
limitations of accelerometry are outlined in section 4.3. Future work may consider 
the use of waterproof accelerometers such as the Actigraph GT3X+ that may 
provide more complete data as there is less probability that the device will need to 
be removed (Rowlands and Stiles, 2012). In the current study EI:EE identified more 
under-reporters and over-reporters compared to the Goldberg equation. It is thus 
unlikely that EI:EE was over or under estimating misreporting to a greater extent 
than EI:BMR using the Goldberg equation. Furthermore, EI:EE values from the 
current study fell within the range of EI:EE assessed by DLW from a previous study 
in children (Bandini et al., 1997) suggesting that EE measured by the RT3 may be 
comparable to the current gold standard. There are also, however, a number of 
factors that can influence under reporting in youngsters that were not accounted for 
in the present study, such as BMI and working hours of mothers as well as family 
income and number of siblings (Vågstrand et al., 2009). Additionally there are 
factors that affect reporting accuracy that were not accounted for, such as parental 
assistance with food diaries and weight stability. If individuals are not weight stable 
they are likely to be in positive or negative energy balance which could be attributed 
to over- or under-reporting (Forrestal, 2011). Furthermore, future work is required to 
validate this technique of estimating EE against DLW.  
 
In this sample of adolescents from Bedfordshire between 23% and 31% increasing 
to 62.1% (in overweight individuals) of participants may under report and up to 
11.1% over report. Reporting prevalence varies depending on the method of 
reporting assessment and the novel application of a triaxial accelerometer to identify 
EE resulted in more under and over reporters being identified than when compared 
to the widely used Goldberg equation (EI:BMR). Thus suggesting that the use of 
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equations that group participants into PAL categories may miss some variance in 
reporting compared to direct assessment of EE. It appears the EI:EE technique of 
this study identifies misreporting in reasonable proportions compared to past 
research. As dietary misreporting can produce distorted associations between diet 
and health outcomes (Rossell et al., 2003) the high prevalence of under reporting in 
all groups within this population is likely to have implications for research in this 
field. To this end, it would be of interest for future work to assess how accounting for 
underreporting impacts on associations of diet and health when utilising 
accelerometer derived EE compared to the Goldberg equation and compare this to 
the reference DLW technique. Although misreporting was more prevalent in females 
and overweight adolescents, a substantial proportion of normal weight and male 
participants also misreport, thus, misreporting should be considered in all 
adolescent populations when assessing dietary intakes. 
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Chapter Six: Study Three 
Associations between GI, GL and other dietary factors with 
the metabolic syndrome in postpubertal adolescents. 
6.0 Introduction 
The glycaemic index (GI) and glycaemic load (GL) of the diet have been associated 
with obesity and associated metabolic risk factors in adult populations (Du et al., 
2009, Brand-Miller et al., 2002). Both GI and GL were significantly associated with 
an adverse lipid profile and CHD in healthy American (Yungsheng et al., 2006; 
Culberson et al, 2009), Japanese (Murakami et al, 2006) and British (Frost et al 
1999) adults. In a large healthy cohort of Dutch adults, greater intakes of GI and GL 
and lower intakes of fibre were associated with an increased incidence of type II 
diabetes. In 6,192 adults with  type 2 diabetes (57.5 yrs), dietary GL has been 
positively associated with mortality (Burger et al., 2012) when adjusting analysis for 
CVD factors, BMI, PA, diet and severity of diabetes, but only in normal weight 
participants (BMI <25 kg/m2). This association remained when dietary misreporters 
(EI:BMR) were excluded from the analysis and thus selective misreporting of 
overweight individuals was not an attributable factor (Burger et al., 2012). Based on 
evidence from (Arner et al., 1991) that non-obese individuals with diabetes have 
less peripheral insulin resistance but a more deficient insulin response compared to 
overweight, it was thus postulated that a high GL diet may have a more 
exaggerated BG response in these individuals putting them at greater risk of CVD 
related mortality.  
These associations have been potentially explained by evidence that low glycaemic 
CHO foods elicit slower rates of digestion and prolonged feedback to the satiety 
centre of the hypothalamus and thus increasing satiety following their consumption 
(Radulian et al., 2009, Ludwig., 2000, Holt et al., 1992). Additionally, higher rates of 
fat oxidation have been observed during exercise, following ingestion of low GI 
foods (Stevenson et al., 2009) and following consumption of a low GI and low GL 
meal (Scazzina et al., 2011) 
In youths there is less evidence of associations between GI and GL, obesity and the 
metabolic syndrome. The association of GI, GL and CHO with the metabolic 
syndrome, as assessed by two metabolic syndrome definitions (the IDF and ATPIII 
criteria) was assessed in 760 Australian adolescents aged 13-15 yrs old (O‟Sullivan 
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et al., 2010). Associations of insulin resistance (HOMA-IR) and a sample defined 
metabolic cluster (based on BMI, fasting insulin, glucose, TG and blood pressure 
values („high risk‟ or „low risk‟)) were also assessed. The prevalence of the 
metabolic syndrome was 3.6% (IDF), and 4% (ATPIII); 25.9% of participants were in 
the high risk cluster. A 20 unit increase in GL and a 30g increase in CHO were 
associated with significantly increased odds of having metabolic syndrome as 
defined by the IDF criteria (OR 2.18; 1.26-3.78 and 3.86; 1.80-8.28, respectively). 
No significant associations were observed between glycaemic CHO and the 
metabolic syndrome when utilising the ATPIII, cluster-defined or HOMA-IR 
definitions. The IDF criteria is the only definition to include WC as a mandatory risk 
factor and, thus this association may be mediated by central adiposity. 
An observational study found no significant association between higher glycaemic 
CHO intake and insulin sensitivity in 120 overweight Latino youths (10-17 yrs old), 
defined as an „at risk‟ population (Davis et al., 2007). Scaglioni et al (2005) also 
found no association between GI and insulin sensitivity in 95 normal weight 8 year 
olds. These studies, however, used a 24 hr recall and FFQ, respectively, to identify 
nutritional intakes, whereas O‟Sullivan et al (2010) used 3 day food records; 
different methods of obtaining food intakes and quantifying GI and GL makes it 
difficult to make comparisons across studies. Moreover, despite being defined as an 
„at risk‟ group, Davis et al (2007) defined participants as „at risk‟ by having a family 
history of type 2 diabetes and thus not all participants actually expressed an 
impaired insulin sensitivity. Furthermore, the age group investigated (10-17 yrs) 
means that participants will be at very different stages of puberty, which is known to 
impact on insulin sensitivity (Moran et al., 1999). Together, these factors may be 
attributed to the lack of adverse association between glycaemic CHO and insulin 
sensitivity. 
Although there appears to be a link between an increased glycaemic CHO intake 
and metabolic risk factors, there is contrasting evidence as to which component, GI 
or GL, is more strongly linked to health in youths. Adolescents are likely to be 
making more autonomous lifestyle choices regarding their eating behaviours in 
comparison to during childhood which are likely to shape their future eating habits 
(Ebbeling et al., 2005), yet, there is a lack of research investigating these 
associations in UK adolescents. Understanding such associations in this age group 
is important as metabolic abnormalities  have been shown to track from childhood 
and adolescents into adulthood (Camhi and Katzmarzyk, 2010). Additionally, the 
99 
 
impact of puberty does not seem to have been accounted for in past research which 
has assessed the relationships of GI and GL with health markers. This is important 
since there is a transient increase in insulin resistance which returns to pre-pubertal 
levels in the last stage of maturational growth (approximately 13 years of age) 
(Moran et al., 1999). It is understood that this can influence metabolic health 
parameters (Hannon et al., 2006) which may confound associations between GI and 
GL with metabolic risk factors. The age range of studies assessing adolescents, 
typically spanning from 12-18 yrs of age, means that no study has assessed a 
solely post-pubertal adolescent population. 
An important consideration when investigating diet and health relationships is that of 
dietary misreporting. For example, Rosell et al (2003) found that misreporting of 
dietary intakes  led to spurious relationships between PUFA and fats from milk in 
under reporters compared to non-under reporters (Rosell et al., 2003). However, 
Rosell et al (2003) did not identify and account for over reporting in the non-under 
reporting group, and therefore intakes from this group may not represent valid 
reporting. 
In order to overcome the problems associated with misreporting, some researchers 
have taken to excluding individual participants who misreport (Sluijs et al., 2010; 
Lau et al., 2006). This, however, is not recommended, on the basis that it introduces 
unknown bias into the sample, being that only those participants reporting „normal‟ 
intakes are examined (Gibson, 2005). A different approach, however, is to analyse 
all participants whilst adjusting statistical analysis for reported EI. If dietary intakes 
can be observed relative to EI this may attenuate the effect of over and under 
reporting (Poslusna, et al 2009), this will of course only be of value in those who 
misreport their entire diet as a whole rather than selectively for different 
macronutrients.  
To this end, the current investigation will assess the associations of GI and GL with 
risk factors for the metabolic syndrome in a post-pubertal adolescent population 
from Bedfordshire. As outlined in chapter 2, EI:EE (EE assessed by RT3 
accelerometer) may be an appropriate method for assessing misreporting in this 
population. Due to the potential impact of misreporting, analyses will examine these 
associations including all participants and also when misreporters are excluded, 
comparing both the Goldberg equation and EI:EE to assess misreporting. 
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6.1 Methodology 
Participants 
Of the 105 14-19 year olds recruited for the SIRENS and CROSSROADS studies 
72 adolescents (45 males and 27 females) provided both adequate nutritional intake 
(3 days weighed food diary including one weekend day) and PA data (at least 3 
days of accelerometer wear including one weekend day), see section 3.9 for more 
details.  Participants were recruited as previously outlined in section 3.0. 
 
Experimental Design 
Data collection was conducted between 7am and 10 am as participants were 
required to have fasted from 9pm the previous evening. See section 3.3 for further 
details.  
 
Measurements 
Age, ethnicity and SES 
As outlined previously (section 4.1) Age (to two decimal places), ethnicity 
(white/non-white) and SES (IMD scores) were measured. 
 
Anthropometry and Body Composition 
As explained in section 3.5, stature, body mass, BMI, fat mass, fat free mass and 
WC measurements were taken for all participants.  
 
Dietary Intake 
Three day weighed food diaries were completed by each participant as described in 
section 3.10. For all macronutrient variables the residuals method of energy 
adjustment was utilised in order to attenuate the impact energy misreporting may 
have on these variables. The residuals method adjusts for energy intake whilst 
producing a variable fully independent of energy intake (Mirmiran et al., 2006). This 
was achieved through linear regression analysis with EI as the independent variable 
and the intake of the nutrient under adjustment as the dependent variable. An 
individual‟s energy adjusted nutrient intake was determined by calculating the 
residual difference between the observed nutrient value of that participant and the 
value predicted from the regression equation (Gibson, 2005). To provide a 
meaningful adjusted value, the residual score was added to the nutrient intake 
corresponding to the mean EI of the population (Gibson, 2005). When stratifying the 
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groups by sex or weight status the residual adjustment was made based on the 
mean energy intake for each respective group separately. GI did not require 
adjustment for energy since its calculation is independent of energy intake. 
 
Dietary Misreporting 
Dietary misreporting was assessed by three separate techniques: comparing 
EI:BMR using two variants of the Goldberg equation to assign 95% confidence limit 
(CL) cut-offs beyond which are classified as misreporting (1.55 PAL and MVPA 
PAL);  and comparing EI:EE when EE is estimated directly by triaxial accelerometry 
(RT3). This method applied the previously defined 95% CL (0.21) for estimating EE 
from the reference method DLW to define misreporting (Black and Cole, 2001, 
Black et al., 1997). 
 
Physical Activity 
PA engagement was monitored using the RT3 triaxial accelerometer as outlined 
previously (section 3.9) 
 
Cardiorespiratory fitness  
CRF was assessed by incremental cycle ergometer test (see section 3.8) Peak 
volume of oxygen consumed at maximal exercise was measured by a portable 
online gas analysis system (Cortex Metamax 3B). 
 
Resting systolic and diastolic blood pressure 
Resting SBP and DBP were recorded as per the procedures outlined in section 3.7. 
 
Fasting finger prick blood samples 
Fasting blood samples were obtained from each participant; the 40 µL samples 
were immediately measured for TG, HDL and BG as described in section 3.4.2. 
 
Metabolic syndrome risk factors 
For each component of the metabolic syndrome (WC, TG, HDL, SBP, DBP and BG) 
cut-points were applied to identify the presence of these individual risk factors for 
metabolic syndrome in children and adolescents as defined by the International 
Diabetes Federation (IDF) definition (Alberti et al., 2006):  
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 High WC: WC ≥90th percentile for age and sex according to reference values of 
UK children and adolescents (McCarthy et al., 2001);  
 Hypertriglyceridemia: TG ≥1.7 mmol.L;  
 Low HDL-C <1.03 mmol.L;  
 high blood pressure: SBP ≥130 mmHg or DBP ≥85 mmHg; 
 high fasting BG: BG ≥5.6 mmol.L.  
 
According to the IDF criteria, adolescents who have central adiposity (high WC) plus 
at least two additional risk factors are classed as having the metabolic syndrome 
(Alberti et al., 2006). 
 
Clustered metabolic risk 
Clustered metabolic risk score was constructed by standardising to the mean (by 
sex) and summing the standardised scores of the following variables: DBP, TG, 
inverse HDL (HDL x -1) to confer higher risk with increasing values, BG and WC. 
Prior to standardising to the mean, the following non-normally distributed variables 
were log transformed: WC, HDL (prior to inverting the score), TG and BG. Having a 
high clustered metabolic risk (Crisk) score was defined as ≥ 1 SD above the mean 
Crisk score for the population (Andersen et al., 2006). 
 
Statistical Analysis 
Statistical analyses were conducted using SPSS, descriptive data are presented as 
mean and standard deviation. The following variables were non-normally distributed 
and were subsequently log transformed to improve their distribution (BMI, BF%, 
WC, EI, GL, PRO, fat, CHO, PUFA, MUFA, SFA, sugar, salt, %fat, % PUFA and % 
SFA). BMI z-score was calculated using UK 1990 reference values (Culberson et 
al., 2009), as were BF% z-scores, however a raw WC was utilised as the population 
reference data does not address the upper age range (17-19 yrs) of the population 
investigated. Differences between sex and weight status were assessed using One-
way ANOVA. When assessing the relationship between dietary and metabolic risk 
variables time spent SED was adjusted for based on the evidence that being SED 
mediates GI- and GL-health relationships (Hare-Bruun et al., 2006). Nutrient intakes 
(including GL) were adjusted for energy using the residuals method. The 
relationship between nutritional variables and metabolic risk factors was assessed 
using partial correlation analysis adjusted for age, sex, SES, zBMI and the 
103 
 
percentage of time spent SED. Binary logistic regression analysis was employed to 
assess the relationship between GI and GL as continuous variables with metabolic 
risk factors as defined by the IDF criteria of the metabolic syndrome for adolescents 
(Alberti et al., 2006) and high clustered metabolic risk score as dichotomous 
variables. The following covariates were included in the logistic regression analysis: 
sex, age, ethnicity, SES, % MVPA and residual intakes of fat, PRO, fibre and 
respectively for GI or GL. Associations of Glycaemic CHO variables (GI and GL) 
with metabolic risk factors were further assessed by MANCOVA with metabolic risk 
factors as continuous variables. The difference in risk variables was assessed 
across upper and lower quantiles of GI and GL intake adjusted for the following 
covariates: sex, age, ethnicity, SES, % MVPA and residual intakes of fat, PRO, 
fibre. Logistic regression and MANCOVA were conducted in all participants and 
separately for males and females. Associations of diet with metabolic health risk 
factors were explored when including all participants and when excluding those 
identified as misreporters as assessed by three techniques for identifying dietary 
misreporting: The Goldberg equation 1.55 PAL and MVPA PAL and EI:EE (RT3 
triaxial accelerometry). For MANCOVA the assumption of homogeneity of 
regression slopes was met as no significant (P >0.05) interaction effects were 
observed for metabolic risk factors between any independent or covariate variables. 
Furthermore there was no collinearity between covariates entered into the MANVOA 
models. In order to avoid bias in the logistic regression model residual adjusted 
CHO was removed as a covariate because multiple linear regression analysis 
revealed that the variances of the regression coefficients for residual adjusted CHO 
and glycaemic CHO variables (GI and GL) were dependent and thus the 
assumption of collinearity was violated. In order to make additional models 
comparable residual adjusted CHO was also excluded from adjustment of 
MANCOVA. For all analyses the significance level was set at P >0.05. 
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6.2 Results 
 
Table 17, shows anthropometric and adiposity characteristics of Bedfordshire 
adolescents (this table is the same as table 3 but with the addition of SES and 
FFM). Males and females have a similar mean age, on average males are 
significantly taller, yet females are of a similar mean weight. Females have a 
significantly greater mean BMI (P=0.003) and BF% (P= <0.001) compared to males 
but on average exhibit as lightly raised WC compared to males. 
 
Table 17. Participant characteristics 
 
 
COMBINED 
(n=98) 
Males 
(n=61) 
Females 
(n=37) 
P
 
 
Age (yrs) 17.36 (1.40) 17.46 (1.22) 17.21 (1.64) 0.389 
Height (cm) 172.40 (9.85) 177.80 (7.32) 163.64 (6.59) 0.000 
Weight (kg) 71.25 (16.30) 71.66 (15.45) 70.59 (17.78) 0.746 
BMI (kg/m
2
) 23.89 (5.59) 22.64 (4.65) 25.92 (6.39) 0.003 
BF (%) 23.30 (10.89) 17.98 (7.49) 31.94 (10.02) 0.000 
FFM (kg) 51.78 (11.60) 56.83 (8.72) 43.45 (11.01) 0.000 
WC (cm) 80.33 (12.20) 79.44 (11.64) 81.76 (13.08) 0.346 
SES (IMD) 14.54 (11.00) 13.86 (11.43) 15.66 (10.30) 0.435 
Means (± SD); P significant at <0.05 for comparison of males and females 
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According to the IDF criteria for the metabolic syndrome in children and adolescents 
(Alberti et al., 2006) the prevalence of participants with low HDL levels and thus an 
adverse value was 34.7% and for high TG the prevalence was 12%. 38% of 
participants had a high WC, although the prevalence of participants with a raised 
fasting BG was just 6.7%. DBP and SBP were classed as high in 13.2% and 10.5% 
of participants, respectively. With regard to clustered risk score 17.3 % of 
participants had a high score and 13.2% were classed as having the metabolic 
syndrome (table 18). 
 
Table 18. Metabolic syndrome risk factors and prevalence in Bedfordshire 
adolescents 
 
All participants ( N=75) Males (N=46) Females (N=29) 
 
Mean (SD) 
Participants   
with risk  
factor (%)  
Mean (SD) 
Participants  
with risk 
factor (%) 
Mean (SD) 
Participants  
with risk 
factor (%) 
HDL (mmol/L) 1.13 (0.32) 26 (34.7%) 1.12 (0.31) 15 (32.6%) 1.15 (0.35) 11 (37.9%) 
TG (mmol/L) 0.91 (0.70) 9 (12%) 0.82 (0.43) 4 (9.7%) 1.04 (0.98) 5 (17.2%) 
WC (cm) 81.39 (12.88) 29 (38.2%) 79.71(12.18) 8 (17%) 84.12 (13.71) 21 (72.4%) 
BG (mmol/L) 4.81 (0.51) 5 (6.7%) 4.89 (0.48) 2 (4.3%) 4.69 (0.53) 3 (10.3%) 
DBP (mmHg) 72.06 (8.17) 10 (13.2%) 70.67 (8.27) 5 (10.6%) 74.32 (7.60) 5 (17.2%) 
SBP (mmHg) 115.64  (11.83) 8 (10.5%) 118.58 (11.78) 6 (12.8%) 110.87 (10.45) 2 (6.9%) 
Clustered risk 
score 
0.21 (3.19) 13 (17.3%) -0.28 (3.04) 6 (12.8%) 0.99 (3.31) 7 (25%) 
Prevalence of 
 Met S 
- 10 (13.2 %) - 5 (10.6%) - 5 (17.2%) 
Metabolic risk factors: HDL, <1.03mmol.L; TG, ≥1.7 mmol.L; WC, ≥90th percentile for 
age and sex; BG, ≥5.6 mmol.L; DBP, ≥ 85 mmHg; SBP, ≥ 130 mmHg; high clustered risk, 
≥1 SD above the mean. 
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Table 19. Partial correlations of dietary variables and metabolic risk factors  
 
GI GL Fibre PRO Fat CHO Sugar 
WC † 
Correlation .183 .120 .290 -.109 -.145 .095 -.064 
P Value 0.133 0.324 0.016 0.372 0.235 0.435 0.602 
HDL 
Correlation .138 .192 -.036 .099 -.096 .161 -.127 
P Value 0.262 0.116 0.768 0.422 0.434 0.189 0.303 
TG 
Correlation -.008 -.008 .025 -.225 .127 -.017 .042 
P Value 0.947 0.945 0.840 0.065 0.304 0.889 0.732 
BG 
Correlation -.094 -.106 -.139 -.092 .234 -.075 .151 
P Value 0.446 0.388 0.257 0.455 0.054 0.545 0.219 
SBP 
Correlation .007 -.006 -.175 .217 -.011 -.074 .033 
P Value 0.953 0.960 0.153 0.075 0.930 0.548 0.787 
DBP 
Correlation .007 -.046 -.057 .052 .128 -.129 -.157 
P Value 0.955 0.712 0.645 0.673 0.298 0.293 0.200 
Clustered 
Risk score 
Correlation -.078 -.068 .020 -.243 .225 -.068 .076 
P Value 0.525 0.579 0.874 0.046 0.065 0.581 0.535 
 Correlations controlled for age, sex, SES, BMIzscore and MVPA; †, ZBMI 
not controlled for in analysis. 
 
Metabolic risk factors were assessed in terms of their clinical significance based on 
cut points that define a non-risk or high risk value for each parameter (Alberti et al., 
2006). Subsequently, binary logistic regression analyses were conducted to assess 
the odds of being in a high risk category according to dietary GI or GL. Due to the 
nature of group analysis, some models were not viable due to the low participant 
numbers in some risk categories e.g. TG risk. Models which were not viable (BG, 
DBP, SBP) have not been included. 
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Table 20. Multivariate adjusted OR (and 95% CIs) of having a cardiometabolic 
risk factor with increasing dietary GI and GL  
 
ALL PARTICIPANTS (n = 72) 
 
TG 
 
P  
HDL  
 
P  
WC  
 
P  
High clustered 
Risk score 
P  
GI 
1.05 
(0.71-1.55) 
0.822 
1.15 
(0.92-1.45) 
0.215 - - 
1.04 
(0.63-1.73) 
0.879 
GL 
0.00 
(0.00-0.00) 
0.087 
0.00 
(0.00-1.80) 
0.057 - - 
0.00 
(0.00-1.30) 
0.051 
  
 
 
 
 
   
GI† 
1.25 
(0.92-1.70) 
0.148 
1.21 
(0.97-1.50) 
0.092 
1.70 
(1.16-2.50) 
0.007* 
1.25 
(0.96-1.63) 
0.101 
GL† 
0.00 
(0.00-0.26) 
0.030* 
0.00 
(0.00-0.17) 
0.034* 
0.00 
(0.00-2.55) 
0.055 
0.00 
 (0.00-0.93) 
0.049* 
Models adjusted for sex, age, SES, MVPA, BMI, fat, PRO and fibre; †, model is not 
adjusted for BMI; GI (1 unit increase), GL (1g increase). - , model not viable. 
In model 1 of the logistic regression models of all participants, a 1 unit increase in 
GI was associated with increased odds of having hypertriglyceridemia, low levels of 
HDL, and high clustered risk score. A 1g  increase in GL was associated with 
reduced odds of having hypertriglyceridemia, low levels of HDL and high clustered 
metabolic risk. However, as these are non significant associations (confidence 
intervals range from <1 to >1) it makes it difficult to suggest if the odds ratio would 
actually fall above or below 1 and thus the direction of association cannot be 
ascertained. 
 
A second set of models were conducted without adjustment for BMI (†) this was 
done because WC is associated with BMI and so that the impact of weight status on 
the logistic regression models could be assessed. Excluding BMI strengthened 
associations to the extent that some became significant. According to these data a 
1g increase in GL is associated with significantly reduced odds of having 
hypertriglyceridemia (OR 0.00, P =0.030), low HDL (0.00, P =0.034, high clustered 
risk (0.00, P =0.049). Although GI models came closer to indicating significant 
increased odds ratios (reduced P value) for HDL, TG and Crisk, associations 
remained non-significant. A 1 unit increase in GI, however, was associated with 
significantly increased odds of having a high WC (P =0.007), where as GL was 
associated with a non-significant reduced odds of having a high WC. 
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Table 21. Odds ratio (and 95% CIs) for cardiometabolic risk factors with 
dietary GI and GL in males 
 
Males (n = 45) 
 
HDL P  
Clustered 
risk 
P  
GI 
2.04 
(1.07-3.90) 
0.031* -  
GL 
0.00 
 (0.00-0.00) 
0.014* -  
  
   
GI† 
2.09  
(1.11-3.93) 
0.022* 
2.57 
 (1.02-6.46) 
0.045* 
GL† 
      0.00 
 (0.00-0.00) 
0.011* 
0.00 
 (0.00-16.15) 
0.059 
Models adjusted for sex, age, SES, MVPA, BMI, fat, PRO and fibre. †, model is not 
adjusted for BMI; GI (1 unit increase), GL (1g increase). - , model not viable. 
 
When associations were assessed in males, there was a significantly increased 
odds of having low HDL per unit increase in GI (2.04,1.07-3.90; P =0.031). When 
BMI was excluded from the model the odds ratio is slightly increased (2.09, 1.11-
3.93; P = 0.022). Per unit increase in GI there was a significantly increased odds of 
having a high clustered risk score (2.57, 1.02-6.46; P= 0.045). Per unit increase in 
GL there was significantly lower odds of having low HDL (0.00, 0.00-0.00; P = 
0.014) and this association is strengthened following removal of BMI from the 
logistic regression model.  
 
Due to the issues of running binary logistic regression analysis with limited group 
sizes, ANCOVA was employed to assess any associations between dietary GI and 
GL with metabolic risk factors. For this technique the dependent variable is 
continuous and thus issues of small group numbers when split into a risk or non-risk 
category are eliminated. 
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Table 22. Mean (±SD) cardiometabolic risk factor values across quantiles of GI 
and GL for all participants 
 
GI GL RES 
N=72 
1 
(54.96) 
2 
(62.04) 
F P 
1 
(75.50) 
2 
(94.74) 
F P 
         
HDL (mmol.L) 1.17 (0.34) 1.12 (0.31) 0.78 0.381 1.06 (0.30) 1.21 (0.34) 3.62 0.062 
† 
  
1.75 0.190 
  
3.69 0.059 
TG (mmol.L) 0.91 (0.81) 0.92 (0.65) 0.03 0.865 0.82 (0.65) 1.00 (0.81) 0.84 0.364 
† 
  
0.58 0.449 
  
0.60 0.443 
WC† (cm) 79.14 (10.67) 83.56 (10.41) 4.84 0.031 79.49 (12.69) 80.93 (12.42) 0.02 0.880 
         
BG (mmol.L) 4.79 (0.60) 4.74 (0.41) 2.50 0.119 4.80 (0.54) 4.73 (0.49) 0.06 0.813 
† 
  
1.50 0.226 
  
0.05 0.831 
SBP(mmHg) 115.06 (11.20) 115.34 (11.17) 1.39 0.242 116.53 (10.01) 114.31 (12.27) 0.04 0.851 
† 
  
0.04 0.968 
  
0.01 0.935 
DBP(mmHg) 72.22 (8.73) 71.33 (7.69) 1.47 0.229 71.16 (8.14) 72.28 (8.47) 0.94 0.336 
† 
  
0.04 0.840 
  
0.69 0.408 
Crisk score 0.11 (3.17) 0.35 (3.23) 0.78 0.380 0.04 (3.32) 0.41 (3.07) 0.65 0.424 
† 
  
0.98 0.327 
  
0.21 0.647 
1 and 2 represent the lower and upper quantile, respectively; analysis adjusted for 
covariates: sex, age, ethnicity, SES, MVPA and residual intakes of fat, PRO, fibre; 
†, model is not adjusted for BMI. 
 
WC is significantly higher in participants within the highest quintile group of GI (P = 
0.031) no other associations are significant. However, there is a non-significant 
trend for a higher mean clustered risk score in those from the highest quantiles of GI 
and GL. HDL is lower in the highest quantile of GI group and higher in the highest 
quartile of GL group, and this association approaches statistical significance after 
removal of BMI from the model (P = 0.059). There also appears to be a trend for TG 
to increase with increasing GI and GL but this association is non-significant. Both 
SBP and DBP only slightly vary according to quintile of GI and GL intake. 
Furthermore, BG appears to decrease slightly (P= 0.119 and 0.813, respectively) as 
GI and GL consumption increases. 
 
When ANCOVA was run according to sex and weight status, no associations 
between GI, GL and metabolic risk factors were significant (results not presented). 
However, associations between diet and risk factors were similar for males and 
normal weight participants, this was also the case when comparing female and 
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overweight participants. It is noteworthy that the trends in these non significant data 
show a negative association of GI and GL with fasting BG in all groups. Furthermore 
WC appears to reduce with increasing GL in male and normal weight participants 
and TG appear to reduce with increasing GI in females (see appendix 7). 
 
Table 23. Mean (±SD) metabolic risk factor values across quantiles of GI and 
GL with dietary misreporters excluded from analysis (EI:BMR PAL 1.55). 
 
GI GL RES 
N=72 
1 
(55.37) 
2 
(61.90) 
F P 
1 
(74.60) 
2 
(87.90) 
F P 
         
HDL (mmol.L) 1.15 (0.25) 1.17 (0.44) 0.13 0.722 1.11 (0.39) 1.21 (0.32) 1.13 0.294 
† 
  
0.37 0.548 
  
0.92 0.343 
TG (mmol.L) 0.91 (1.08) 0.89 (0.49) 0.14 0.712 0.79 (0.54) 1.00 (1.03) 0.01 0.933 
† 
  
0.79 0.380 
  
0.01 0.909 
WC† (cm) 76.82 (8.86) 79.96 (12.08) 0.72 0.402 76.58 (8.81) 80.20 (12.04) 0.43 0.517 
         
BG (mmol.L) 4.88 (0.61) 4.67 (0.42) 1.03 0.316 4.75 (0.55) 4.80 (0.52) 0.26 0.615 
† 
  
1.22 0.276 
  
0.23 0.637 
SBP(mmHg) 115.19 (11.56) 111.60 (11.03) 3.72 0.061 115.56 (11.24) 111.24 (11.21) 0.08 0.773 
† 
  
1.11 0.298 
  
0.00 0.959 
DBP(mmHg) 71.35 (8.87) 69.24 (7.27) .922 0.343 70.43 (7.79) 70.12 (8.51) 0.08 0.786 
† 
  
0.36 0.551 
  
0.02 0.877 
Crisk -0.53 (2.81) -0.55 (3.09) 0.43 0.516 -0.85 (2.88) -0.24 (3.00) 0.20 0.659 
   
0.07 0.794 
  
0.01 0.935 
1 and 2 represent the lower and upper quantile, respectively; analysis adjusted for 
covariates: sex, age, ethnicity, SES, MVPA and residual intakes of fat, PRO, fibre; 
†, model is not adjusted for BMI. 
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 Table 24. Mean (±SD) metabolic risk factor values across quantiles of GI and 
GL with dietary misreporters excluded from analysis (EI:BMR PAL MVPA). 
 
GI GL RES 
N=72 
1 
(55.61) 
2 
(62.05) 
F P 
1 
(74.67) 
2 
(88.49) 
F P 
         
HDL (mmol.L) 1.22 (0.36) 1.13 (0.36) 1.51 0.227 1.16 (0.38) 1.19 (0.35) 0.24 0.628 
† 
  
2.42 0.128 
  
0.16 0.689 
TG (mmol.L) 0.92 (1.13) 0.91 (0.85) 0.02 0.894 0.72 (0.36) 1.10 (1.13) 0.30 0.585 
† 
  
0.43 0.518 
  
0.39 0.535 
WC† (cm) 76.23 (9.23) 80.90 (12.98) 
  
75.73 (8.45) 81.37 (13.28) 
  
   
1.30 0.261 
  
0.14 0.707 
BG (mmol.L) 4.86 (0.61) 4.71 (0.44) 0.26 0.614 4.86 (0.61) 4.71 (0.44) 0.17 0.684 
† 
  
0.48 0.494 
  
0.20 0.654 
SBP(mmHg) 113.09 (11.11) 112.28 (11.28) 0.21 0.646 114.68 (11.32) 110.76 (10.73) 0.14 0.706 
† 
  
0.03 0.870 
  
0.05 0.819 
DBP(mmHg) 71.42 (8.87) 66.61 (7.35) 0.62 0.438 70.92 (8.16) 70.09 (8.18) 0.06 0.802 
† 
  
0.17 0.681 
  
0.03 0.858 
Crisk -0.65 (3.07) -0.21 (3.18) 0.07 0.792 -0.78 (2.88) -0.09 (3.33) 0.16 0.689 
   
0.38 0.543 
  
0.03 0.873 
1 and 2 represent the lower and upper quantile, respectively; analysis adjusted for 
covariates: sex, age, ethnicity, SES, MVPA and residual intakes of fat, PRO, fibre; 
†, model is not adjusted for BMI. 
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 Table 25. Mean (±SD) metabolic risk factor values across quantiles of GI and 
GL with dietary misreporters excluded from analysis (EI:EE) 
 
GI GL RES 
N=72 
1 
(55.88) 
2 
(61.95) 
F P 
1 
(71.40) 
2 
(90.39) 
F P 
         
HDL 1.31 (0.35) 1.17 (0.38) 4.85 0.037 1.21 (0.39) 1.26 (0.35) 0.02 0.894 
   
6.09 0.020 
  
0.00 0.993 
TG 0.63 (0.17) 0.94 (0.53) 2.78 0.108 0.77 (0.55) 0.80 (0.27) 0.00 0.968 
   
3.94 0.058 
  
0.01 0.906 
WC 74.28 (0.66) 80.46 (12.85) 0.68 0.416 75.44 (9.85) 79.36 (12.45) 0.01 0.934 
         
BG 4.87 (0.66) 4.70 (0.44) 0.02 0.893 4.72 (0.64) 4.84 (0.48) 3.63 0.068 
   
0.01 0.943 
  
4.01 0.056 
SBP 114.62 (11.63) 112.36 (9.35) 0.04 0.845 115.41 (10.86) 111.61 (9.93) 0.24 0.629 
   
0.00 0.955 
  
0.35 0.558 
DBP 72.16 (9.10) 70.39 (6.59) 0.27 0.606 72.14 (8.22) 70.42 (7.60) 0.84 0.368 
   
0.14 0.709 
  
0.97 0.333 
Crisk -1.46 (2.04) -0.28 (2.90) 0.96 0.336 -1.08 (2.75) -0.63 (2.40) 0.09 0.772 
   
2.07 0.162 
  
0.00 0.992 
1 and 2 represent the lower and upper quantile, respectively; analysis adjusted for 
covariates: sex, age, ethnicity, SES, MVPA and residual intakes of fat, PRO, fibre.  
 
Table 26. Summary of the impact of excluding dietary misreporters on 
associations between metabolic risk factor variables and GI or GL. 
Risk factor Misreporters included Misreporters excluded EI:EE (RT3) 
WC Higher in high GI 
quintile ( P = 0.031) 
Association attenuated 
HDL Not associated Lower in high GI quintile (P = 0.020) 
TG Not associated Higher in high GI quintile (P = 0.058) 
BG Not associated Higher in high GL quintile (P = 0.056) 
Only when model was not adjusted for BMI. 
 
ANCOVA was run with misreporters excluded, comparing the association of GI and 
GL with metabolic risk factors with misreporting assessed by three different 
techniques. When misreporters were identified by EI:BMR PAL1.55 and excluded, 
113 
 
there was a trend for HDL to increase with GI but this was non-significant. The 
removal of misreporters based on the EI:BMR MVPA PAL technique showed a 
trend for HDL to decreases with dietary GI, indeed, this association is non-
significant. The EI:EE model, however, was the only of the three to show significant 
associations between glycaemic CHO and risk factors (summarised in table 26); 
HDL was significantly lower in the higher quintile of GI (P =0.037) and TG is 
borderline significantly higher in those with in the higher GI quintile (P =0.058). 
Furthermore, following removal of under reporters assessed by EI:EE, there is a 
non-significant trend for BG to increase in those in the higher quintile for GL, and 
after exclusion of BMI from the model BG is borderline significantly higher in those 
consuming a higher GL diet (P =0.056) 
 
6.3 Discussion 
 
The observational associations of dietary GI and GL with risk factors for the 
metabolic syndrome were assessed in postpubertal adolescents from Bedfordshire. 
Additionally, these associations were examined following removal of misreporters. 
Misreporting was assessed by 3 separate techniques; 2 variants of the widely used 
Goldberg equation (EI:BMR) and a novel approach to identifying EE (RT3 
accelerometer) for the application of EI:EE; the impact of removing misreporters 
was compared between the 3 techniques. 
When analysing the group as a whole, binary logistic regression revealed that a unit 
increase in GI significantly increased the likelihood of having a high WC (OR 1.70, 
CI 1.16-2.50; P= 0.007), however, this was only significant when BMI was excluded 
from the model. GL was not associated with a high WC. Similarly, in adult females, 
Hare-Bruun et al (2006) identified that increasing dietary GI was associated with 
gains in body fat and WC; GL shared no significant associations with adiposity 
variables. These data suggest that reducing the GI of the diet rather than GL could 
be more impactful on lowering adiposity. 
 
In the present study, in contrast to a positive association between risk and GI, a unit 
increase in GL was associated with a reduced likelihood of having the following 
metabolic risk factors: TG (OR 0.00, CI 0.00-0.26; P= 0.030); HDL (OR 0.00, CI 
0.00-0.17; P= 0.034) and cumulative risk as assessed by clustered risk scores: 
Crisk (OR 0.00, CI 0.00-0.93; P= 0.049). On the contrary to these findings, in 
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Australian adolescents identified that GL was significantly associated with incidence 
of the metabolic syndrome (O‟Sullivan et al., 2010) as defined by the IDF criteria 
(Alberti et al., 2006).  
 
Furthermore, a reduced odds of having low HDL per unit increase of GL is not 
consistent with many past research studies (Murakami et al., 2006; Yungsheng et 
al., 2006; Culberson et al., 2009; Denova-Gutierrez et al., 2009) in which GL was 
associated with an adverse lipid profile (low HDL and high TG), but these were 
conducted in adults. Moreover, although these studies controlled for intake of other 
macronutrients and in some cases PA, diet was assessed by FFQ or self report diet 
history and PA was self reported via questionnaire. The current investigation, 
however, used a more objective assessment of PA (traixial accelerometry), which is 
less prone to reporting errors than PA questionnaires (Sirard and Pate, 2001, Trost, 
2007). Furthermore, more precise information regarding the type and quantity of 
foods consumed may have been acquired by employing a weighed food diary, 
compared to a FFQ; improving calculations of GI and subsequently GL (Slyper et 
al., 2005). 
 
 The finding of the present study that GI is associated with a high WC is in 
agreement with past research in adults and previous work in chapter 4 of this thesis. 
Few published studies of youngsters, however, appear to have demonstrated 
positive associations between GI and adiposity variables. GI and GL were positively 
associated with adiposity in 16 year old adolescents (Nielsen et al., 2005), however, 
this was only observed in males. Furthermore, like the present population under 
investigation, the adolescents assessed by Neilsen et al (2005) were of an age that 
could be entirely postpubertal (16 yrs), but, unfortunately, they did not assess 
pubertal status. 
 
Limitations associated with running logistic regression with small sample sizes 
meant that stratifying the sample into sub groups produced little valid data, however, 
it was possible to assess logistic regression in males due to the greater group size 
compared to females. When males were analysed separately compared to the 
group as a whole, a unit increase in GI was associated with an increased odds of 
having a high Crisk score (OR 2.57, CI 1.02-6.46; P= 0.045) (following exclusion of 
BMI from the model) and low HDL (OR 2.04, CI 1.07-3.90; P= 0.031), and this 
association was strengthened when BMI was removed from the model (P= 0.022). 
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For GL the negative association with HDL risk remained but associations were 
stronger (P= 0.014 and 0.011 including and excluding BMI, respectively), the 
association of GL with Crisk was not present in males alone. 
As logistic regression was not always a viable statistical method, MANCOVA was 
employed so that associations could be assessed with risk factors as continuous 
variables. The narrow range of dietary GI consumed by this group made stratifying 
the sample into categories of low, moderate and high GI implausible, however, 
when stratified into 2 quantiles of GI intake for MANCOVA, the lower GI quintile 
(54.96) and upper GI quintile (62.04) represented a low GI (<55) and moderate GI 
(55-69) group, respectively. 
In the present study, when assessed as a whole group stratified by low and high 
quantiles of GI (54.96 vs 62.04) and GL (75.5 vs 94.74); WC was significantly 
greater in the higher compared to lower quintile of GI (83.56 vs 79.14  cm; P= 
0.031), consistent with earlier analysis by logistic regression and with previous 
studies of European adults (Hare-Bruun et al., 2006) and adolescents (Neilsen et 
al., 2005). Contrasting findings, however, have been observed in British youths; a 
study of 818 children (4-10 yr olds) and 818 adolescents (11-18 yr olds) based on 
data from the NDNS showed that GL was independently associated with higher risk 
of overweight (BMI) in children (P= 0.04) and central obesity (waist to height ratio) in 
adolescents (P= 0.02), whereas GI was not associated with adiposity (Murakami et 
al., 2013). Although the dietary assessment techniques of both studies are 
comparable (weighed food diaries) and an almost identical range of confounding 
variables was adjusted for, Murakami et al (2013) employed a much larger sample 
size, providing greater statistical power than the current study (Lenth, 2001). 
However, they also utilised an age range of adolescents (11-18 yrs) that is likely to 
encompass individuals of varying pubertal status (Moran et al., 1999). Puberty has 
been shown to impact on metabolic risk factors (Hannon et al., 2006), via a transient 
increase in insulin resistance (Moran et al., 1999), which may confound associations 
of diet and health markers. Importantly, the present investigation analysed a solely 
postpubertal population to avoid the potential effects of puberty. 
In the present study GL was not associated with any risk factors for the metabolic 
syndrome when expressed as a continuous variable. HDL was, however, greater in 
the higher compared to lower quintile of GL (1.06 vs 1.21 mmol/L; P= 0.062) and 
this association approached significance (P=0.059) when BMI was not included in 
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the model. Chapter 1 showed that adjusted GL is negatively correlated with %fat (r -
0.61; P= <0.01), this could be a reason for the lack of association with GL and 
health markers, being that fat intake was controlled for in these analyses. This may 
also explain the borderline significant positive association between GL and HDL 
cholesterol, as it may be that those consuming a higher GL diet concomitantly 
consumed less dietary fat. However, although in the past, lower fat intakes have 
been associated with a more beneficial lipid profile and cardiometabolic health  (Hu 
et al., 2001), more recently, it appears that high fat-low CHO, or specifically, low GI 
and GL diets can have a favourable impact on lipid profile and CVD risk 
(Mozaffarian et al., 2011, Chess and Stanley, 2008). It does appear, however, that 
the type of fat rather than the total amount consumed, such as replacing SFA with 
PUFA and MUFA (Sirtori et al., 2009; Cicero et al., 2010) can be beneficial for 
cardiometabolic health (Abete et al., 2011) and in chapter 4 it was observed that 
adjusted GL was also significantly negatively correlated with %SFA but also 
%MUFA and %PUFA (P=<0.01). Therefore, a lower GL was associated with a lower 
fat intake in general, making it difficult to suggest why there was a lack of 
association between increased GL and poor metabolic health. 
MANCOVA was run with the population stratified separately for sex and also weight 
status, since associations between glycaemic CHO and health markers may be 
mediated by these factors in adults and youths (Hare-Bruun et al., 2006, Nielsen et 
al., 2005). This analysis revealed that no associations were significant between 
metabolic syndrome risk factors and glycaemic CHO. A reason for this lack of 
association could be due to the reduced statistical power as a result of stratifying an 
already small sample population into smaller groups (Lenth, 2001). Interestingly, 
however, these analyses revealed that in the female group and overweight group 
the associations between glycaemic CHO and metabolic risk factors were similar, 
this was also the case for male participants and those classed as overweight. Table 
17 shows that the males indeed have an average BMI of 22.64 kg/m2, classing them 
as a normal weight group, where as the mean BMI of the females was 25.92 kg/m2 
classing them as overweight. It thus appears that caution may need to be taken 
when comparing these groups to populations from previous research. 
Misreporting has been found to impact on associations between diet and health 
(Rosell et al., 2003) and a small number of studies have assessed associations 
between glycaemic CHO and health markers with and without misreporters included 
in analyses. In adults previous research has found that dietary misreporting had 
117 
 
minimal impact on associations between glycaemic CHO (assessed by FFQ) and 
BMI (Lau et al., 2006), whereas, Sluijs et al (2010) observed that removal of 
misreporters strengthened associations of GI and GL with type 2 diabetes risk, but 
the effect was minimal. A study of British children and adolescents (Murakami et al 
2013), reported that adjusting for and excluding misreporters did not alter any 
associations between GI and GL with adiposity. This suggests that associations of 
glycaemic foods with health may not be hindered by inaccurate food intakes. 
However, this may only be the case in circumstances where food intakes are merely 
underestimated, rather than entirely omitted since the latter is more likely to produce 
false values for GI and subsequently GL. However, Sluijs et al (2010) assessed 
misreporting by means of the Goldberg equation and did not account for the PAL of 
the population. Moreover, Murakami et al (2013) assessed misreporting by 
comparison of EI to estimated energy requirement, however, this was calculated by 
equations published from the US Dietary Reference Intakes (Institute-of-Medicine, 
2005); encompassing estimated PAL categories based on PA diary data and thus 
errors in PAL estimation may under estimate EE and subsequently undereporting. 
Burger et al (2010), however, found that a 22g GL increase was positively and 
significantly associated with an increased total mortality risk (HR 1.42; 1.07-1.88) in 
normal weight subjects with type 2 diabetes and that this association was 
augmented by the exclusion of energy misreporters. Individuals with type 2 diabetes 
have been shown to under report to a greater extent than overweight individuals 
(Sallé et al., 2006) and thus the impact of excluding misreporters may have been 
greater in this group compared to previous studies (Sluijs et al., 2010;  Murakami et 
al., 2013). Furthermore, these associations were still observed even though 
misreporting was assessed using the Goldberg equation and the low activity PAL of 
1.55 x BMR which is known to under estimate misreporting (Black, 2000). 
In the current study, removing misreporters resulted in altered associations between 
glycaemic CHO and metabolic risk factors. Using either variant of the Goldberg 
equation (1.55 PAL and MVPA PAL) to identify and exclude misreporters resulted in 
attenuation of the positive association observed between GI and WC prior to 
excluding those who inaccurately report. Interestingly, however, when misreporters 
were excluded subsequent to being identified by EI:EE and stratified by low and 
high quantiles of GI (55.88 vs 61.95) and GL (71.40 vs 90.37); HDL was significantly 
reduced in those individuals who consumed a higher compared to lower GI diet 
(HDL 1.17 vs 1.31 mmol/L; P= 0.037) and this association was stronger when BMI 
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was excluded in the model; this is an association that was not seen in earlier 
analyses. Furthermore, following removal of BMI from the model, TG were 
borderline significantly raised in those consuming a higher compared to lower 
glycaemic index diet (TG 0.94 vs 0.63 mmol/L); P= 0.058). This suggests that 
increased dietary GI is associated with an adverse lipid profile and that these 
associations may only be observed after removal of misreporters. It is important to 
consider the characteristics of non-misreporters who were included in this analysis. 
It was reported in chapter 5 (Table 15) that the valid reporters had a significantly 
lower BMI and WC than underreporters, and furthermore, when identified by EI:EE, 
BMI was lower in valid reporters than when identified by EI:BMR (1.55 PAL and 
MVPA PAL, respectively) (22.67 vs 23.14 and 23.34 kg/m2) as was WC (77.45 vs 
78.43 and 78.62 cm). Thus, the observed associations of GI with HDL and TG were 
present in valid reporters who were also a more normal weight group. It is not 
possible to suggest that these associations were only present due to the fact that 
valid reporters are of a normal weight as it was observed that misreporting and valid 
reporting occurred in normal and overweight individuals (chapter 5). 
Although the associations of glycaemic CHO with lipid profile appear to be 
consistent with past research, there are inconsistencies as to whether GI or GL is 
most important. Slyper et al (2005), demonstrated that although GI and GL 
(assessed by 3 day food diary) were shown to significantly negatively correlate with 
HDL; GL, and not GI, was shown to be an independent negative  predictor of HDL 
(P= 0.009) as assessed by multiple regression analysis in 32 children and young 
adults aged 11-25 yrs from the USA (Slyper et al., 2005). Slyper et al (2005) also 
observed a negative correlation between GL and %fat, like in the present study, 
however, unlike the present investigation did not control for (other than CHO) 
macronutrient intake including fat and fibre in their regression analysis. 
Furthermore, they did not assess and account for pubertal status, nor was 
misreporting considered. Together, these factors may explain the discrepancy 
between findings of the two studies. Slyper et al (2005) did not report mean dietary 
GI or GL intakes making it difficult to draw comparisons between these studies in 
terms of glycaemic CHO consumption. 
Another interesting effect of excluding misreporters in the current study was in 
relation to associations between BG and GL. There appeared to be a non-significant 
trend for BG to be lower in those individuals consuming a higher GI and GL diet 
prior to removal of misreporters, a finding that is comparable to a study investigating 
119 
 
glycaemic CHO and glucose control in adults (Du et al., 2008). However, following 
removal of misreporters, assessed by EI:EE, the direction of the association 
between glycaemic CHO  and BG appeared to reverse, and a borderline significant 
increase was observed in those in the higher compared to lower quintile of dietary 
GL (4.84 vs 4.72 mmol/L; P= 0.056), after removal of BMI from the model. 
According to (Livingstone and Black, 2003) under reporters tend to specifically 
misreport foods that contribute to GI and GL; fruits and vegetables appear to be 
over reported whilst biscuits, milk products and sugars tend to be under reported. 
The fact that excluding misreporters resulted in altered associations of health 
markers with GI suggests that some misreporters are very likely to be entirely 
excluding certain CHO foods rather than just underestimating their reported intakes. 
This is because the nature of GI calculation, i.e. not effected by quantity, means that 
underestimating the amount consumed will have little effect on the diet‟s overall GI.   
It appears that assessing and excluding misreporters based on the novel application 
of the RT3 accelerometer to estimate EE and comparing the ratio of EI:EE altered 
associations between glycaemic CHO and metabolic risk factors in a manner that 
was not observed when misreporting was assessed by either variant of the 
Goldberg equation (EI:BMR). The fact that EI:EE identified a greater proportion of 
misreporters compared to the Goldberg equation, and provided a potentially more 
accurate assessment of misreporting as outlined in chapter 4, could be a reason for 
the difference seen following removal of misreporters between the techniques. It is 
important, however, to highlight that EI:EE(RT3) has not been validated against a 
reference method such as DLW, however, this technique does identify a 
comparable proportion of misreporters compared to past research, as outlined in 
chapter 4. 
One of the main findings from this investigation is that HDL levels appear to be 
lower in those individuals consuming a higher GI diet. Reduced levels of HDL can 
have implications for heart disease CVD and stroke; HDL facilitates the catabolism 
of surplus cholesterol from peripheral tissues (including arterial walls) (McArdle et 
al., 2007). This cholesterol is transported as LDL which can contribute to an 
atherogenic state (Despres and Lemieux, 2006). In these circumstances, fibrous 
plaques formed with in the lining of arterial cell walls can obstruct blood vessels 
potentially leading to myocardial infarction and ischemic stroke (Daniels et al., 
2008).  
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The following mechanisms have been proposed, linking increase GI to an adverse 
lipid profile: The rise in circulating insulin, following consumption of a high GI meal, 
subsequently results in the uptake of surplus energy (glucose) from the blood 
stream for use or storage in insulin sensitive tissues such as the liver, adipose 
tissue and skeletal muscle as well as the inhibition of lipolysis and glycogenolysis 
(Radulian et al., 2009). This leads to a faster down regulation of BG; often to below 
fasting level. This hypoglycaemia stimulates the release of hormones such as 
adrenaline and glucagon to restore euglycaemia and activate fat oxidation to meet 
the energy demands of the body (Weiss & Gills 2008). Subsequent increased levels 
of circulating FFAs at rest, however, has been associated with an adverse lipid 
profile and CVD as well as peripheral insulin resistance in insulin sensitive (non-
adipose) tissue (Weiss & Gills 2008). Whereas, following a low GI meal, 
postprandial rises in gut hormones and insulin are reduced and the prolonged 
absorption of CHO suppresses the counteregulatory response and FFA release 
(Jenkins et al., 2002). Moreover, a low GI meal is likely to suppress lipoprotein 
production, as a lower insulin response has been shown to reduce activity of 
insulin–stimulated 5-hydroxi-3-methylglutoryl-CoA reductase which is the rate-
limiting enzyme in cholesterol synthesis (Rodwell et al., 1976). The link between 
these factors and the development of the metabolic syndrome has been detailed 
more extensively in section 2.1. 
Further important implications of this study surround the impact of misreporting on 
relationships between glycaemic CHO and health parameters in this adolescent 
population. Not only will this have implications for observational research but also 
intervention studies assessing the impact of altered dietary glycaemic CHO on 
health outcomes. Some scientists have argued that excluding misreporters will 
introduce unknown bias into the sample, being that only those participants reporting 
valid intakes are examined (Gibson, 2005). Alternatively energy intakes can be 
controlled in an attempt to attenuate the effect of misreporting energy (Posluna et 
al., 2009). The current study, however, identified that it may be important to exclude 
misreporters from examination since even after controlling for energy intake via the 
residuals method, different associations with health parameters following exclusion 
of misreporters emerged. 
This investigation has a number of strengths being that dietary intakes were 
assessed by weighed food diaries and PA was assessed via the objective method 
of triaxial accelerometry. Furthermore, although residual confounding cannot be fully 
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accounted for, analyses were adjusted for a number of known confounding factors 
and thus may be less likely. Furthermore associations were observed both in the 
presence and absence of misreporters. Certain limitations should also be noted: As 
this study is observational the direction and causality of the observed associations 
cannot be established and thus further work is required in this postpubertal 
adolescent population to identify the impact of altering dietary glycaemic CHO on 
metabolic risk factors. Furthermore, the novel technique of identifying EE from the 
RT3 accelerometer for the assessment of misreporting by EI:EE has not been 
validated and the limitations of this method have been outlined in chapter 5, 
however, the fact that this technique resulted in different associations between GI 
and health markers compared to a widely used yet potentially less accurate method 
(the Goldberg equation) is of great importance and this requires further work.  
In conclusion, this study supports the evidence in adults and a limited number of 
studies in youths that increased dietary GI is associated with increased odds of 
having a high WC. Associations between GL and risk factors are less clear, logistic 
regression analysis revealed that GL appears to be associated with lower odds of 
having low HDL, hypertriglyceridemia and high clustered metabolic risk. Excluding 
misreporters from analysis had important implications for these associations. After 
removal of misreporters by EI:EE(RT3), MANCOVA revealed that although GL was 
not significantly associated with any risk factors, a borderline significant positive 
association with BG emerged that was not present in prior analyses. Increased GI 
(moderate vs low GI) was significantly associated with reduced HDL and increased 
TG (borderline significant) after removal of misreporters. These findings have 
implications for future dietary recommendations for adolescents who are an age 
group that are making more autonomous lifestyle decisions regarding their eating 
behaviours (Ebbeling et al., 2003) and a group in which metabolic abnormalities 
have been shown to track into adulthood (Camhi and Katzmarzyk, 2010). Further 
intervention analysis is required to assess causality and direction of these 
associations. 
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 Chapter Seven: Study Four 
Associations between physical activity and fitness with the 
metabolic syndrome in postpubertal UK adolescents: the 
impact of different PA thresholds. 
 
7.0 Introduction 
PA (Wareham et al., 2005) and CRF (Blair et al., 2001b) are well regarded as 
important determinants of metabolic health. This has been evidenced in adults and 
youths, however, there appear to be inconsistencies as to whether PA or CRF is 
more strongly associated with health outcomes. Lee et al (2010) assessed 
metabolic risk factors and the prevalence of the metabolic syndrome across levels 
of CRF (treadmill VO2max test) in 909 young (24yrs) Korean males.  The authors 
identified that having a low and moderate, versus high CRF was independently 
associated with an increased likelihood of having the metabolic syndrome following 
adjustment for age, smoking status and body composition. Karelis et al (2008) 
identified in a group of overweight and obese sedentary women (57.7 ± 4.8 yrs) that 
those classed as having the metabolic syndrome had significantly lower CRF and 
PA energy expenditure compared to those without the metabolic syndrome; 
however, logistic regression revealed that PA energy expenditure was 
independently associated with increased odds of having the metabolic syndrome. 
Although Karelis et al (2008) estimated PA energy expenditure from the reference 
technique of DLW, other research has observed that the intensity of PA undertaken 
may be more influential on health outcomes than total PA. Studies of adults provide 
evidence that being more SED may have a stronger negative impact on health 
markers than MVPA (Healy et al., 2008b, Healy et al., 2011), whereas evidence in 
youths suggest that MVPA is a more important predictor of metabolic risk factors 
(Ekelund et al., 2012). A widely utilised PA assessment method is accelerometry 
which measures acceleration of the body in one (uniaxial), two (biaxial) or three 
(triaxial) planes (Rowlands, 2007). Arbitrary „activity counts‟ derived from 
accelerometry data require recoding in order to provide biological meaning. This is 
achieved through the use of PA cut-points for different PA intensities that have been 
derived according to different EE validation studies (Rowlands et al., 2004b, 
Vanhelst et al., 2010a, Chu et al., 2007b). Employing such cut-points allows for the 
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exploration of associations between health markers and total PA or accumulated 
minutes of PA at various intensities: time spent SED; in LPA; in MPA; in VPA and in 
MVPA to be assessed (Ekelund et al., 2007c, Bailey et al., 2012b). 
 
Accelerometry has been used to explore associations between PA and health 
markers in youths; Ekelund et al (2007) investigated the independent associations 
of PA (measured via 3-4 day accelerometry) and CRF (via a maximal cycle 
ergometer test) with metabolic risk factors in 1709 9-10 and 15-16 yr olds. Both PA 
and CRF were separately and independently associated with individual and 
clustered metabolic risk factors, a potential confounding limitation of this study is 
that CRF was estimated from HR and oxygen consumption was not measured 
(Rowlands et al., 1993). Moreover, in a large sample (20,871) of pooled data in 4-18 
year old male and females; MVPA was independently negatively associated with 
WC and SBP and positively with HDL, when controlled for SED time (Ekelund et al., 
2012). However, SED time was not associated with cardiometabolic risk factors 
when accounting for time spent in MVPA. Subsequent to the evidence that MVPA is 
an important determinant of health outcomes, the UK government recommend that 
at least 30 and 60 minutes of MVPA per day should be engaged in by adults and 
youths, on 5 and 7 days per week, respectively (DOH, 2011). A previous 
government report (DOH, 2008) demonstrated that only 24% of girls and 32% of 
boys were meeting the minimum  60 minute MVPA per day recommendations 
(DOH, 2008).  In contrast to evidence that MVPA is most beneficial to health, in 
adults, SED time has been observed as an independent positive predictor of WC, 
TG insulin resistance, CRP, BP, clustered metabolic risk score and negatively of 
HDL when analyses were adjusted for MVPA (Healy et al., 2008b, Healy et al., 
2011). Thus, there appear to be contrasting findings regarding which components of 
PA might be most beneficial to health. This evidence would suggest that 
recommendations based on associations of MVPA with health parameters may be 
flawed and thus better understanding of these associations is very important. 
 A potential confounding factor concerning these studies is the lack of standardised 
procedures for the reduction of raw accelerometry data. Previous research has 
defined non-wear time as 10 consecutive minutes of zero counts (Bailey et al., 2013 
and Husset et al., 2007) whereas others have removed non wear time defined as 60 
minutes of consecutive zero counts (Ekelund et al., 2012). This will impact upon the 
number of participants classed as providing acceptable PA data and therefore the 
124 
 
number of participants assessed. Furthermore, this is likely to bias the sample 
towards individuals engaging in physical activity and exclude those who spend less 
time physically active (Denton et al., 2013).  Additionally there are various 
thresholds which are inconsistently utilised in the literature for calculating PA 
intensities (Ekelund et al, 2011). A review of trends in PA levels as assessed by 
accelerometry demonstrated that the prevalence of youths (9-19 year old males and 
females) achieving the recommended 60 minutes per day of MVPA ranged between 
1% and 100%. There are vast inconsistencies amongst studies, which have been 
predominantly attributed to differences in intensity thresholds (Ekelund et al., 2011). 
There are a range of accelerometers available to objectively assess PA levels that 
feature in the literature. The most widely used monitors include the omnidirectional 
Actical and Actiwatch (Rowlands, 2007) as well as the ActiGraph range, which 
features the triaxial and water-proof GT3x (Robusto and Trost, 2012) and the triaxial 
Stayhealthy RT3 (Rowlands, 2007).  Triaxial accelerometry has been utilised in past 
studies to assess free-living PA and its relationship with health in children and 
adolescents using the RT3 (Stayhealthy, Inc.) accelerometer. For instance, 
(Krekoukia et al., 2007) assessed associations of PA (measured via RT3 over 4 
consecutive days) and CRF (estimated from heart rate using the physical working 
capacity test at 170 bpm (PWC170) with insulin resistance, lipid profile and 
inflammation in 110 lean and obese 9-11 year old children. CRF was negatively 
associated with insulin resistance but this disappeared following adjustment for age, 
sex and fat mass (FM), however total daily PA (negatively) and WC (positively) 
explained 49% (P< 0.01) of the variance in insulin resistance (HOMA-IR). The use 
of PWC170 to estimate CRF is a flaw of this study; PWC170 has been shown to 
have a wide variability with a 10-15% error in children (Rowland et al., 1993) and 
thus the CRF of the these youths may not have been accurately represented 
(Krekoukia et al., 2007). In contrast to this, in a sample of 100 10-14 year old 
children, Bailey et al (2012) identified that clustered metabolic risk was significantly 
lower in those identified as having a high CRF as opposed to low CRF, following a 
maximal cycle ergometer test that predicts oxygen uptake from a formula based on 
work rate. High and low fitness were defined as >37.0 and >42.1 mL/kg/min for girls 
and boys, respectively, based on evidence that these values are associated with a 
reduced metabolic risk in children examined in the EYHS (Ruiz et al., 2007).  PA 
subcomponent thresholds were derived for 7 day RT3 accelerometry from the cut-
points of Rowlands et al (2004) (see table 27); clustered risk was not associated 
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with any PA subcomponents. Unlike previous studies utilising RT3 data in youths 
(Hussey et al., 2007, Krekoukia et al., 2007), Bailey et al., (2012) collected 
accelerometry data over 7 consecutive days; participants were excluded from 
analysis if they failed to wear the accelerometer for 3 or more days. The authors 
explain that a minimum daily wear time of 9 hours for weekdays (Mattocks et al., 
2008) and 8 hours for weekend days was required (Rowlands et al., 2008). This 
was based on evidence that this wear time criteria is sufficient for assessing 
habitual PA in youngsters. Many authors neglect to note this information, making 
comparison across studies difficult. 
 
Table 27. PA category thresholds of Rowlands and Chu  
Variable Rowlands Chu 
SED (cpm) <288 <420 
LPA (cpm) 288-969 420-1859 
MPA (cpm) 970-2,332 1860-4109 
VPA (cpm) ≥2,333 ≥4110 
     CPM, counts per minute. 
Rowlands et al (2004) produced cut-points for setting thresholds of activity 
intensities (SED, LPA, MPA, VPA) whilst validating the RT3 in 19 boys (mean age 9 
±1 years), which have since been used to assess PA levels in a number of studies 
of young people (Bailey et al., 2013, Rowlands, 2007, Bailey et al., 2012a). More 
recently, however, different cut-points have been developed using the RT3 
accelerometer which have also been validated against oxygen consumption in 35 8-
12 year old Chinese children (Chu et al., 2007), See table 27. Chu et al (2007) 
derived cut-points from receiver operator curves (ROC) analysis which gave 
sensitivity and specificity values of 72-98% indicating that the intensity thresholds 
gave an accurate distinction between intensity categories. The difference between 
these validated cut-points (table 27) could affect the proportion of individuals 
classed within PA categories and subsequently any associations with health 
markers. For instance, the Chu activity count cut-point for MPA is 890 counts higher 
than that of Rowlands, and thus time spent in MVPA would be lower when utilising 
this cut-point. Only one study has compared the use of different PA cut-points and 
this was conducted in a group children; this study employed a sample of 104 10-14 
year olds from the UK and collected PA data by means of 7 day accelerometry 
(RT3) (Bailey et al., 2013). The authors observed a greater mean time spent SED (+ 
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40.2 and 67.7 mins) and a lower mean time in MVPA (- 65.1 and 50.6 mins) as 
assessed by the Chu compared to Rowlands cut-points in boys and girls, 
respectively. Associations of PA with CRF and cardiometabolic risk factors were 
different depending on the cut-points utilised; BF% was significantly positively 
associated with MPA, but only in girls when using the Chu thresholds. SED time 
was significantly and positively associated with TG using the Rowlands cut-points 
whereas DBP was negatively associated with MPA but only when utilising the Chu 
cut-points.  
As outlined above, there is a lack of uniformity in terms of methodological protocol 
used across studies utilising accelerometry and CRF data. This may be attributable 
to the differences observed between these studies with regards to associations of 
PA and CRF with metabolic health in youths. There is a need for consensus when 
utilising accelerometer thresholds for determining PA levels at different intensities to 
provide more accurate data regarding physical activity engagement of youths in 
relation to recommended guidelines. This is of particular importance as current 
recommendations are defined in terms of MVPA levels and are based on the 
association with health outcomes (DOH, 2011). Different cut-points for determining 
PA have not been compared in adolescents, furthermore, few studies control for 
nutritional intake when analysing associations of PA, CRF and health markers; this 
may have implications for associations of PA and health as outlined in chapter 1.  
Therefore the current investigation aims to assess the associations of CRF and PA 
with metabolic risk factors in a sample of UK adolescents whilst controlling of 
nutritional intake. Additionally the study will compare the associations of metabolic 
health parameters with PA as determined by the thresholds of Rowlands et al 
(2004) versus Chu et al (2007). 
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7.1 Methodology  
 
Participants 
Of the 105 participants recruited as part of the SIRENS and CROSSROADS studies 
as outline previously (in chapter 4), 76 participants met the wear time criteria for 
sufficient physical activity data and of those participants, a total of 72 participants 
also completed 3 day weighed food diaries. 
 
Experimental Design 
Data collection was conducted between 7 and 10 am as participants were required 
to have fasted from 9am the previous evening. See section 4.1 for further details. 
Associations of PA with metabolic health risk factors were assessed. Two 
thresholds for determining time spent in different PA subcategories (SED, LPA, 
MPA, VPA and MVPA) were compared and the impact of using the different 
thresholds on PA-health relationships explored. 
 
Measurements 
 
Age, ethnicity and SES 
Age (to two decimal places), ethnicity (white/non-white) and SES (IMD scores) were 
measured as explained previously (Section 4.1) 
 
Physical Activity 
Participants were issued with a RT3 triaxial accelerometer which was worn at the 
hip for 7 consecutive days; see accelerometer protocols as outlined previously 
(section 3.9). Time spent in PA intensity categories was calculated by applying two 
sets of thresholds that have been validated for use in youths, and for RT3 
accelerometer: the (Rowlands., 2004) thresholds, and the thresholds of (Chu et al., 
2007). The following different intensity cut-points were utilised for calculating 
engagement in individual PA categories according to CPM registered by the RT3 as 
displayed previously in the table 27. 
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Cardiorespiratory fitness 
Peak volume of oxygen consumed at maximal exercise was measured using a 
portable online gas analysis system (Cortex Metamax 3B) during an incremental 
cycle ergometer test as outlined previously (section 3.8). 
 
Resting systolic and diastolic blood pressure 
Resting SBP and DBP were recorded as described in section 3.8 
 
Fasting finger prick blood samples 
Fasting blood samples were obtained from each participant and then immediately 
analysed for TG, HDL and BG as described in section 3.5.2. 
 
Metabolic syndrome risk factors 
Metabolic risk was quantified by calculating the prevalence of individual IDF 
metabolic syndrome risk factors and determining a clustered metabolic risk score as 
outlined in chapter 6  section 6.1. 
 
Statistical Analysis 
Statistical analyses were conducted using SPSS, descriptive data are presented as 
mean and standard deviation. The following variables were non-normally distributed 
and were subsequently log transformed to improve their distribution (VPA, BMI, 
BF%, WC, PRO, fat, CHO). Adiposity variables, BMI and BF% were converted to Z-
scores based on population means for the age group (Culberson et al., 2009), 
however a raw WC was utilised as the population reference data does not address 
the upper age range (17-19 yrs) of the population investigated. Differences between 
sex and weight status were assessed by One-way ANOVA. Partial Pearson‟s 
correlation analysis was used to assess the relationship between time spent in 
different PA categories for both thresholds and were adjusted for sex, age and total 
PA. Partial correlations were also utilised to compare the relationship between PA 
and metabolic risk variables adjusted for sex, age, SES, total PA and zBMI. 
MANCOVA were conducted to assess the differences in metabolic risk variables 
between upper and lower quantiles of time spent in each PA category adjusted for 
the following covariates: sex, age, SES ethnicity, SES, zBMI, total PA and dietary 
variables (residual intakes of fat, PRO and CHO). There were no covariates sharing 
colinearity assessed by multiple linear regression analysis. The assumption of 
homogeneity of regression slopes, however, was violated by the covariate variables 
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sex and SES when their interaction with the dependant variables was assessed 
using a customised MANCOVA, therefore the MANCOVA model was rerun with sex 
and SES excluded as covariates to ensure assumptions were not violated.  Binary 
logistic regression analysis was employed to assess the associations between PA 
variables as continuous variables with metabolic risk factors as defined by the IDF 
criteria of the metabolic syndrome for adolescents (Alberti et al., 2006) and high 
clustered metabolic risk score as dichotomous variables. Logistic regression was 
also adjusted for age, ethnicity, SES, zBMI, total PA and dietary variables (residual 
intakes of fat, PRO and CHO), however, SES and sex were excluded as covariates 
so that logistic regression and MANCOVA models were comparable. MANCOVA 
and logistic regression analysis were utilised using the thresholds of Rowlands and 
Chu separately so that the impact of using the different thresholds could be 
compared. For all analyses the significance level was set at P <0.05. 
 
 
7.2 Results 
Table 28 displays participant characteristics for the group (total) and males and 
females, separately. As a group, mean age was 17.35 yrs and according to mean 
BMI the group are classed as being of normal weight status (24.49 kg/m2).  Males 
were significantly taller and had a greater FFM than females. Females had a 
significantly greater BF% and BMI than males. 
 
Table 28. Participant characteristics, mean and standard deviation 
 
Total 
n=72 
Male 
n=45 
Female 
n=27 
 
P
 
Age (y) 17.35 (1.49) 14.48 (1.27) 17.34 (1.50) 0.290 
Height (cm) 172.05 (9.77) 177.68 (6.79) 162.99 (6.44) 0.000 
Weight (kg) 72.77 (16.97) 71.81 (16.189) 74.31 (18.36) 0.544 
BMI kg/m
2 
24.49 (6.03) 22.71 (4.79) 27.34 (6.78) 0.001 
BF (%) 
 
23.30 (10.89) 17.98 (7.49) 31.94 (10.02) 0.000 
FFM (kg) 51.78 (11.60) 56.83 (8.72) 43.45 (11.01) 0.000 
WC (cm) 80.33 (12.20) 79.44 (11.64) 81.76 (13.08) 0.346 
SES (IMD) 14.54 (11.00) 13.86 (11.43) 15.66 (10.30) 0.435 
P significant at <0.05 for comparison of males and females 
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As shown in table 29, below, time spent in MPA, VPA and MVPA were significantly 
higher in males compared to females, when utilising either threshold, additionally 
SED time was significantly greater in females versus males, but only when 
assessed by the Chu thresholds.  When assessed using Rowlands thresholds, the 
average total accumulated time of MVPA was above the 60 minute guideline (65.60 
mins); 53% of participants achieved >60 mins MVPA. Males achieved a mean time 
of 73.14 mins in MVPA (63.8% >60 mins MVPA) whilst females undertook 53.38 
mins per day (37.9% >60 mins MVPA).  When assessed by Chu, however, the total 
time accumulated of MVPA was considerably lower than 60 minutes (27.20 mins); 
only 6.6% of all participants achieve >60 mins MVPA, Males achieve 32.45 mins 
(10.6% >60 mins MVPA) whilst females accumulate just 18.55 mins of MVPA per 
day (0% of females achieve >60 mins MVPA). 
 
Table 29. Time accumulated in each PA category using the PA thresholds of 
Rowlands and Chu. 
 
Rowlands Chu 
 
Total n= 72 Males n= 45 Females n= 27 Total n= 72 Males n= 45 Females n= 27 
SED (mins) 
517.67(106.93) 504.79 (111.73) 538.54 (96.88) 560.17 (102.93) 540.00 (102.13) 592.85 (97.22)* 
LPA (mins) 
134.51 (57.77) 128.43 (58.47) 144.37 (56.22) 129.25 (55.06) 130.98 (57.87) 126.44 (51.04) 
MPA (mins) 
50.42 (23.96) 54.93 (25.75) 43.11 (18.95)* 24.05 (15.51) 27.80 (16.23) 17.97 (12.25)* 
VPA (mins) 
14.48 (13.01) 17.02 (14.84) 10.35 (7.94)* 3.46 (14.15) 5.06 (17.86) 0.85 (1.02)* 
MVPA (mins) 
65.60 (36.13) 73.14 (40.34) 53.38 (23.95)* 27.20 (23.84) 32.54 (27.45) 18.55 (12.59)* 
% >60 mins MVPA 53% 63.8% 37.9% 6.6% 10.6% 0% 
Means (±SD); *, significantly different from males (P=<0.05). 
 
Table 30, displays partial correlations between PA components. Regardless of 
threshold used SED time was negatively correlated with LPA, MPA, VPA and 
MVPA. Other than Chu-LPA, which was not significantly correlated with Chu-VPA, 
all other PA components were positively, significantly correlated with each other    
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Table 30. Partial correlations of PA components respectively assessed by the 
Rowlands et al (2004) 2004 and Chu et al (2007) thresholds. 
 
SED LPA MPA VPA MVPA 
N=72 r P r P r P r P r P 
Rowlands 
          
SED 
 
. -0.936 0.000 -0.823 0.000 -0.470 0.000 -0.786 0.000 
LPA -0.936 0.000 
 
. 0.625 0.000 0.245 0.039 0.549 0.000 
MPA -0.823 0.000 0.625 0.000 
 
. 0.476 0.000 0.842 0.000 
VPA -0.470 0.000 0.245 0.039 0.476 0.000 
 
. 0.696 0.000 
MVPA -0.786 0.000 0.549 0.000 0.842 0.000 0.696 0.000 
 
. 
Chu 
          
SED 
 
. -0.929 0.000 -0.575 0.000 -0.275 0.020 -0.502 0.000 
LPA -0.929 0.000 
 
. 0.337 0.004 0.015 0.902 0.277 0.019 
MPA -0.575 0.000 0.337 0.004 
 
. 0.463 0.000 0.850 0.000 
VPA -0.275 0.020 0.015 0.902 0.463 0.000 
 
. 0.536 0.000 
MVPA -0.502 0.000 0.277 0.019 0.850 0.000 0.536 0.000 
 
. 
   Correlations adjusted for: age, sex and total PA. 
 
Table 31 shows that partial correlations revealed that time spent in LPA was 
significantly and positively associated with CRF but only when PA was assessed by 
the Rowlands thresholds. SBP and DBP were significantly and positively associated 
with time spent SED as assessed by both thresholds, associations with SBP were 
stronger when PA was assessed by the Chu thresholds. SBP and DBP were 
negatively associated with LPA and MVPA and clustered risk scores were also 
significantly and negatively associated with LPA when utilising the Rowlands 
thresholds. When assessed by the Chu thresholds, LPA was negatively associated 
with SBP and DBP; DBP was also significantly, negatively associated with VPA and 
MVPA 
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Table 31. Partial correlations of PA, as assessed by the Rowlands et al (2004) and Chu et al (2007) thresholds, with CRF and 
metabolic risk factors 
 
CRF (VO2 peak) WC HDL TG BG SBP DBP Crisk 
N=72 r P r P r P r P r P r P r P r P 
Rowlands 
                
SED -.020 0.865 -0.086 0.479 -0.036 0.772 -0.114 0.352 0.122 0.316 0.300 0.012* 0.328 0.006** 0.133 0.276 
LPA .234 0.050* 0.032 0.794 0.086 0.480 0.015 0.902 -0.192 0.115 -0.283 0.019* -0.348 0.003** -0.261 0.030** 
MPA -.005 0.967 0.167 0.166 0.015 0.901 0.216 0.074 0.027 0.826 -0.227 0.061 -0.177 0.146 0.077 0.530 
VPA -.087 0.472 -0.09 0.458 -0.107 0.382 0.08 0.515 -0.017 0.890 -0.109 0.373 -0.169 0.164 0.021 0.867 
MVPA -.116 0.334 -0.009 0.944 -0.081 0.510 -0.113 0.356 0.106 0.385 -0.331 0.005** -0.354 0.003** 0.139 0.256 
Chu 
                
SED .031 0.799 -0.117 0.326 -0.081 0.510 -0.113 0.356 0.106 0.385 0.331 0.005** 0.354 0.003** 0.139 0.256 
LPA .156 0.195 0.093 0.437 0.125 0.305 0.125 0.308 -0.171 0.161 -0.326 0.006** -0.356 0.003** -0.188 0.121 
MPA -.153 0.204 0.044 0.716 -0.038 0.755 0.062 0.614 -0.015 0.903 -0.214 0.078 -0.164 0.179 0.015 0.906 
VPA -.089 0.461 -0.039 0.747 -0.038 0.754 -0.03 0.804 -0.079 0.521 -0.036 0.766 -0.261 0.030* -0.157 0.198 
MVPA -.054 0.655 -0.002 0.986 0.002 0.987 0.031 0.800 -0.017 0.890 -0.175 0.150 -0.243 0.045* -0.063 0.605 
Correlations adjusted for: Sex, SES, age and zBMI; *, P value <0.05; ** P <0.01.  
. 
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Table 32. All participants: MANCOVA-Metabolic risk factors (mean and standard deviation) across 2 quantiles of time in respective PA 
categories assessed by the Rowlands et al (2004) and Chu et al (2007) thresholds. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 and 2 represent the lower and upper quantile, respectively; analysis adjusted for: sex, age, SES, ethnicity, SES, zBMI, total PA and residual intakes 
of fat, PRO and CHO; †, model is not adjusted for BMI; a, minutes 
 
N=72 
Rowlands 
 
SED T 
Chu 
 
SED T 
 
1 
(436.48
a
) 
2 
(598.85
 a
) 
F P 
1 
(482.72
 a
) 
2 
(637.61
 a
) 
F P 
HDL  (mmol.L) 1.15 (0.37) 1.13 (0.27) 0.12 0.728 1.15 (0.37) 1.12 (0.27) 0.00 0.975 
TG  (mmol.L) 1.02 (0.92) 0.80 (0.33) 1.52 0.222 1.02 (0.92) 0.80 (0.33) 1.40 0.241 
WC (cm)† 81.75 (14.07) 81.04 (11.74) 1.05 0.310 82.17 (13.80) 80.63 (12.02) 0.28 0.599 
BG (mmol.L) 4.77 (0.48) 4.87 (0.55) 1.19 0.280 4.78 (0.47) 4.85 (0.56) 0.52 0.473 
SBP (mmHg) 114.87 (13.92) 116.42 (9.42) 1.51 0.224 115.61 (13.41) 115.68 (10.20) 0.26 0.610 
DBP  (mmHg) 70.24 (8.94) 73.88 (6.97) 6.50 0.013 70.46 (8.84) 73.67 (7.20) 5.38 0.024 
† 
  
7.89 0.007 
  
5.90 0.018 
Crisk -0.05 (3.83) 0.47 (2.43) 1.16 0.286 0.03 (3.74) 0.38 (2.58) 0.77 0.382 
 
Rowlands 
 
LPA T 
Chu 
 
LPA T 
 
1 
(90.74
 a
) 
2 
(178.28
 a
) 
F P 
1 
(85.45
 a
) 
2 
(173.04
 a
) 
F P 
HDL  (mmol.L) 1.08 (0.28) 1.19 (0.35) 2.24 0.139 1.08 (0.24) 1.19 (0.38) 5.26 0.025 
TG  (mmol.L) 0.79 (0.26) 1.03 (0.94) 1.81 0.183 0.76 (0.26) 1.06 (0.93) 2.63 0.110 
WC (cm)† 82.36 (13.08) 80.44 (12.73) 0.63 0.430 80.16 (10.06) 82.64 (15.23) 0.26 0.615 
BG (mmol.L) 4.94 (0.54) 4.69 (0.46) 4.62 0.035 4.84 (0.55) 4.80 (0.48) 0.54 0.466 
SBP (mmHg) 119.29 (12.16) 112.00 (10.42) 7.76 0.007 117.64 (11.91) 113.64 (11.57) 4.03 0.049 
DBP  (mmHg) 73.26 (7.21) 70.86 (8.96) 2.17 0.146 73.32 (7.05) 70.80 (9.07) 3.50 0.066 
Crisk 0.58 (2.95) -0.15 (3.41) 3.64 0.061 0.15 (2.71) 0.27 (3.65) 0.92 0.340 
 
Rowlands 
 
MVPA T 
Chu 
 
MVPA T 
 
1 
(39.95
 a
) 
2 
(91.24
 a
) 
F P 
1 
(13.00
 a
) 
2 
(41.40
 a
) 
F P 
HDL  (mmol.L) 1.13 (0.25) 1.15 (0.38) 0.42 0.518 1.12 (0.25) 1.15 (0.38) 0.03 0.854 
TG  (mmol.L) 0.91 (0.85) 0.91 (0.51) 0.25 0.618 0.98 (0.87) 0.84 (0.47) 0.21 0.648 
WC (cm)† 80.83 (11.74) 81.97 (14.06) 0.46 0.501 82.54 (12.82) 80.26 (13.01) 0.13 0.724 
BG (mmol.L) 4.73 (0.46) 4.90 (0.56) 1.16 0.285 4.80 (0.48) 4.84 (0.55) 0.00 0.991 
SBP (mmHg) 115.05 (11.75) 116.24 (12.05) 0.00 0.969 114.08 (11.68) 117.21 (11.93) 1.69 0.199 
DBP  (mmHg) 73.76 (8.25) 70.37 (7.83) 4.20 0.044 73.32 (8.56) 70.80 (7.67) 0.52 0.474 
Crisk 0.27 (2.91) 0.14 (3.49) 0.08 0.779 0.65 (3.32) -0.25 (3.02) 0.01 0.907 
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Table 33. Male participants: MANCOVA-Metabolic risk factors (mean and standard deviation) across 2 quantiles of time in 
respective PA categories assessed by the Rowlands and Chu thresholds. 
 
N=72 
Rowlands 
 
SED T 
Chu 
 
SED T 
 
1 
(417.44
 a
) 
2 
(588.50
 a
) 
F P 
1 
(464.26
 a
) 
2 
(619.03
 a
) 
F P 
HDL 1.10 (0.35) 1.15 (0.27) 0.53 0.470 1.10 (0.34) 1.15 (1.15) 0.71 0.406 
TG 0.93 (0.55) 0.72 (0.26) 3.00 0.091 0.93 (0.53) 0.72 (0.26) 4.23 0.047 
WC† 4.85 (0.45) 4.94 (0.53) 0.03 0.857 83.16 (14.73) 76.12 (7.56) 0.10 0.749 
BG 83.14 (15.06) 76.43 (7.54) 0.02 0.900 4.84 (0.45) 4.95 (0.54) 0.05 0.832 
SBP 117.28 (13.22) 119.83 (10.35) 3.29 0.078 118.60 (14.56) 118.57 (8.46) 0.52 0.474 
DBP 69.07 (8.75) 72.21 (7.65) 5.85 0.020 69.75 (9.19) 71.63 (7.27) 2.37 0.132 
Crisk -0.16 (3.84) -0.39 (2.14) 0.22 0.644 -0.06 (3.79) -0.50 (2.12) 0.02 0.903 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 and 2 represent the lower and upper quantile, respectively; analysis adjusted for: sex, age, SES, ethnicity, SES, zBMI, total PA and residual intakes 
of fat, PRO and CHO; †, model is not adjusted for BMI; a, minutes 
 
 
Rowlands 
 
LPA T 
Chu 
 
LPA T 
 
1 
(84.82
 a
) 
2 
(170.22
 a
) 
F P 
1 
(85.14
 a
) 
2 
(174.91
 a
) 
F P 
HDL 1.08 (0.19) 1.17 (0.39) 1.19 0.281 1.07 (0.24) 1.18 (0.36) 5.99 0.019 
TG 0.76 (0.25) 0.89 (0.56) 1.62 0.211 0.74 (0.24) 0.91 (0.55) 1.67 0.204 
WC† 4.84 (0.34) 4.95 (0.65) 1.51 0.227 79.30 (7.58) 80.11 (15.54) 0.00 0.971 
BG 82.81 (13.87) 76.75 (9.70) 0.06 0.813 4.89 (0.54) 4.90 (0.45) 0.02 0.887 
SBP 122.20 (11.41) 115.13 (11.30) 8.50 0.006 122.43 (11.81) 114.90 (10.73) 7.17 0.011 
† 
  
9.36 0.004 
  
5.40 0.025 
DBP 72.41 (7.42) 69.00 (8.84) 1.59 0.215 72.24 (6.86) 69.17 (9.33) 1.89 0.177 
Crisk 0.20 (2.72) -0.76 (3.33) 0.26 0.613 -0.14 (2.00) -0.43 (3.86) 0.64 0.430 
 
Rowlands 
 
MPA T 
Chu 
 
MPA T 
 
1 
(34.79
 a
) 
2 
(74.23
 a
) 
F P 
1 
(15.91
 a
) 
2 
(39.20
a
) 
F P 
HDL 1.13 (0.27) 1.12 (0.35) 0.69 0.413 1.14 (0.27) 1.11 (0.34) 0.32 0.576 
TG 0.72 (0.22) 0.92 (0.56) 1.51 0.226 0.86 (0.37) 0.79 (0.49) 3.11 0.086 
WC† 4.90 (7.80) 4.89 (0.43) 0.22 0.639 77.36 (8.51) 81.98 (14.72) 2.32 0.136 
BG 78.18 (0.55) 81.18 (15.30) 0.02 0.883 4.87 (0.36) 4.92 (0.60) 0.00 0.953 
SBP 121.98 (12.23) 115.33 (10.58) 4.87 0.033 119.48 (11.73) 117.73 (12.02) 1.69 0.201 
DBP 72.48 (7.83) 68.94 (8.47) 2.67 0.111 71.35 (8.42) 70.02 (8.25) 0.80 0.378 
Crisk -0.28 (1.91) -0.28 (3.91) 0.28 0.600 -0.23 (2.65) -0.33 (3.45) 1.26 0.269 
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Table 34. Female participants: MANCOVA-Metabolic risk factors (mean and standard deviation) across 2 quantiles of time in respective PA 
categories assessed by the Rowlands and Chu thresholds. 
 
N=72 
Rowlands 
 
MVPA T 
Chu 
 
MVPA T 
 
1 
(33.26
a
) 
2 
(72.17
a
) 
F P 
1 
(7.85
 a
) 
2 
(28.53
 a
) 
F P 
HDL  (mmol.L) 1.08 (0.24) 1.22 (0.42) 3.66 0.071 1.12 (0.27) 1.13 (0.35) 0.75 0.393 
TG  (mmol.L) 0.91 (0.31) 1.18 (1.34) 0.01 0.933 0.86 (0.38) 0.80 (0.49) 1.93 0.173 
WC (cm)† 87.73 (14.28) 80.76 (12.70) 1.10 0.308 77.84 (8.50) 81.51 (14.86) 0.94 0.337 
BG (mmol.L) 4.69 (0.53) 4.69 (0.55) 0.00 0.974 4.86 (0.36) 4.93 (0.60) 0.04 0.842 
SBP (mmHg) 113.25 (7.42) 108.67 (12.50) 0.65 0.432 119.61 (11.72) 117.60 (12.00) 0.75 0.391 
DBP  (mmHg) 78.11 (6.17) 70.79 (7.25) 5.44 0.031 72.04 (8.15) 69.35 (8.35) 1.60 0.214 
Crisk 1.88 (3.14) 0.17 (3.35) 2.72 0.116 -0.07 (2.76) -0.50 (3.35) 1.33 0.256 
1 and 2 represent the lower and upper quantile, respectively; analysis adjusted for: sex, age, SES, ethnicity, SES, zBMI, total PA and residual intakes 
of fat, PRO and CHO; †, model is not adjusted for BMI; a, minutes 
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When participants were assessed as a whole group (table 32), using both 
thresholds resulted in a significantly higher mean DBP (P= 0.024 and 0.013, 
Rowlands and Chu respectively) in the higher SED time group. When assessed by 
the Chu threshold, HDL (P= 0.025) was significantly increased and SBP reduced 
(p= 0.049) in the high LPA group compared the lower LPA group. MPA, however 
was not associated with any cardio-metabolic risk factors. When assessed by the 
Chu threshold the higher VPA group had a significantly lower mean DBP (P= 
0.031), no associations with VPA were significant when assessed by Rowlands (not 
presented). Accumulating <60 mins compared to >60mins MVPA was not 
associated with any risk factors, however when stratified into a lower vs higher 
group of MVPA and assessed by Rowlands DBP was significantly lower (P=0.044) 
in the higher MVPA group. 
 
 In males when assessed by the Rowlands thresholds (table 33) DBP was 
significantly greater (P= 0.02) in the higher SED time group, however, when 
assessed by the Chu threshold mean TG levels were significantly lower (P= 0.047) 
in the higher SED time group. In the higher LPA time group SBP was significantly 
lower (P= 0.004 and 0.025) when PA was assessed by both Rowlands and Chu 
thresholds, respectively; associations were strengthened when BMI was excluded 
from the model. Additionally, HDL was significantly higher (p= 0.019) in the high 
LPA group when assessed by the Chu thresholds. SBP was significantly lower in 
the higher MPA group when employing the Rowlands thresholds (P= 0.033).  
 
In females only (table 34) MVPA was associated with any cardio-metabolic risk 
factors; DBP was significantly lower (P= 0.031) in the higher MVPA group when PA 
was assessed using the Rowlands cut-points. Results for other levels of PA were 
non-significant in the female group and thus not presented. Achieving greater than 
60 minutes of MVPA was not associated with any metabolic risk factors in any 
group. 
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  Table 35. All participants: Associations between CRF and metabolic risk 
factors 
 
VO2 Peak CRF risk 
N=72 
1 
 
2  
 
F P 
Low risk
a 
 
High risk
a 
 
F P 
HDL   1.09 (0.36) 1.18 (0.29) 0.31 0.904 1.19 (0.36) 1.05 (0.37) 0.59 0.455 
TG 1.11 (0.94) 0.74 (0.27) 1.53 0.221 0.75 (0.30) 1.17 (1.01) 4.83 0.032 
† 
  
8.68 0.004 
  
15.17 0.000 
WC† 88.19 (14.49) 75.25 (7.23) 12.93 0.001 75.34 (7.89) 90.65 (13.82) 23.63 0.000 
BG 4.81 (0.54) 4.85 (0.50) 0.01 0.904 4.81 (0.52) 4.86 (0.51) 0.89 0.348 
SBP 114.24 (12.10) 116.95 (11.88) 8.48 0.005 115.42 (12.06) 115.93 (12.07) 2.40 0.127 
DBP 73.67 (7.02) 70.13 (8.90) 0.07 0.785 70.12 (8.43) 74.40 (7.20) 0.00 0.962 
† 
  
3.04 0.086 
  
4.44 0.037 
Crisk 1.63 (3.52) -1.05 (2.31) 0.04 0.840 -1.12 (2.25) 2.29 (3.43) 4.07 0.048 
† 
  
13.90 0.000 
  
30.91 0.000 
1 and 2 represent the lower and upper quantile, respectively; a, low risk defined as 
CRF ≥37.0 and  ≥42.1 mL/kg/min; high risk defined as <37.0 and  <42.1 mL/kg/min, 
for females and males, respectively; Adjusted for: sex, age, SES, ethnicity, SES, 
zBMI, total PA and residual intakes of fat, PRO and CHO; †, model is not adjusted 
for BMI 
Increasing CRF was associated with a significantly increased SBP but reduced WC, 
TG and both clustered risk scores were also reduced but only when BMI was 
excluded from model. When CRF was expressed as high or low risk, those in the 
CRF risk group had significantly higher TG, WC DBP and clustered risk scores 
(Table 35). 
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      Table 36.  Male participants: Associations between CRF and metabolic risk 
factors 
 
VO2 Peak CRF risk 
N=72 
1 
 
2  
 
F P 
Low risk
a 
 
High risk
a 
 
F P 
HDL   1.04 (0.27) 1.21 (0.32) 0.01 0.945 1.18 (0.29) 0.93 (0.30) 0.06 0.813 
TG 0.98 (0.54) 0.66 (0.18) 0.93 0.341  0.74 (0.28) 1.11 (0.70) 1.45 0.236 
† 
  
5.56 0.023 
  
8.28 0.006 
WC† 85.13 (13.91) 74.06 (6.52) 7.22 0.011 75.98 (6.68) 91.93 (17.68) 14.56 0.000 
BG 4.85 (0.39) 4.94 (0.58) 1.45 0.236 4.87 (0.50) 4.99 (0.46) 2.19 0.148 
SBP 120.12 (10.70) 116.98 (12.85) 0.01 0.909 117.72 (11.31) 121.41 (13.40) 0.15 0.701 
DBP 72.08 (8.12) 69.20 (8.34) 0.00 0.952 70.19 (8.41) 72.23 (7.98) 0.37 0.545 
Crisk 0.83 (3.41) -1.39 (2.17) 0.15 0.697 -0.95 (2.30) 2.11 (4.19) 0.73 0.398 
† 
  
4.01 0.052 
  
12.72 0.001 
1 and 2 represent the lower and upper quantile, respectively; a, low risk defined as 
CRF ≥37.0 and  ≥42.1 mL/kg/min; high risk defined as <37.0 and  <42.1 mL/kg/min, 
for females and males, respectively; Adjusted for: sex, age, SES, ethnicity, SES, 
zBMI, total PA and residual intakes of fat, PRO and CHO; †, model is not adjusted 
for BMI 
In males increasing CRF was associated with a significantly reduced WC and TG 
(Table 36). When CRF was expressed as high or low risk, those in the CRF risk 
group had a significantly higher TG and WC (BMI excluded). 
 
Table 37.  Female participants: Associations between CRF and metabolic risk 
factors 
 
VO2 Peak CRF risk 
N=72 
1 
 
2  
 
F P 
Low risk
a 
 
High risk
a 
 
F P 
HDL   1.02 (0.27) 1.28 (0.40) 7.86 0.011 1.23 (0.23) 1.11 (0.40) 1.14 0.300 
† 
  
10.03 0.005 
  
2.25 0.149 
TG 0.98 (0.41) 1.19 (1.41) 1.20 0.287 0.79 (0.39) 1.20 (1.16) 2.38 0.140 
WC† 90.70 (11.10) 78.29 (14.37) 7.88 0.011 72.43 (12.04) 89.91 (11.50) 7.55 0.012 
BG 4.91 (0.56) 4.51 (0.46) 5.65 0.028 4.57 (0.56) 4.78 (0.54) 0.72 0.406 
† 
  
6.71 0.017 
  
1.36 0.258 
SBP 115.64 (9.68) 104.92 (9.03) 0.95 0.342 105.06 (10.19) 112.76 (10.31) 0.05 0.834 
DBP 76.14 (6.58) 71.52 (8.42) 0.03 0.862 69.79 (9.07) 75.66 (6.61) 0.39 0.538 
Crisk 2.66 (3.00) -0.54 (3.08) 10.86 0.004 -1.88 (2.16) 2.39 (3.08) 6.76 0.018 
† 
  
19.99 0.000 
  
14.94 0.001 
1 and 2 represent the lower and upper quantile, respectively; a, low risk defined as 
CRF ≥37.0 and  ≥42.1 mL/kg/min; high risk defined as <37.0 and  <42.1 mL/kg/min, 
for females and males, respectively; Adjusted for: sex, age, SES, ethnicity, SES, 
zBMI, total PA and residual intakes of fat, PRO and CHO; †, model is not adjusted 
for BMI 
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In females, a higher VO2 peak was associated with an increased HDL (P=0.011) 
and a significantly reduced WC, BG and clustered risk score. Adjustment for BMI 
attenuated associations of CRF with HDL, clustered risk and BG; P values were 
lower when BMI was excluded from the model. When CRF was classified as low or 
high risk to health, those in the high risk group (CRF <37.0 and < 42.1 mL/kg/min, 
for females and males, respectively) had significantly higher mean WC and 
clustered risk scores; again, adjusting for BMI attenuated the associations observed 
between clustered risk scores and CRF risk (Table 37). 
 
 
Table 38. Odds ratio and 95% CI for expressing a metabolic risk factor per unit 
increase of time (mins) spent in respective PA categories 
 
 ALL PARTICIPANTS (n = 72) 
ROWLANDS VPA P MVPA P VO2 peak P 
HDL† 2.35 (0.23-24.29) 0.472 0.99 (0.95-1.04) 0.738 0.90 (0.83-0.97) 0.008 
TG† 0.00 (0.00-0.31) 0.013 1.00 (0.91-1.05) 0.556 0.83 (0.72-0.96) 0.014 
WC† 0.09 (0.01-1.63) 0.104 0.98 (0.92-1.04) 0.526 0.77 (0.67-0.89) 0.000 
BG† 0.08 (0.00-27.28) 0.389 0.95 (0.60-1.50) 0.810 0.93 (0.80-1.07) 0.284 
Crisk† 0.02 (0.00-0.69) 0.030 1.00 (0.94-1.07) 0.940 0.58  (0.40-0.83) 0.003 
CHU VPA P MVPA P  
HDL† 3.55 (0.34-36.64) 0.287 0.48 (0.02-10.88) 0.646   
TG† 0.15 (0.00-6.93) 0.330 
a
0.01 (0.00-0.74) 0.036   
WC† 1.32 0.852 0.12 0.330   
BG† 0.18 (0.00-92.16) 0.590 0.00 (0.00-1.05) 0.052   
Crisk† 0.02 (0.00-0.86) 0.041 0.13 (0.00-7.80) 0.326   
Analysis adjusted for: sex, age, SES, ethnicity, SES, zBMI, total PA and residual 
intakes of fat, PRO and CHO; †, model is not adjusted for BMI; a, model is adjusted 
for BMI. 
 
Logistic regression analysis was run in order to assess associations of PA and CRF 
with metabolic risk factors expressed as a clinical health marker (Table 38). Per unit 
increase in VO2 peak there was a significantly reduced odds of being classed as 
having a risk factor for HDL (P= 0.008), TG (P= 0.014), WC (P= <0.001) and having 
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a high clustered risk score (P= 0.003), these associations were attenuated and were 
non-significant when BMI was included in the model apart for HDL which remained 
significant (P= 0.025).  As outlined below, significant associations were only 
observed in PA models assessing associations of metabolic risk factors with VPA 
and MVPA. When assessed by the Rowlands thresholds, a 1 minute increase in 
time spent in VPA was associated with significantly reduced odds of having 
hypertriglyceridemia  (P= 0.013) and having a high clustered risk score (P= 0.030), 
these associations were non-significant when BMI was adjusted for. When PA was 
assessed by the Chu thresholds, VPA was associated with a significantly reduced 
likelihood of having a high clustered risk score (P= 0.041) whilst increasing MVPA 
was associated with reduced odds of hypertriglyceridemia (P =0.036), but only 
when BMI was not adjusted for in the model. BP was not associated with PA or 
CRF. 
 
 
7.3 Discussion 
To the author‟s knowledge, this is the first study to assess the associations of CRF 
and PA with risk factors of the metabolic syndrome in a group of postpubertal 
adolescents. In addition, this is the first study to compare two published thresholds 
for determining PA intensity (Rowlands et al., 2004, Chu et al., 2007) and the 
respective associations of PA with metabolic health in adolescents whilst controlling 
for dietary intake. The main findings of this study were that CRF and PA are both 
associated with individual risk factors for the metabolic syndrome but that 
associations vary according to sex. However, there is a discrepancy in the mean 
time accumulated in different PA intensities depending on the threshold used (Chu 
et al., 2007 or Rowlands et al., 2004). Furthermore, it appears that this discrepancy 
subsequently results in different associations between PA and metabolic risk 
factors, depending on the threshold utilised.  
 
The mean daily time accumulated in different PA categories varied according to the 
threshold used to assess PA. Time spent SED and in LPA appeared to be least 
affected by the use of different thresholds. Time in MPA (50.42 vs 24.05 mins) and 
VPA (14.48 vs 3.46 mins) was much greater when assessed by the Rowlands 
compared to the Chu thresholds, respectively. Therefore time spent in MVPA was 
considerably higher when assessed by Rowlands compared to when employing the 
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Chu thresholds. On average the Rowlands thresholds classify the whole group 
(65.60 mins MVPA) and males (73.14 mins MVPA) as sufficiently active (based on 
the government recommendations of >60 mins MVPA per day) whereas according 
to the Chu thresholds neither group is sufficiently active (males: 32.54; females: 
18.55 mins MVPA). Females were significantly more SED than males when using 
the Chu thresholds and both thresholds identified that females engaged in 
significantly less MPA, VPA and MVPA. There are clearly implications of using 
different thresholds to calculate time accumulated in PA in this population, 
especially when such large discrepancies are evident when estimating time in 
MVPA. 
 
Partial correlations revealed that LPA was the only PA variable to be correlated with 
CRF when controlling for sex, SES, age and zBMI but this was only observed when 
PA was assessed by the Rowlands thresholds (r = .234; P= 0.05). In contrast to 
this, Bailey et al (2013) observed that CRF was significantly negatively associated 
with LPA using the Rowlands and Chu thresholds in children. The authors also 
observed a significant positive association of CRF with VPA (Rowlands) and MPA 
(Chu). As both studies have utilised the same thresholds and data reduction 
protocols these differences in PA and CRF associations may be attributable to the 
difference in age of the two populations. As children progress through their 
adolescent  years PA engagement declines (Kimm et al., 2002), indeed Bailey et al 
(2013) observed that the boys in their study engaged in 55.00 and 22.70 minutes 
more MPA than the adolescent males of the current study, when using the 
Rowlands and Chu thresholds, respectively. This was also observed in girls, who 
engaged in 44.09 and 35.00 minutes more MPA than females in the current study 
when using the Rowlands and Chu thresholds respectively; this difference may 
explain the contrasting associations between the two studies. Eklund et al (2007) 
also observed that CRF was negatively associated with SED time and positively 
with LPA, MPA and VPA in 9-10 year old children; however, this association was 
also present in adolescent 15-16 year olds. In addition, this study (Eklund et al., 
2007) used thresholds (>3000 CPM and < 100 CPM to define MVPA and time spent 
SED, respectively) which are different to those used in the current study and that of 
Bailey et al (2013), and may therefore be an additional factor associated with these 
contrasting relationships. 
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Having higher CRF levels has been consistently related to having a cardio-
protective effect and has been associated with a lower incidence of CVD and 
mortality rates in adults and youths (Blair et al., 2001a, Ekelund et al., 2007a). In the 
present study, MANCOVA revealed that WC and clustered risk score were 
significantly lower in those individuals with greater CRF; this association was 
present in all participants and in males and females. In all participants as a group 
and in males TG levels were significantly reduced in those with a higher CRF. 
Additionally, in females, HDL was significantly increased and BG reduced in the 
higher CRF group. Therefore in this population it appears that having a higher CRF 
is beneficial for  lipid profile and central adiposity and  BG in females, furthermore 
clustered risk score was consistently reduced in those who had a greater CRF. 
Clustered metabolic risk represents a constellation of metabolic risk markers that  
may detect an array of cardiometabolic disturbances; health status is worse in 
individuals with multiple risk factors than those with a single risk factor (Gami et al., 
2007). Assessing clustered risk may be more informative as it can  ameliorate the 
daily fluctuations in individual markers (Anderssen et al., 2007b). 
 
 
The government recommendation that adolescents should engage in at least 60 
minutes of MVPA (DOH, 2011) is based on evidence in youths and adults that 
higher intensity activities such as MPA and VPA are more beneficial to health 
(Ekelund et al., 2007, Husseyet al., 2009). In the present study however, MPA, VPA 
and MVPA were only favourably associated with blood pressure. MPA was inversely 
associated with SBP (p=0.033) in males when using the thresholds of Rowlands. 
Bailey et al (2013), who compared the same thresholds but in 104 children (10-
14yrs) found that MPA was not associated with any metabolic risk factors apart from 
sharing an inverse relationship with DBP (p=0.028) as well as BF% in girls when 
utilising the Chu thresholds. Differences may be attributed to the fact that children 
engaged in more MPA than adolescents in the current study, as outlined earlier in 
this section. In the present study VPA was only associated with DBP when 
participants were assessed using the Chu thresholds; DBP was significantly lower in 
those engaging in more VPA (P= 0.031); the same association was observed using 
partial correlation analysis (r -.261; P= 0.030). Similarly, Bailey et al (2013) also 
observed that VPA was not associated with metabolic risk factors in boys nor in 
girls. This similarity between boys (Bailey et al., 2013) and these male adolescents 
could be explained by the fact that time in VPA accumulated by the two populations 
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was very similar (only 11.56 minutes more, according to Rowlands and 1.36 
minutes less based on the Chu thresholds). Furthermore, (Ekelund et al., 2007a) 
also demonstrated that MPA and VPA were inversely associated with DBP and SBP 
(as did (Hussey et al., 2007) and were not associated with TG or HDL in 1709 
children (9-10yrs old) and adolescents (15-16yrs old), conversely however, BG was 
also negatively associated with MPA and VPA. The present study has observed, in 
all participants (males and females), that those in the higher quintile of MVPA had a 
significantly lower DBP (P= 0.044) but only when assessed by the Rowlands 
thresholds, this was also observed in partial correlation analysis using both 
thresholds. In a large (n= 20871) multi-site study of children and adolescents (4-18 
yrs old) (Ekelund et al., 2012) it was observed that increasing MVPA (assessed by 
the Actigraph accelerometer) was associated with a reduced SBP; however, unlike 
the present investigation, MVPA was also associated with reduced WC, TG, insulin 
and increased HDL and the authors reported that SED time did not share any 
significant associations with cardiometabolic risk factors. The PA thresholds utilised 
by Ekelund et al (2012), compared to the current study, are markedly higher for 
assessing MVPA and lower for SED PA; >3000 CPM for MVPA and <100 CPM for 
SED whereas the Rowlands and Chu cut-points are >970 and >1860 CPM for 
MVPA and <288 and <420 CPM respectively. Therefore, those engaging in the 
Ekelund et al (2012) study had to engage in considerably higher intensity activities 
compared to the adolescents of the current study to accumulate MVPA, and this 
higher intensity of activity might be more favourably associated metabolic risk 
factors. However, Ekelund et al (2012) ran accompanying analyses using MVPA 
cut-points of >2000 CPM (similar to those of the Chu thresholds) and found their 
associations with metabolic risk were unchanged.   
This highlights the inconsistencies in terms of PA data analysis used between 
different studies and, although its impact is not clear, this difference might impact on 
the associations between PA and metabolic health. A further difference between 
these studies is the protocol for obtaining and reducing data from the 
accelerometer.  The present investigation used at least 2 acceptable week days 
(540 mins) and 1 weekend day (480 mins) of accelerometer wear time, yet, 
contrastingly, Ekelund et al (2012) used data from children who provided only 1 day 
of wear time ≥500 mins, which may provide a less accurate representation of 
habitual PA than the current study. Furthermore, the present study classed non-
wear time (which was discarded) as any period of zero counts lasting ≥10 
consecutive mins as opposed to Ekelund et al (2012) who defined non-wear time as 
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≥60 mins of consecutive zero counts, allowing non zero interruptions lasting 2 
minutes. Therefore the current study may have discarded more data as non wear 
time compared to Ekelund et al (2012) potentially resulting in more participants 
meeting the required daily wear time and being subsequently included in the 
statistical analysis.  Therefore, Ekelund et al (2012) may have examined a less 
biased sample, than the present study. In addition, the greater sample size 
employed by Ekelund et al (2012) in comparison to the current study, means that 
their study will have a greater statistical power. 
 
When exploring associations with lower intensity components of PA such as time 
spent SED and in LPA, more associations with metabolic risk factors emerged 
compared to associations with MVPA. When utilising either the Rowlands and Chu 
thresholds, in all participants, an increased SED time was associated with a higher 
mean DBP (P= 0.024 and 0.013, respectively). This was also the case in males 
assessed by the Rowlands thresholds. When assessed by the Chu thresholds, TG 
levels were significantly lower in males engaging in more SED time, although such a 
finding is not in agreement with previous research in youths (Ekelund et al., 2007). 
Conversely, although Bailey et al (2013) observed that TG was also the only risk 
factor associated with SED time in boys, they identified a positive association 
suggesting that being SED may be detrimental to lipid profile as supported by 
previous research in children, adolescent and adults (Ekelund et al., 2007a, Hussey 
et al., 2007). This lack of agreement between the two studies may be related to the 
differences in accumulated SED time; the adolescents of the current study spent 
approximately 75 minutes more time SED than the children of Bailey et al‟s (2013) 
investigation. 
 
Furthermore, Bailey et al (2013) reported that LPA was not associated with any 
metabolic risk factors in children, although they did observe positive associations 
between LPA and BF%. In the present investigation however, engaging in more 
LPA was associated with a reduced mean BG (P= 0.035), SBP (P= 0.007) and 
clustered risk (VO2) score (P=0.055) in all participants using the Rowlands 
thresholds; partial correlations also revealed that LPA was associated with reduced 
clustered risk (r -.261; P= 0.030). Additionally, in males, SBP was significantly lower 
in those completing more LPA when assessed by both thresholds. In males and the 
group as a whole, increased LPA as assessed by Chu was also associated with 
significantly higher HDL levels (P= 0.019 and P=0.025, respectively). Similarly, in 
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the EYHS (Ekelund et al., 2007a) LPA was inversely associated with clustered risk, 
DBP and SBP, in contrast however; LPA was the only PA component not to be 
associated with BG. In this group of adolescents being less SED and engaging in 
more LPA appears to be associated with improved BG and BP values and may also 
be a benefit to lipid profile, however, there appear to be conflicting associations of 
HDL with LPA and TG with SED activities in this group.  
 
In order to further assess the associations of CRF and PA with cardio-metabolic risk 
factors, binary logistic regression analysis conducted in all participants allowed for 
risk factors to be assessed in terms of clinical cut points for health risk. Per unit 
increase in CRF there were reduced odds of having hypertriglyceridemia (HTG) (P= 
0.014), low HDL (P= 0.008), high WC (P=<0.001) and high clustered metabolic risk 
score (P=0.003). Apart from HDL, these associations were not significant when 
analyses were adjusted for BMI, therefore it seems that these associations are 
mediated by weight status, yet the association of HDL with CRF appears to be 
independent of BMI. 
 
When risk factors were examined using logistic regression, the only PA components 
to share a significant association with risk were VPA and MVPA. When assessed by 
the Rowlands thresholds an increase in VPA was associated with a reduced 
likelihood of having HTG (P= 0.041) and high clustered risk score (P= 0.030) but the 
association with clustered risk was mediated by BMI. VPA was also associated with 
a reduced clustered risk score (P= 0.041) when utilising the thresholds of Chu, 
which when used to assess MVPA revealed a significantly reduced odds of having 
HTG (P= 0.036), moreover, this association with clustered risk was attenuated by 
the inclusion of BMI in the model. These associations appear to be in contrast to the 
findings of Bailey et al (2013) who did not observe any associations between VPA, 
MPA and risk and to the findings from MANCOVA analysis in the current study of 
which VPA and MVPA were only associated with BP (confusing). The different 
associations observed from logistic regression analysis compared to MANCOVA in 
the present study may have been observed due to the nature of the different 
analysis. Logistic regression split the sample into a non-risk and risk group for each 
metabolic risk factor (respectively); therefore the statistical power of this analysis 
depends on the number of participants exhibiting risk factors. Of the 75 participants 
examined, the prevalence of these associated risk factors was: 12% TG, 17.3% 
Clustered risk and 34.7% HDL. Although the group size for TG and clustered risk 
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appear small the relatively high prevalence of low HDL in this group compared to 
other risk factors might suggest that this finding is more statistically robust. 
 
In the current study WC was not associated with any PA components as assessed 
by either PA thresholds, however, it was associated with CRF in all groups. In a 
study of 152 children (7-10 yrs old), SED time (positively) and VPA (negatively) 
were significantly correlated with WC in boys only, whereas CRF was significantly 
negatively correlated with BMI and WC in boys and girls (Hussey et al., 2007). 
Similarly to the current study, Hussey et al (2007) also used RT3 accelerometry and 
the thresholds of Rowlands to assess PA, as did Bailey et al (2013); both studies 
found that PA (MPA and VPA) was associated with WC and BF% in children. The 
greater time accumulated in MVPA by children (Bailey et al., 2013, Hussey et al., 
2007) as compared to the adolescents of the current study (Bailey et al., 2013) may 
be responsible for the contrasting findings between the adolescents of this 
investigation and past research in children. 
 
The proportion of participants classified as sufficiently active (>60 mins of MVPA) by 
the two thresholds were markedly different, (Table 29) the Rowlands thresholds 
classified 53% of the group, 63.8% of males and 37.9% of females as sufficiently 
active. Contrastingly, the Chu thresholds classified only 6.6% of the group and 10.6 
% of males as sufficiently active; no females achieved >60 mins MVPA when 
assessed by the Chu thresholds. These variations can be attributed to the 
difference in MVPA cut-points between the Rowlands and Chu thresholds. Bailey et 
al (2013), observed a very similar difference in terms of time accumulated in MVPA 
when using the Chu et al (2007) and Rowlands et al (2004) thresholds.  
 
The associations observed between CFR and metabolic risk factors were stronger 
than those observed between PA and health parameters. It is important to highlight 
that when assessing the associations of PA and health risk a secondary analysis 
was conducted that controlled for CRF. Following adjustment for CRF, PA was no 
longer associated with any metabolic risk factors and thus it seems that CRF 
mediates associations of PA and health markers in this population. Metabolic health 
parameters may be mediated by CRF through increased mitochondrial volume and 
density, increased electron transport chain enzyme activity (Hawley, 2002) and 
increased capillary and limb blood flow (Holten et al., 2004). The mediating effect of 
CRF over PA could be explained by the fact that increased PA may have a 
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beneficial effect on CVD and type 2 diabetes risk but through increases in CRF 
subsequent to these physical activities (Rennie et al., 2003). The current study 
revealed that although MPA and VPA were associated with reduced BP, LPA 
appeared to be associated with improved BP, BG and lipid profile. Evidence in 
adults has revealed that low to moderate and moderate to high PA modulates 
insulin secretions, increases fatty acid oxidation and promotes glucose uptake from 
the blood through increased AMP-activated protein kinase (AMPK) activity (Chen et 
al., 2003). However, a 4-fold increase in AMPK activity has been observed 
immediately following high intensity exercise (~75% VO2max) but not after lower 
intensity exercise (~50% VO2max) (Wojtaszewski et al., 2000). The current findings 
then may be in line with evidence that breaking SED activities and engaging in more 
LPA is associated with health improvements (Healy et al., 2008b, Healy et al., 
2011). 
 
There are some limitations of the present study that should be noted; the relatively 
small sample size of this study means that the strength of the associations may be 
weaker than compared to some previous studies in this age group. It is possible that 
the data acquisition period of this study (minimum of 3 days of 900 and 800 minutes 
for week days and weekend days) and the one minute epoch may not have fully 
represented the true PA habits of this population. However, it was ?larger than that 
of previous research (Ekelund et al., 2012), and a shorter epoch was not possible 
with the technology available. Participants were recruited from schools and colleges 
from the Bedfordshire area and therefore the findings from this group of post-
pubertal adolescents cannot be generalised to other populations. Furthermore, as 
this research is observational, the direction of causality of the associations cannot 
be determined.  
 
This study demonstrates that that using different PA thresholds to assess PA 
intensity impacts on the relationships between PA components and metabolic risk 
factors, however a consistent relationship emerged between MVPA (negative) and a 
SED (positive with BP) suggesting that limiting SED behaviour and engaging in 
higher intensity activity is beneficial for BP in this adolescent population. There was 
also evidence that increasing LPA is related to an improved fasting BG and lipid 
profile but this was not consistent between males and females. Furthermore, 
regardless of threshold used, increasing VPA was associated with reduced odds of 
having a high clustered risk score. The associations observed between CRF and 
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risk factors were stronger than those observed with PA; CRF was inversely 
associated with WC, clustered risk and factors associated with an adverse lipid 
profile. 
The effect of using different thresholds will clearly have implications for identifying 
sufficiently active youths, as these recommendations are endorsed by the 
government and based on the health benefits associated with MVPA, it is important 
that consensus is arrived at regarding the thresholds used to accurately assess 
MVPA engagement. 
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Chapter Eight: Study Five 
The impact of a low glycaemic index diet on the metabolic 
health of postpubertal adolescents with features of the 
metabolic syndrome. 
 
8.0 Introduction 
In adults and youths, consumption of a diet high in GI and GL has been associated 
with central obesity and individual risk factors for the metabolic syndrome, as well 
as increased clustering of cardiometabolic risk (Culberson et al., 2009, O‟Sullivan et 
al., 2010). GI and GL have been independently associated with adverse lipid profile 
and CVD in adults (Yungsheng et al, 2006; Culberson et al, 2009). Furthermore, 
increased GI and GL intakes have been associated with incidence of type 2 
diabetes in healthy adults (Sluijs et al, 2010) and in subjects with type 2 diabetes GL 
has been positively associated with CVD related mortality risk (Burger et al., 2012); 
these associations are thus evident in adults classed as healthy and „at risk‟. In 769 
Australian adolescents (13-15 yrs), O‟Sullivan et al (2010) assessed the 
associations of glycaemic CHO with the prevalence of the metabolic syndrome as 
defined by the ATPIII and IDF (Alberti et al., 2006) criteria, separately. A 20 unit 
increase in GL was associated with significantly increased odds of having the 
metabolic syndrome as defined by the IDF criteria (O‟Sullivan et al., 2010), but not 
when the metabolic syndrome was defined by the ATPIII criteria. The IDF criteria is 
the only definition to include WC as a mandatory factor for having the syndrome 
(see section 6.1); the authors postulated that WC may partly explain the relationship 
between GL and metabolic risk factors. In contrast, however, Davis et al (2007) 
observed that GI and GL were not associated with adiposity or insulin dynamics in a 
group of overweight Latino youths (10-17 yrs) with a family history of type 2 
diabetes. Davis et al (2007), however, utilised two weekday 24 hour recalls, one of 
which was via telephone whereas O‟Sullivan et al (2010) employed a 3 day food 
record (2 week 1 weekend day) to assess diet which may have contributed to the 
equivocal findings of these studies. By not including a weekend day, Davis et al 
(2007) may not have captured a true representation of habitual intake and the fact 
that food items were recalled may compromise the accuracy of type and quantity of 
foods recorded (Rockett and Colditz, 1997, Kipnis et al., 2001). An issue with a 
number of investigations that assess the association of glycaemic CHO and health 
150 
 
parameters is that the different dietary reporting methods they employ makes 
comparisons between studies difficult. The difference between the types of 
information obtained from different reporting methods may pose particular problems 
when assessing the GI and GL of the diet, due to the detail required on the type and 
quantity of food consumed (Collins et al., 2010). 24 hour recalls and FFQs require 
participants to remember and recall their food intakes (Hu, 2008) whereas food 
diaries are designed to be completed immediately after eating and are thus less 
prone to reporting errors (Kipnis et al 2001). 
 
There is also observational evidence that these associations extend beyond the 
specific risk factors for the metabolic syndrome; glycaemic CHO consumption has 
been linked to increased markers of poor liver function and markers of systemic 
inflammation (CRP) (Valtueña et al., 2006), as well as a reduction in the anti-
inflammatory cytokine adiponectin (Qi et al., 2005) and some researchers have 
suggested these factors may mediate poor metabolic health (Eckel et al., 2005, 
Fernández-Real and Ricart, 2003, Sutherland et al., 2004). Dietary GI has been 
associated with liver steatosis (as measured by liver echography) in 247 apparently 
healthy adults (Valtuena et al, 2006); being insulin resistant strengthened 
associations suggesting that high GI foods are a greater burden to those who have 
difficulty controlling BG levels. In a sample of 902, type 2 diabetic women from the 
Nurses‟ Health study, higher GL was associated with significantly lower adiponectin 
levels, this was observed across normal weight, overweight and obese participants, 
according to BMI (Qi et al., 2005). This research group also presented the same 
findings in a sample of diabetic male adults (Qi et al., 2005). 
 
Although observational evidence suggests that glycaemic CHO is associated with 
metabolic risk factors, these studies cannot determine the direction and causality of 
such associations and thus, it is important that intervention studies are conducted to 
further inform this interaction. Intervention studies in both adults and youths have 
revealed that reducing dietary GI and GL can reduce adiposity (Spieth et al., 2000, 
Pereira, 2004) and have a beneficial effect on metabolic health (Rizkalla et al., 
2004, Jebb et al., 2010). Some intervention studies in overweight and obese adults 
have reported that greater weight loss is observed following a low compared to high 
GI diet, however, this is only observed in those with reduced insulin sensitivity 
(Pittas et al., 2005, Ebbeling et al., 2007). In 39 overweight and obese young adults 
(18-40yrs) a diet designed to elicit a 10% weight loss (60 % of required energy) low 
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in GL compared to low fat (high in CHO and GL) elicited greater improvements in 
insulin resistance, TG, CRP and blood pressure (SBP and DBP), despite very 
similar reductions in weight and FM  (Pereira, 2004). Those on the low GI diet had a 
smaller reduction in resting metabolic rate (RMR) and reported feelings of less 
hunger compared to the low fat diet. A limitation of this work is the lack of matched 
macronutrient intake between the two diets and thus health improvements may be a 
result of additional dietary factors other than GL. Furthermore, Pereira et al (2004) 
used a heavily controlled dietary intervention, supported by daily checkups and strict 
menus; this may not be a practical approach for the general population. It may be 
that an adlibitum diet is a more „adherable‟ approach  to health improvement 
through lowering dietary GI and GL (Ebbeling et al., 2005). In adult males, just 4 
weeks on a low GI diet compared to high (using a crossover design) resulted in 
significant improvements in glucose control (HbA1c) and lipid profile (Rizkalla et al., 
2004), this was also observed in 210 type II diabetic men and women (Jenkins et 
al., 2008). There is little evidence for the effects of low GI interventions on health in 
UK populations, however, one study conducted within the UK, compared 4 diets 
over a 4 week period: a low GI compared to high GI diet of either low or high SFA 
content in 548 adults with existing metabolic risk factors (Jebb et al., 2010). 
Improved lipid profile; reduced TC, LDL and apoB concentrations resulted from 
reducing dietary SFA, however reducing dietary GI further enhanced TC and LDL 
improvements. All groups failed to significantly improve insulin sensitivity, although, 
the low fat/LGI group improved insulin sensitivity to the greatest extent. Despite the 
fact that these diets were designed for weight maintenance, body weight was 
slightly reduced as a result of lowering dietary fat intake; there was no evidence of 
an effect of GI on weight management (Jebb et al., 2010). A limitation of the above 
studies (Jebb et al., 2010, Pereira et al., 2004, Ebbeling et al., 2007) is that CRF or 
PA were not adjusted for in their analysis. In a prospective cohort of 13,621 men 
and women, (Héroux et al., 2010) observed that accounting for fitness (maximal 
exercise test) substantially attenuated the previously significant relationship 
between an unhealthy eating index and all cause mortality. Interestingly initial 
adjustment for self-reported PA had very little impact on the original association; the 
mortality risk estimates were reduced by 13.5 and 55.0 % after controlling for PA 
(self-report) and fitness, respectively. According to (Pischon, 2010) objectively 
assessed fitness and additionally PA should be accounted for due to the apparent 
intermediary effects of these variables on diet-health relationships. Although it is not 
possible to say if this would affect the associations of GI and GL on health 
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outcomes it is important to account for these factors based on this evidence. 
Despite these limitations it appears that reducing dietary GI and GL, particularly in 
those exhibiting obesity and metabolic risk factors, may promote weight loss and be 
beneficial in the amelioration of metabolic risk.  
 
There is limited and equivocal evidence in youngsters of the impact of altering 
glycaemic CHO consumption on health outcomes. Unfortunately, the low GI/GL 
dietary interventions have tended to employ small sample sizes and are not well 
controlled. In a study of 16 obese but otherwise healthy adolescents (13-21 years 
old) from the USA, Ebbeling et al (2003) employed an ad libitum low GL diet and 
observed greater fat loss in comparison to a reduced fat intervention over 6 months. 
Although the two diets were described as not significantly different in energy, there 
was a mean difference of 692 kcals between baseline and the low GL diet 
compared to only 148 kcals in the low fat diet and thus it is unclear as to whether 
greater fat loss was observed due to reduced GL or energy (Ebbeling et al., 2003). 
Furthermore, although the diet was described as ad libitum, in order to reduce the 
GL it was necessary to reduce CHO intake and thus the intervention was not truly 
ad libitum. Although Ebbeling et al (2003) observed a beneficial effect of low GL 
compared to low fat on adiposity, they found that insulin resistance increased in 
both groups but the change was non-significant for the low GI group. It was 
suggested that the increased insulin resistance was a result of hormonal changes 
during puberty (Ebbeling et al., 2003). The ages of the adolescents studied by 
Ebbeling et al (2003), like the majority of observational studies, span across a range 
encompassing individuals at different stages of maturational growth. Individuals still 
in puberty are likely to have a greater central adiposity and insulin resistance 
compared to those who have finished puberty (Staiano and Katzmarzyk, 2012, 
Moran et al., 1999); these factors have been evidenced to influence metabolic risk 
factors (Hannon et al. 2006). Therefore puberty may confound the influence of 
lowering glycaemic CHO on adiposity and health outcomes. Moreover, there 
appears to be a distinct lack of research investigating the effects of lowering dietary 
GI in postpubertal adolescents. However, in otherwise healthy but overweight and 
obese prepubertal children (11 yrs old), from Hungary, Fajcsak et al (2008), 
observed the impact of an ad libitum low GL diet on adiposity and metabolic risk 
markers. The intervention centred on exchanging 50% of the high GI foods 
consumed with low GI alternatives and there was no significant difference between 
calories consumed at baseline and during the intervention.  Significant reductions in 
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fat mass and the prevalence of metabolic risk factors were observed after the six 
week intervention. Unfortunately this study did not report the GI and GL of the diet 
during the intervention period nor did the authors employ a control group, 
furthermore, in lowering the GL of the diet, portion sizes were indirectly restricted 
and the thus the diet was not truly ad ad libitum. Speith et al (2000) examined the 
effects of an unrestricted low GI diet compared to a standard reduced fat for the 
management of obesity in 190 children (10 yrs old) from the USA. The low GI diet 
centred on food selection rather than restriction; children were advised to consume 
low GI CHO, PRO and fat at every meal and snack. The low fat diet emphasised 
consumption of low fat, low sugar and foods of a low energy density and was thus 
energy restricted (approximate energy restriction of 250-500 kcals per day). The 
authors observed a significant decrease in BMI of 1.15 kg/m2, by contrast the low fat 
diet group showed no change in BMI. This low GI intervention had no restriction of 
energy or specific macronutrients, children were encourage to eat to satiety and 
snack when hungry, however, the low fat diet was heavily restricted on energy 
intake. These effects may be attributable to the lack of adherence to a heavily 
restricted compared to a more flexible diet, but as dietary change was not monitored 
throughout the intervention the impact of either dietary prescription on nutritional 
intakes cannot be observed. Furthermore, because the macronutrient intake of 
these diets was very different it is difficult to attribute the effect solely to GI. 
However, this evidence does provide support for an ad libitum diet in the reduction 
of obesity in children yet there are no studies exploring its effect on metabolic risk 
factors. Like the majority of GI interventions in adults, none of the above studies in 
youths adjusted their analysis for physical activity of fitness and thus the true extent 
of the impact of these dietary changes on health may not have been demonstrated 
(Pischon, 2010). 
 
In adults and youths, the majority of interventions examining the impact of lower 
glycaemic CHO on health outcomes alter the GL of the diet (Ebbeling et al., 2007, 
Ebbeling et al., 2003, Pereira, 2004, Fajcsak et al., 2008) and in order to manipulate 
dietary GL, CHO intake must be limited, thus restricting the flexibility. In youths an 
ad libitum approach may be more beneficial than restricted diets since adolescents 
have been shown to value the opportunity to make autonomous choices regarding 
their food choices and are less likely to adhere to energy restricted diets (Ebbeling 
et al., 2005). Therefore, if a truly ad libitum low GI diet can have a positive impact on 
health outcomes and or weight loss in adolescents, it may be an approach that can 
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be generalised to the wider population; however, there is currently no research that 
has explored this in an adolescent population. Additionally much of the evidence in 
youth is based within the USA and thus, the application of an ad libitum low GI diet 
has not been assessed in a UK population. This is important because many of the 
GI tables used to define the GI of individual foods are based on research from the 
USA and Australia (Aston et al., 2008) and therefore little is known of its application 
within a UK based intervention in an adolescent population. Identifying a dietary 
intervention that can be well adhered to by adolescents is of particular importance 
because metabolic complications observed in this age group have been shown to 
track into adulthood (Camhi and Katzmarzyk, 2010). Furthermore, although studies 
of low GI interventions in youths have assessed overweight participants, none 
appear to be exhibiting existing metabolic complications; despite evidence in adults 
suggesting that reduced GI may be more beneficial for those „at risk‟ (Pittas et al., 
2005, Ebbeling et al., 2007, Valtueña et al., 2006). It is therefore important to 
determine the impact of an ad libitum low GI diet on metabolic risk factors in 
adolescents exhibiting poor metabolic health. There also appears to be no research 
in adolescents examining the effect of a low GI intervention on additional important 
markers of cardiometabolic health such as liver function and inflammation. 
 
To this end, the current investigation will explore the impact of a truly ad libitum low 
GI dietary intervention on metabolic risk factors compared to a control group, in 
postpubertal adolescents from the UK. These associations will be assessed in a 
„metabolically unhealthy‟ population as defined by the IDF criteria for the metabolic 
syndrome, based on the evidence that reducing dietary glycaemic CHO may be 
more beneficial for „at risk‟ groups and may be mediated by a high WC in 
adolescents (Pittas et al., 2005, O‟Sullivan et al., 2010). When analysing the effect 
of this intervention, the impact of adjusting for objectively measured PA and CRF 
will also be considered. Furthermore, due to the extent and impact of dietary 
misreporting on glycaemic CHO and metabolic health relationships, as previously 
observed in UK adolescents within chapter 3, dietary misreporting will also be 
assessed in this group. 
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8.1 Methodology 
Participants  
Participants from Bedfordshire were recruited for the SIRENS study as outlined in 
section 3.2. In order to take part participants had to be overweight (high WC) and 
exhibit 1 additional metabolic syndrome risk factors for the metabolic syndrome as 
defined by the IDF child and adolescent criteria. Participants were screened as part 
of initial data collection procedures at the Centre for Obesity Research (COR) within 
the Luton and Dunstable Hospital to identify if they were eligible to participate. 
 
Experimental design 
The SIRENS study was a randomised controlled trial assessing the impact of a 12 
week, ad libitum, low GI dietary intervention compared to control group on metabolic 
risk factors. Prior to enrolment into either intervention or control group, participants 
provided baseline data; the measures are outlined below. At week 6 and after the 
participants had completed week 12 of the intervention these measures were 
repeated. Participants attended the COR for all measures. 
 
Measures 
Age, ethnicity, SES, pubertal status  
As previously outlined in section 4.1, age (years), ethnicity (white or non-white) and 
SES (IMD scores) were measured at baseline. Age was calculated for follow up 
data collection sessions based on the date of each participants data collection, 
respectively. Pubertal status was self assessed by each participant when they 
consented to take part. The study consent and information form included a sex 
specific line drawing diagram of the Tanner scale of sexual maturation (stages 2-5), 
as shown in Appendix 2; individuals who were in Tanner stage 5 were classed as 
having finished puberty (Marshall and Tanner, 1970a, Marshall and Tanner, 1969). 
Participants were thus informed (on the information sheet) that they could only 
participate if they deemed themselves to be at Tanner stage 5. 
 
Anthropometry and body composition 
Stature, WC, body mass, fat mass and BMI were measured as outlined in section 
3.5. 
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Diet 
Three day weighed food diaries (included 2 week day and 1 weekend day) were 
used to assess habitual dietary intake, GI and GL as outlined in section 3.10. 
Participants were required to complete follow up food diaries in weeks 6 and 12; 
participants were required to record their food intakes on the same three 
consecutive days at each dietary follow up.  
 
Physical activity 
PA level was assessed at baseline via 7 day accelerometry (RT3) as outlined in 
section 3.9. The thresholds of Chu (Chu et al., 2007a) were used to determine time 
spent in difference categories of PA intensity as outlined in section 6.2. 
 
CRF 
Peak oxygen uptake was measured during a maximal incremental cycle ergometer 
test at baseline, this was outlined in detail in section 3.9. 
 
Venous blood sampling 
Venous blood samples were collected at baseline, week 6 and after week 12 of the 
intervention. These procedures have been described in section 3.4.1. Once 
samples were collected, they were immediately delivered to the L&DH biochemistry 
laboratories where the samples were assayed by L&DH biochemistry staff and 
stored in aliquots at -80˚C for further assessment at a later stage. 
Metabolic risk factors and liver function markers were assayed at the L&DH 
biochemistry laboratories, as per their laboratory procedures. Markers of 
inflammation and fasting insulin were assayed by the biochemistry laboratory of the 
Addenbrookes, Cambridge University Hospital, see Appendix 4, for assay details. 
 
 Lipid profile: Fasting HDL and TG 
 Inflammation: Adiponectin; Tumor Necrosis Factor alpha (TNF-α); 
Interleukin-6 (IL-6); and high sensitivity C-reactive protein (hs-CRP). 
 Liver function: gamma-glutamyl transpeptidase (GGT); alkaline phosphatise 
(ALP); alanine transaminase (ALT); albumin; and bilirubin. 
 Glucose control: Fasting plasma glucose, Fasting insulin; HbA1c. 
 Insulin resistance was calculated using the homeostatic model of insulin 
resistance (HOMA-IR) and was calculated using the following formula: 
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HOMA-IR = fasting insulin (mU/L) x fasting glucose (mmol/L) (Wallace et al., 
2004). 
 
Metabolic risk factors and clustered metabolic risk score was calculated as outlined 
in section 6.2 
 
Intervention groups  
All participants who consented to taking part and met the inclusion criteria (see 
section 3.2) provided baseline data by attending the COR and were subsequently 
randomised to either the control or low GI dietary intervention group using stratified 
minimisation via the MINIM computer software package for windows. The groups 
were matched based on sex, age, ethnicity and WC into either the low GI dietary 
group or the control group. Prior to enrolment, baseline metabolic health risk factors 
were checked to ensure participants were classed as „at risk‟. The experimental 
design of the SIRENS study is summarised below in figure 4. Prior to starting the 
intervention, both the control and low GI groups were made aware that they were 
required to maintain their usual exercise and PA habits during the entire intervention 
period. 
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Clinical referrals: GPs and 
Paediatric Clinic (L&DH) 
Advertisements: Local newspaper 
Schools; University campus and 
Hospital. 
 Assessment of pubertal 
status and waist 
circumference (WC) 
Exclusion criteria: < Tanner stage 
5, WC <90
th
 percentile 
 
Inclusion criteria: 
Tanner stage 5, WC 
>90
th
 percentile 
Baseline heath measures 
Inclusion criteria: At 
least 1 metabolic 
disorder 
Exclusion criteria: No 
metabolic disorders 
 
Randomise into dietary or control 
group by minimisation (match for 
age, sex and WC) 
CRF, Physical activity levels 
and 3 day weighed food diary 
Control group Low GI diet group 
Week 1-6: Once weekly low 
GI intervention, consultations 
sessions, based on 
motivational interviewing  
Week 1-6: 
Participants maintain 
habitual dietary and 
exercise behaviours 
Week 6: Mid 
intervention health 
measures and 3 day 
weighed food diary. 
 
 
Week 3: 3 day non-
weighed food diary 
Food diary 
Post intervention:Final 
data collection. Tailored 
dietary advice, based on 
food diary. 
SIRENS RCT design 
Introduction to the 
GI and low GI 
eating 
Week 12: 3 day 
weighed food diary. 
 
Week 6-12: 
Participants maintain 
habitual dietary and 
exercise behaviours 
Week 6-12: Once weekly low 
GI intervention, consultations 
sessions (week 8 and 10- 
Telephone contact) 
Week 6: Mid 
intervention health 
measures and 3 day 
weighed food diary. 
 
 
Week 12: 3 day weighed 
food diary. 
 
Post intervention: Final 
data collection 
 Figure 4. SIRENS trial design 
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Low Glycaemic index dietary intervention 
The low GI diet regime was developed in consultation with dieticians at the COR, 
L&DH. Participants in the low GI intervention group attended weekly (apart from 
weeks 8 and 10) consultations sessions over the 12 week period (see intervention 
schedule, figure 6). Each session was guided by the PhD candidate who had been 
trained in the use of motivational interviewing for behaviour change and this 
approach formed the basis for all consultation sessions (see figure5) for 
consultation design). Participants were given pre arranged time slots to attend their 
consultation, which lasted 20-30 minutes. However, any consultation session that 
followed a dietary assessment required up to 40 minutes allowing for extra time to 
discuss the food diary with the participant and correct any unclear entries or 
anomalies.        
 
 
 
 
 
 
 
Figure 5. Low GI consultation design. 
 
 
 
 
 
 
 
 
Low GI intervention 
Individual consultations 
 
Weeks  1 to 12 
  Behavioural Targets 
Reduce dietary GI by 
consuming low and 
moderated GI foods and 
avoiding high GI foods. 
Whilst maintaining a 
balanced diet. 
Behavioural change skills 
Self monitoring 
Goal-setting 
Reinforcement 
Family support 
Barrier analysis 
Problem solving 
Motivational techniques 
       TOOLS 
To aid participants and 
researcher: 
Food diaries 
GI booklets 
GI traffic light lists 
Meal plans 
 
              MOTIVATIONAL INTERVIEWING 
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Baseline data collection: 
Metabolic health screen 
VO2 max, Physical activity-RT3s   † 
                   
                     INDIVIDUAL CONSULTATIONS 
WEEK 1- LOW GI INTRODUCTION; ASSESS FOOD DIARY FROM [WEEK -1] 
WEEK 2 
WEEK 3 
WEEK 4-ASSESS FOOD DIARY FROM [WEEK 3] 
WEEK 5 
WEEK 6--- 
WEEK 7- ASSESS FOOD DIARY FROM [WEEK 6] 
 
WEEK 3-NON WEIGHED 3 
DAY FOOD DIARY 
WEEK 6 -WEIGHED 3 DAY 
FOOD DIARY  † 
WEEK 8 -Telephone contact 
 
WEEK 9 – INDIVIDUAL CONSULTATION 
WEEK 10 - TELEPHONE CONTACT 
WEEK 11 – INDIVIDUAL CONSULTATION 
WEEK 12- TELEPHONE CONTACT 
MID INTERVENTION DATA COLLECTION † 
WEEK 13- POST INTERVENTION HEALTH MEASURES 
WEEK 12 -WEIGHED 3 
DAY FOOD DIARY   † 
Explain and hand out 3 day weighed food diaries † 
WEEK  -1 
Participants RANDOMISED into low GI intervention group  
Low GI Intervention schedule 
Figure 6. Low GI intervention flow chart; †, also required by control 
group. 
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Low GI regime 
 Because a number of low GI foods are high in fat it was important to ensure that 
participants were not over consuming these foods. Thus the low GI intervention was 
centred on regular balanced meals based on food groups from the Eatwell plate, 
and this was encouraged for all meals and snacks. Participants were guided on how 
to make simple replacements for high GI foods in their diet with lower GI foods. The 
regime was fully ad libitum and thus not restricted by energy or controlled for 
macronutrient intake. Therefore the participants were not required to make 
substantial changes to their normal diet. Evidence suggests that the flexibility of an 
ad libitum diet suits the desire for autonomy that many youngsters and in particular, 
adolescents, seek (Ebbeling et al, 2003), and thus is likely to improve adherence to 
the diet.   
 
The initial consultation session in week 1 lasted approximately 1 hour and consisted 
of a 10 minute introductory power point presentation that explained the purpose of 
the intervention and the concept and benefit of a low GI diet. Participants were also 
required to bring their completed 3 day weighed food diary that was given to them 
during the previous week. Weighed food diaries were a primary tool in the reduction 
of dietary GI; in the first consultation session (See intervention flow chart, figure 6) 
they were used to gain a rapid impression of the habitual dietary intake of each 
participant and explore with the participant which foods they consume that could be 
swapped for lower GI options. This was done as a collaborative process allowing 
the participants to decide on their own food choices. In this session participants 
were also given a GI traffic light list of staple foods that included high GI foods to 
avoid (in red), moderate GI foods to consume in moderation (in orange) and low GI 
foods that should be consumed in all meals and snacks (in green) (see appendix 5). 
Because many of the foods listed on the international table of GI are from Australia 
and the USA, the GI traffic light list was developed specifically for this intervention 
and included foods within the international tables which most represented those 
consumed within the UK. This list was used in all consultation sessions and was 
also given to the participants to guide their food choices during the 12 week 
intervention. The international tables of GI were also utilised in these sessions as 
tools for identifying the GI of foods consumed and potential low GI swaps. As the 
intervention progressed participants were required to complete a non-weighed food 
diary at week 3 which was used as a guidance tool for the participants to identify if 
they were making the right low GI food choices. At this stage participants were also 
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given a low GI recipe booklet which they could use to help make meal choices; 
recipes were based on those published in the New Glucose Revolution for Diabetes 
(Brand-Miller et al., 2007) . The intervention flow chart highlights the time points 
throughout the intervention at which follow up data collections and consultations 
took place (see figure 6). 
 
Control group 
The control group were required to attend 3 consultation sessions throughout the 12 
week period. At week 1, participants handed in their completed 3 day weighed food 
diary. Like the low GI group, at this point the control group were given the same 
guidance on eating healthy balanced meals using the Eatwell plate (FSA., 2012). 
This was done in order to match the underlying guidance for balanced meals issued 
to the low GI group in order to avoid over consumption of high fat low GI foods. 
Participants were required to attend follow up data collection and nutritional 
assessment at week 6 and 12. The control group were offered an additional 
consultation at the end of the intervention that matched the guidance given to the 
intervention group at week 1. See study design flow diagram above (figure 6). 
 
Statistical analysis 
Analyses were completed using the Statistical Package for Social Sciences (SPSS 
19, IL.); descriptive statistics are presented as mean and standard deviation (SD), 
dietary intakes for the intervention period are presented as mean and standard error 
(SE). The following variables were non-normally distributed and were subsequently 
log transformed to improve their distribution to acceptable levels: FM, WC, HDL, 
TG, fat, PUFA, SED, LPA, MPA, and MVPA. All nutrient intakes (g) were adjusted 
for energy intake using the residuals method as outlined previously in section 6.1.  
BMI and BF% were converted to Z-scores based on population means for the age 
group. Differences between group baseline characteristics were assessed by One-
way ANOVA. MANCOVA was used to assess between group (LGI and control) 
differences by time period (baseline, week 6 and week 12) and the interaction of 
group by time period of dietary variables (CHO, PRO, fat, fibre SFA, MUFA, PUFA), 
hunger and satiety as well as all health parameter variables. MANCOVA were 
adjusted for the following covariates in a sensitivity analysis approach: model 1(age, 
sex, SES, ethnicity, zBMI); model 2 additionally included (energy, PRO, fat, CHO, 
fibre); model 3 additionally included (CRF and % MVPA) and model 4 additionally 
included (EI:EE). For the same variables as the MANCOVA (apart for dietary 
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variables) analyses were also run as linear mixed models ANCOVA in order to 
account for within subject correlations of repeated observations and these analysis 
were adjusted for using the covariates of model 4. No colinearity was observed 
between covariates of MANCOVA models apart for EI:BMR and thus EI:EE (RT3) 
was included as a covariate in model 4. The assumption of homogeneity of 
regression slopes, however, was violated; there were significant interaction effects 
observed for group by: age and DBP, ALT, CRP, bilirubin; zBMI and CRP, bilirubin; 
energy and CRP, ALT, bilirubin; SES and bilirubin, ALT, CRP; and fibre and ALP; 
therefore results of MANCOVA and mixed models for these independent variables 
should be interpreted with caution. The assumption of homogeneity of variance 
between groups was not violated as assessed by critical F values. 
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8.4 Results 
Recruitment and enrolment schematic 
 
Figure 7. Flow of participants through trial. 
 
Figure 7 shows that 11 and 10 participants were enrolled into the LGI and control 
group, respectively. However, due to unequal dropout rates between enrolment and 
week 6 data collection, the control group was comprised of 6 and the LGI group 10 
30 Adolescents recruited 
7 males; 23 females  
8 individuals not screened (5 males; 
3 females ): 
 
1 fear of needles 
1 could not attend health screen 
6 did not meet inclusion criteria 
 
22 screened for eligibility 
(3 male; 19 female) 
21 enrolled 
1 female not enrolled: 
Non compliance with diet 
and PA baseline data 
Low GI group 
N = 11 
(1 male) 
 
Control group 
N = 10 
(2 males) 
 
 
WEEK 6 data  
N = 6 
(1 male) 
WEEK 6 Data 
N = 10 
(1 male) 
5  females dropped out before 
week 12 
 
4 dropped out 
before week 6 
(1 male) 
1 female 
dropped out 
before week 12 
WEEK 12 Data 
N = 5 
(1 male) 
WEEK 12 Data 
N = 5 
(1 male) 
1 dropped out before week 6 
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participants. By week 12 data collection group sizes had become even due to 
further unequal dropout rates.  
 
Table 39. Baseline participant characteristics, physical activity and CRF levels 
for intervention and control group. 
  Low GI group 
n= 10 
Control group 
n= 6 
 
P
 
 
Males (n) 1 
  
1 
 Age (yrs) 16.74 (2.27) 15.95 (0.95) 0.44 
Ethnicity  
non-white [n (%)] 7 (70%) 4 (66.7%) 
a
N/S 
SES (IMD) 21.29 (14.65) 20.24 (9.75) 0.88 
Height (cm) 160.10 (4.99) 168.38 (6.90) 0.01 
Weight (kg) 81.07 (13.90) 92.87 (10.26) 0.09 
BMI (kg/m
2
) 31.63 (5.31) 32.82 (3.60) 0.57 
zBMI  2.56 (0.78) 2.74 (0.51) 0.62 
BF(%) 41.12 (4.65) 41.43 (3.91) 0.89 
FM (kg) 33.89 (9.61) 38.62 (6.63) 0.25 
FFM (kg) 47.18 (4.63) 54.25 (5.78) 0.02 
WC (cm) 93.80 (9.82) 95.73 (6.46) 0.63 
PA and CRF           
Total PA mins 688.07 (104.18) 842.25 (48.44) 0.01 
SED mins 558.77 (110.88) 633.37 (98.36) 0.24 
LPA mins 98.45 (45.34) 143.92 (38.42) 0.08 
MPA mins 15.15 (13.81) 27.83 (23.08) 0.17 
VPA mins 0.27 (0.38) 4.65 (10.23) 0.16 
MVPA mins 15.43 (14.13) 32.48 (32.63) 0.15 
>60 mins MVPA [n (%)] 0 
 
1 (16.6%) - 
VO2 peak (ml/kg/min
-1
) 24.40 (5.70) 26.00 (3.69) 0.55 
P, significant at <0.05 for between groups comparison; 
a
N/S, Chi-squared test no significant 
difference between groups. 
 
Baseline characteristics of those participants providing at least 6 week data (Table 
39) show that there were more participants in the low GI group (LGI) compared to 
control (n= 10 and  6, respectively) and that there was only 1 male in each group. 
The LGI group was older and had a slightly greater proportion of non-white 
participants; SES scores were very similar between the two groups. The control 
group was significantly taller, heavier and had a greater FFM than the LGI group, 
WC was approximately 2 cm greater in the control group but this was non-
significant; %BF and zBMI, however, was not different between the two groups. The 
control group engaged in significantly greater total PA and LPA than the LGI group. 
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Although non-significant, SED, MPA, VPA and MVPA were greater in the control 
group. On average neither group achieved > 60 minutes of MVPA and only one 
male participant in the control group achieved >60 minutes of MVPA. CRF as 
measured by VO2 peak was similar between the two groups. 
 
Table 40. Baseline dietary intakes of the intervention and control groups 
 Low GI group 
n = 10 
Control group 
n = 6 
P value 
 
KCAL 1624.72 (584.49) 2600.34 (1050.63) 0.03 
GI 57.80 (3.91) 60.47 (4.27) 0.22 
GL
a
 (g) 163.11 (18.95) 162.65 (13.05) 0.96 
CHO
a
 (g) 281.75 (28.88) 276.35 (27.32) 0.72 
PRO
a  
(g) 64.21 (16.88) 75.01 (9.39) 0.18 
Fat
a  
(g) 75.5 (5.04) 70.97 (13.76) 0.35 
SFA
a  
(g) 25.84 (4.17) 22.13 (8.23) 0.25 
MUFA
a 
(g) 23.9 (3.55) 24.05 (6.04) 0.95 
PUFA
a  
(g) 12.91 (0.2) 12.94 (0.17) 0.74 
Fibre
a
 (g) 15.21 (2.55) 14.73 (5.80) 0.82 
%CHO 52.03 (6.56) 52.83 (3.62) 0.78 
%PRO 14.82 (4.66) 15.27 (3.22) 0.83 
%FAT 32.89 (3.00) 31.74 (6.56) 0.63 
%SFA 11.60 (2.50) 9.81 (3.29) 0.23 
%MUFA 9.90 (2.22) 10.50 (3.08) 0.65 
%PUFA 5.03 (2.24) 6.30 (2.42) 0.30 
Mean (± SD); P significant at <0.05 for between groups comparison. 
 
As shown in table 40, baseline the control group consumed a significantly greater 
energy intake compare the LGI group, this may be attributed of the greater height 
and mass of the control group. No other dietary variables as adjusted means or % 
of energy were significantly different. However the LGI group appear to be 
consuming less PRO and more SFA than the control group. GL was similar between 
the two groups, GI intake was slightly higher in the control group; for both groups, 
mean GI intake was classified as moderate. 
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Scatter plot comparing baseline EI:BMR (MVPA PAL) and EI:EE (RT3)  
 
Figure 8, Misreporting of energy as assessed by EI:BMR (MVPAL) and EI:EE 
(RT3) between groups. 
 
According to EI:BMR (MVPA PAL), of the 16 overweight participants, 8 were valid-
reporters, 6 were under-reporters and 2 over-reported their energy intakes. 
Whereas, EI:EE (RT3) classified 6 as valid-reporters, 8 as under-reporters and 2 as 
over-reporters. Of the 6 control group participants only 1(16.6%) individual under-
reported and 1 over-reported, as determined by both EI:BMR and EI:EE. Of the 10 
low GI group participants, 5 (50%) under-reported according to EI:BMR and this 
increased to 7 (70%) when assessed by EI:EE (figure 8). 
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Table 41. Comparison of mean (SD) baseline metabolic syndrome (IDF 
criteria) risk factors (prevalence of risk) and prevalence of metabolic 
syndrome between groups. 
 
low GI 
n = 10 
Control 
N = 6 
P value 
 
   HDL mmol.L 1.22 (0.24) 1.25 (0.17) 0.70 
<1.03mmol.L [n (%)] 3 (30%) 1 (16.7) 
a
NS 
   TG mmol.L 1.34 (1.10) 1.05 (0.93) 0.45 
≥1.7 mmol.L [n (%)] 1 (10%) 1 (16.7) 
a
NS 
   SBP mmHg 113.10 (9.08%) 116.58 (12.68) 0.53 
≥ 130 mmHg [n (%)] 0 
 
1 (16.7) 
a
NS 
   DBP mmHg 78.30 (7.00) 75.08 (5.22) 0.35 
≥ 85 mmHg [n  (%)] 2 (20%) 0 
 
a
NS 
   BG mmol.L 5.02 (0.45) 4.96 (0.55) 0.81 
≥5.6 mmol.L [n (%)] 1 (10%) 1 (10%) 
a
NS 
   Crisk Score 0.34 (2.90) -0.75 (2.51) 0.46 
>1 SD  [n (%)] 2 (20%) 0 
 
a
NS 
Metabolic Syndrome 
IDF [n (%)] 2 (20%) 0 
 
a
NS 
P significant at <0.05 for between groups comparison ; aNS, Chi-squared test no 
significant difference between groups. 
 
Table 41, Mean fasting TG levels and clustered risk score were higher and more 
individuals were classed as having a low HDL and high clustered risk score in the 
LGI group compared to the control group. Two participants were classified as 
having the metabolic syndrome; both were in the LGI group. However, none of the 
risk factor mean values or frequency of individuals at risk were significantly different 
between the two groups. 
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Table 42. Dietary intake during the intervention period for intervention and control group. 
Mean and standard error; a,low GI group baseline n= 7; week 6 n= 4; week 12 n= 3. Control group baseline n= 5; week 6 n= 2; week 
12 n= 2. †, significant between group*time-period interaction P= <0.05 ◊◊, significantly different from baseline P <0.01 (◊, P=<0.05). 
 
low GI 
 
Control group 
 
Baseline (n=11) WK 6 (n=10) wk 12 (n=5) 
 
Baseline (n=10) WK 6 (n= 6) WK 12 (n= 5) 
 
Mean SE Mean SE Mean SE 
 
Mean SE Mean SE Mean SE 
Energy (kcal) 1624.7 211.2 1329.3 222.6 1454.8 298.7 
 
2600.3 272.7 2254.9 272.7 2295.2 298.7 
GI (%) 57.80 1.55 49.55 ◊◊ 1.64 52.73 2.20 
 
60.47 2.00 59.74 2.00 58.51 2.20 
GL (g) 163.11 6.47 117.32◊◊ 6.82 138.90 ◊ 9.15 
 
162.65 8.35 139.32 8.35 137.10 ◊ 9.15 
PRO (g) 64.21 4.35 70.81 4.58 85.43 ◊◊ 6.15 
 
75.01 5.61 68.66 5.61 84.31 6.15 
Fat (g) 75.50 4.28 57.99 ◊◊ 4.51 66.83 6.05 
 
70.97 5.52 55.10 ◊ 5.52 70.91 6.05 
SFA (g) 25.84 2.18 18.75 ◊ 2.30 17.69 ◊ 3.08 
 
22.13 2.81 17.21 2.81 24.75 3.08 
PUFA (g) 11.66 2.07 10.96 2.18 16.92 2.93 
 
12.39 2.68 10.59 2.68 13.84 2.93 
MUFA (g) 23.90 2.09 18.57 2.21 18.87 2.96 
 
24.05 2.70 18.70 2.70 23.57 2.96 
CHO (g) 281.75 10.37 221.59 ◊◊ 10.94 246.94 ◊ 14.67 
 
276.35 13.39 231.77 ◊ 13.39 242.80 14.67 
Fibre (g) 15.21 2.55 14.36 2.18 15.79 4.03 
 
14.73 5.80 12.19 7.02 12.45 6.62 
Sugar (g) 129.12 54.40 91.13 ◊ 23.66 78.96 ◊ 26.61 
 
103.98 46.55 93.68 34.17 96.68 42.43 
% PRO 14.82 1.13 17.69 1.13 15.62 1.60 
 
15.27 1.46 16.45 1.46 18.88 1.60 
% Fat 32.89 2.25 29.37 2.25 31.94 3.18 
 
31.74 2.91 31.31 2.91 34.23 3.18 
% SFA 11.60 1.12 9.58 1.12 9.11 1.58 
 
9.81 1.45 9.52 1.45 11.60 1.58 
% PUFA 5.03 1.00 6.33 1.00 7.97 1.41 
 
6.30 1.29 6.14 1.29 6.01 1.41 
% MUFA 9.90 0.97 8.57 0.97 8.13 1.37 
 
10.50 1.25 10.46 1.25 12.00 1.37 
% CHO 52.03 2.28 52.68 2.28 51.96 3.23  
52.83 2.95 52.11 2.95 47.84 3.23 
% Sugar 22.87 2.52 23.49 2.52 17.36 3.56 
 
19.23 3.25 19.60 3.25 19.01 3.56 
Hunger scorea 39.57 7.06 36.92 9.34 25.11 10.79 
 
32.20 8.36 41.17 13.21 42.00 13.21 
Satiety scorea 50.62 6.12 52.25 8.10 53.11 9.35  
50.03 7.24 40.33 11.45 48.00 11.45 
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As displayed in Table 42, Energy intake declined at week 6 and increased slightly at 
week 12 in both groups, however, there was no significant interaction between 
group*time period and there was no significant within-subjects change in energy 
intake in either group. 
 
 There was a significant reduction in GI in the LGI group between baseline and 
week 6 (P=0.001), at week 12, however, GI had increased and was no longer 
significantly different from, yet remained lower than, baseline. In the control group 
there was a slight but non-significant reduction in GI at week 6 and 12 compared to 
baseline. MANCOVA revealed a significant reduction in GI of 7.52 in the LGI group 
relative to the control group at week 6 compared to baseline (β = -7.52 (SE 3.62); 
P= 0.045)); at week 12 compared to baseline this interaction was no longer 
significant. GL was also significantly reduced at week 6 (P= <0.001) as well as week 
12 (P= 0.038) compared to baseline in the LGI group. In the control group, however, 
there was also a significant reduction in GL at week 12 compared to baseline 
(P=0.047) similar to that of the LGI group.  
 
Total PRO intake increased in both groups by week 12 compared to baseline and 
this increase was significant in the LGI group. Fat intake significantly declined at 
week 6 (P= 0.008 and 0.050) for the LGI and control groups. Similar declines in 
SFA were observed in both groups at week 6, however, at week 12 SFA continued 
to decline at week 12 whereas it increased in the control group; the reduction in 
SFA for the LGI group was significant at week 6 (P=0.032) and 12 (P= 0.038). 
Changes in MUFA and PUFA were non significant for both intervention groups. 
CHO intake significantly declined at week 6 in both groups, however, the reduction 
was greater in the LGI group (P= <0.001) compared to the control (P= 0.024). CHO 
intakes increased from week 6 at week 12 in both groups, however the difference 
from baseline remained significant for the LGI group (P= 0.061).  
 
Sugar intake significantly declined in the LGI group from baseline at week 6 (P= 
0.050) and decreased further at week 12 (P= 0.031). Fibre intakes appeared 
relatively unchanged in both groups. There were no significant changes in 
macronutrients relative to energy and thus, other than for total PRO which increased 
in both groups, the decline in total macronutrients observed may be attributed to the 
reduction in energy consumed at week 6 and 12 relative to baseline in both groups.  
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Overall daily hunger and satiety score were not significantly altered during the 
intervention, however, hunger scores decreased from baseline at week 6 and 12 in 
the LGI group, but increased in the control group. There was also a slight increase 
in satiety scores in the LGI group, where as it marginally decreased in the control 
group. See figure 9, for a graphical representation of changes in energy, glycaemic 
CHO and hunger scores. 
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Figure 9. Mean dietary GI (a), GL (b), energy (c), Hunger (d) and satiety (e) scores for intervention and control group across 
study time points (1 = Baseline; 2 = week 6; 3= week 12).▲, P= < 0.01 for within group change compared to baseline; ◊, P= < 0.05 
for interaction of group*time period compared to baseline. 
a b c 
d e 
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MANCOVA and linear mixed models were adjusted using the sensitivity analysis 
approach, 4 separate models were analysed but adjusted for the following 
covariates: Model 1) age, sex, ethnicity, SES, zBMI; Model 2 built on model 1, 
additionally adjusting for energy, and residual adjusted dietary variables (fibre, fat, 
PRO, CHO); Model 3 also included CRF and %SED and model 4 additionally 
included EI:EE and thus finally controlled for dietary misreporting. 
 
Weight and Adiposity  
Figure 10 displays adjusted (model 4) mean weight and adiposity variable values for 
each group during the three intervention time-points: 1 (baseline); 2 (week 6); 3 
(week 12).  
Mancova and linear mixed model analysis revealed that there was no significant 
change in weight or adiposity in either group. FFM changes were similar for both 
groups during the intervention. For body weight, FM and zBMI there was little 
change in the LGI group, however, there does appear to be a non significant trend 
for an increase from baseline in these variables for the control group. 
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Figure 10. Graphs showing weight and adiposity changes for intervention and control groups during the intervention: a (weight); 
b (zBMI); c (BF %); d (fat mass); e (fat free mass). Analysis adjusted for age, sex, ethnicity, SES, kcal, and residual adjusted dietary 
variables (fibre, fat, PRO, CHO), CRF, MVPA and EI:EE.
c d 
c 
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Metabolic syndrome risk factors 
Table 43, figure 11 and figure 12, show that none of the adjusted MANCOVA or 
Linear mixed models revealed a significant group*time-period interaction for any 
metabolic risk factor variables; according to MANCOVA there were also no 
significant within group changes observed. However, pairwise comparisons of 
adjusted means from linear mixed model analysis revealed a significant within group 
reduction in clustered risk score at week 12 compared to baseline in the LGI group 
(P= <0.01). In the control group there was a significant reduction in SBP at week 12 
compared to baseline (P= <0.05). Mixed models also revealed that BG and DBP 
were marginally significantly reduced at week 6 compared to baseline in both 
groups (P= <0.1), however, by week 12 BG had continued to decline in the LGI 
group where as it had slightly increased in the control group. SBP was also 
marginally significantly reduced at week 12 compared to baseline in the LGI group. 
 
Trends in outcome variables over time for intervention and control groups using line 
graphs. For SBP, DBP, TG, Clustered risk and BG changes appear to be similar in 
both the LGI and control groups. However, WC can be seen to decrease 
considerably at week 6 and remain stable between weeks 6 and 12 in the control 
group compared to the LGI group which appears to increase slightly between week 
6 and 12. Additionally HDL cholesterol reduced in both groups between baseline and 
week 6 but increased above baseline in the control group between week 6 and 12 
and continued to decline at week 12 in the LGI group 
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Table 43. Linear mixed effects for metabolic syndrome risk factors between 
intervention groups 
 
Model 4 
 a
Linear Mixed Effects 
Intervention group*time period 
 
 β Estimate 
Period 2 vs 1 
β Estimate 
Period  3 vs 1 
 
 
β 
P  
Value 
β 
P  
Value 
SBP  0.23 (4.96) 0.964 3.53 (3.90) 0.380 
DBP  -4.05 (3.32) 0.238 -3.88 (1.79) 0.052 
BG  0.04 (0.16) 0.811 0.02 (0.19) 0.920 
TG  -0.10 (0.10) 0.305 0.09 (0.21) 0.679 
WC  -0.17 (1.47) 0.906 -0.14 (1.50) 0.926 
HDL  0.04 0.587 -0.04 0.644 
Crisk  -1.01 (0.78) 0.209 -0.62 (0.40) 0.146 
a
 LGI group as reference group; analysis adjusted for age, sex, ethnicity, SES, zBMI, kcal, 
and residual adjusted dietary variables (fibre, fat, PRO, CHO), CRF, MVPA and EI:EE 
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 Figure 11. Graphs showing change in mean values of metabolic risk factors for the control and intervention group: SBP, DBP, 
clustered risk score, BG. Model 4: analysis adjusted for age, sex, ethnicity, social economic status, zBMI, kcal, and residual adjusted dietary 
variables (fibre, fat, PRO, CHO), CRF, MVPA and EI:EE; for mixed models: ▲, significantly different from baseline (P= <0.05). 
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 Figure 12. Graphs showing change in mean values of metabolic risk factors for the control and intervention group: TG, WC,HDL. 
Analysis adjusted for age, sex, ethnicity, social economic status, zBMI, kcal, and residual adjusted dietary variables (fibre, fat, PRO, CHO), 
CRF, MVPA and EI:EE; for mixed models: ▲▲, significantly different from baseline (P= <0.01). 
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Inflammatory markers and cytokines 
 
For inflammatory markers and cytokines there were no significant interaction effects 
for group* time-period, however as the models progress to include dietary and 
fitness variables as covariates the P value can be seen to decline suggesting the 
strength of associations is increasing as diet and CRF and PA are adjusted for (see 
appendix 6). 
 
 
Figure 13 Displays adjusted means for inflammatory markers and cytokines. Using 
MANCOVA did not identify any significant within-subjects differences over the 
intervention time-period. However, linear mixed models (which adjust for the 
correlation of repeated observations) did identify a marginally significant reduction in 
adiponectin and IL-6 from baseline to week 12 in the LGI group (P= <0.1) (Table 
44). In the control group there was a marginally significant increase in TNF from 
baseline to week 12  (P= <0.1).  
 
Although adiponectin is marginally reduced at week 12 compared to baseline it can 
be observed in figure 13 that adiponectin begins to increase at week 6 and Hs-CRP 
starts to decrease at week 6 suggesting a favourable effect in the LGI group at 
week 6 which appears to reverse between weeks 6 and 12. It can be observed that 
changes in TNF in each group relative to baseline are very similar 
 
Table 44. Linear mixed effects for inflammatory markers and cytokines 
between intervention groups 
 
 
 
 
 
 
 
 
 
a
 LGI group as reference group; analysis adjusted for age, sex, ethnicity, SES, zBMI, kcal, 
and residual adjusted dietary variables (fibre, fat, PRO, CHO), CRF, MVPA and EI:EE 
Model 4 
 
a
Linear Mixed Effects 
Intervention group*time period 
 
 β Estimate 
Period 2 vs 1 
β Estimate 
Period  3 vs 1 
 
 
β 
P  
Value 
β 
P  
Value 
Adiponectin  
0.34 (0.72) 0.641 -0.48 (0.48) 0.354 
CRP  
-0.23 (0.86) 0.793 0.10 (1.10) 0.927 
TNF  
-1.07 (1.25) 0.403 -1.19 (1.07) 0.290 
IL-6  
-0.33 (0.28) 0.270 -1.38 (0.87) 0.142 
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 Figure 13. Graphs showing change in adjusted mean values of inflammatory markers for the control and intervention 
group: Adiponectin, IL-6, CRP, TNF. Analysis adjusted for age, sex, ethnicity, social economic status, zBMI, kcal, and 
residual adjusted dietary variables (fibre, fat, PRO, CHO), CRF, MVPA and EI:EE. 
181 
 
Glucose control and liver function 
 
In table 45, linear mixed models showed that insulin was significantly reduced at 
week 6 compared to baseline and week 6 and 12 in the control group (P= <0.05). 
As displayed in figure 14, the LGI and control group ALP was significantly reduced 
at week 12 versus baseline (P =<0.01) and between week 6 and week 12 (P= 
<0.05), furthermore in the LGI group ALP was significantly reduced at week 6 
compared to baseline (P= <0.05).  In the control group ALT significantly increased 
at week 6 (P= <0.05), in the LGI group, ALT decreased (non-significantly) at weeks 
6 and 12. However, at week 12 in the control group ALT reduced significantly (P= 
<0.01) at week 12 compared to week 6 and to below baseline values. In figure 15, 
MANCOVA revealed a significant increase in insulin at week 12 compared to 
baseline and week 6 (P=<0.05) in the LGI group. In the control group HOMA-IR was 
significantly reduced at week 6 (P= <0.01) and week 12 (P= <0.05) compared to 
baseline. There were no other significant within group changes in HbA1c, GGT, 
albumin and bilirubin in either group.  
 
Adjusted beta estimates (β) for linear mixed models showed, however, that there 
were marginally significant reductions in HbA1c at week 6 (β -0.20; P= 0.078) and 
week 12 (β -0.43; P= 0.062) versus baseline in the LGI group relative to changes in 
the control group (Table 45). Insulin at week 6 and 12 significantly increased from 
baseline in the LGI group relative to the control group by 48.74 (P= 0.017) units and 
30.71 (P= 0.045), respectively. The same interaction was observed for HOMA-IR 
with an increase of 1.43 at week 6 versus baseline in the low GI group relative to 
the control group (β = 1.43, P= 0.024). Interactions were significant following 
adjustment for CRF and PA in model 3; additional adjustment for EI:EE in model 4 
did not alter these associations (see appendix 6). This was observed when the 
interaction was assessed by MANCOVA and when the additional adjustment for the 
correlation of repeated observations was made using linear mixed model analysis.  
 
Linear mixed models also revealed a significant group*time-period interaction for the 
liver function marker ALT with a significant reduction of 8.57 at week 6 compared to 
baseline in the LGI relative to the control group (β= -8.57, P= 0.012).  
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Trends in the data show that despite a significant and marked increase in insulin 
and HOMA-IR at week 12 compared to baseline for the LGI group relative to the 
control group (assessed by ANCOVA and mixed effects),  at week 6, the within 
groups comparison for these variables  remains relatively unchanged. 
Furthermore, for those variables where there was no significant effect of the 
intervention such as GGT and bilirubin there appears to be a reduction in these 
values at week 6 versus baseline in the LGI group relative to the control group. 
This was also the case for some metabolic risk factor and inflammatory variables; 
thus it seems the LGI intervention may be associated with a favourable effect on 
some outcome variables at week 6 that may be lost between week 6 and 12. 
Conversely, HbA1c , appears to remain stable at week 6 compared to baseline 
and begins to decline between weeks 6 and 12 as opposed to the control group 
where this value increases throughout the intervention. Moreover for ALT and 
ALP values decline throughout the intervention compared to baseline in the LGI 
group.   
 
 
Table 45. Linear mixed effects for glucose control and liver function markers 
between intervention groups 
Model 4 
 
a
Linear Mixed Effects 
Intervention group*time period 
 
 β Estimate 
Period 2 vs 1 
β Estimate 
Period  3 vs 1 
 
 
β 
P 
Value 
β 
P 
Value 
HbA1c  -0.20 (0.11) 0.078 -0.43 (0.19) 0.062 
Insulin   48.74 (18.31) 0.017 30.71 (13.45) 0.045 
HOMAIR  1.43 (0.56) 0.024 0.91 (0.51) 0.113 
ALP  -12.73 (9.66) 0.242 -10.49 (6.21) 0.125 
ALT   -8.57 (3.13) 0.012 -3.94 (4.22) 0.365 
GGT  0.17 (0.98) 0.863 0.21 (0.84) 0.806 
Albumin  -3.67 (3.13) 0.257 -1.41 (1.63) 0.398 
Bilirubin  3.55 (4.92) 0.481 2.41 (5.04) 0.638 
a
 LGI group as reference group; analysis adjusted for age, sex, ethnicity, SES, zBMI, kcal, 
and residual adjusted dietary variables (fibre, fat, PRO, CHO), CRF, MVPA and EI:EE 
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 Figure 14, Graphs showing change in adjusted mean values of liver function markers for the control and intervention group: 
GGT, Bilirubin, Albumin, ALT, ALP. Analysis adjusted for age, sex, ethnicity, social economic status, zBMI, kcal, and residual 
adjusted dietary variables (fibre, fat, PRO, CHO), CRF, MVPA and EI:EE; for mixed models: ▲, significantly different from baseline (P= 
<0.05); ▲▲, (P= <0.01); within groups: , significantly different from baseline (P= <0.05); , (P= <0.01). 
 
 
   
B
il
ir
u
b
in
 
G
G
T
 
A
L
T
 
A
L
P
 
A
lb
u
m
in
 
184 
 
 
 
 
 Figure 15. Graphs showing change in adjusted mean values of glucose control markers: for the control and intervention 
group: HbA1c, insulin, HOMA-IR. Analysis adjusted for age, sex, ethnicity, social economic status, zBMI, kcal, and residual adjusted 
dietary variables (fibre, fat, PRO, CHO), CRF, MVPA and EI:EE. MANCOVA: , significantly different from baseline (P= <0.05). , 
significantly different from baseline (P= <0.05). Mixed model: ▲, significantly different from baseline (P= <0.05); ▲▲, (P= <0.01); for 
within groups: , significantly different from baseline (P= <0.05).   
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8.3 Discussion 
The present study investigated the impact of an ad libitum 12 week low GI dietary 
intervention on risk factors of the metabolic syndrome, markers of glucose control, 
liver function and inflammation in a sample of overweight and obese postpubertal 
adolescents, with a high WC and one additional metabolic risk factor, from 
Bedfordshire. 
 
This work provides novel insight into the feasibility of prescribing an ad libitum low 
GI dietary intervention on the dietary intakes of a UK adolescent population. Three 
day weighed food diary data recorded at baseline showed that mean dietary GI and 
GL was moderate both for the LGI and control group (GI 57.8 and 60.47, 
respectively). GI was significantly reduced (-8.25, P= 0.001) in the LGI group at 
week 6 compared to baseline. Between week 6 and 12, however, GI had increased 
in the LGI group by 3.18 units and was no longer significantly different from, yet 
remained below, baseline. In the control group GI remained relatively stable, slightly 
reducing by <1 unit at week 6 and <2 units by week 12 compared to baseline. 
 
The reduction in GI seen in the LGI group is comparable, despite a considerable 
age difference, to a 6 month low GI dietary intervention prescribed to 106 
overweight adults with type 2 diabetes (mean age 60 yrs) from Canada who 
reduced their GI from baseline (81.5) by over 10 units to 69.6 and their GL by 37.8 
(g) (Jenkins et al., 2008). This diet aimed to evoke a 10 – 20 % reduction in GI and 
food options and quantities were controlled based on the individual energy 
requirements of each participant. In 110 UK adults with high central adiposity, and 
thus deemed at risk of developing the metabolic syndrome, a 6 month low GI 
intervention also elicited a similar change in GI of -7.2 units, however this study also 
heavily restricted fat and energy intakes to maintain weight (Jebb et al., 2010). An 
ad libitum approach was used by Ebbeling et al (2008) to lower GL in 11 obese 
young adults (18-35 yrs) form the USA over 6 months. Although, CHO intakes were 
indirectly controlled in order to reduce GL there was a similar reduction in GI to that 
of the present study of approximately 10 units. 
 
 Furthermore, in the present study, when assessing the interaction of time-period 
and intervention group a significant reduction in GI of 7.52 in the LGI group relative 
to the control group at week 6 compared to baseline was evident (P= 0.045). In 
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contrast to GI, GL decreased in both groups from baseline at week 6 and 12. This 
change in GL appeared to be in line with decreases in total CHO seen in both 
groups. It is likely that the very similar reduction in energy in both groups at week 6 
and 12 in relation to baseline is attributable to the reduced CHO intake and 
subsequently GL; by week 12 GL values in both groups had significantly reduced 
(P=<0.05) to 138.90 and 137.10, respectively. However, the reduction in GL in the 
LGI group (P= <0.001) was greater than that of the control group (-45.79 and -
23.33, respectively) at week 6 and it is likely that this is related to the considerable 
GI reduction in the LGI group at this time point. It seems that a significantly reduced 
GL in the control group was achieved due to a non-significant but 5% decrease in 
%CHO and a concomitant slight increase in %Fat and %PRO at week 12 compared 
to baseline. Because dietary fat and protein slow rates of gastric emptying and 
digestion they are associated with a number of low GI foods. Some dieticians have 
expressed concern in the past that an ad libitum low GI diet is thus likely to have an 
unfavourable effect on fat consumption (Franz, 2003). However, in the present 
study this was not observed, in fact, data  trends show that there was a slight 
reduction in %fat in the LGI group at week 6 and %SFA reduced at both week 6 and 
12 approximately 2.5%. Comparatively, in the control group, %fat and %SFA had 
both increased by approximately 2% at week 12 of the intervention compared to 
baseline. However, none of these changes were found to be significant. It thus 
appears that a flexible diet centred on the substitution of high for low GI foods 
consumed within the context of a balanced diet, (Eatwell plate, FSA, 2013) elicited a 
potentially beneficial change in BF% and SFA intake, that was not observed in the 
control group who consumed habitual diet in the context of the eatwell plate. It also 
appears that this approach resulted in similar glycaemic CHO changes to a 
relatively restricted low GI approach (Jenkins et al., 2008) and ad libitum low GL diet 
(Ebbeling et al., 2008) in adults. 
 
Unfortunately, few studies that have prescribed low glycaemic CHO diets in 
adolescents, particularly those described as ad libitum, report the change in GI and 
GL during the intervention. Ebbeling et al (2003) prescribed a 6 month ad libitum 
low GL diet compared to a conventional low fat diet in obese 13-20 yr olds from the 
USA. At 6 months in the LGL group, GL (g/1000 kcal) had significantly reduced from  
baseline (86) to 68 g/1000 kcal and this was the product of a significantly reduced % 
CHO intake and a non significant reduction in GI from baseline (58) to 53. In the 
conventional low fat group % fat intake had significantly declined but GL, GI and 
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CHO were unchanged. The difference between this study and the present 
investigation is that Ebbeling et al (2003) required of their participants to reduce 
their CHO intake in order to elicit a reduction in GL and was thus not truly ad libitum. 
The present study only focused on swapping high GI foods with low GI alternatives 
to maintain flexibility of the diet and thus macronutrients as a % of energy were 
relatively unchanged in both groups. Contrastingly, the adolescents from the US 
maintained a reduced GL and GI for a markedly greater time period compared to 
those in the current study, who could not maintain the reduction in GI observed at 6 
weeks for a further 6 week period. Furthermore, a 12 month follow up conducted by 
Ebbeling et al (2003) identified that GI and GL reductions were maintained for a 
further 6 months. In their study (Ebbeling et al., 2003), participants attended 2 
nutritional education and behavioural therapy session each month for 6 months, 
although this is less intensive than the current study which employed a weekly 
consultation session, perhaps the reduced frequency presented less burden to the 
participants and thus eliciting a greater adherence to the intervention.  
 
Although, in these Bedfordshire adolescents, no significant changes in hunger and 
satiety scores were observed in either group, it can be seen in figure 10, that hunger 
scores decreased from baseline in the LGI group, but increased slightly in the 
control group. Moreover, there was a non significant trend of increased satiety 
scores for the LGI group, whereas there was a decline in the control group. This is 
supported by evidence that satiety was significantly more prolonged (delayed 
subsequent ad libitum meal intake) following consumption of a low compared to 
high GI meal in 16 overweight 12-18 year olds (Ball et al., 2003). It is important, 
however, to highlight the lack of compliance with completing the hunger and satiety 
questionnaires of which at baseline n = 7 and 5; at week 6 n= 4 and 2 and at week 
12 n = 3 and 2 for the LGI and control group, respectively. Furthermore, to avoid 
hindering food record compliance, the hunger and satiety questionnaire was 
completed once for each of the 3 dietary recording days to obtain an „overall‟ score 
rather than repeating the questionnaire after each meal.  
 
A number of past intervention studies have shown that a reduced glycaemic CHO 
diet can have a beneficial effect on metabolic health. There is however limited 
evidence in both adults and youngsters and there does not appear to be any 
evidence of a beneficial impact on clustered metabolic risk score in youths. In the 
present study, however, clustered risk score was shown to be significantly reduced 
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(P= <0.01) at week 12 from baseline in the LGI group and although it was reduced 
in the control group the difference was not significant when within-subject 
correlations were accounted for by mixed model analysis. Previous research 
(Pereira, 2004) involving 39 young adults comparing a low GL  and low fat diet 
showed a trend (P=0.07) for greater improvements in DBP and SBP in the low GL 
group after approximately 9 weeks. This was observed despite similar relative 
energy intakes and adiposity changes in both groups. In the present study, 
marginally significant improvements in SBP and DBP occurred after 6 weeks in the 
LGI group, however, a similar trend was observed for DBP at 6 weeks in the control 
group and these trends were observed despite no reductions in adiposity. The 
present investigation did not identify significant improvements in lipid profile (HDL or 
TG) in either group, which could relate to a lack of adiposity change during the 12 
week intervention. In light of this, however, Pereira et al (2004) also observed 
significantly greater improvements in TG in the low GL group, suggesting that the 
benefit on lipid profile as a result of reduced GL outweighed that of weight loss. The 
authors observed a significantly smaller decline in resting energy expenditure in the 
low GL diet group vs low fat group, but not to the extent that a significant change in 
adiposity could occur over a short period. Because of the evidence that 
hyperinsulinemia may play a critical role in the development of dyslipidemia and 
other metabolic risk factors, via enhanced hepatic VLDL rich TG secretion (Reaven, 
1995, Fried and Rao, 2003) it was postulated that the greater improvement in lipid 
profile in the low GL group may have been caused by the larger reduction in insulin 
concentrations seen in this group (Pereira et al., 2004). Improvements in metabolic 
health risk factors were also observed in a group of 8 overweight and obese 
Hungarian children (11 year olds) prescribed a 6 week ad libitum low GL dietary 
intervention. Slight improvements in lipid profile were observed; with a small 
increase in HDL and a decrease in TG. Moreover, reductions in BG were similar to 
those of the present study at week 6: 5.31 vs 4.96 mmol.L and 5.01 vs 4.85 mmol.L, 
respectively. Furthermore, Fajcsak et al (2008) observed a significant reduction in 
the number of metabolic risk factors present at baseline following the intervention 28 
vs 15, however they did not calculate a clustered risk score. These changes 
occurred in the presence of a significant reduction in BF% and although described 
as ad libitum, this intervention restricted portion sizes in an attempt to control dietary 
GL and thus it is quite possible that energy intake was reduced as a consequence 
of this intervention. Yet, because dietary changes were not assessed and there was 
no control group in Fajcsak et al‟s (2008) study it is very difficult to distinguish which 
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dietary factors were likely to have attributed to the improved metabolic health or if 
they were linked to reduced adiposity.  
 
The significant improvement in clustered metabolic risk score in the LGI group 
occurred despite no change observed in lipid profile or WC in this group. It is 
noteworthy, however, that assessing clustered risk may provide more insight into 
metabolic changes than individual  risk factors alone,  as a clustered score can 
compensate for daily fluctuations that exist amongst  individual risk markers 
(Anderssen et al., 2007b).  Furthermore, the reductions in BG, DBP and SBP, may 
have contributed to the overall reduction in clustered risk. A reduced BP following 
the low GI diet could be explained by the mechanism of reduced nitric oxide (NO) 
oxidation (Blaak et al., 2012). NO, a potent vasodilator, is oxidised at an increased 
rate in the presence of hyperglycaemia induced oxidative stress, leading to reduced 
NO concentrations and subsequent impairments in vasodilatation (Williams et al., 
1998).  This may be supported by the current work, which also observed marginal 
reductions in some inflammatory markers in the LGI group, as outlined below.  
 
A number of intervention studies in adults have shown that reducing dietary GI and 
GL has a beneficial effect on inflammatory markers. In the present study there was 
no significant interaction of group and time-period. Within group comparisons, 
however, demonstrated that there was a marginally significant reduction in IL-6 
between baseline and week 12 in the LGI group, furthermore, despite similar trends 
in both groups, there was a marginally significant increase in TNF in the control 
group at the same time-point. Thus it appears that the low GI diet may have had a 
beneficial effect on inflammation that was not observed in the control group. In 
contrast to improved inflammation the LGI group there was a marginally significant 
decrease in adiponectin (a potent anti-inflammatory cytokine) observed at week 12 
compared to baseline. It is noteworthy, however, that despite a potentially beneficial 
effect of the LGI diet on inflammation, at week 12, CRP levels had increased above 
baseline. Thus there seem to be inconsistent findings in this study for inflammation 
changes as a result of lowering dietary GI but the lack of reduction in adiposity as a 
result of the intervention may have hindered improvements in inflammation.  (Pittas 
et al., 2005) observed that a 24 week low GI diet was not associated with a 
significantly reduction in plasma CRP concentrations once body weight change was 
controlled for. Similarly, it was identified that a 10 week low vs high GI diet resulted 
in a reduced concentration of CRP (16%), however, this change was not significant 
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(Sørensen et al., 2005). Moreover, in the study of Pereira et al (2004) in adults 
(outlined earlier in this section), in addition to improved BP and TG, a significantly 
greater reduction in CRP was observed in the low GL compared to the reduced fat 
control group. This occured despite equal reductions in body fat between the two 
groups, and this was attributed to reduced insulin concentrations in those following 
the low GI diet. It has also been observed that both a traditionally „healthy American 
diet‟ and an energy matched legume rich low GI diet had a beneficial effect on 
inflammation in 64 healthy 35-75 yr old males; (Hartman et al., 2010), observed a 
significant reduction in CRP and TNF during a 4 week intervention period separated 
by a 2 week washout diet period. Unfortunately, the lack of evidence for younger 
populations makes comparison to other adolescent populations difficult.  
 
Previous research has highlighted that a high GI diet was associated with increased 
liver steatosis in 247 Italian adults who were otherwise healthy but had a high WC 
(Valtueña et al., 2006) they reported significantly higher ALT values (a marker of 
liver damage) in those consuming a high GI diet. The authors proposed that a high 
GI diet could exacerbate hepatic fat deposition via increased lipogenisis and 
reduced FFA oxidation at the liver and that the effects would be heightened in those 
with insulin resistance (Valtueńa et al., 2006). In the present study it was observed 
that there may have been favourable changes in liver function markers in the LGI 
group compared with detrimental changes in the control group. The liver function 
marker ALP significantly reduced (P= <0.01) at week 12 compared to baseline 
during the LGI intervention and in the control group ALT significantly increased at 
week 6 (P= <0.05), whereas it was non-significantly reduced in the LGI group. 
However, in a group of elderly, non diabetic, normal and over-weight individuals, 
over a 5 year longitudinal study, glycaemic CHO was not associated with markers of 
liver function GGT or ALT, but a reduced dietary fibre intake was associated with 
increased GGT (Arner et al., 1991). It is possible that glycaemic CHO may only be 
associated unfavourably with liver function in those with insulin resistance, or in the 
case of the current study, those who are metabolically at risk. 
 
There were no significant changes in glucose control marker, HbA1c, within either 
group. In the LGI group, however, values decline between weeks 6 and 12 by 0.31, 
whereas this value increases throughout the intervention in the control group. The 
decline in HbA1c at week 12 in the LGI group may be attributable to greater 
reduction in GI observed at week 6; this is because HbA1c is a long term marker 
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indicating glucose control over the preceding 120 days (approximately) therefore, 
during the 42 days between baseline and week 6 measures, the LGI diet may not 
have had a sufficient effect on glucose control to show an improvement. A longer 
intervention period may have produced a significant reduction in HbA1c for the LGI 
group. Subsequent to the contrasting HbA1c values between groups,  mixed model 
interactions demonstrated that the LGI intervention produced a marginally 
significant reduction in HbA1c relative to the control group at weeks 6 of - 0.20 
(0.11); P= 0.078 and a greater reduction at week 12 of -0.43 (0.19); P= 0.062. Thus 
it appears that the LGI intervention may have elicited lower long term BG levels. 
Similarly in type II diabetic adults a reduction in HbA1c of -0.50 was observed after a 
6 month low GI diet and a subsequent reduction in GI of 10 units (P= <0.001). 
Furthermore in adult males HbA1c levels were significantly reduced after a low GI 
intervention of just 4 weeks compared to a high GI diet separated by a 4 week 
crossover (Jenkins et al., 2004). 
 
The evidence that long term glucose control was improved in the LGI group of this 
investigation is not supported by any improvements in insulin or HOMA-IR values. 
According to adjusted mean values, insulin and HOMA-IR were significantly 
reduced at week 6 and 12 compared to baseline in the control group, whereas 
insulin had in fact doubled at week 12 in the LGI group. Subsequently, there was a 
significant group by time period interaction for insulin, showing an increase in insulin 
at week 6 of 48.74 (P= 0.017) and week 12 of 30.71 (P= 0.045) compared to 
baseline in the LGI group relative to the control group. This interaction was also 
observed at week 6 for insulin resistance with an increase in HOMA-IR of 1.43 
(P=0.024) in the LGI group relative to changes in the control group. In light of a 
significant reduction in HbA1c in the LGI group (interaction of group with time-
period), these findings for insulin could be regarded as contradictory. However, 
figure 15, shows that this increase in insulin and HOMA-IR in the LGI group does 
not appear to occur until after week 6. Therefore, the marginally significant reduction 
in BG at week 6 may be attributable to the improved HbA1c level observed at week 
12 which was potentially induced by the significant reduction in GI observed in this 
group at week 6. These data introduce the question of why would improvements in 
HbA1c in LGI but not control group be observed when there was little variation in 
fasting BG scores between the two groups and a reduction in insulin and HOMA-IR 
values in the control group. This may be attributable to the fact that BG is a fasting 
value; it does not highlight the specific postprandial impact on BG and insulin 
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following the control diet relative to that of the LGI diet. In support of this notion, it 
has been identified that postprandial hyperglycaemia contributes up to 70% of daily 
hyperglycaemia and postprandial glucose concentrations were positively associated 
with HbA1c (Bonora et al., 2001), however, as this was observed in adults with 
existing type 2 diabetes, it may not apply to the metabolically „at risk‟ adolescents of 
the current study. The dietary intake data suggests that there would be a reduced 
postprandial BG response in the individuals consuming the lower GI and GL diet 
shown at the week 6 time point and thus this may be reflected in the reduce HbA1c 
value observed at week 12 in the LGI group. The potential for this intervention to 
improve long term glucose control is an important finding, as evidence supports that 
a reduction in long term plasma glucose levels, measured by HbA1c is inversely 
associated with CVD risk (Blaak et al., 2012). 
 
In agreement with the current study, Ebbeling et al (2003) also observed that insulin 
resistance (HOMA-IR) increased in overweight adolescents. This occurred following 
prescription of both an ad libitum low GL diet or a reduced fat control diet, however, 
HOMA-IR increased significantly less in the low GL group (P= 0.02). This alteration 
occurred despite a significant reduction in BMI and BF% observed in the low GL 
group and this effect remained after adjustment for BMI change.  It was postulated 
that the increased insulin resistance was a result of hormonal changes during 
puberty (Ebbeling et al., 2003) and that the low GL diet had slowed the increase in 
insulin resistance initiated by puberty. Perhaps the reduced GI and GL observed in 
the LGI group of the SIRENS study at week 6 may have slowed a puberty related 
increase in insulin resistance (between baseline and week 6). However, that does 
not explain why the control group saw significant reductions in insulin resistance 
during the intervention. Perhaps one explanation could be that the LGI group 
consisted of more participants still under the influence of puberty and thus 
experiencing increased HOMA-IR levels, however, this study attempted to control 
for pubertal development by only including individuals who self reported being at 
≥Tanner stage 5 based on comparison with reference images of pubic hair growth 
(Marshall and Tanner, 1970a, Marshall and Tanner, 1969). It could be possible that 
self reporting of Tanner stage lead to inaccurate classification of pubertal status, 
and thus a confounding of results by pubertal hormones, however, in the context of 
this study, self report was deemed the most appropriate technique. Thus, in 
adolescents, pubertal changes may be hindering low GI and GL induced 
improvements in insulin resistance that have not been seen in studies of adults; in 
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39 overweight adults, Pereira et al (2004) found that insulin resistance improved 
significantly in those prescribed a low GL (experimental) and low fat (control) 10% 
weight loss diet, yet improvements were significantly greater in the low GL group. 
Nonetheless, a GI reduction of 10 units, similar to that of the present study, has 
been shown to improve insulin sensitivity in overweight men, however, the GI intake 
of these adult males was considerably higher at baseline than the adolescents of 
the present study (80 vs 57.8) (Radulian et al., 2009). Moreover, the authors did not 
measure fibre intakes. According to (Hu et al., 2001) there is a lack of support for 
decreasing GI and GL intakes improving insulin sensitivity, and that dietary fibre 
may be more strongly responsible for its attenuation. Studies have shown that 
increased fibre intake, particularly from wholegrain foods, was associated with 
improved insulin sensitivity in healthy and insulin resistant adults; whereas, GI and 
GL were not associated with any improvements (Mozaffarian et al., 2011, Chess 
and Stanley, 2008). In the present study, however, fibre intakes were similar 
between both groups and were not significantly altered as a result of the 
intervention. Moreover, fibre intakes actually slightly declined (non-significantly) in 
both groups between baseline and week 6 (to a greater extent in the control group) 
and in the LGI group, fibre intakes returned to baseline levels by week 12. In the 
control group, however, fibre intakes had remained reduced at the end of the 
intervention, and thus, although modest, the reduction in fibre in the control group 
does not support the previous evidence in adults (Mozaffarian et al., 2011, Chess 
and Stanley, 2008) that suggest increased dietary fibre is associated with improved 
insulin sensitivity.  
 
This improvement in insulin and insulin resistance in the control group could also be 
explained by the Hawthorne effect; there may have been an increase in healthy 
behaviours by the control group despite being specifically asked not to alter their 
normal eating or physical activity habits, other than to consume all meals and snack 
in the context of the eatwell plate (FSA, 2012). However, the reported dietary 
changes do not support a notion that the control group changed their diet during the 
intervention to the extent at which insulin levels might be improved. Nor were 
beneficial changes in adiposity observed for this group. A limitation of this study 
however is the lack of follow up CRF and PA assessment after baseline data 
collection. It is possible that PA and CRF changes may have occurred during the 
intervention in either group that were not accounted for. It was decided that PA and 
CRF assessment during the intervention may have added too great a burden to the 
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participants and therefore was only conducted at baseline. Additionally it is possible 
that the nutritional intakes reported in food diaries was not a true reflection of the 
foods and drinks that were consumed during the 12 week period. However, the use 
of weighed food diaries to assess nutritional intake at baseline and throughout the 
intervention was considered a strength of this study, yet this method is not without 
limitations. It is known that in order to make recording intakes easier, individuals 
may reduce or alter the foods they eat to decrease the number of foods that require 
recording (Livingston et al., 2004). Additionally, because of the nature of the 
intervention it is quite plausible that individuals may under record or entirely exclude 
foods they regard as less healthy. Excluding foods would affect the calculation of 
dietary GI and subsequently GL. However, misreporting just the quantity of foods 
may have little effect on GI calculations but would more likely impact upon the 
calculation of GL. Indeed in the present study dietary misreporting was prevalent in 
over 50% of adolescents and only 1 member of the control group was classed as an 
under-reporter. This is a common issue relevant to studies involving dietary 
assessment, yet the current study attempted to control for misreporting by adjusting 
the analysis (model 4) for baseline EI:BMR, this is something that does not appear 
to have been done in previous low GI or GL intervention studies of youths. 
 
The change observed in metabolic risk factors during this 12 week intervention 
appears to have occurred with no significant changes in weight or adiposity in either 
group. However, BF%, fat mass and body weight do appear to be increasing at 
week 6 and further at week 12 from baseline in the control group, where as they 
remain relatively stable in the LGI group. Perhaps if the intervention period 
extended past 12 weeks a significant change in adiposity may have been observed 
between the intervention groups. This was the case in a 6 month intervention of 16 
overweight adolescents; Ebbeling et al (2003) employed an ad libitum low GL diet 
and observed greater fat loss in comparison to a reduced dietary fat intervention. 
However, their low GL group consumed considerably less calories (-692 kcals) 
during the intervention compared to the control group (-148 kcals) and thus fat 
reductions may be the result of a reduced energy intake. Unfortunately, satiety was 
not measured and thus differences in energy intake cannot be attributed to an 
altered appetite (Ebbeling et al, 2003). Furthermore, dietary misreporting was not 
accounted for which may impact associations of glycaemic CHO with health 
markers, as highlighted in chapter 3 of this thesis. In a more recent intervention 
study comparing 4 diets over a 4 week period: a low GI compared to high GI diet of 
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either low or high SFA content in 548 adults; lowering dietary fat was associated 
with a slight reduction in body weight, however, reducing dietary GI appeared to 
have no impact on weight loss (Jebb et al., 2010). However, this diet was heavily 
restricted in terms of proportions of macronutrients and energy, and thus adherence 
to this intervention may have been affected by its restrictive nature. This notion is 
supported by evidence from Speith et al (2000) who examined the effects of an 
unrestricted low GI diet compared to a standard reduced fat diet. The low GI diet 
centred on food options rather than restriction (like in the present study), where as 
the low fat diet aimed to restricted energy by 250-500 kcals, despite this there was a 
significant reduction in BMI in the LGI group; there was no change in BMI in the low 
fat diet group (Spieth et al., 2000). 
 
Trends in the data highlight that there may have been an unfavourable effect of the 
LGI diet between weeks 6 and 12 of the intervention (apart from HDL). Whereas, 
between baseline and week 6 trends suggest that outcome variables were either 
improved or at least maintained at baseline levels. This consistent trend may be 
related to the greater reduction in GI and GL relative to controls at week 6.  
Furthermore, any favourable alterations in outcome variables appear to be lost at 
week 12 when GI has subsequently also increase in the LGI group. 
 
 The fact that GI began to increase between week 6 and 12 highlights that 
adherence to the LGI diet after 6 weeks may have decreased. There are a number 
of factors that could contribute to reduced adherence; it is possible that participants 
began to lose interest in the study after 6 weeks, however, in comparison to a 
number of studies that have maintained dietary adherence, 12 weeks is a markedly 
reduced time period. Because participants were required to travel to the Luton and 
Dunstable Hospital for data collection and or the University of Bedfordshire campus 
(depending on their location) for consultations, this often meant depending on 
parents for transportation or taking public transport. Unfortunately it was not 
possible to provide any form of financial inducements to cover transport or parking 
expenses. Additionally, a number of participants commented on the fact that they 
were not noticing weight loss, even though it was made very clear that the SIRENS 
study was focused on health improvement rather than weight loss. This appeared to 
reduce enthusiasm and motivation for the study in some individuals. Those 
intervention participants that were particularly enthusiastic tended to be those that 
felt they were losing weight. Unfortunately, no structured interviews were conducted 
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to provide robust qualitative information regarding the feasibility of the study. 
However, those participants that remained on the intervention at 12 weeks did 
report that the intervention was easy to understand and felt it was something they 
found straight forward to follow. 
 
A limitation of the existing low glycaemic CHO intervention studies in adults and 
youngsters (Jebb et al., 2010, Pereira et al., 2004, Ebbeling et al., 2007, Ebbeling et 
al., 2003, Fajcsak et al., 2008) is that CRF and PA were not adjusted for in their 
analyses. In a prospective cohort of 13,621 men and women, (Héroux et al., 2010) 
identified that accounting for CRF substantially attenuated the associations of a 
healthy eating index and reduced all cause mortality rates. Therefore the current 
investigation accounted for baseline CRF and PA (%MVPA) in its statistical 
analysis. This was done in a sensitivity analysis approach building more covariates 
into each new MANCOVA model to determine the effect of accounting for diet, CRF 
and PA (see methodology section 8.1). In most cases the inclusion of CRF and PA 
(model 3, see appendix 6) increased the strength of interaction effects observed 
between the two intervention groups. Furthermore, the current study attempted to 
account for dietary misreporting at baseline by including EI:EE as a covariate 
(model 4); this appeared to slightly strengthen the interactions observed between 
groups but had little impact on P values to the extent that significance was greatly 
altered. However, for the liver function variables ALP and ALT, there appeared to be 
an attenuation of interaction effects as the covariate models included CRF, PA 
(model 3) and EI:EE (model 4).  
 
The use of accelerometry to objectively assess PA and CRF is a strength of this 
investigation, however this technique is not without limitations, and these have been 
previously outlined in 4.3. There are a number of additional limitations of this study 
that should be considered, firstly the small sample size means that the statistical 
power of the investigation is limited. However, an a-priory sample size calculation 
was conducted before conducting this study which identified that to detect a 
significant change in HOMA-IR between two groups, with a power of >0.85, a 
sample size of n= 3 per group would be required. Furthermore, there was only one 
male participant in each group, thus making it difficult to generalise the findings to a 
wider mixed sex population.  
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In summary, this study provides new insight into the effectiveness of an ad libitum 
low GI diet centred on low GI food exchanges on the nutritional intakes of 
overweight and obese adolescents form the UK. The evidence suggests that this 
approach was an effective avenue for reducing dietary GI and GL in comparison to 
previous studies of which the diets tend to be more controlled. Furthermore this 
change was achieved despite no significant change in proportions of 
macronutrients; thus providing a potential platform for future studies to explore the 
effects of changing dietary GI without confounding from other dietary changes. 
Despite a lack of significant improvement in individual metabolic risk factors, there 
was a significant reduction in clustered risk score for the LGI group at week 12. 
There was also a borderline significant improvement in a long term marker of 
glucose control as a result of the LGI intervention compared to those in the control 
group, which could have important clinical significance and may warrant further 
investigation over a longer time period than the 12 weeks. This, however, was 
contradicted by an increase in insulin resistance in the LGI group compared to the 
control group and thus there appears to be equivocal evidence for a beneficial effect 
of this LGI dietary intervention, although pubertal status may have been an 
influencing factor. Interestingly, the greatest reduction in GI and GL occurred 
between baseline and week 6, however, at week 12 there was an increase in GI 
and GL in the LGI group; to this end, it appears that there may have been a decline 
in adherence to the intervention after 6 weeks and this may be attributable to the 
trends for improvement in BG, liver function markers and TG between baseline and 
week 6. Unfortunately the small sample size makes it difficult to draw definitive 
conclusions on the impact of this intervention on health parameters; future work is 
required to further understanding of how this flexible dietary intervention may impact 
on metabolic health in a larger sample of adolescents. 
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Chapter Nine: General discussion  
9.0 Metabolic health in Youths 
Childhood and adolescent obesity has risen in recent decades and by the year 2015 
it is estimated that 1 in 3 of the world‟s adult population will be obese. In England, 
between 1995 and 2007, childhood and adolescent obesity rates increased from 
3.1% to 6.9% and 5.2% to 7.4% in boys and girls, respectively and the prevalence 
of overweight and obese in the England is 17.9% and 21.8% for boys and girls, 
respectively (Stamatakis et al., 2010). The metabolic syndrome, represents a 
clustering of obesity related risk factors (dyslipidemia, hypertension, impaired 
fasting glucose)  for CVD, insulin resistance and type 2 diabetes (Despres and 
Lemieux, 2006). The prevalence of this syndrome is rising in youngsters  (Eckel et 
al., 2005) and  has been observed in 4.5% of US (Ford et al., 2008)  and 4.1 % of 
European (Vissers et al., 2007) adolescents. Young people with the metabolic 
syndrome are more likely to express these risk factors in adulthood (Camhi and 
Katzmarzyk., 2010), and thus, appropriate strategies for improving metabolic health 
in youths is of great importance. 
 
Observational studies have provided evidence in healthy and „metabolically at risk‟ 
adults and youths, that modifying the quantity and or quality of dietary CHO intake 
(Rizkalla et al., 2004, Jebb et al., 2010) can beneficially alter a number of risk 
factors linked to the development of type 2 diabetes and CVD. However, little is 
known of the current dietary glycaemic CHO intakes of UK adolescents and thus it 
was important to gain understanding of the current general macronutrient as well as 
glycaemic CHO intakes of this under researched group. 
9.1 Dietary intakes of Bedfordshire adolescents 
In the adolescents assessed by this work, as shown in chapter 4, the dietary GI 
represented that of a low-moderate intake 58.40 and energy adjusted GL 
(g/1000kcal) was 77.37. This was very similar to a previous study of overweight 
adolescents from the USA (Ebbeling et al., 2003) adolescents where intakes of GI 
and GL (g/1000kcal) were 58 and 79, respectively. This group appeared to be 
consuming macronutrients in line with current government recommendations 
(SACN, 2008.  Although GI intakes appear to be moderate (GI 55-60), evidence has 
shown that small changes in dietary GI, within the range observed by this work are 
associated with improved adiposity and metabolic health (Hare-Bruun et al., 2006, 
Du et al., 2009). This evidence, despite in a relatively small sample, provides an up 
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to date insight into the current glycaemic CHO intakes which may help inform future 
dietary health improvement strategies for adolescents. 
9.2 Glycaemic CHO and adiposity  
 
Despite evidence that reducing both GI and GL can promote reduced adiposity, in 
adults, it seems that lowering GI might be more beneficial than GL (Du et al., 2009, 
Hare-Bruun et al., 2006). In youths, however, the evidence is less clear (Nielsen et 
al., 2005, Murakami et al., 2013). A stronger relationship between GI and adiposity 
compared to GL may be explained by evidence that rates of fat oxidation and diet 
induced energy expenditure were consistently higher following a low GI-low GL 
breakfast when compared to an iso-caloric high GI-low GL breakfast (Scazzina et 
al., 2011). Therefore reducing the GI of the diet may be more beneficial for adiposity 
than reducing the GL alone; this effect was also observed after the following meal 
(Scazzina et al., 2011). This is supported by the current work; chapter 4 revealed 
that in postpubertal adolescents, consuming a moderate dietary GI of 62 compared 
to a low GI of 54 was associated with a significantly greater BMI (P=0.009), BF% 
(P=0.018) and WC (P= 0.017). GL, however, was not associated with adiposity in 
any analyses. It appears that dietary GI and not GL is an important determinant of 
obesity and therefore potential poor metabolic health, although such results should 
be viewed with caution due to observed dietary reporting issues. 
9.3 Dietary misreporting in Bedfordshire adolescents 
 
Due to the impact that misreporting of dietary intakes can have on associations of 
diet and health, (Rosell et al., 2003) it was important to quantify the prevalence of 
dietary misreporting in this group and to attempt to control for its impact. Chapter 4, 
identified that that underreporting may be an issue, as this group consumed a 
markedly lower energy compared to that of the reported UK national average for 
adolescents (SACN, 2011) 2423.60 vs 2964 and  1750.86 vs 2110 kcals for males 
and females, respectively. A limitation of much past research in youths is the lack of 
consideration for dietary misreporting when assessing diet and health relationships. 
 
To quantify the extent of misreporting in this group, an established technique (the 
Goldberg equation EI:BMR) was compared to that of a novel approach for 
assessing dietary misreporting which utilised EE obtained directly from 
accelerometry data; EI:EE (RT3), as shown in chapter 5. This data highlighted the 
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relatively high prevalence of dietary misreporting, particularly underreporting in this 
group. The EI:EE (RT3) technique identified approximately 10% more participants 
as underreporters compared to the Goldberg equation; 42.5 vs 30.3 %, respectively. 
A comparable study of 2868 UK adolescents (13 years old), which utilised 
accelerometry to calculate misreporting, also identified similar proportions of under 
reporters (between 37.1 and 51.8%) (Noel et al., 2010), compared to the current 
study. Furthermore, in comparison to DLW studies in children it appeared that the 
EI:EE (RT3) technique identified a plausible proportion of misreporters (Champagne 
et al., 1998) and RT3 estimates of EE were comparable to those measured by DLW 
in 12 year olds (Perks et al., 2000). Furthermore, this technique is likely to more 
accurately account for PA energy expenditure than the Goldberg equation which 
may underestimate dietary misreporting (Noel et al., 2010). Thus the novel 
application of EI:EE, using the RT3 accelerometer, may be suitable as a future 
assessment method of dietary misreporting, is a less complex and potentially more 
practical application of accelerometry than previously used. However, future 
validation studies of this technique compared to DLW are required. 
 
9.4 Glycaemic CHO and metabolic health 
 
In adults, there is a strong base of evidence in support of a positive association 
between metabolic risk factors and the risk of developing the metabolic syndrome, 
yet evidence is lacking in youths. A number of studies in youths have also 
evidenced that glycaemic CHO is adversely associated with lipid profile, BG and 
blood pressure (O‟Sullivan et al., 2010, Marukami et al., 2013). However, these 
studies incorporate an age group of participants of varying pubertal status and thus 
findings may be confounded by puberty. In this postpubertal group, however, it was 
identified in chapter 6, that no significant associations were observed between 
dietary GI, GL and metabolic risk factors when using either variant of the Goldberg 
equation (1.55 PAL and MVPA PAL) to identify and exclude misreporters. 
Interestingly the significant positive association observed between GI and WC was 
attenuated following the exclusion of misreporters. This may be attributable to the 
high proportion of overweight underreporters; after their exclusion from analysis this 
association may be lost.  However, after excluding misreporters (as identified by 
EI:EE (RT3)) and stratifying participants by low and high quantiles of GI (55.88 vs 
61.95); HDL was significantly lower (1.17 vs 1.31 mmol/L; P= 0.037) and TG was 
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borderline significantly raised (TG 0.94 vs 0.63 mmol/L); P= 0.058) in those 
individuals who consumed a higher compared to lower GI diet. Furthermore when 
stratified by low and high GL (71.40 vs 90.37), the direction of the non-significant 
association between BG and GL appeared to reverse, and a borderline significant 
increase was observed in those in the higher compared to lower quintile of dietary 
GL (4.84 vs 4.72 mmol/L; P= 0.056) after removal of BMI from the model. These are 
associations that were not observed in earlier analyses and thus highlights the 
importance of accounting for misreporting, being that an apparent positive 
association between GI and an adverse lipid profile, as well as GL and BG, 
emerged only after excluding dietary misreporters from statistical analysis, when 
identified by a novel approach (EI:EE RT3). 
 
Contrastingly, in overweight adults (Sluijs et al., 2010) and youths (Marukami et al., 
2013) it has been identified  that accounting for and adjusting analysis for 
misreporting resulted in a minimal effect on associations between glycaemic CHO 
and metabolic health. However, these studies did not account for directly assessed 
PA when calculating misreporting and thus may have underestimated 
underreporting. Similarly to the current findings, however, Burger et al (2010) 
reported that GL was positively and significantly associated with mortality but only 
after excluding under reporters, in a type II diabetic population. Individuals with type 
2 diabetes under report to a greater extent than overweight individuals (Sallé et al., 
2006) and thus the impact of excluding misreporters may have been greater in this 
group compared to previous studies (Sluijs et al., 2010;  Murakami et al., 2013). 
This suggests that accounting for dietary misreporting in „at risk groups‟ such as 
those in the current work may be of particular importance when assessing diet and 
health relationships. Excluding misreporters presents a limitation in that only „valid‟ 
dietary reporters were assessed, yet, it appears that the inclusion of misreporters 
and the type of assessment method of misreporting resulted in quite different 
findings and therefore is something that should be considered in future studies of 
similar populations. Because dietary GI is not affected by the quantity but rather 
glycaemic quality of the diet, and the fact that exclusion of misreporters  altered 
associations between GI and health, it is likely that underreporters were entirely 
omitting certain CHO containing foods rather than just misreporting the quantity 
consumed. However, it is important to consider the fact that misreporters were more 
overweight than valid reporters in the current work and thus these altered 
associations could be mediated by adiposity, yet, it is difficult to confirm this notion 
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being that misreporting occurred across a broad range of weight statuses. An 
important consideration in this work was to account for PA and CRF when 
assessing the associations of diet and health. It does not appear that previous 
studies have controlled for these factors when assessing the associations of 
glycaemic CHO and health parameters, and this is strength of the current work.  
9.5 Physical activity, cardiorespiratory fitness and metabolic health 
 
CRF (Blair et al., 2001b) and PA (Wareham et al., 2005) as well as the type of PA 
that individuals engage (Healy et al., 2011, Ekelund et al., 2012) in are important 
determinants of adiposity and associated metabolic health complications, yet there 
is little evidence of these associations in postpubertal adolescents. Additionally, 
there are inconsistencies in the way in which PA behaviours are measured and 
quantified in youths which may be a contributing factor explaining equivocal findings 
in the literature (Ekelund et al., 2011a). Therefore the current thesis explored the 
associations of PA (comparing two different PA thresholds for youths; (Rowlands et 
al (2004) and Chu et al (2007)) and CRF with metabolic health, but importantly 
accounted for the potential confounding effects of dietary intake. 
 
Chapter 7, demonstrated that in this group, the use of different PA thresholds 
resulted in disparate proportions of time spent in different PA categories. 
Importantly, the Rowlands thresholds defined the group as sufficiently active 
according to time spent in MVPA (65.60 mins) whereas, according to the Chu 
thresholds, the group were not sufficiently active (<60 mins MVPA) as they only 
engaged in 27.20 mins of MVPA. Furthermore, it was identified, when utilising either 
threshold that the adolescents (aged 14-19 yrs) of the current investigation engaged 
in less PA than a comparable sample of children age 10-14 yrs; for example, when 
applying the Rowlands thresholds, adolescent males engaged in 55 minutes less 
MPA than boys from the same region of the UK and female adolescents engaged in 
44.09 mins less MPA than girls. This comparison is consistent with past research 
that PA declines as children enter their adolescent years (Kimm et al., 2002) and 
highlights the importance of maintaining PA levels as children progress into 
adulthood. 
 
In this group and consistent with previous literature (Blair et al., 2001a, Ekelund et 
al., 2007a), higher CRF was associated with a significantly reduced WC, TG and 
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clustered risk score in all participants. In females, CRF was associated with more 
favourable fasting BG and HDL levels. However, in contrast, PA engagement 
appeared to be less associated with metabolic health, as supported by previous 
research in children (Bailey et al., 2012a). Despite government recommendations 
stating that young people should engage each day in at least 60 mins MVPA (DOH, 
2011), in the present work, the only risk factors to be associated MPA and VPA 
were  DBP and SBP and this was observed using either sets of intensity thresholds. 
In contrast, in a large study of children and adolescents, increased time spent in 
MVPA was associated with more favourable SBP, WC, TG and HDL levels (Ekelund 
et al., 2012), the disparity between these studies may be explained by the different 
thresholds used by Ekelund et al (2012); as they utilised much higher cut-offs to 
determine MPA and VPA than this in this work. Furthermore, Ekelund et al (2012) 
assessed PA using an Actigraph accelerometer and utilised a 60 second as 
opposed to 10 second zero count protocol for classifying and removing non-wear 
time from raw accelerometer data. 
 
In this work, being in the highest compared to lowest quintile of LPA was associated 
with a reduced BG, SBP and clustered risk score in all participants when utilising 
the Rowlands thresholds. But when using the Chu thresholds higher LPA was, 
instead, associated with an improved HDL level. Additionally, being more SED was 
associated with a higher DBP using either set of thresholds. However, TG levels 
were significantly lower in males engaging in more SED time when assessed by the 
Chu thresholds; a finding which is contradictory to previous evidence in youths 
(Ekelund et al., 2007). On the contrary to the current work, Bailey et al (2013) 
observed that being more SED was associated unfavourably with TG in a 
comparable group of children.  However, these children (Bailey et al., 2013) 
accumulated more time SED than the adolescents in the current study, which may 
be attributable to these confounding associations. 
 
Although applying either sets of intensity thresholds identified significant 
associations between PA and health parameters, there are discrepancies as to the 
relationship between metabolic risk factors and time spent in different PA 
categories. Therefore, clear consensus on which thresholds are most appropriate 
for this age group is required to allow accurate comparisons to be made between 
studies. 
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Directly assessing CRF via a maximal exercise test is strength of this study, 
however, there were limitations of this procedure that should be considered. Firstly, 
cycle ergometer tests have been shown to elicit a 7-12% lower oxygen consumption 
compared to treadmill running when assessing VO2 max in adults and adolescents 
(Hermansen and Saltin, 1969, Loftin et al., 2004) and thus CRF levels may have 
been undersetimated. However, a cycle ergometer test was regarded as more 
appropriate given that some participants may not have had experienced treadmill 
running before and may be more comfortable on a cycle ergometer. Furthermore, 
being seated on a stationary bike posed less risk if a participant was to become faint 
and fall which is a rare yet potential consequence of intense exercise (Pina et al., 
1995). Furthermore, there was limited time to familiarise participants with the cycle 
ergometer test, since much of the testing was conducted within schools and 
colleges during lesson time. 
 
The objective assessment of PA using accelerometry is usually regarded as a 
superior method compared to pedometry and the completion of self-report PA 
questionnaires which are prone to reporting errors (Sirard and Pate, 2001, Trost, 
2007). Accelerometry is not without its limitations, however, as addressed in section 
4.1 of this thesis. For example, in the current study, the 1 minute epoch used to 
capture activity data meant that the sporadic nature of some higher intensity 
exercises may not have been captured (Rowlands., 2007). More modern devices 
compared to those available for this research, such as the Actigraph GT3x can 
measure in a 10 second epoch over an extended period, due to its superior battery 
life and memory capacity and thus may have more validly in detected high intensity 
PA. It is possible that a shorter epoch and a detection of higher intensity activity 
might have resulted in a significant association between MVPA and metabolic 
health risk factors in the adolescent population. The RT3, however, has been shown 
to be a valid measure of PA in youth compared to DLW (Krekoukia et al., 2007, 
Rowlands et al., 2004a). 
 
In addition, employing a shorter epoch (such as 10 seconds) would have more 
accurately estimated EE and thus predictions of energy requirements, improving the 
assessment of dietary misreporting further. It does not appear that assessment of 
EE for the calculation of misreporting has been compared whilst using different 
epochs in previous studies. Future work should investigate the potential of varying 
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epoch length on the effectiveness of methods designed to account for misreporting 
and the subsequent impact on associations between diet and health. 
9.6 Impact of a flexible low GI diet on metabolic health in postpubertal 
adolescents 
 
In order to identify the impact of altering dietary GI on health outcomes in an 
adolescent population, a 12 week, ad libitum low GI intervention was conducted in a 
subsample of overweight and obese postpubertal adolescents who expressed risk 
factors for the metabolic syndrome as presented in chapter 8. Currently there is a 
lack of research into the effects of reducing dietary GI and GL in adolescent 
populations, however, in children and adolescents from the USA and children from 
Hungary, it has been observed that a low GL diet reduced BMI, adiposity and the 
prevalence of metabolic risk factors (Speith et al., 2000, Ebbeling et al., 2003, 
Fajcsak et al., 2008). Although these studies describe their intervention as ad 
libitum, they remain restrictive in that proportions of macronutrients may be set to 
manipulate dietary GL and often indirectly restrict energy intake. Such parameters 
may mean that the diet is more complex for the general population to follow. 
However, the intervention of the current work only focused on manipulating dietary 
GI and is a truly flexible, ad libitum diet, and may promote better compliance and 
adherence than previous studies. 
 
Data gathered from 3 day weighed food diaries provided novel insight into the 
impact of this 12 week low GI intervention in a group of postpubertal adolescents. 
Despite identifying no significant changes in proportions of macronutrients, dietary 
GI and GL significantly reduced between baseline and week 6 by 8.25 units in the 
LGI group. In the LGI group, GI and GL intake increased at week 12 compared to 
week 6 yet values remained below baseline. In the control group GI was relatively 
unchanged, however GL did decline throughout the intervention and by week 12 
was similar to that of the LGI group and significantly different from baseline.  
The increase in GI between week 6 and 12 suggests that there may have been 
issues with adherence to the intervention diet following 6 weeks. It was postulated 
that because this was not an intervention targeting weight loss, but rather metabolic 
health, that individuals may have lost motivation if they did not feel they were losing 
weight, despite being made aware of the focus of the intervention before taking part, 
although such evidence was anecdotal. Furthermore, there was no significant 
change in mean BMI, BF% or fat mass in either group.  However, the dietary 
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changes observed at week 6 suggest this ad libitum low GI diet was successful in 
reducing GI and GL whilst maintaining original proportions of macronutrients. This 
allows for the effect of a reduced GI diet on metabolic health to be examined in 
relative isolation to other macronutrients. However, although non- significant, there 
was a slight reduction in the proportions of fat and SFA consumed following the LGI 
diet that were not observed in the control group. This is encouraging as it suggests 
that a flexible diet focusing on substitution of high GI foods with low GI foods in the 
context of habitual diet and the Eatwell plate (FSA, 2012) may promote a more 
healthful dietary profile than just consuming habitual diet in the context of the 
Eatwell plate, however, more studies utilising this approach would be required to 
confirm this. The current intervention elicited a similar reduction in GI in adolescents 
to previous research in adults  which employed more heavily restricted diets (Jebbet 
al., 2010, Ebbeling et al., 2008, Jenkins et al., 2008), where GI was reduced by 
approximately 10 units. Unfortunately, of the evidence in youths, dietary changes 
were not monitored during the intervention and thus comparison cannot be made 
between these studies. Some authors have stated it is too complex to be applied to 
a general population (Franz, 2003) but the current study contradicts this notion, as it 
appears that the application of low GI eating in a health context may be a beneficial 
approach to improving the diet quality of UK adolescents.  
 
Furthermore, there was a significant reduction in clustered metabolic risk score in 
the LGI group (P= <0.01) that was not observed in controls when within-subject 
correlations were accounted for. In addition, mixed models showed that BG was 
marginally significantly reduced at week 6 compared to baseline in both groups (P= 
<0.1), however, by week 12 BG had continued to decline in the LGI group whereas, 
in the control group it had slightly increased. There were also marginally significant 
improvements in DBP and SBP in the LGI group, however, this was also observed 
for DBP in the control group at week 6. In overweight adults, a low GL diet was 
shown to improve BP in comparison to a reduced fat diet, however this study also 
observed significantly greater improvements in lipid profile, which was not observed 
in the current study (Pereira, 2004), although these diets were designed to reduce 
body weight by 10%. Contrastingly, in the current study, weight and adiposity were 
relatively unchanged. In three previous studies, two of children and one of 
adolescents, fat mass and BMI have been reduced following low GL diets, however 
in two instances dietary change was not monitored during the intervention (Speith et 
al., Fajcsak et al., 2008) and in another, it was not clear if adiposity changes were a 
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result of altered GL or a reduced energy intake (Ebbeling et al., 2003) and thus the 
evidence in youths is not clear. Despite there being no significant improvements in 
lipid profile in the current intervention, the significant improvement in clustered 
metabolic risk score in the LGI group suggests that there may have been a 
beneficial effect in this group of overall metabolic health. To the author‟s knowledge 
this is the first low GI intervention in youths to show an improved clustered 
metabolic risk score. 
 
Despite being inversely associated with GI in the current observational evidence, 
HDL was not increased subsequent to reducing dietary GI. Evidence suggests that 
the assessment of HDL particle size and functionality may be more important 
markers of atherogenic risk than total HDL levels (Kypreos et al., 2013, Kontush and 
Chapman, 2012). There appears to be a lack of research assessing the relationship 
between glycaemic CHO and HDL functionality. Impaired HDL functionality can 
effect anti-inflammatory activity and accelerate atherosclerosis (Kontush and 
Chapman, 2012) and may play a potential role in glucose homeostasis and the 
development of diabetes (Soran et al., 2012). It is possible that the impact of the low 
GI diet may have altered HDL functionality instead of total HDL levels, the failure to 
assessment this marker is a limitation of the current work. 
 
The LGI group had a marginally significant improvement in long term glucose 
control compared to those in the control group; relative to the control group, HbA1c  
was reduced at weeks 6 by 0.20 (0.11); P= 0.078 and at week 12 by 0.43 (0.19); P= 
0.062. In contrast to evidence showing an improved glucose control, insulin 
resistance significantly increased in the LGI group relative to the control group at 
week 6 compared to baseline by 1.43 (P= 0.024). The fact that insulin declined in 
the control group relative to the LGI group is an unexpected finding, and the dietary 
changes observed in the control group do not represent those associated with 
improved insulin resistance. Furthermore, it is important to note that the above 
metabolic health changes occurred in the absence of a significant reduction in 
adiposity. Therefore, it is likely that additional factors are influencing the variation in 
insulin resistance between the two groups. It was postulated that the impact of 
puberty may still be impacting on insulin levels, despite attempting to control for the 
effects of puberty in the experimental design. As pubertal status was self assessed, 
it is possible that certain individuals may not have accurately assessed their own 
stage of maturational growth. Additionally, within the remit of this PhD, it was only 
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possible to assess insulin resistance using an indirect marker, for the current 
investigation the HOMA-IR method, which utilises fasting BG and insulin levels to 
estimate the degree of insulin resistance for each individual was utilised. 
Unfortunately this method does not provide as accurate results as direct methods 
such as the clamp technique or an insulin suppression test (Muniyappa et al., 2008) 
and thus some caution should be used when interpreting these data. However, 
direct methods are expensive, time intensive and require expertise to be conducted. 
Despite this the HOMA-IR method has been shown to have reasonable linear 
correlations with clamp studies (Wallace et al., 2004, Radziuk, 2000). 
 
9.7 Application of the GI in health promotion  
 
Evidence provided from this current work and past research (Scazzina et al., 2011) 
appears to demonstrate that reducing the GI of the diet may be more beneficial than 
reducing dietary GL in improving metabolic health. Furthermore, this work appears 
to be the first to show that a flexible, ad libitum, low GI diet in the context of a 
balanced diet, was an appropriate approach to lowering dietary GI whilst eliciting a 
healthful diet in UK adolescents.  This is promising for future health improving 
strategies, as despite criticism that the GI may be a difficult concept to grasp by the 
general public (Franz., 2003, Pi-Syunyer., 2002), in the context of low GI food lists 
and high for low GI food swaps, it appeared that adolescents found the diet straight 
forward to understand and follow. This is supported by the apparent compliance in 
lowering dietary GI, as observed in the food diaries, but also anecdotally, in 
conversation during low GI consultations. However, the poor retention rate of 
intervention participants should not be overlooked. It became apparent during 
dietary consultations, however, that individuals were not aware of the concept of the 
GI before their participation in this intervention and they had never been introduced 
to low GI food lists. If future health promotion or improvement programmes in the 
UK were to truly incorporate low GI eating as a strategy, much action is required to 
raise awareness of it as a concept. Indeed, in the current intervention, difficulties 
arose when trying to find appropriate low GI substitutes for certain food items, 
despite the fact a UK low GI list was created for this intervention. This was because 
the most comprehensive lists are based on analysis of foods from the USA and 
Australia (Aston et al., 2008), so even when referring to the extensive international 
GI tables (Chess and Stanley, 2008) it was often difficult to identify appropriate 
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substitutes. A meal time that seemed consistently difficult to identify appropriate low 
for high GI substitutes was breakfast, as many of the breakfast cereals consumed 
by youngsters tend to consist of refined grains and or be high in added sugars. The 
potential low GI breakfast cereal substitutes, such as muesli, porridge or bran based 
cereals, where often regarded as unappealing by the participants. 
 
A feasible way of increasing a youngster‟s ability to make healthy GI choices could 
be to include a GI value on packaging of CHO containing foods and beverages; 
currently, only a very limited number of products on the UK market have this value 
displayed, yet it would be a very simple way of allowing individuals, especially 
adolescents who are making more autonomous decisions regarding their nutrition 
(Ebbeling et., 2003), to make more healthy food choices. A recent international 
study comparing diets of varying protein and GI content targeting weight control 
identified that individuals reported better scores of acceptance and positive 
experiences for a diet high in protein rather than low in GI (McConnon et al., 2013). 
This could be related to a better understanding of the benefits of a high protein diet 
due to the increased media attention they have received.  In Australia, however, 
there has been a large campaign raising awareness of dietary GI and its importance 
on health, many foods on the Australian market have been tested and display a GI 
value on their packaging. It is also important to consider that certain foods are 
manufactured differently in different countries, regardless of whether or not the food 
item has the same branding and name, therefore the GI of foods tested in the USA 
and Australia, which make up the majority of foods on the current international GI 
tables, can be different to those on the market in the UK and the rest of Europe 
(Chess and Stanley, 2008). Thus, GI tables should be used with some caution when 
utilising data that was obtained from different countries and to this end, more 
studies assessing the GI of foods consumed within the UK are required. Recently a 
culmination of international nutrition and health experts met in June 2013, to form an 
International Scientific Consensus Summit, entitled, „Glycemic Index, Glycemic 
Load and Glycemic Response‟. In the preliminary draft consensus statement it was 
agreed that given the rise in obesity and diabetes and with the evidenced potential 
for low GI to be beneficial for these factors, there is an increasing requirement to 
disseminate information regarding the GI and GL to the general public and health 
professionals. Also, it was stated that low GI should be considered in the context of 
future healthy diets. (www.gisymbol.com.au/cmsAdmin/uploads/GI-Summit-
Consensus-Statement.pdf, accessed June, 2013). 
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9.8 Issues with food diary compliance  
 
In order to estimate dietary GI and GL it was important to gain detailed information 
regarding the type, brand and quantity (weight) of a food or drink as well as 
considering food that was weighed but not consumed (leftovers). This can pose a 
burden to the participant in that weighing and recording what they eat can be an 
inconvenient, laborious and time consuming task (Livingstone et al., 2004) and thus 
requires a great deal of self motivation to complete. Respondents must be literate 
and numerate to be able to complete their food diary independently; in the case of 
the SIRENS study, one participant required support from a parent to complete their 
food diary.  Evidence has shown that some individuals are likely to alter their eating 
habits to simplify the process of recording or due to a need to consume a diet they 
consider „socially desirable‟ (Livingston et al., 2004), such as eating less during 
recording days or consciously neglecting to record certain foods. Although biased EI 
is a common issue when assessing diet generally, unfortunately, in adolescents, 
nutrient intake data is particularly prone to bias in the form of underreporting in 
comparison to children and adults (Bandini et al., 1990, Livingstone et al., 2004). 
However, as the current work accounted for misreporting the impact of this should 
have been minimised.  
 
Alternative techniques to dietary assessment such as dietary recalls and FFQs can 
be less labour intensive for respondents; however, these techniques require food 
items to be recalled from memory which can hinder the accuracy of these methods. 
More recently technological advances have introduced the prospect of capturing 
dietary intake using a mobile smart phone device, such as the DietCam (Kong and 
Tan, 2012) which aims to use algorithm within its software to estimate food type and 
volumes from 3 separate images of a plate of food. This may be a good prospect for 
assessing diet in youngsters who are likely to be more familiar with new 
technologies than their older counter parts. A study assessing the preferences for 
dietary assessment methods in adolescents identified a strong preference for 
methods incorporating technology such as those that take images of foods (Alberti 
et al., 2006). The authors postulated that this may improve compliance and 
accuracy when measuring dietary intakes in this group. However, analyses of these 
images are far from implantation in research. Other similar systems that use camera 
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technology require intensive user interaction and images to be sent to multiple paid 
individuals who manually analyse the images which can make these processes 
labour intensive and expensive (Kong and Tan, 2012).  
9.8 Issues with accelerometer compliance  
 
With measurement of PA, compliance issues can result in long periods of non-wear 
time and this was seemingly observed in the current work by the 28.6% of 
participants that did not wear their accelerometer for a sufficient time period. This 
impacted on the statistical power of the study, in that assessment of associations of 
PA and diet (controlled for PA) with health markers could only be conducted on 
those who wore their accelerometer for a sufficient time period. An issue which 
became apparent during this work was that some of the adolescents expressed 
reluctance to wear the RT3 accelerometer; as the device must be attached to the 
waistline of trousers or a belt (much like a traditional pager), it is usually constantly 
visible to others. Female adolescents, in particular, expressed that the device was 
not aesthetically pleasing and “did not go with their clothing”, nor could it be worn 
with a dress. Additionally, participants may have been weary of their peers being 
aware that they were having their activity monitored, especially in the context of the 
SIRENS study which was centred on individuals with poor health.   Future work 
would benefit from using a device that can be worn underneath clothing out of view 
from others. An alternative could be to use the Actigraph GT3x triaxial 
accelerometer, which can be worn underneath clothing as it is attached to the 
participant via its own elastic waist belt. Furthermore, as previously outlined, this 
device is also water proof, which allows for the device to be worn during some water 
based activities. Together these factors could improve compliance and widen 
opportunities to wear the monitors and thus providing richer PA data. 
 
9.9 Issues with intervention studies in youths 
 
The high dropout rates in this intervention study and subsequent low sample size 
means that its findings must be interpreted with caution. Retention of intervention 
participants was an issue; from those who were fully enrolled at baseline (n=21), 
dropout rates at week 6 were 24% and at week 12 dropout had increased to 52%. 
Additionally, recruiting the target sample size of 25 per group was highly challenging 
and took much longer than initially anticipated. 
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Recruitment comprised of firstly forming links with and disseminating the study 
details to schools, colleges and GP surgeries. This often required formal meetings 
with senior members of staff before being allowed to advertise the study at these 
sites, which proved time intensive. Many schools and even some GP practices 
didn‟t seem comfortable with being part of study that broached the issue of obesity 
in youngsters and declined participation. Recruitment strategies evolved over time 
to achieve recruitment targets and included creating information for the Hospital 
website, additional newspaper advertisements and a press release that lead to an 
interview on a local regional radio station to promote awareness of the study in the 
Bedfordshire area. It appears that participants were less motivated to take part and 
adherence to the intervention reduced as the trial progressed; dropout rates and 
dietary GI and GL increased in the LGI group at week 12 compared to week 6. 
Unfortunately a limitation of this study is a lack of qualitative data gaining insight into 
reasons for dropping out or not taking part initially. Such information would be 
helpful when designing future studies in this area.  
 
Although no official qualitative data was collected to inform the research team of 
possible reasons for recruitment and retention challenges, anecdotal evidence from 
this group would suggest that some parents were more concerned about their 
child‟s weight and health than the participants themselves and that parental 
encouragement was key for some individuals in determining their participation. 
However, some individuals clearly wanted to take part for their own reasons; for 
instance, a number of participants had older family members with obesity related 
health issues and expressed concern for their own health. In the case of many of 
the females, participants wanted to change their appearance and be slimmer.  
Where participants had actively enrolled for their own reasons, they appeared to be 
more motivated to take part in all aspects of the study. These individuals may have 
felt the study had relevance to them making participation more interesting, 
subsequently increasing compliance (Ross et al., 1999). Unfortunately, no record of 
motives to take part in the SIRENS study was taken. This is a limitation of the work, 
and future studies should seek to explore motives and barriers to participation and 
adherence to this flexible low GI diet in adolescents. 
 
A fear of needles was a significant hindrance to recruitment, often, when a non-
returned consent form was followed up, the reason given for not taking part was a 
fear of needles. In some instances parents would cancel screening appointments at 
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the last minute due to the fact that they could not encourage their child to have a 
venous blood sample taken. This challenge also prolonged data collection sessions 
when participants were reluctant to have blood samples taken which, at times, 
disrupted testing schedules. In addition, it was, occasionally, difficult to locate an 
appropriate vein, which may have been influenced by the young age of the 
participants and high adiposity. However, this was certainly not the case in all 
participants, in fact, in those individuals who actively enrolled onto the study for their 
own reasons, blood sampling was much more straight forward regardless of 
whether or not they were averse to having  their blood sampled. 
 
Another issue with conducting this intervention was the lack of independence in this 
sample regarding transportation. A large number of participants had to depend on 
their parents for transportation or use public transport to attend data collections and 
weekly consultations, as the majority of participants were not within walking 
distance of the Hospital or University campus. This meant that in many instances 
scheduling of data collection and consultations had to account for the participant 
and their parent‟s free time, limiting availability. In addition, there was no provision 
for this study to provide any financial support for transportation or to cover the 
expense of parking at the Hospital. The relatively low availability of funding for this 
RCT and thus the lack of financial inducement or „thank you‟ gift is a possible 
hindrance to recruitment and retention rates. Previous studies have shown that 
children and adolescents are more likely to overlook risks to participating in 
research  or withdraw from participation when monetary gain is part of 
participation(Wendler et al., 2002, Field et al., 2004). This may have improved the 
statistical power of the study and subsequently strengthened associations between 
reduced dietary glycaemic CHO and metabolic risk factors. 
 
9.10 Representativeness of findings 
 
The findings of this thesis provide novel insight into the associations of glycaemic 
CHO and metabolic health and the impact of different PA thresholds when 
assessing PA and health relationships in a postpubertal adolescent population that 
will be important for future health improvement strategies and research. However, 
limitations lie in the generalisability of these findings. Although the observational 
work was on a general adolescent population, participants were only recruited from 
within Bedfordshire; mainly from the towns of Bedford and Luton, thus these 
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findings may not be generalisable to a greater UK population. Yet it is important to 
note that this sample is likely to be representative of other towns in the South East 
of England, outside of the greater London area. Moreover, according to the sample 
size calculation conducted a-priory, as described in section 3.11, this observational 
work is statistically under-powered, a sufficient sample size was estimated as 
n=137, despite not achieving this with the total number of participants recruited and 
assessed (n=105), the lack of compliance for sufficient accelerometer wear time 
meant that the sample size was reduced further when adjusting analysis for PA 
(n=75). Furthermore, with regard to those enrolled in the intervention, the findings 
are limited to overweight and obese individuals with a risk factor for the metabolic 
syndrome, however, this could be regarded as a strength of this research being that 
there appears to be a lack of interventions in youths targeting an „at risk population‟. 
Moreover, the intervention sample was small and heterogeneous; the majority of 
participants were females; as only 2 male participants were enrolled in the trial, it is 
not possible to generalise the effects of this intervention to male adolescents and 
the small sample size limits the statistical power of the findings. However as 
described in section 3.11 the a-priory sample size calculation estimated that only 3 
participants per group would be required to detect an effect of the intervention on 
insulin resistance (HOMA-IR). However, to detect a significant difference between 
the control and intervention groups a required sample size of 15 in each group was 
estimated, and thus, as only 11 intervention and 10 control participants were 
assessed at baseline, the intervention was also statistically underpowered and the 
results should be interpreted with caution. 
 
9.11 Conclusion 
 
 Together this evidence highlights the potential of low GI for the improvement of 
cardiometablic health. The observational and intervention study evidence, supports 
the future promotion of low GI in the context of a healthy diet in youngsters, and 
specifically in adolescents from the UK, for whom there is limited information 
regarding their current glycaemic CHO intake and association with metabolic health, 
or the impact of a low GI intervention. This work also highlights the importance of 
assessing and accounting for dietary misreporting when investigating diet and 
health relationships in this population. There was promising evidence that this highly 
flexible low GI diet was an appropriate avenue for reducing dietary GI whilst 
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maintaining a healthful macronutrient composition and that this approach may have 
a beneficial effect on long term glucose control, blood pressure and clustered 
metabolic risk score. Interestingly, however, insulin resistance was not improved by 
the intervention. Unfortunately, the small sample size utilised for the intervention 
means that its findings should be interpreted with some caution. Future studies 
should endeavour to overcome challenges of recruitment and retention in such 
populations to more clearly identify any associations between reducing GI and 
metabolic health improvement. 
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Chapter Eleven Appendices 
Appendix 1 
CROSSROADS Physical Activity, Nutrition and Health.                                 
    
 
Dear Potential participant 
Re: Cross sectional Study: Risk of Adolescent Disease (CROSSROADS) 
We would like to invite you to take part in a school-based nutrition, physical activity and health research 
study. The study aims to assess how diet, physical activity engagement and fitness levels relate to the 
health of 15-19 year olds from schools, sixth-forms and colleges in the Bedford area.  
If you would like to take part you must sign the consent form (a) attached to this document. If you are under 
16 your parent or guardian will also need to read this information sheet and sign the consent form (b). If 
you have any questions about this information sheet, or would like further details, please ask a member of 
the research team - you can find their contact details at the bottom of this sheet. 
The study will be conducted at your school, sixth-form or college. You will only be required for testing on 1 
day for a relatively short time period, and will be asked to wear a physical activity monitor and keep a 
weighed food diary and return these to us at your place of education a few days later. 
 
What happens in the data collection? 
On the night prior to the data collection day, we will remind you to fast over night (10-12 hours).  Therefore 
you must not consume any food or drink for 10 hours prior to the school start time (you will be allowed to 
sip water).  Please come to your school with a snack so that you can eat something immediately after you 
have seen the researchers for the initial data collection.  
When you arrive at the school, you will immediately see the researchers (who will be in a room on the 
school or college grounds) to have your initial data collection (about 20 minutes) which includes a measure 
of your height, weight and muscle and fat levels (by standing on a scale with two metal plates) and a 
measure of your BG and cholesterol levels (by taking a fingerprick blood sample from your finger).  This is 
a very simple and easy procedure and requires the drops of blood collected to be put into a machine to 
measure cholesterol and glucose.  Once these measurements are completed you will be able to eat your 
snack and continue your lessons.  You will then visit the research team again later during the day to 
complete the remaining measurements.  
For the remaining data collection (about 30 minutes) you will have your waist circumference, blood 
pressure and heart rate measured.  You will also be required to undertake some exercise on a stationary 
bike and to wear a plastic mask over your mouth and nose to enable us to measure gases in your expired 
air.  It is expected that towards the end of the session you will find it hard work but you will be advised that 
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you can stop at any point should you wish to.  The exercise session will last between 8-12 minutes. You 
will also be asked to complete some questionnaires relating to physical activity levels.  
After the testing in school / college, we will also ask you to keep a 7-day physical activity diary and to wear 
a small box on your waist for 7-days.  This is an accelerometer which monitors physical activity levels.  
This is very expensive and must be removed when swimming or bathing/showering.  Please make sure 
you take good care of this and please bring it back when asked so that we may use it straight away for the 
next person.  During the same week that we ask you to wear the physical activity monitor you will also be 
asked to complete a 3 day weighed food diary. You will be given a food diary and weighing scales, so that 
you can provide us with an accurate measure of the food and drink you regularly consume. We will explain 
how to do this in more detail when we meet you. Once this has been completed and returned to us at your 
school or college the testing will be complete. 
There is a risk that we might find some abnormal results such as high blood pressure, high blood 
cholesterol or glucose readings.  If so, we will inform you and as a precaution will suggest you visit your 
general practitioner (GP) or we may be able to offer you a place on one of our physical activity / nutrition 
projects. 
It is your responsibility to provide information regarding your health status or previous experiences of 
unusual feelings with exercise.  You cannot take part in the study if you have a chronic medical condition 
such as heart disease, asthma (not controllable with medication) or any other condition that may put you at 
risk when performing having the fitness test.   
Your participation in this study is entirely voluntary and the results will be strictly confidential (only the 
researchers and you will see the individual results). All data will be stored in a secure locked filing cabinet 
or on a password protected computer file that can only be accessed by members of the research team. 
 Before giving your full consent to the study, we ask that you discuss this with your parent or guardian to 
make sure you understand what the study involves. If you have any questions about the study, please 
contact a member of the research team (contact details below). Remember, this study is voluntary and you 
can leave the study at any time by telling a member of the research team that you no longer wish to take 
part. 
It is hoped that the work from this study will be published in a scientific journal but your data will be kept 
confidential at all times.    
 
 
 
 
 
CROSSROADS research team contact details: 
Ben Davies, E-mail: Ben.Davies@beds.ac.uk, Telephone: 07795661777 
Dr. Catherine Kerr, E-mail:Catherine.Kerr@beds.ac.uk, Telephone: 07908625240 
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Informed Consent 
CROSSROADS (Cross Sectional Study: Risk of Adolescent Disease)  
If the participant is under 16 years of age, please sign the below informed consent (a) to assent to 
taking part. However, your parent or guardian must also consent to your participation by signing 
the below parental/guardian informed consent (b)  
Informed Consent Form  
Please complete all the details below. All information obtained will be treated as confidential.  Completed 
forms must be returned to ____________________________or the PE office, before any testing 
commences.  Please return as soon as possible.               
Please read the following statements carefully.  Please sign only when you have agreed with the 
statements. 
I have been asked to participate in a school-based nutrition, physical activity and health research study in 
15-19 year olds.  I give my free consent by signing this form. 
I understand that I will be involved in the following:  
• The research will be carried out as described on the information sheet 
• If I decide to withdraw from participation, my decision will be accepted. 
• I understand that I am responsible for providing information regarding my health status or previous 
experiences of unusual feelings with physical effort.   
• I have no injury or illness that will affect my ability to successfully complete the tests.   
• I have read and understood the information above, and my questions have been answered to my 
satisfaction.  
Informed consent (a)  (If participant is over 16) 
Name: ....................................................................……   
Date of Birth: ………………………….. 
Permanent Address: 
………………………………………………………………………………………………………………………….....
..........................................................................................................................................................................
..................................... 
Contact Telephone No:………………………………………………………………………………. 
Signature of participant…………………………………………         Date……………………………… 
Signature of researcher .................................................................................... 
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Parental/Guardian Informed consent form (B) (If participant is under 16) 
I have been asked to allow my child to participate in a school-based nutrition, physical activity and health 
research study in 15-19 year olds.  I give my free consent by signing this form. 
• By signing this form I give my free consent to allow my child to participate in the research project, 
should my child wish to take part.   
• I have read and understood the information above, and my questions have been answered to my 
satisfaction.  
 
Name of Child: ....................................................................……   
 
Date of Birth: ………………….. 
  
Permanent Address:  
 
………………………………………………………………………………………………………………………….................................... 
.................................................................................................................................................................. 
.............. 
 
Parent/Guardian Contact Telephone No:………………………………………………………………………………. 
 
Signature of parent/guardian…………………………………………         Date……………………………… 
Signature of Researcher .................................................................................... 
 
Along with this form, please also return the following completed form: Physical activity readiness 
questionnaire – this checks that you are well enough to complete the exercise test. 
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Adapted Physical Activity Readiness Questionnaire for Youth 
This questionnaire offers a safe, preliminary health-screening prior to participation in exercise... 
 
 Has your doctor ever said that you have a heart condition?    
Yes        No 
 Do you have chest pain brought on by exercise?  
Yes        No  
 In the past month, have you experienced chest pain when you were NOT doing exercise?   
        
Yes        No 
 Do you lose consciousness or lose balance as a result of dizziness? 
Yes        No 
 Do you have a bone or joint problem that could be aggravated by  exercise?     
      
Yes        No 
 Does your doctor currently prescribe medication for blood pressure  
   or a heart condition (e.g., diuretics or water pills)?     
Yes        No 
 Do you know of any other reason why you should not participate in exercise?   
Yes        No 
If „yes‟, please give the reason; 
……………………………………………………………………………………………………………………………………………………………......................
Blood sampling question 
 Can you answer yes to any of the following? Have you ever had any form of Hepatitis? Have you any 
reason to think you might be HIV positive? Could taking blood be hazardous to your own or the 
researchers health?  
Yes        No        
Participant name (Please PRINT NAME)……………………………………….. 
Signed………………………………………………. Date………………. 
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Appendix 2 
Non sex specific SIRENS information and consent form 
 
Direct Telephone: 01582 497172/497421   Direct Fax: +44 01582 564543 
 
Participant Information Sheet – Part 1 
The SIRENS study (Study of Insulin Resistance factors using Exercise and Nutritional Strategies) 
 
Dear Participant or Parent/Carer 
 
Re: Study 
 
We would like to invite you to take part in a research project to find the answer to the following question: 
Can we improve the health of 14-19 year-olds with above average waist circumference using aerobic 
exercise (e.g. cycling, jogging), resistance exercise (e.g. lifting weights), or a special diet? 
 
Before you decide if you want to take part, it‟s important to understand why the research is being done and 
what we might be asking you to do. So please consider this letter carefully and talk to your family, friends, 
doctor or nurse if you want to. If you would like to take part you must sign the consent form attached to this 
document. If you have any questions about this information sheet, or would like further details, please ask 
a member of the research team - you can find their contact details at the bottom of this sheet. 
 
Please be aware that if you have any of the following medical conditions: Type 1 or Type 2 diabetes 
mellitus, heart dysfunction, thyroid problems, or are receiving long-term treatment for a health condition, or 
if you: think you may be pregnant, have an eating disorder, have experienced any recent dramatic weight 
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changes, use medication that contains steroids, are an alcohol or drug abuser, have a known family history 
of hypercholesterolaemia (high levels of cholesterol in the blood), haemoglobinopathy (abnormal structure 
of haemoglobin in the blood, e.g. sickle-cell anemia), cardiac disease or renal disease, then unfortunately 
you cannot take part in this study. This is because the above conditions can affect your metabolic health 
and could influence the findings of our research project. 
 
Purpose of the Study 
More and more young people are becoming overweight and showing signs of being at risk of disease later 
in life. Being overweight (having a higher than average waist circumference) can lead to poor metabolic 
health (e.g. high blood pressure and high levels of fat and sugar in the blood), and possibly disease (e.g. 
heart disease or stroke or Type 2 diabetes) later on in life. It is important that we try to find the best way to 
help overweight people lose body fat and improve their health, particularly when there may already be 
signs of increased risk of developing type 2 diabetes, for example. 
 
Exercise and diet can be used to help lose body fat and improve the chances of not developing disease, 
but we are not sure what type of exercise or diet is best. We would like to compare 2 different exercise 
programmes (aerobic and resistance), and a special diet programme against a control group (who receive 
a lifestyle consultation at the end of the study) to see which is best for improving the health of young 
people who are overweight and are at more risk of poorer metabolic health (as shown by having high blood 
pressure or raised cholesterol etc). 
 
Why have you been invited? 
You have been invited to join our study because you are 14-19 years-old; we are aiming to recruit 100 
people like you to take part. We are recruiting 14-19 year olds as little is known about the best way to treat 
people of this age who are overweight and have poorer metabolic health status. We also only want to 
include people who have gone through puberty as we know that hormone levels will be more stable (which 
is important for this study). We do not know yet if you are one of these people, so we need to test this first. 
 
Do you have to take part? 
No, it is up to you. We will speak to you individually to make sure you clearly understand the nature of the 
study and will give you a copy of an information sheet which provides details of the study. If after a 
minimum of 24 hours you decide that you would like to take part in the study we will ask for your consent 
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by signing a form to indicate that you understand what is being asked of you and that you are happy to 
take part (we will provide you with a copy of this to keep). You are free to stop taking part at any time 
during the research without giving a reason. If you decide to stop, this will not affect any care you receive. 
 
What will happen to you if you take part? 
1. We first need to check that you have finished or are at the end of puberty. Females who are classified 
as Tanner Stage 5 for pubic hair (see Tanner Pubic Hair Ratings Scale on Page 8) can take part in this 
study. Males who are classified as Tanner Stage 5 for pubic hair (see Tanner Pubic Hair Ratings Scale 
on Page 8) can take part in the study. Anyone in Tanner Stage 1 to 4 cannot take part in the study. 
 
2. If you are at the end of puberty (Tanner Stage 5) and would like to take part in this study, we will first 
need to measure your waist circumference (using a tape measure) at a suitable location (either at your 
school, GP surgery, college, the University of Bedfordshire, or at the Luton & Dunstable Hospital 
[L&DH]). If you have been referred to us, your GP or health practitioner at the L&DH may have taken 
this measurement for us. 
 
3. If your waist circumference is high for someone your age and sex, we will then ask you to visit the 
L&DH on a separate morning so that we can assess your metabolic health e.g. blood pressure, fats 
and sugar in the blood (if this is during an academic term, we should be able to offer testing times 
before the start of the school or working / college day). If we are measuring your waist circumference at 
the L&DH, we may then take measurements of metabolic health immediately afterwards. When you 
arrive at the hospital, you will be asked to come along to where we are taking these measurements (we 
will give you directions to our location). 
 
A blood sample (to measure insulin levels, liver function and other indicators of metabolic health) will 
first be taken from your lower arm. This will involve a needle being inserted into a vein on the lower part 
of your arm so that blood can be drawn out into a container. This procedure is similar to the one you 
would normally expect at a hospital or your GP‟s surgery and we would not take more than 12 ml in any 
one sample. We will then take a finger prick blood sample. This is a very simple procedure and simply 
requires drops of blood to be squeezed from the finger and collected into a tube. The blood will 
immediately be put into a machine to measure cholesterol and sugar levels. You will then have your 
muscle and fat levels measured (by asking you to stand on a platform which looks like weighing scales 
with two metal plates) along with your blood pressure and height. On the night before we take these 
measurements, we will ask you to fast overnight (10-12 hours). It is very important that you do not 
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consume any food or drink in the 10 hours before your measurement time (although you can sip water). 
Please bring a snack which you can eat after your measurements have been taken. 
 
4. If we find that you have above normal or slightly undesirable values for one or more of the following: 
blood pressure, blood cholesterol measures (high-density lipoprotein, triglycerides), blood sugar 
(glucose), insulin resistance (which means that your body doesn‟t respond well to insulin which can 
lead to T2DM), then you will be eligible to take part in the study. 
 
5. If eligible, you will be randomly (by chance) assigned to either an exercise programme, a diet 
programme, or to act as a control (which means you will not take part in the diet or exercise 
programmes but will have your metabolic health and fitness assessed and be offered a diet and 
exercise counseling session with a trained advisor at the end of the study). If you have normal values 
for each of these measures you will not be invited to take part in any of the interventions but your data 
will be used so we can report on how common it is for young people to have poor metabolic health. Half 
of the people eligible to take part in the study will be assigned to an exercise group, a quarter to the 
special diet group, and a quarter to the control group. 
 
What the interventions involve 
Each programme will last 12 weeks. Before you take part in the programme you will be asked to undertake 
a fitness test on a stationary bike.  It is expected that towards the end of the exercise you will find it hard 
work but you can stop at any point if you wish to. The fitness test will last approximately 8-12 minutes. We 
will also ask you to keep a 7-day physical activity diary and to wear a small box (accelerometer) on your 
waist for 7-days to monitor physical activity levels. This must be removed before swimming or washing and 
we ask you to take great care of this equipment. 
 
If you are entered into the aerobic exercise programme, you be asked to visit the L&DH or the University of 
Bedfordshire 3 times per week (for 12 weeks) and to undertake approximately 45 minutes of moderate-
intensity exercise on a stationary bike or treadmill (or cross-trainer). If you are randomized into the 
resistance exercise programme you will need to visit the L&DH or the University of Bedfordshire twice per 
week to complete a circuit of various weight exercises to improve strength. This will last approximately 40 
minutes. All of these sessions will be supervised by a qualified fitness trainer. 
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If you are entered into the diet programme you will be given advice on eating foods that have a low 
glycaemic index (or GI) whilst maintaining a healthy balanced diet. Low GI foods are foods that cause 
smaller increases in your blood sugar levels compared to high GI foods, which cause bigger increases in 
blood sugar after you eat them. The diet does not restrict the number of calories that you can eat. 
 
You will be given a lot of help and guidance as to what foods to choose whilst on this dietary programme. 
You will be asked to attend 2 separate group meetings at the L&DH or the University of Bedfordshire 
before the diet starts. On the 1st meeting you will receive information about completing weighed and non-
weighed food diaries, which you will need to complete a total of 4 times during the study (for 3 days at a 
time). During the 2nd group meeting (about a week later) you will be provided with information about the 
importance of eating low GI foods and the diet itself. You will then be required to attend one-to-one 
discussions lasting approximately 15-30 minutes, once per week for the first 6 weeks of the diet and then 
at weeks 9 and 11. During other times during your 12 week dietary programme the research team may 
wish to contact you by telephone, text and/or e-mail (subject to your consent) to provide you with further 
support. 
 
If you are entered into the control group, you will be asked to continue your normal lifestyle so that we may 
compare the results of our intervention groups to a group that does not change their lifestyle. You will still 
have your health and diet assessed and will be given feedback on your current health status as well as 
dietary and physical activity advice once the study has finished, if you wish. 
 
All exercise and diet sessions will take place late afternoon/evening on each weekday (i.e. Monday to 
Friday). A variety of times will be offered from which you can pick those that are best for you. 
 
6 weeks into the programme you will have your height, waist circumference, muscle and fat levels, blood 
pressure and a venepuncture blood sample taken. At the end of the programme, you will take part in all 
measurements again. During the study please do not take part in any other research weight management 
or health research projects. 
 
If at the end of the study we feel that you may benefit from further health improvements, we will advise your 
GP and may put you in contact with a healthcare professional at the L&DH. 
Expenses and Payments 
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As you will be required to visit the L&DH or the University of Bedfordshire a number of times, you may be 
required to pay for car parking. However, you may wish to walk, cycle, or use public transport to travel to 
the hospital, and you may also want to ask your parent or another member of your family to drive you by 
car and pick you up once your session has finished. Alternatively it may be possible to park a short 
distance away from the hospital or university and walk in from there with or without a companion 
depending on your circumstances. 
What are the possible risks of taking part? 
There are risks associated with exercise such as feeling light headed and fainting but every effort will be 
made to minimise these, such as the completion of a physical activity readiness questionnaire (attached). 
There are also risks when we are taking blood samples from you, such as infection and pain/discomfort, 
but anyone taking blood samples from you will have been trained to do so and will be following the 
hospital‟s guidelines for carrying out such procedures. 
 
What are the possible benefits of taking part? 
All participants will receive a thorough assessment of fitness and metabolic health (includes assessment of 
cardiovascular and metabolic health measures). If you take part in one of the exercise or diet programmes, 
it may be that your body fat levels will be reduced and that your metabolic health (blood pressure, 
cholesterol, blood sugar, insulin resistance) might be improved. Your fitness levels and ability to take part 
in exercise may also be improved by taking part in the exercise programmes. You may also find it easier to 
live a healthy lifestyle in the future once the study has finished. Participants acting as controls will receive 
individualised one-to-one guidance on lifestyle changes that could be made to improve health and reduce 
waist circumference. 
 
Thank you for reading so far. If you are still interested please go to Part 2. 
 
Participant Information Sheet – Part 2 
What happens when the study ends? 
When the study ends, you will no longer take part in the programme you took part in during the study. It will 
be suggested that you continue to be physically active and to eat a healthy diet. 
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If you are in the control group, you will be offered guidance on how to improve your health during a 30 
minute one-to-one diet and physical activity discussion at the end of the study and may be put in contact 
with a health practitioner at the L&DH if appropriate. In this session your current food intake and exercise 
habits can be discussed and advice will be given based on this information. 
 
What will happen if I don’t want to carry on with the study or I can no longer consent to participate 
during the study? 
If you withdraw from the study, or can no longer make the decision to continue with the study, the 
information and samples collected from you so far may still be used for research purposes. 
 
What if there is a problem? 
If you have a concern about any part of the study, you or your parent/guardian should ask to speak to the 
researchers who will do their best to answer your questions (Dr Catherine Kerr, Tel: 01234-793268 / e-
mail: catherine.kerr@beds.ac.uk for general queries or those to do with the exercise and diet interventions; 
Ben Davies, Tel: 07795661777 / e-mail: ben.davies@beds.ac.uk). If you are unhappy with answers to your 
queries and should wish to complain formally, you can contact the University of Bedfordshire Research 
Institute (Professor Mark Lewis: Telephone (Department secretary): 01234-793268). 
 
In the event that something does go wrong and you are harmed during the research and this was because 
of someone being careless then you may be able to take legal action for compensation against the 
University of Bedfordshire, but you may have to pay your legal costs. The above formal complaints 
procedures will still be available to you. You will not receive compensation for any injury caused by a 
procedure outside of the study procedures or if you do not carry out the study procedures in the way you 
have been asked. 
 
Will anyone else know I am taking part in this study?  
We will keep your information and any data collected during the study in confidence. This means we will 
only tell those who have a need or right to know (appropriate research team members). Your data will be 
stored securely in a locked filing cabinet or on a password protected file on a computer and will only be 
used for the current study. Wherever possible, we will only send out information that has your name and 
address removed. Your GP will be notified that you are taking part in this study.  
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What will happen to any samples I give? 
As we said earlier, we will be collecting blood samples from you to measure your metabolic health. These 
samples will be collected by Hospital staff or trained members of the research team who will transport the 
samples to the L&DH phlebotomy laboratory for immediate analyses. Some samples may be frozen and 
stored securely in a laboratory at the L&DH or the Sport & Exercise Sciences laboratory at the University of 
Bedfordshire for analysis at a later date, but will only be used for the current study. Only the 
Hospital/laboratory staff and the research team will have access to your samples. Blood samples and their 
results will be kept in confidence and will only be handled and seen by those who have a need or right to 
know. Any remaining samples that are no longer required will be destroyed following routine Hospital 
procedures.  
 
What will happen to the results of the research study? 
The findings of this study identified as scientifically important will be provided to you in a summary 
document once the data has been analysed. It is intended that this information is published in a scientific 
research journal. The published data will be fully anonymous and therefore no-one will be able to identify 
you in any published material. 
 
Who is organising and funding the research? 
The organisers and funders of this project are the L&DH Centre for Obesity Research and the University of 
Bedfordshire.  
 
Who has reviewed the study? 
Before any research goes ahead it has to be checked by a Research Ethics Committee. They make sure 
that the research is fair. Your project has been checked and approved by the Essex 1 Research Ethics 
Committee. 
 
Further information and contact details. 
For further information on the study, please follow the guide below: 
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1) For general information about the research, visit the National Research Ethics Service website at: 
www.nres.npsa.nhs.uk, where the study is outlined. 2) For specific information about this research project 
or advice as to whether you should participate, contact Ben Davies, a member of the research team (E-
mail: ben.davies@beds.ac.uk; Telephone:  07795 661777). 3) If you are unhappy or have concerns during 
the study, please contact Catherine Kerr, E-mail: catherine.kerr@beds.ac.uk; Telephone (Department 
secretary): 01234-793268. 
 
If you would like to take part in this study, please return the following completed forms to the below address 
or by email to ben.davies@beds.ac.uk: 
 
1. Physical activity readiness questionnaire – this checks that you or your child is well enough to 
complete the exercise test. 
2. Consent form - this is to confirm you understand what is expected if you participate and you are 
happy to do so. 
 
Please also check the Tanner Pubic Hair ratings scale below. If you are in Tanner stage 5 you can take 
part in this study. If you are not in Tanner stage 5, you cannot take part in this study. 
 
Please remember, as mentioned earlier, that if you have any the following medical conditions: Type 1 or 
Type 2 diabetes mellitus, heart dysfunction, thyroid problems, or are receiving long-term treatment for a 
health condition, or if you: think you may be pregnant, have an eating disorder, have experienced any 
recent dramatic weight changes, use medication that contains steroids, are an alcohol or drug abuser, 
have a known family history of hypercholesterolaemia (high levels of cholesterol in the blood), 
haemoglobinopathy (abnormal structure of haemoglobin in the blood, e.g. sickle-cell anemia), cardiac 
disease or renal disease, then unfortunately you cannot take part in this study. 
 
Please send completed forms to the following address: 
 
Ben Davies 
Department of Sport & Exercise Sciences 
University of Bedfordshire 
Polhill Avenue 
Bedford 
Bedfordshire 
MK41 9EA 
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Tanner Pubic Hair Ratings Scale for Boys 
 
 
Tanner Pubic Hair Ratings Scale for Girls 
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Adapted Physical Activity Readiness Questionnaire for Youth 
 
This questionnaire offers a safe, preliminary health-screening you prior to participation in 
exercise. 
 
 Has your doctor ever said that you have a heart condition?    
Yes        No 
 
 Do you have chest pain brought on by exercise?  
Yes        No 
   
 In the past month, have you experienced chest pain when you were NOT doing exercise?
           
Yes        No 
 
 Do you lose consciousness or lose balance as a result of dizziness? 
Yes        No 
 
 Do you have a bone or joint problem that could be aggravated by    
exercise?           
Yes        No 
 
 Does your doctor currently prescribe medication for blood pressure  
     or a heart condition (e.g., diuretics or water pills)?     
Yes        No 
 
 Do you know of any other reason why you should not participate in exercise?  
   
Yes        No 
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If „yes‟, please give the reason on the next page; 
……………………………………………………………………………………………………………
……………………………………………………………………………………………………………
………………………… 
Participant name (Please PRINT NAME)……………………………………….. 
 
Signed………………………………………………. Date………………. 
 
 
Consent Form  
 
The SIRENS study (Study of Insulin Resistance factors using Exercise and Nutritional 
Strategies) 
 
Please tick box  
 
1.  I confirm that I have read, or have had explained to me, the information sheet  
 for the above study and fully understand what is involved. I have had the opportunity 
 to consider the information, ask questions and have had these answered satisfactorily 
 by a member of the research team, or my GP. 
 
 
2. I understand that my participation is voluntary and that I can stop taking part at any time 
without giving any reason, without my medical care or legal rights being affected. 
 
 
3. I understand that relevant sections of data collected during the study may be looked at 
by 
members of the research team from the University of Bedfordshire and Luton & 
Dunstable 
Hospital, where it is relevant to my taking part in this research. I give permission for 
these 
individuals to have access to my data. 
 
 
4. I agree to take part in the above study.  
 
 
 
Name of Participant:……………………………………………….. 
Date of Birth:………………………………………. 
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Permanent 
Address:…………………………………………………………………………………………………
…. 
 
...................................................................................................................................................
................................................................ 
 
 
Contact Telephone 
No:……………………………………………………………………………………………. 
 
Contact Email 
address:……………………………………………………………………………….........................
.. 
 
Name of participant‟s 
GP:…………………………………………………………………………………………. 
 
GP 
Address:…………………………………………………………………………………………………
……… 
 
 
Signature:…………………………………………….  Date:………………………. 
 
 
 
Signature of researcher: .................................................................................... 
 
 
Please send completed forms to the following address: 
Ben Davies 
Department of Sport & Exercise Sciences, University of Bedfordshire, Polhill Avenue, 
Bedford, Beds, MK41 9EA 
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Appendix 3 
3 day weighed food diary instruction sheet 
 
Introduction 
 
We would like you to fill out a weighed food diary of all the food and 
drink you consume over 3 days in a row, one of these days must be a 
Saturday or Sunday (therefore you could choose, Thursday, Friday and 
Saturday or Sunday, Monday and Tuesday). You will need to take the 
food diary with you so you can record what you eat and drink whilst you 
are not at home. 
 
 
Each diary entry should include (See example sheet): 
 
 Everything you eat and drink, it could be a main meal or small 
snack (including sweets and even water). 
 
 Please include extras like sauces, gravies and dressings that you 
put on you your food. 
 
 Please give as much information as possible about the amount 
and type of food or drink you are consuming (weight of the food or 
drink, any brand names e.g. Heinz baked beans).  
 
 If possible, please put any packaging in clear bags provided. 
Especially if you cannot weigh the items (i.e. crisp packet 
eaten out and about) 
 
 Include the time of day, try to say if the meal or snack is for 
breakfast, lunch or dinner and where the food was eaten (e.g. 
home or elswhere). 
 
  
 
 
 255 
 We have provided a food description prompt card to help you list 
the type of foods you eat (PLEASE SEE PROMPT SHEET). 
 
 Please list all of the ingredients in whatever item you eat or drink. 
e.g. If at lunchtime you have a ham sandwich you should list the 
amounts and type of foods (e.g. 25 grams of Sainsbury‟s honey 
roast ham (sliced); 15 grams of iceberg lettuce; two slices of 
kingsmill wholemeal bread [85 grams], SEE EXAMPLE DIARY. 
 There are sections on the diary to enter the different meals you eat 
(breakfast, lunch, dinner etc), separated by a gray bar. If you need 
more space to write in each section, just go over the gray shaded 
bar into the next section and start the next meal after the next gray 
shaded area (see example). 
 
When recording 
 
 Record what you consume at the same time as eating or drinking 
it, this way you won‟t forget what you have eaten. 
 Any meals or snacks you don‟t prepare, try to get help from the 
person making the meal to weigh the amounts and list the type of 
foods in the meal. 
 
Weighing your food and drink 
 
Because this is a weighed food diary you have been provided with 
weighing scales so that you can weigh the foods and drinks you 
consume. This is very important so we can accurately work out how 
much of each type of food you are eating or drinking. If you cannot 
weigh your food or drink, please provide a description of the amount of 
food or place any packaging in the plastic wallet provided and explain 
the quantity of the packaged food you have eaten. 
 
Here is an example of how to weigh a ham sandwich with lettuce (make 
sure the scales are set to weigh in grams): 
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 Turn on the scales by pressing the ON button 
 
 Weigh the empty container. Place the container (e.g. plate) you 
will be eating from, on the scales. You should use this plate to 
weigh the ingredients on. Make sure you write the weight of the 
empty plate. You should repeat this process if you eat out of or off 
an additional container (e.g. if you have a plate of toast and a bowl 
of cereal) 
 
  Before putting any food on the plate press the  ZERO button, the 
scales should now have the plate on but display no weight (0.00 
grams) 
 
 Add to the plate both pieces of bread (remember to list the type 
(e.g. wholemeal) and if possible the brand of bread (e.g. Hovis) in 
the ‘Food & Drink’ column. Record the weight (in grams) of the 
bread in the ‘Weight served’ column. 
 
 Press zero to reset the scales to 0.00 grams and add any butter or 
spread to the bread. List the type of and brand of spread and 
record the weight of the butter in the appropriate sections. 
 
 Press zero to reset the scales and repeat the process with the 
lettuce.  
 
 Whenever a new ingredient is added, the scales should be zeroed 
so that the weight of each ingredient can be recorded separately 
as it is added to the plate. 
 
 Use the weight on packaging to help diary entries if you consume 
the total contents of the packet. 
 Any drinks you have should be weighed in the same way 
 
 
 Any leftovers, not eaten, should be re-weighed and noted in the 
diary. If there is food leftover, re-weigh the container or containers 
that you have eaten or drunk from (with any leftovers on/in) and 
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write this in the ‘weight leftover’ column on the same line as 
where you have written the weight of the empty container. Put a 
tick next to the foods or drinks that are left on/in the container. 
Make sure you eat or drink from the same container or 
containers you weighed at the beginning.  
  
 
 
 258 
 
 
Example food diary 
 Today is_ Thursday ___           Today’s date is_07/03/11__       Recording day  1  2  3        Name:                                                                                                                                                                                          
                                                                                                                                                                      (please circle)          Participant number:                
 
 
Food & Drink (Please describe in detail) 
Weight of 
empty 
container 
(g) 
Weight 
served 
(g) 
Weight 
leftover(g) 
(tick items 
left) 
Leave 
blank 
(office use only) 
                                                                                                                                                                     - remember to weigh your empty plate or container-                                                                         
 
remember 
to include 
 
Drinks 
 
Snacks 
 
Wrappers 
 
Time 
eaten: 
7.45am 
 
Type of 
meal: 
(circle) 
 
  B. L. 
 
  D. S. 
 
Where  
eaten: 
 
Home 
 
Elsewhere 
 
 
Sainsbury’s own- Cornflakes.  Bowl 
400g 
40 g 411 g  
Sainsbury’s Semi-skimme, pasturised milk   110 g   
Toasted wholemeal pitta bread, Sainsbury’s Plate 
650g 
55 g ----------  
Flora Pro active, polyunsaturated, spread.  34 g   
Bovril beef extract  5 g   
Sainsburys - Muliti-vitimin tablet with iron-
200mg per tablet 
 1 g   
Tap water  240g   
Tetley tea bag and hot water 
 
cup 
350g 
202 g 364 g  
Sainsbury - Semi-skimmed milk, pasteurised  40 g   
     
     
     
                                                                                                                                                                    
- remember to weigh your empty plate or container-                                                                         
 
remember 
to include 
 
Drinks 
 
Snacks 
 
Wrappers 
 
Time 
eaten: 
_1pm_ 
 
Type of 
meal: 
(circle) 
 
Hardboiled egg  Plate 
600g 
61 g 640 g  
Sainsbury Clementine  65 g   
sainsburys value - Strawberry yoghurt  125g   
Granny smith apple  100 g   
sainsburys - Wholemeal pitta bread  109 g   
lettuce  23g   
sainsburys - Wafer thin honey cured ham 
slices 
 28g   
Sliced tomato  31g   
Tap water  440 g   
Tea bag and hot water Cup 
350g 
200g 355 g  
Londis - Skimmed milk, pasturised  45g   
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Appendix 4 
  
Venous blood assay methodologies 
a) Conducted by the L&DH biochemistry Laboratories  
(Synchron ® Clinical Systems, Beckman Coulter®,  Chemistry Information manual, 2005) 
 
ALP 
ALP reagent is used to measure alkaline phosphatase activity by a kinetic rate method using a 2-
amino-2-methyl-1-propanol (AMP) buffer. In the reaction, alkaline phosphatase catalyzes the 
hydrolysis of the colorless organic phosphate ester substrate, p-nitrophenylphosphate, to the yellow 
colored product, p-nitrophenol, and phosphate. This reaction occurs at an alkaline pH of 10.3. 
 
ALT 
ALT reagent is used to measure analyte activity by a kinetic rate method. In the reaction, alanine 
aminotransferase catalyzes the reversible transamination of L-alanine and alpha-ketoglutarate to 
pyruvate and L-glutamate. The pyruvate is then reduced to lactate in the presence of lactate 
dehydrogenase (LDH) with the concurrent oxidation of reduced 
β-nicotinamide adenine dinucleotide (NADH) to β-nicotinamide adenine dinucleotide (NAD). 
 
Albumin  
Albumin reagent is used to measure albumin concentration by a timed endpoint method. In the 
reaction, albumin combines with bromcresol purple (BCP) to form a colored product. 
 
CRP 
CRP reagent is used to measure the C-Reactive Protein concentration by a turbidimetric method. In 
the reaction, C-Reactive Protein combines with specific antibody to form insoluble antigen-antibody 
complexes. 
 
GGT 
GGT reagent is used to measure the γ-glutamyl transferase activity by an enzymatic rate method.1 In 
the reaction, the γ-glutamyl transferase catalyzes the transfer of a gamma-glutamyl group from the 
colorless substrate, γ-glutamyl-p-nitroaniline, to the acceptor, glycylglycine with production of the 
colored product, p-nitroaniline. 
 
Glucose 
GLU reagent is used to measure the glucose concentration by a timed endpoint method.1 In the 
reaction, hexokinase (HK) catalyses the transfer of a phosphate group from adenosine triphosphate 
(ATP) to glucose to form adenosine 
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diphosphate (ADP) and glucose-6-phosphate. The glucose-6-phosphate is then oxidized to 6-
phosphogluconate with the concomitant reduction of β-nicotinamide adenine dinucleotide (NAD) to 
reduced β-nicotinamide adenine dinucleotide (NADH) by the catalytic action of glucose-6-phosphate 
dehydrogenase (G6PDPH). 
 
HDL 
LDL and VLDL in human serum or plasma are precipitated by dextran sulfate (50 000 Mw) and 
magnesium in the separating reagent. The LDL and VLDL portions are then removed by 
centrifugation. The cholesterol in the HDL fraction which remains in the supernatant is assayed with 
an enzymatic cholesterol reagent HDLC reagent is used to measure the cholesterol concentration by 
a timed-endpoint method. In the reaction, the cholesterol esterase (CE) hydrolyzes cholesterol esters 
to free cholesterol and fatty acids. The free cholesterol is oxidized to cholestene-3-one and hydrogen 
peroxide by cholesterol oxidase (CO). Peroxidase (HPO) catalyzes the reaction of hydrogen peroxide 
with 4-aminoantipyrine (4-AAP) and phenol to produce a colored quinoneimine product. 
 
HbA1c 
The SYNCHRON® System(s) utilizes two unique cartridges, Hb and A1c, to determine hemoglobin 
A1c concentration as a percentage of total hemoglobin. 
Hemoglobin reagent is used to measure total hemoglobin concentration by a colorimetric method. 
The SYNCHRON® System(s) automatically proportions the appropriate sample and reagent volumes 
into the cuvette. The ratio usedis one part sample to 8.6 parts reagent. The System monitors the 
change in absorbance at 410 nanometers. This change in absorbance is directly proportional to the 
concentration of total hemoglobin in the sample and is used by 
the System to calculate and express total hemoglobin concentration. 
 
Triglycerides  
GPO reagent is used to measure the triglycerides concentration by a timed endpoint 
method.Triglycerides in the sample are hydrolyzed to glycerol and free fatty acids by the action of 
lipase. A sequence of three coupled enzymatic steps using glycerol kinase (GK), glycerophosphate 
oxidase (GPO), and horseradish peroxidase 
(HPO) causes the oxidative coupling of 3,5-dichloro-2-hydroxybenzenesulfonic acid (DHBS) with 4-
aminoantipyrine to form a red quinoneimine dye. 
 
 
b) Conducted by the Addenbrookes, Cambridge University Hospital, Biochemistry 
Laboratories 
 
IL-6 and TNFα 
The cytokines (IL-6 and TNFα) were measured using an ultrasensitive 7-plex electrochemical 
luminesecence immunoassay from MesoScale Discovery, MD, USA. The assay was run according to 
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the manufacturer‟s instructions (MesoScale Discovery 2013, Human Inflammatory 7-plex ultra-
sensative kit package insert, (online), Available, 
http://www.mesoscale.com/CatalogSystemWeb/Documents/Human_ProInflam_7-plex_US.pdf, (July 
2013). 
 
Adiponectin 
Adiponectin was measured using a two-site microtitre plate-based DELFIA assay. The microtitre plate 
is coated with a monoclonal anti-adiponectin capture antibody. Diluted sample is added to the plate. 
After incubation and washing a biotinylated polyclonal anti-adiponectin detection antibody is added to 
the plate. After incubation and washing Europium labelled Streptavidin is added to the plate. After 
another wash fluorescence is generated in the wells by the addition of Enhancement Solution. The 
assay uses 20µl of diluted sample per well (1 in 50 dilution). 
 
Insulin 
For insulin measures, samples were assayed in singleton on a 1235 AutoDELFIA automatic 
immunoassay analyser using a two-step time resolved fluorometric assay (Kit No. B080-101). All 
reagents, standards and consumables are those recommended and supplied by the manufacturer. 
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Appendix 5 
Low GI traffic light list example (breads) 
Healthy Low GI List 
 High =  more than 70 
 Medium = 56-69 
 Low = 55 or less 
 Try to eat LOW GI foods more often and avoid HIGH 
GI foods! 
  BREAD  
FOOD GI value 
Garlic bread High 
Fruit loaf (Tesco Value) 90 
Multigrain bread (Sainsbury's) 80 
Hovis, wholemeal 68 
Hovis, white 73 
Baguette/ French stick        77 
Bagel, white 72 
White bread, sliced 71 
Bread roll, white 71 
Wholemeal bread (Sainsbury's) 71 
Fruit and cinnamon bread (Tesco Finest) 71 
Crusty white bread 70 
Bread roll, whole wheat 70 
Pita bread, white 68-Meduim 
Wholemeal, stoneground (whole wheat) bread 66 
chapatti 63 
Malt loaf, organic (Tesco) 62 
Oatmeal batch bread (Tesco) 62 
Multi-grain batch bread (Tesco) 62 
Fruit loaf, sliced (Tesco) 57 
Pita bread, wholemeal 56 
Multi-seed bread 56 
Crusty malted wheat bred (Tesco Finest) 52-Low 
Corn Tortilla wrap 52 
100 % whole grain bread  (must be 100%!) 51 
Pumpernickel bread 50 
Sourdough rye bread 48 
Burgen® Mixed grain bread 44 
Burgen® Soy and linseed bread 36 
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Appendix 6 
Unpresented data from chapter 8: Study 5 
MANCOVA: Test of between subject effects met risk  
 
source 
 
Type III Sum of Squares df 
Mean 
Square F Sig. 
Period2 * intervention 
 
 model 1 
MeanSys 19.592 2 9.796 .144 .867 
MeanDias 54.697 2 27.348 .661 .523 
BG .022 2 .011 .063 .939 
Crisk_score 1.883 2 .941 .221 .803 
TG .211 2 .106 .138 .871 
WC .017 2 .008 .000 1.000 
HDL .021 2 .011 .345 .711 
Period2 * intervention 
 
model 2 
MeanSys 35.763 2 17.881 .307 .738 
MeanDias 23.994 2 11.997 .347 .710 
BG .097 2 .048 .265 .769 
Crisk_score .109 2 .055 .020 .980 
TG .089 2 .044 .062 .940 
WC 9.912 2 4.956 .269 .766 
HDL .011 2 .006 .192 .826 
Period2 * intervention 
 
 
 model 3 
MeanSys 44.902 2 22.451 .372 .693 
MeanDias 7.940 2 3.970 .113 .894 
BG .000 2 .000 .001 .999 
Crisk_score .040 2 .020 .007 .993 
TG .167 2 .083 .151 .861 
WC 17.720 2 8.860 .542 .588 
HDL .023 2 .012 .411 .668 
Period2 * intervention MeanSys 21.569 2 10.784 .174 .841 
 
MeanDias 6.007 2 3.003 .083 .921 
Model 4 BG .015 2 .008 .051 .950 
 
Crisk_score .248 2 .124 .046 .955 
 
TG .010 2 .005 .010 .990 
 
WC 24.315 2 12.157 .736 .490 
 
HDL .035 2 .018 .608 .553 
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Parameter estimates mets risk factors 
B Std. Error t Sig. 95% Confidence Interval 
  
95% Confidence Interval 
    Lower Bound Upper Bound Sig. Lower Bound Upper Bound 
WC model 1 2v1 -0.07 3.51 -0.02 0.985 -7.21 7.08 
  
3v1 0.03 3.85 0.01 0.993 -7.80 7.87 
 
model 2 2v1 2.03 3.31 0.61 0.546 -4.78 8.83 
  
3v1 2.45 3.75 0.65 0.519 -5.25 10.15 
 
model 3 2v1 2.92 3.18 0.92 0.368 -3.64 9.47 
  
3v1 3.30 3.68 0.90 0.379 -4.30 10.91 
 
model 4 2v1 3.117 3.203 .973 .341 -3.509 9.742 
  
3v1 
4.383 3.911 1.121 .274 -3.707 12.473 
TG model 1 2v1 -0.09 0.64 -0.15 0.885 -1.39 1.21 
  
3v1 0.27 0.70 0.38 0.704 -1.16 1.69 
 
model 2 2v1 0.20 0.65 0.31 0.757 -1.14 1.54 
  
3v1 0.22 0.74 0.30 0.769 -1.30 1.73 
 
model 3 2v1 -0.14 0.58 -0.24 0.812 -1.35 1.06 
  
3v1 -0.37 0.68 -0.55 0.589 -1.77 1.03 
 
model 4 2v1 -.076 .568 -.133 .895 -1.251 1.100 
  
3v1 
-.021 .694 -.030 .976 -1.456 1.414 
HDL model 1 2v1 0.04 0.13 0.34 0.734 -0.22 0.31 
  
3v1 -0.07 0.14 -0.52 0.608 -0.36 0.21 
 
model 2 2v1 0.05 0.13 0.36 0.722 -0.22 0.32 
  
3v1 -0.04 0.15 -0.26 0.796 -0.35 0.27 
 
model 3 2v1 0.01 0.13 0.06 0.950 -0.27 0.28 
  
3v1 -0.11 0.15 -0.74 0.466 -0.43 0.20 
 
model 4 2v1 .001 .134 .006 .995 -.276 .278 
  
3v1 
-.154 .164 -.944 .355 -.493 .184 
SBP model 1 2v1 0.28 6.03 0.05 0.963 -12.00 12.56 
  
3v1 3.28 6.60 0.50 0.623 -10.17 16.74 
 
model 2 2v1 1.87 5.89 0.32 0.753 -10.24 13.97 
  
3v1 5.19 6.66 0.78 0.443 -8.50 18.89 
 
model 3 2v1 1.96 6.11 0.32 0.752 -10.65 14.56 
  
3v1 6.03 7.08 0.85 0.403 -8.59 20.65 
 
model 4 2v1 1.664 6.201 .268 .791 -11.163 14.491 
  
3v1 
4.460 7.571 .589 .562 -11.201 20.121 
DBP model 1 2v1 -4.03 4.70 -0.86 0.398 -13.60 5.54 
  
3v1 -5.52 5.15 -1.07 0.292 -16.01 4.97 
 
model 2 2v1 -3.12 4.53 -0.69 0.497 -12.44 6.20 
  
3v1 -3.84 5.13 -0.75 0.461 -14.38 6.70 
 
model 3 2v1 -2.10 4.67 -0.45 0.656 -11.74 7.53 
  
3v1 -1.95 5.41 -0.36 0.722 -13.12 9.22 
 
model 4 2v1 -1.917 4.750 -.404 .690 -11.744 7.910 
  
3v1 
-.947 5.800 -.163 .872 -12.945 11.050 
BG model 1 2v1 0.02 0.30 0.06 0.953 -0.60 0.63 
  
3v1 0.11 0.33 0.34 0.736 -0.56 0.79 
 
model 2 2v1 0.12 0.33 0.37 0.716 -0.56 0.80 
  
3v1 0.27 0.37 0.73 0.473 -0.49 1.04 
 
model 3 2v1 0.00 0.31 0.01 0.994 -0.63 0.63 
  
3v1 0.01 0.35 0.04 0.967 -0.72 0.75 
 
model 4 2v1 -.021 .305 -.070 .945 -.653 .610 
  
3v1 
-.113 .373 -.304 .764 -.884 .657 
Crisk model 1 2v1 -1.00 1.51 -0.66 0.513 -4.07 2.07 
  
3v1 -0.60 1.65 -0.36 0.719 -3.96 2.76 
 
model 2 2v1 -0.24 1.28 -0.19 0.851 -2.87 2.38 
  
3v1 -0.06 1.44 -0.04 0.968 -3.03 2.91 
 
model 3 2v1 -0.16 1.29 -0.12 0.905 -2.82 2.51 
  
3v1 -0.12 1.50 -0.08 0.937 -3.22 2.98 
 
model 4 2v1 -.065 1.299 -.050 .961 -2.752 2.623 
  
3v1 
.366 1.586 .231 .820 -2.916 3.647 
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Test of between subject effects inflammation and cytokines 
Source 
Dependent 
Variable 
Type III 
Sum of 
Squares df 
Mean 
Square F Sig. 
Period2 * intervention 
 
Model 1 
ADIPONECTIN 1.91 2.00 0.96 0.16 0.853 
HsCRP 1.96 2.00 0.98 0.24 0.784 
TNF 1.99 2.00 1.00 0.04 0.957 
ILsix 0.37 2.00 0.19 0.01 0.989 
BNP 13.90 2.00 6.95 0.19 0.831 
Period2 * intervention 
 
 Model 2 
ADIPONECTIN 6.07 2.00 3.03 0.59 0.565 
HsCRP 4.46 2.00 2.23 0.55 0.583 
TNF 4.36 2.00 2.18 0.17 0.848 
ILsix 9.43 2.00 4.71 0.26 0.771 
BNP 75.06 2.00 37.53 1.34 0.283 
Period2 * intervention 
 
Model 3 
ADIPONECTIN 2.66 2.00 1.33 0.29 0.749 
HsCRP 4.03 2.00 2.01 0.77 0.478 
TNF 2.65 2.00 1.32 0.10 0.907 
ILsix 20.27 2.00 10.13 0.57 0.577 
BNP 58.18 2.00 29.09 1.08 0.357 
Period2 * intervention 
 
Model 4 
ADIPONECTIN 1.55 2.00 0.77 0.16 0.850 
HsCRP 1.18 2.00 0.59 0.25 0.782 
TNF 0.05 2.00 0.02 0.00 0.998 
ILsix 33.56 2.00 16.78 1.06 0.367 
BNP 66.85 2.00 33.42 1.21 0.321 
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Parameter estimates inflammation and cytokines 
   
B Std. Error t Sig. 
95% Confidence Interval 
   
Lower Bound Upper Bound 
ADIPONECTIN Model 1 2v1 0.42 1.89 0.22 0.826 -3.45 4.29 
  
3v1 -0.72 2.01 -0.36 0.722 -4.83 3.39 
 
Model 2 2v1 -0.80 1.88 -0.42 0.676 -4.71 3.11 
  
3v1 -2.22 2.08 -1.07 0.296 -6.53 2.08 
 
Model 3 2v1 0.19 1.84 0.10 0.921 -3.65 4.02 
  
3v1 -1.17 2.05 -0.57 0.576 -5.44 3.11 
 
Model 4 2v1 0.20 1.87 0.10 0.918 -3.73 4.12 
  
3v1 -0.90 2.17 -0.41 0.684 -5.43 3.64 
HsCRP Model 1 2v1 -0.86 1.55 -0.56 0.583 -4.02 2.31 
  
3v1 0.20 1.64 0.12 0.903 -3.16 3.57 
 
Model 2 2v1 -1.56 1.66 -0.94 0.358 -5.01 1.89 
  
3v1 -0.16 1.83 -0.09 0.930 -3.96 3.63 
 
Model 3 2v1 -0.16 1.40 -0.12 0.909 -3.08 2.76 
  
3v1 1.48 1.56 0.95 0.353 -1.77 4.74 
 
Model 4 2v1 -0.19 1.33 -0.14 0.890 -2.97 2.60 
  
3v1 0.77 1.54 0.50 0.622 -2.45 3.99 
TNF Model 1 2v1 -0.54 3.65 -0.15 0.883 -8.02 6.93 
  
3v1 0.62 3.88 0.16 0.873 -7.32 8.57 
 
Model 2 2v1 0.09 3.00 0.03 0.976 -6.14 6.32 
  
3v1 1.67 3.31 0.50 0.619 -5.19 8.53 
 
Model 3 2v1 0.06 3.16 0.02 0.985 -6.54 6.66 
  
3v1 1.33 3.53 0.38 0.711 -6.04 8.69 
 
Model 4 2v1 0.02 3.13 0.01 0.995 -6.53 6.57 
  
3v1 0.20 3.62 0.05 0.958 -7.39 7.78 
ILsix Model 1 2v1 -0.44 3.21 -0.14 0.891 -7.03 6.14 
  
3v1 -0.37 3.42 -0.11 0.914 -7.37 6.63 
 
Model 2 2v1 -2.48 3.51 -0.71 0.487 -9.75 4.79 
  
3v1 -1.98 3.86 -0.51 0.614 -9.99 6.03 
 
Model 3 2v1 -3.59 3.65 -0.98 0.337 -11.21 4.02 
  
3v1 -3.62 4.07 -0.89 0.385 -12.12 4.88 
 
Model 4 2v1 -3.67 3.43 -1.07 0.299 -10.85 3.52 
  
3v1 -5.61 3.97 -1.41 0.174 -13.92 2.71 
BNP Model 1 2v1 1.81 4.71 0.38 0.703 -7.83 11.45 
  
3v1 3.00 5.00 0.60 0.554 -7.25 13.25 
 
Model 2 2v1 4.70 4.39 1.07 0.296 -4.41 13.80 
  
3v1 7.81 4.84 1.61 0.121 -2.22 17.84 
 
Model 3 2v1 4.70 4.47 1.05 0.305 -4.62 14.02 
  
3v1 7.20 4.99 1.44 0.164 -3.20 17.60 
 
Model 4 2v1 4.73 4.54 1.04 0.310 -4.77 14.23 
  
3v1 8.06 5.25 1.54 0.141 -2.93 19.05 
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Between subject effects: interaction of time period*intervention group for glucose control and 
liver function markers 
Source Dependent Variable Type III Sum of Squares df Mean Square F Sig 
Period * intervention  
 
 
Model 1 
HbA1c .062 2 .031 .896 .432 
insulin 1540.822 2 770.411 .341 .717 
HOMAIR 1.526 2 .763 .306 .741 
ALP 154.883 2 77.441 .934 .418 
ALT 122.673 2 61.336 1.572 .245 
GammaGT .508 2 .254 .031 .970 
Albumin 17.031 2 8.516 .344 .715 
Bilirubin 13.165 2 6.582 .649 .539 
Period * intervention 
 
 
Model 2 
HbA1c .048 2 .024 .518 .614 
insulin 4183.554 2 2091.777 2.120 .182 
HOMAIR 4.532 2 2.266 2.342 .158 
ALP 21.555 2 10.777 .144 .868 
ALT 104.807 2 52.403 1.281 .329 
GammaGT 1.833 2 .917 .152 .862 
Albumin 23.291 2 11.646 .539 .603 
Bilirubin 13.041 2 6.520 .892 .447 
Period * intervention 
 
 
Model 3 
HbA1c .059 2 .029 .541 .608 
insulin 8670.115 2 4335.058 24.275 .001 
HOMAIR 6.502 2 3.251 8.641 .017 
ALP 23.048 2 11.524 .157 .858 
ALT 62.449 2 31.224 .975 .430 
GammaGT 1.937 2 .969 .175 .843 
Albumin 6.778 2 3.389 .127 .883 
Bilirubin 26.081 2 13.041 1.962 .221 
Period * intervention 
 
 
Model 4 
HbA1c .036 2 .018 1.188 .378 
insulin 8932.946 2 4466.473 31.317 .001 
HOMAIR 6.785 2 3.392 10.052 .018 
ALP 26.978 2 13.489 .159 .857 
ALT 61.480 2 30.740 .858 .478 
GammaGT 2.024 2 1.012 .169 .849 
Albumin 5.173 2 2.587 .153 .862 
Bilirubin 29.412 2 14.706 3.715 .103 
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Parameter estimates glucose control and liver function 
   
B Std. Error Sig. 95% Confidence Interval 
  
Time point 
comparison 
   
Lower Bound Upper Bound 
HbA1c Model 1 2v1 -0.13 0.18 0.459 -0.51 0.25 
  
3v1 -0.43 0.33 0.214 -1.15 0.28 
 
Model 2 2v1 -0.16 0.23 0.499 -0.70 0.37 
  
3v1 -0.48 0.50 0.368 -1.62 0.67 
 
Model 3 2v1 -0.15 0.25 0.577 -0.76 0.47 
  
3v1 -0.83 0.84 0.363 -2.89 1.23 
 
Model 4 2v1 -0.14 0.13 0.353 -0.48 0.21 
  
3v1 -0.62 0.45 0.224 -1.77 0.53 
ALP Model 1 2v1 -4.31 8.58 0.624 -22.85 14.24 
  
3v1 -22.16 16.22 0.195 -57.20 12.88 
 
Model 2 2v1 -0.35 9.26 0.971 -21.71 21.01 
  
3v1 -10.11 19.97 0.626 -56.16 35.93 
 
Model 3 2v1 0.91 9.23 0.925 -21.68 23.50 
  
3v1 -15.60 30.92 0.632 -91.26 60.07 
 
Model 4 2v1 0.81 9.93 0.938 -24.72 26.35 
  
3v1 -17.22 33.49 0.629 -103.30 68.86 
ALT Model 1 2v1 -9.35 5.89 0.136 -22.07 3.36 
  
3v1 1.33 11.12 0.906 -22.69 25.36 
 
Model 2 2v1 -9.15 6.86 0.219 -24.97 6.66 
  
3v1 4.08 14.78 0.790 -30.01 38.17 
 
Model 3 2v1 -7.94 6.10 0.241 -22.86 6.98 
  
3v1 2.75 20.43 0.897 -47.23 52.73 
 
Model 4 2v1 -8.02 6.45 0.269 -24.61 8.56 
  
3v1 1.26 21.75 0.956 -54.64 57.16 
GammaGT Model 1 2v1 0.23 2.70 0.934 -5.61 6.07 
  
3v1 -0.94 5.11 0.857 -11.97 10.10 
 
Model 2 2v1 -1.07 2.64 0.696 -7.15 5.01 
  
3v1 -2.86 5.68 0.628 -15.97 10.24 
 
Model 3 2v1 -1.44 2.53 0.590 -7.64 4.75 
  
3v1 0.02 8.48 0.998 -20.74 20.77 
 
Model 4 2v1 -1.40 2.64 0.618 -8.18 5.38 
  
3v1 0.76 8.89 0.935 -22.08 23.60 
Albumin Model 1 2v1 -3.89 4.69 0.422 -14.01 6.24 
  
3v1 -2.59 8.85 0.775 -21.72 16.54 
 
Model 2 2v1 -3.01 4.98 0.562 -14.50 8.48 
  
3v1 -10.91 10.74 0.340 -35.68 13.86 
 
Model 3 2v1 -2.66 5.57 0.650 -16.28 10.97 
  
3v1 -5.31 18.65 0.785 -50.94 40.31 
 
Model 4 2v1 -2.45 4.44 0.605 -13.85 8.96 
  
3v1 -1.73 14.96 0.912 -40.18 36.71 
Bilirubin Model 1 2v1 -2.89 3.00 0.353 -9.38 3.59 
  
3v1 -5.27 5.67 0.369 -17.52 6.98 
 
Model 2 2v1 -3.37 2.90 0.279 -10.05 3.32 
  
3v1 0.86 6.25 0.894 -13.55 15.27 
 
Model 3 2v1 -3.58 2.78 0.245 -10.37 3.22 
  
3v1 10.24 9.30 0.313 -12.53 33.00 
 
Model 4 2v1 -3.47 2.14 0.167 -8.98 2.04 
  
3v1 12.09 7.23 0.155 -6.49 30.67 
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Appendix 7   
Unpresented data from chapter 5: Study 3 
Mean (±SD) cardiometabolic risk factor values across quantiles of GI and GL for males 
 
GI GL RES 
 
1 
(54.62) 
2  
(62.82) 
F P 
1  
(100.07) 
2  
(120.19) 
F P 
         
HDL 1.08 (0.26) 1.20 (0.31) 0.22 .639 1.08 (0.26) 1.20 (0.31) 2.22 .145 
   
1.38 .248 
  
1.69 .202 
TG 0.73 (0.37) 0.91 (0.49) 0.03 .868 0.77 (0.39) 0.87 (0.48) 0.78 .383 
   
1.89 .177 
  
0.94 .340 
WC 76.93 (9.08) 81.88 (14.33) 3.05 .089 80.10 (15.16) 78.97 (9.07) 0.01 .956 
         
BG 4.94 (0.55) 4.83 (0.43) 0.54 .468 4.94 (0.57) 4.83 (0.41) 0.24 .626 
   
0.38 .542 
  
0.24 .631 
SBP 118.11 (9.17) 117.85 (12.89) 1.86 .181 119.32 (10.68) 116.75 (11.64) 1.16 .289 
   
0.04 .850 
  
0.69 .410 
DBP 70.73 (8.97) 70.27 (7.76) 1.67 .202 70.73 (8.78) 70.27 (7.95) 0.01 .937 
   
0.12 .731 
  
0.01 .960 
Crisk -0.80 (2.43) 0.19 (3.50) 0.24 .631 -0.34 (3.76) -0.23 (2.86) 0.03 .865 
   
1.75 .194 
  
0.15 .698 
 
 
 Mean (±SD) cardiometabolic risk factor values across quantiles of GI and GL for females 
 
GI GL RES 
 
1 
(55.58) 
2  
(62.39) 
F P 
1  
(96.37) 
2  
(88.55) 
F P 
         
HDL 1.08 (0.24) 1.21 (0.44) 0.07 .793 1.15 (0.47) 1.14 (0.24) 0.25 .624 
   
0.03 .858 
  
0.23 .636 
TG 1.36 (1.41) 0.82 (0.22) 1.04 .321 1.02 (0.49) 1.13 (1.30) 0.26 .619 
   
0.84 .372 
    
WC - - 
  
- - 
  
 
83.39 (14.85) 85.97 (13.66) 0.27 .610 81.55 (13.36) 87.27 (14.48) 0.42 .526 
BG 4.87 (0.67) 4.57 (0.35) 0.77 .393 4.63 (0.48) 4.79 (0.59) 0.93 .347 
   
0.71 .410 
  
0.97 .336 
SBP 111.54 (12.24) 109.50 (9.39) 0.77 .392 109.17 (9.37) 111.53 (11.86) 0.22 .644 
   
0.43 .522 
  
0.20 .662 
DBP 75.29 (8.43) 72.64 (7.10) 1.01 .329 73.53 (7.99) 74.23 (7.80) 0.11 .749 
   
0.67 .424 
  
0.10 .751 
Crisk  1.98 (4.05) 0.33 (2.55) 1.62 .219 0.95 (3.93) 1.26 (3.04) 0.02 .882 
   
0.54 .471 
  
0.02 .891 
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Mean (±SD) cardiometabolic risk factor values across quantiles of GI and GL for normal weight 
participants. 
 
GI GL RES 
 
1 
(54.20) 
2  
(61.18) 
F P 
1  
(68.58) 
2  
(94.38) 
F P 
         
HDL 1.19 (0.24) 1.21 (0.42) 0.70 .409 1.09 (0.26) 1.30 (0.38) 2.49 .124 
   
1.14 .294 
  
2.24 .114 
TG 0.64 (0.17) 0.82 (0.33) 2.18 .149 0.69 (0.27) 0.78 (0.29) 0.93 .342 
   
2.69 .110 
  
1.05 .312 
WC 73.20 (7.42) 74.18 (6.14) 
  
73.67 (5.75) 73.75 (7.63) 
  
   
0.17 .684 
  
0.83 .369 
BG 4.96 (0.57) 4.66 (0.40) 1.47 .234 4.83 (0.58) 4.78 (0.44) 0.33 .572 
   
3.00 .092 
  
0.14 .713 
SBP 115.10 (9.34) 113.39 (12.07) 1.01 .322 115.50 (9.85) 113.02 (12.64) 0.00 .954 
   
0.25 .618 
  
0.01 .946 
DBP 70.20 (9.34) 68.72 (7.36) 0.38 .540 69.28 (7.73) 69.57 (8.96) 0.04 .835 
   
0.34 .567 
  
0.05 .828 
Crisk -1.44 (1.84) -1.25 (2.41) 0.04 .850 -1.40 (2.06) -1.28 (2.24) 0.69 .412 
   
0.39 .538 
  
0.88 .354 
 
 
Mean (±SD) cardiometabolic risk factor values across quantiles of GI and GL for overweight 
participants. 
 
GI GL RES 
 
1 
(56) 
2  
(62.90) 
F P 
1  
(91.62) 
2  
(93.40) 
F P 
         
HDL 0.97 (0.20) 1.13 (0.27) 2.00 .173 1.00 (0.25) 1.10 (0.25) 0.12 .730 
   
2.21 .153 
  
0.24 .630 
TG 1.41 (1.41) 1.03 (0.52) 1.72 .205 1.08 (0.50) 1.30 (1.31) 0.03 .875 
   
1.83 .191 
  
0.04 .846 
WC 92.11 (8.02) 94.02 (14.06) 0.01 .927 93.02 (15.70) 93.28 (7.33) 0.02 .878 
         
BG 4.95 (0.59) 4.76 (0.47) 0.87 .362 4.88 (0.49) 4.82 (0.57) 0.21 .655 
   
1.04 .321 
  
0.03 .859 
SBP 120.96 (7.88) 113.28 (8.06) 3.23 .088 118.85 (12.34) 115.00 (11.41) 0.51 .484 
   
3.43 .079 
  
0.00 .978 
DBP 75.35 (7.88) 75.25 (5.92) 0.06 .814 76.00 (8.19) 74.72 (5.50) 0.01 .945 
   
0.17 .686 
  
0.38 .546 
Crisk 3.15 (3.58) 2.21 (2.82) 1.57 .225 2.80 (3.83) 2.49 (2.61) 1.57 .225 
   
1.80 .195 
  
1.80 .195 
 
 
 
